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Background: Patient self-monitoring with telehealth technologies has not 
demonstrated savings to secondary care budgets but there remains optimism 
regarding potential benefit for people with long-term conditions. 
Aim: To critically assess whether remote vital-sign telemonitoring is perceived 
to have derived benefits for patients.  
Design: Mixed methods research was adopted with questionnaire distribution 
to service users and their informal carers and with semi-structured one-to-one 
interviews conducted with clinical practitioners and senior managers. 
Sample: Questionnaires were distributed to 274 patients living with long-term 
conditions who were using telemonitoring provided by one integrated health 
and social care organisation in Northern Ireland.   Data from 97 patients and 
49 carers were analysed. A total of 16 clinical practitioners experienced with 
the use of remote vital-sign telemonitoring in their therapeutic regimens, 
across a range of professions, were interviewed along with eight senior 
managers or commissioners.  
Results: The great majority of patients (90.7%) were supportive of technology 
and agreed that the remote monitoring system assisted me in managing my 
health on a day-to-day basis.  They reported that telehealth technology gave 
them control for self-management, better understanding, timely access to 
support, peace of mind and empowerment. These observations were echoed 
by clinicians who were equally supportive and saw greater future use of 
innovative technologies in the delivery of health and care. They did not view 
remote monitoring as any diminution of care.   
Conclusion: Whilst not necessarily saving money, remote vital-sign 
telemonitoring enabled collaboration between patients, carers and the 
clinicians where patients were empowered to actively self-manage their long-
term conditions. Patients accepted technology and support increased use as 
part of their care regime in the future. Healthcare systems should become 
open to the exploitation of new technologies in order to realise the real patient 
benefit.   
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LIST OF ABBREVIATIONS AND ACRONYMS 
 
Acronym or Term Meaning 
BDO BDO Stoy Hayward is an accountancy and 
business advisory firm. 
Carers Family and/ or friends who assist the patient 
in the use of RVT. 
CHF Congestive Heart Failure (also sometimes 
referred to as Chronic Heart Failure). 
COPD Chronic Obstructive Pulmonary Disorder. 
ECCH  European Centre for Connected Health 
[later renamed Centre for Connected Health 
(CCH)] a department within the Public 
Health Agency (PHA). 
EU European Union. 
DAWN 4S DAWN Clinical Software for the warfarin 
dosing of patients from their INR result. 
DM Diabetes Mellitus. 
DoH Department of Health. 
HPSS Health and Personal Social Services. 
HSCB  Health and Social Care Board. 
Hub Means the item of patient equipment or 
client equipment (as relevant) to which 
monitoring data is sent by peripherals and 
which transmits the monitoring data to the 
central solution.  
INR International Normalised Ratio – for 






























Means a day during which the patient 
Equipment, installed/delivered at the 
request of the practitioner.   
NICE National Institute for Health & Care 
Excellence. 
Patient and Client 
Council (PCC) 
Is a Northern Ireland Health and Social Care 
organisation, publicly funded to assist the 
public to make a complaint, take the public’s 
views and communicate/ act upon them, 
promote advice and information and help 
the public get involved. 
Patients and service 
users 
People who are prescribed and utilise the 
RVT services and generally have long term 
conditions. 
Peripheral device Means an item of patient equipment or client 
equipment (as relevant) other than the hub. 
Practitioner Healthcare/ clinical professional, doctor, 
nurse, allied health professional or 
pharmacist, of a senior grade, Band 6 or 
above, with experience of utilising RVT. 
QALY Quality-adjusted life year: a measure of 
disease burden.  
RATS RATS INR Monitoring Software for the 
warfarin dosing of patients from their INR 
result. RAT-i Regulating Anticoagulation 
Treatment. 
Researcher Julie-Ann Walkden. 
RTM Remote Telemonitoring. 
RTNI Remote Telemonitoring Northern Ireland. A 
region wide project to commission RVT 
 


























which was awarded to a consortium known 
as TF3. 
RVT Remote vital-sign telemonitoring. 
Self-Management Means a person-centred approach in which 
the individual is empowered and has 
ownership over the management of their life 
and conditions.  The role of health and 
social care professionals, services and 
treatment are to support the person journey 
towards living well in the presence of 
absence of symptoms. 
Senior Manager Northern Ireland Health and Social Care 
system Senior Officer/ Manager/ Leader/ 
Executive with responsibility for 
commissioning, policy or delivery of RVT 




Means the remote telemonitoring and 
delivery of support services through 
information and communication technology, 
using vital signs monitoring and /or 
interpreting changes to a patient’s health. 
TF3 A region wide RVT service for multiple long-
term conditions offering a track and trend or 
nurse triage service with peripheral devices 
connecting to a ‘home-hub’ which in turn 
transfers readings to a central control 
service. The acronym combined the names 
of the three commercial partner who formed 
a consortium to bid for and deliver the 





























The study or the 
research or thesis 
Patient empowerment through use of 
remote vital sign telemonitoring. 
Track and trend Means a tabular and graphical report of 
individual patient monitoring data against 
monitoring parameters which is accessed 
by the practitioner without the patient 
receiving a triage nurse intervention or 
service. 
Triage or nurse triage 
service 
Means the service that assesses the 
patients’ alert, validates the vital signs when 
an alert has been raised, reviews monitoring 
data, obtains more information from the 
patient by asking questions designed to 
clarify or elicit more detail on clinical issues 
and deciding the action to be taken as a 
consequence including escalation to the 
local response team. 
Trust or Trusts or 
SET 
Health and Social Care Trusts are providers 
of clinical services both within the 
community and hospital environments. In 
this study the Trust being examined is South 
Eastern Health and Social Care Trust and is 
referred to as (SET). 
Unacceptable 
reading 
Where an RVT reading is either outside of 
the parameters set by the practitioner or 
where there is a fault with equipment and 
reading is spurious.   
U-Tell A Trust based RVT service for patients who 
receive oral anticoagulation through the 
administration of warfarin and who report, 
via the internet, their INR result to a central 
 


























database accessed directly by Trust nurses 
in the outpatients department. 
Vital Signs Means physical signs such as heartbeat, 
breathing rate, temperature and near 
patient test results that assess a Patient’s 
condition. 
Virtual Ward Means a domiciliary based community 
nursing service that delivers high intensity 
nursing care as an alternative to acute 
based in-patient care. The treatments given 
are more intense and complex than 
standard community or district nursing 
services. 
Warfarinised A patient who is taking Warfarin as an 
anticoagulation therapy. (Trade names for 
Warfarin in USA are Coumadin and 
Jantoven, in Australia Marevan and in 
Canada Apro-warfarin). 
WHO World Health Organisation. 
WSD Whole System Demonstrator – a 
programme within the UK to test remote 
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1 INTRODUCTION 
1.1 Background of the problem 
 
Chronic illness costs up to 7% of gross domestic product (Nolte and McKee, 
2008) and, chronic illnesses contribute to 63% of deaths worldwide according 
to the World Health Organisation (WHO) (2013), with 15 million people aged 
between 30 and 70 years dying each year due to non-communicable disease 
(WHO, 2017).  In 2008, there was optimism that telehealth care could 
economically help address the care needs of people with chronic diseases 
and the local Health and Social Care Board Northern Ireland (HSCB) 
commissioned remote vital sign telemonitoring (RVT) technology through 16 
pilot projects aiming to reduce risk of hospital admission for patients with 
chronic diseases, as reported by BDO Stoy Hayward, (BDO, 2009). 
This optimism currently prevails for conditions such as paediatric asthma 
(Zimlich, 2019) where patient, carer and nurse connectivity promoted 
medicines adherence. This was dispelled as not having an economic benefit 
by Henderson et al. (2013) with a review of the UK’s Whole System 
Demonstrator telehealth project.  Within the Northern Ireland context, the 
development of remote vital-sign telemonitoring enabled patients to digitally 
report their own vital sign readings to their health care practitioners. In the 
host service provider, South Eastern Health and Social Care Trust (SET), an 
initial project was developed specifically for patients taking warfarin for 
anticoagulation. Before the project these patients were normally monitored by 
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specialist anticoagulation nurses at the local Haematology Outpatient 
Department, where a venous sample of blood would be taken for laboratory-
based testing. Instead, the new system (known as U-Tell) enabled self-testing 
of capillary blood and the transmission of the International Normalised Ratio 
(INR) reading to the healthcare system. Patients connected via computer, or 
later using a smartphone, to an internet site, uploaded their readings and 
responses to questions (vital signs) and in so doing sent their critical 
information to the haematology nurses (El-Agnaf et al. 2014).  
Also, between April 2011 and March 2018, a region wide Remote 
Telemonitoring Service was made available to clinical practitioners and 
patients within SET (PHA, 2011). This service was mainly utilised by specialist 
nurses and allied health professionals (AHP) for the management of patients 
with Chronic Diseases such as diabetes, Chronic Obstructive Pulmonary 
Disorder (COPD), post-stroke hypertension and chronic heart failure. This 
service (known as TF3) was a remote monitoring system where peripheral 
devices were used by patients to capture relevant vital signs including blood 
pressure, three-lead electrocardiogram (ECG), estimate of arterial oxygen 
saturation (SPO2), temperature, weight and near patient testing readings, 
typically for blood glucose levels. A home hub would transfer the data, from 
the peripheral devices, to a central Triage Nursing service for monitoring. 
These types of systems are referred to in the literature by many terms 
including telemonitoring, telemedicine, connected health and within the UK’s 
health service as telehealth care (NHS choices. 2013). Within this thesis these 
systems will be referred to as Remote Vital-Sign Telemonitoring (RVT) as it is 
descriptive of the service offered. The strategic context, (detailed in this 
chapter and Appendix 1), will detail the service history, contract and 
operational factors and procedures in more detail.    
A public funded independent review of the TF3 service did not determine that 
there was an economic benefit for the region when key performance indicators 
such as reduced length of stay or reduced admissions were tested, (McElnay 
et al. 2016). Consequently, the Centre for Connected Health (CCH), 
embedded within the Public Health Agency, extended the supplier’s contract 
for 12 months from 1 April 2017 to consider options. Then the CCH did not 
procure a new RVT service at the close of the TF3 contract on 31 March 2018. 
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1.2 Statement of Problem 
 
In 2016, Bengoa emphasised outcome of care as being a purposeful central 
and recurrent theme. He stated,  
“Making better use of technology and data are essential if we are to 
move to a model focussed on service users, on improving the health 
and wellbeing of the population”. (DOHNI. 2016, p23) 
The difficulty lies in the identification of appropriate indicators of success. 
Pinnock et al. (2013) conducted a large-scale study in Scotland and failed to 
demonstrate a discernible difference between hospital admissions rates for 
patients with Chronic Obstructive Pulmonary Disorder (COPD) who utilised 
RVT compared with a control group.   This Randomised Control Trial (RCT) 
had three distinct service issues within the context of possible use of 
technologies, no design of RVT service to gather the appropriate vital signs, 
delays in installation of service for patients and technology overlaid onto 
existing practice. Although an RCT is highly regarded as a design research 
methodology, Wyatt (2012) argued there are too many variables within the 
context of health and technologies for an RCT to be conclusive. 
By contrast, in England, a review of a trial involving 6,191 patients ‘suggested 
some benefits’ (DoH. 2011). Bower et al. (2011) described benefits within five 
categories: use (applicability to condition and ease of operation), clinical 
effectiveness, cost effectiveness, user-experience and organisational. These 
benefits were later challenged by Steventon and Bardsley (2012) who 
suggested variable technology and variable mode of deployment could affect 
outcome. It has also been argued that the large trials failed to recognise any 
health system benefits, and some studies fail to consider the time required to 
enable embedded change (Vinegar, 2013). Henderson et al. (2013) evaluated 
the English RVT Whole System Demonstrator Sites using a questionnaire. 
Whilst this questionnaire was tested to scale (6191 patients and 238 GP 
practices it focused upon service user acceptability and concluded that the 
Whole System Demonstrator did “…not seem to be a cost-effective addition 
to standard support and treatment.”  (Ibid.) 
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Therefore, evidence to date does not suggest how to utilise such technologies 
or demonstrate meaningful patient centric benefit. Rather it suggests that the 
technology was found to be acceptable by users but that it was not considered 
of benefit as hard economic metrics, such as outcome key performance 
indicators (hospital admission rates) were not altered. Thus, there is a need 
to further explore the practice of RVT, in order to consider optimal utility, taking 
account of key influences upon outcome and patient benefit. Current local 
regional health care strategies do not necessarily drive the technology agenda 
but do emphasise the potential impact of outcome-based care and self-care 
and so indirectly may afford an opportunity for RVT to contribute an alternative 
benefit to the health care system (DOHNI. 2016). This thesis will argue that 
the focus of RVT should be outcome focused but that original planned metrics 
for the service failed to recognise the real patient value. Therefore, it is 
important to consider and examine the disease drivers for change, 
environmental factors, the context and technologies in order to derive 
meaning and value for society as well as identifying if there is tangible benefit 
for the patient. 
1.3 Chronic Disease, Long-Term Conditions and a Brief 
Demographic Overview 
 
Within this thesis, as within several Northern Ireland based policy documents 
the term Chronic Diseases (CD), Non-Communicable Diseases (NCD) and 
Long-Term Conditions (LTC) are utilised inter-changeably and are 
synonymous. The ageing population has a large and increasing burden of 
chronic illness and demographics are such that there will be a proportionately 
smaller group of clinical practitioners of working age to care for all needs.  
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Figure 1.1: Population structure by age group forecast for 2025 
(Source Projected population pyramid for the UK 2025 
http://www.bbc.co.uk/schools/gcsebitesize/geography/population/population
_change_structure_rev5.shtml) 
The Demographics demonstrate the likely retracted working age population 
and burgeoning older population by 2025 (Figure 1.1). Indeed, in December 
2012 it was estimated that approximately half a million people in Northern 
Ireland were living with a LTC (LTCANI, 2012). 
From these early developments of RVT there was emergent evidence that 
RVT within NI may well improve health care service delivery and efficiency, 
being able to deliver more care with fewer practitioners, particularly in relation 
to chronic diseases where demand was growing. Living with Long Term 
Conditions – A Policy Framework (DHSSPS, 2012) indicated that by 2032 the 
number of people aged over 85-years will have increased two-fold with 
increasing numbers of people living with one or more LTC. In 2015 population 
estimates, published within the Policy Framework (Ibid.), indicated 30.3% of 
the population with hypertension (high blood pressure), 5.9% with chronic 
heart disease, 2.6% stroke and 6.0% with diabetes (type 1 and 2). Chronic 
Disease has been defined as a disease with a slow progression over a long 
period of time (WHO, 2013.) and will probably require a concomitantly long 
period of clinical management. Disease profiles have changed over the years 
with the health service originally established to focus care upon those with an 
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acute problem accommodated within a hospital. Whereas, today the demand 
for care, for those with chronic disease, is high and the model of centralised, 
hospital-based care, outdated. Indeed, local strategy dictates patient 
empowerment and care as close to home as possible (DHSSPS, 2011). 
 
It has been estimated that chronic diseases (LTC) may cost 7% of a nation’s 
gross domestic product (Nolte and McKee, 2008, p8). The World Health 
Organisation (WHO) recognition of the issues for health care systems with the 
maintenance of health for an ageing population particularly in relation to 
chronic diseases and suggest that chronic diseases are the main cause of 
total deaths worldwide at 63% (WHO, 2013). By 2008 in Northern Ireland it 
was agreed to invest in a new model of care for the most prevalent chronic 
disease groups; chronic obstructive pulmonary disorder (COPD), chronic 
heart failure (CHF) and diabetes mellitus (DM). The demographics and 
morbidity rates suggested that these would be a significant local issue. In 
particular, with an estimated increase of 30% of patients with hypertension, 
CHF, stroke and DM between 2007 and 2020 (DHSS&PS, 2012) the health 
and personal social care system was beginning to experience the burden. 
In Northern Ireland, it was agreed in 2008 to invest in a new RVT model of 
care for three diseases: COPD, CHF and DM and so funders were made 
available to permit pilot projects to be developed.  
 
1.4 General Remote Vital-Sign Telemonitoring 
 
The context for the thesis is a changing demography, burgeoning demand for 
health and social care services, limited resources both financial and human 
and the emergence of new technologies. Whilst Telemonitoring is generally a 
recognised term, as this study specifically focused upon service models and 
technology to transmit patient vital signs and near patient test results, the term 
Remote Vital Sign Telemonitoring (RVT) has been applied; thus, excluding 
the transmission of non-patient health status metrics such as location 
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coordinates or fall sensor data.  RVT is defined within the Regional Remote 
Telemonitoring Northern Ireland (RTNI) contract as… 
 “the remote tele monitoring and delivery of support services through 
information and communication technology, using vital signs 
monitoring and /or interpreting changes to a Patient’s health” (Refer to 
Appendix 2 glossary reference p142).  
From a practical perspective it is where the patient-recorded readings are 
electronically reported to a health care practitioner through the utilisation of 
digital technology. RVT is a home-based service whereby a “hub” provides a 
series of functions: reminders, data collection, storage, processing and 
transfer. The patient is reminded to undertake daily monitoring using 
recording peripheral devices provided.  Then compiled data are transmitted 
via phone-line to a central data centre. If there is an unacceptable reading, 
the system generates an appropriate alert.  Web based technologies enable 
the review of readings by patient, triage nurse and Trust practitioner. Some 
RVT provision does not include the hub or blue tooth enabled peripheral 
devices; rather it is a light-touch service where a patient simply uploads their 
result into a portal or application (app). Therefore, RVT is used to describe a 
more focused subset of telemedicine or telehealth.  
 
The environment for RVT is constantly changing as new technologies, 
sensors and applications are developed (Vogt et al. 2012). However, within 
Northern Ireland the European Centre for Connected Health (ECCH) 
undertook procurement for the region between 2008 and 2011 and then 
managed contract performance until 2018. Unfortunately, local innovation and 
development has faded as the focus of the commissioning authorities was 
upon implementation and deployment of the Remote Telemonitoring Northern 
Ireland (RTNI) service. An award-winning service, (PHA.2012) the RTNI 
service could arguably be described as such a traditional service and yet it 
was only activated in December 2011 with the recruitment of the first patients. 
Indeed, in an InnovateUK call for research published in October 2014, bidders 
were expressly instructed not to offer what was described as ‘traditional’ 
telemonitoring (SBRI Glasgow, 2018). However, for services within Northern 
Ireland, RTNI still ‘feels’ like a new service, not a traditional technology as 
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InnovateUK describe, as the technology was still being inculcated into 
practice.  
 
Although service detail and standards were specified, wide practice variation 
led to variability in uptake rates, clinical opinion, variance in care standards 
and unclear expectation of outcomes.   Observations by practitioners within 
SET suggest there are some critical success factors which enable the 
implementation of emerging remote monitoring technologies to be more or 
less effective. In doing so the concept of optimisation is considered, with a 
goal of optimisation being a theme. For the purpose of the thesis the term 
optimisation is defined as ‘safe and effective use of RVT to enable the best 
possible outcome’. This has been adapted from a utilised by National Institute 
for Health and Clinical Excellence (NICE) when describing Medicines 
Optimisation (NICE, 2015). 
 
RVT has been implemented across the five Health and Social Care Trusts 
and has had variability in success of uptake and attainment of the ECCH’s 
performance targets, with variance in numbers of patients, conditions and 
leadership context. It has been observed that deployment from a leadership 
perspective has varied in approach with one Trust mandating practitioners to 
utilise technology focusing efforts on attainment of performance targets. SET 
took a more laissez faire approach to deployment. It is within this Trust, where 
ECCH performance target achievement was below expected. The thesis will 
examine patient, carer, practitioner and manager experience and opinion. 
This will determine if critical success factors emerge based upon patient need, 
disease group or clinical practice. 
 
Two-years after the RTNI contract was signed there was an official launch of 
the service, entitled ‘A Celebration of Telemonitoring NI’. On the 8th April 2013 
the Minister for Health, Social Care and Public Safety in Northern Ireland, 
addressed a delegation at Stormont, stating “... that practitioners in Northern 
Ireland are at the vanguard”, suggesting that the application of Remote Vital-
sign Telemonitoring was being led, from a practice development perspective, 
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by the Region.  In addition, SET RTNI patients also publicly shared their 
experiences. On 19 March 2013 two carers described how their mother had 
fewer hospital admissions despite her chronic ill health and how the family 
could manage her care.  On 28 March 2013, Mr W indicated that the service 
saved his life, how reassuring it was to have access to a specialist practitioner 
and that he was, “...much more confident with regard to his condition.” 
However, running counter to the very public praise for the service the 2012/13 
SET utilisation of RTNI remained significantly below expected contract levels, 
being half of expected.  Contract currency was not outcome based, did not 
consider patient experience or quality of life, rather counted days a patient 
was in receipt of a service, designated a monitored patient day (MDT). When 
a patient was enrolled onto the service the length of time, in days, they were 
registered and in receipt of RVT, was recorded by the provider and statistics 
reported back to referring Trust on a monthly basis. However, during 2012/13 
it was evident that there were pockets of success within SET but equally there 
were areas where practice development, by practitioners, had not enabled the 
effective application of RVT per se. 
 
1.5 South Eastern Health and Social Care Trust 
 
The SET was established on 1st April 2007 as one of five acute and community 
health and social care Trusts commissioning RVT. The Trust is an integrated 
organisation, incorporating acute hospital services and community health and 
social services and serves a population of approximately 345,000 people. The 
Trust encompasses the local government districts of Ards, North Down, 
Lisburn, Down and part of Castlereagh.  The clinical facilities include Ards 
Community Hospital, Bangor Community Hospital, Downe Hospital, 
Downshire Hospital, Lagan Valley Hospital and the Ulster Hospital. 
Community bases are located in many local towns and villages from Moira in 
the west to Portaferry in the east and from Bangor in the north to Newcastle 
in the south. The Trust is committed to providing health and social care to the 
local population it serves, from conception to death, and strives to meet the 
needs of the community within a budget of approximately £500,000,000 per 
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annum.  The population is located in both rural and urban communities and 
affords residents care within the domiciliary environment, primary care health 
centres, community hospitals and acute General Hospitals. Refer to Appendix 
1 for further Trust context details and a history of clinical interest in the 
deployment of evolving e-Health technologies.  Within the Trust there were 
teams of staff focused upon the care of chronic diseases some of which 
utilised RVT. These included specialist services for diabetes, respiratory and 
cardiology but also a community team that cared for patients who, without 
their service, would have traditionally been in hospital and this service and 
practitioners were referred to as the Virtual Ward. Co-morbidity is significant 
within the older segment of the population only the Virtual Ward practitioners 
cared for patients using the TF3 service for multiple conditions, typically a 
combination of CHF, respiratory, hypertension and diabetes. 
1.6 Policy and operational Context for RVT in Northern 
Ireland 
 
The DHSSPS (2009) Health and Care (Reform) Act (Northern Ireland) created 
an environment to enable innovative care solutions to flourish and find novel 
approaches to deliver care in new and effective ways. The most senior 
managers and civil servants drove an agenda of reform and transformation 
with the goals of enabling health and social care to be delivered effectively, 
efficiently, as close to home as possible and to harness the energy of the new 
five Trusts following whole system restructuring that occurred in 2007.  Then 
followed the work-streams as articulated within Transforming Your Care, 
(HSCB, 2011), a consultative document (DHSSPS, 2012a) and, most 
recently, a post consultation report ‘Vision into Action’ (HSCB, 2013) which 
proposed services as close to home as possible, patient centred care and 
emphasised the genuine need to empower the patient to self-care. Particular 
emphasis was placed upon alternatives to hospital care for those with LTC. It 
was within this progressive environment that there emerged an eagerness for 
technology reform, particularly gaining political support. The e-Health Strategy 
for Northern Ireland was published, which included the overarching strategic 
vision of eHealth to,  
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“…empower people to be more active in their own care and support 
health and social care to achieve real change that delivers the best 
possible health and wellbeing for everyone” (HSCB, 2016). 
 
Prior to this review of eHealth strategy there were drivers from within industry 
as well as practitioners envisaging change through technological 
advancement. Political lobbying from the Private Sector, with the support of 
Department of Enterprise, Trade and Investment (DETI), meant that funding 
from both the DHSS&PS and DETI would be pooled and directed centrally.  
The aim was that local industry and the reputation of Northern Ireland as a 
region within the World Market Place would be enhanced in the field of Health 
and Life Sciences. (MATRIX, 2008) 
1.7 Creation of European Centre for Connected Health and 
Authority Commissioning of RVT 
 
In order to enable change of emphasis within the wider health and social care 
environment and the adoption of innovative technologies the Department of 
Health established new structures dedicated to innovation and technology 
adoption. In 2007, the organisational structures within the re-organised Health 
and Social Care Services were enshrined in statute and stability returned.  In 
2008, the DHSS&PS issued a mandate formally establishing the European 
Centre for Connected Health (ECCH). This was important within the RVT 
thesis as it was both an enabler for change and also established the funding 
mechanisms by which early RVT could be commissioned and implemented. 
A Senior Civil Servant headed the venture and two directors, three project 
managers and part-time consultancy (provided by medical and nursing staff) 
were deployed to create an environment enabling innovation through 
technology within health care.  The Remote Vital-sign Telemonitoring or 
Connected Health as it became known locally was the main focal point.  There 
were three workstreams undertaken by the ECCH, (i) to commission an end-
to-end Remote Vital-sign Telemonitoring System for Northern Ireland (RTNI), 
(ii), to fund and evaluate a multiple of small-scale pilots across each of the five 
Health and Social Care Trusts and (iii) to create strategic linkages with the 
European Union (EU), industry and academia.  Lessons learned from work 
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stream two informed the development of a service specification designed to 
procure the end-to-end service for the region. For a detailed history of this 
period refer to Appendix 1, 10.3. A summary timeline demonstrates the life of 
the RTNI activity from constitution of ECCH on 1 April 2008 to the termination 
of the TF3 RTNI contract on 31 March 2018. (Figure 1.2) 
 
Figure 1.2: RVT Service Timeline 
The contract was awarded for a 6-year term from 1st April 2011 to 31st March 
2017 with £3 million available for each service year.  Within this envelope 
£60,000per annum was available to each of the five Trusts to enable 
infrastructure supports with the residue available to fund both a standing 
charge and a variable element based upon actual utilisation.  Between 1 April 
2011 and 4 December 2011, the service was built, and staff trained. Moreover, 
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the contract currency of Monitored Patient Day (MPD) was established along 
with the Regional monitoring target for each Trust. 
The MPD allocation was calculated based upon each Trust’s financial equity 
share with the divisor being the unit cost of a day of monitoring (excluding the 
standing overhead charge). The contractor had devised a charging formula 
based upon packages given. This single action may have been a key deciding 
factor as to whether RVT could be optimised within the new regional contract 
with TF3 as an alternative solution would have permitted clinicians to select 
from a catalogue the peripheral devices, they required on a patient by patient 
basis. At this juncture of contract development, perverse incentives were 
created, and health outcomes were not considered rather the political impact 
of an apparent low unit price and high-volume currency. Therefore, with 
success being measured as more people in receipt of service for longer period 
of time; it could be argued that a Trust management structure focused upon 
achieving performance targets rather than efficacy and utility. The 
performance management system may drive behaviours whereby, many 
patients would be put onto the system for long periods of time without regard 
for outcome or benefit or even review of ongoing need. Whilst, this practice 
may have occurred in some areas within SET the Trust service’s focus was 
to remain upon patient benefit and outcome rather than a dogged 
determination to attain performance targets regardless of clinical governance 
or patient outcome. However, the corollary to that was that if a practitioner 
could not be motivated to test technology then there were no real sanctions 
or management actions undertaken.  Overall, regional commissioning 
enabled RVT to be implemented within a robust contract framework to ensure 
equality of access, service standards and consistency of practice. However, 
there were negative aspects that affected clinical adoption and application, 
most notably the focus upon the contract currency and lack of patient benefit 
or outcome measures. 
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1.8 The RTNI Contract and Agreement with the TF3 
Consortium 
 
Following a prolonged commissioning process, described above and in Appendix 
1, 10.3, a regional contract for the provision of RVT was agreed. The contract 
was written by the Legal Advisor, DLA Piper, and amounted to four files, which 
described the specified service in very great detail; signed by the five Trust Chief 
Executives, the TF3 Consortium led by Tunstall and was dated 16 March 2011. 
Of particular interest was the first file intentionally did not define RVT, instead 
referring to the service as the “Managed Service” which was articulated, within 
the Schedule 1 Definitions of Terms, to mean, as “any and all elements of the 
service to be provided by the Contractor under this Agreement including as set 
out in schedule 2.1 (Service Description) including the Pre-Operational Services, 
Operational Services, Additional Services and/or Future Services” (Reference 
Appendix 2). 
During the almost 3-year period between August 2008 and the best and final offer 
in December 2010 and final contract agreement in March 2011, the Authority 
Group has defined every element of service to be commissioned within the 
service specification. Not only did tenderers have to explain how each element 
would be attained within their service offering but both service specification and 
best and final offer narrative were combined by DLA Piper into the RTNI Project 
Agreement/ RTNI Managed Service Agreement. 
1.9 RTNI Managed Service Agreement 
 
It was important to understand and explore the development of RVT in the region. 
The two systems being studied enabled patient level data relating to their well-
being to be transferred to the clinician for action, the history and design of both 
are significantly different. One, the RTNI, developed through a complex detailed 
and disciplined approach across organisations, and the other a local collaboration 
between Trust Practitioners and a University where collegiality and iterative 
planning through development and testing. The RTNI managed service was 
specified and described within a ‘Managed Service Agreement’. 
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A law firm, (DLA Piper) wrote and managed the production of the agreement 
between the five Health and Social Care Trusts within Northern Ireland and 
Tunstall Healthcare (UK) Limited, (lead contractor in the TF3 consortium) 
relating to the provision of managed Remote Tele Monitoring Services in 
Northern Ireland (RTNI). 
The agreement extended to four lever arch volumes along with a 
supplementary binder containing the six relevant signatories.  The contents of 
each of the four master folders have been summarised and are documented 
within Appendix 2 and the key feature to note is the list of definitions of terms 
which gives insight to the understanding of the commissioners between 2008 
and 2011 when the contract was being developed. File 1 of 4 contained the 
overarching definitions of services and established the implementation of the 
programme.  The folder described the standards by which the service was to 
be delivered. Within the definitions section of the RTNI Project Agreement 
there were key definitions to be noted and a glossary of terms aiming to 
ensure any risk of ambiguity was minimised. (The glossary can be referenced 
in Appendix 2). 
These terms are important to note within the context of this thesis as the 
researcher has assigned the same meaning to the terms when utilised within 
the research findings and report. The sample of pertinent terms selected and 
captured within this section are illustrative of the level of forethought that was 
employed by the Public Health Authority and Trusts prior to the deployment 
of RVT; it was not the testing of equipment on offer by suppliers, rather a 
genuine attempt to rethink models of care and pathways to positive effect. The 
definition of the RTNI per se, does not appear within the definitions and is 
rather within file 2 of 4, schedule 2.1. 
“A1 overview of Manged Service, The contracts shall ensure the provision 
of an end-to-end Managed Service to facilitate the following: 
• The processing of patient referrals; 
• The delivery and/or installation of appropriate patient equipment to/in a 
patient’s home and/or the provision of a mobile solution as determined 
by the HSC staff and be responsible for any remedial repair work as a 
consequence of installation; 
• The provision of training to the HSC staff and patients/carers; 
• The collection of accurate and reliable monitoring data; 
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• A triage service which validates monitoring data and provides patient 
advice where appropriate and/or the escalation of their care to the local 
response team as appropriate; 
• The provision of relevant monitoring data to HSC staff in an appropriate 
manner and; 
• The removal and/or de-installation and decontamination of patient 
equipment”. 
The Managed Service Agreement file 1 of 4 sets out the detail of service to 
be provided in terms of service development, implementation and testing and 
also which patient groups. These included CHF, COPD and DM and also for 
the secondary prevention within stroke care.  The progress was to be 
measured against pre-agreed targets and the issuing of a ‘milestone 
Achievement Certificate’ was documented.  Any delays and concomitant 
correction plans and remedial actions were discussed along with the actions 
of the Liaison Committee.  These elements were specifically designed to 
enable the development of an entirely new end-to-end service recognising 
that technological developments in the real-world may need more time to 
adapt than in theory or a laboratory.  Indeed, the risk of delay was well 
accounted for with reasonable actions for both parties exclusively 
documented. The contract was novel and designed to realise the translation 
of in-theory laboratory technology proposition into the real-world application. 
At section 9 the document began to address directly the matters relating to 
the Managed Service with the onus placed upon the contractor to fulfil 
obligations with regard to service standards as detailed within the schedule 2-
1 (Service Description).   
At clause 9.8 reference is made to an ‘Additional Service Implementation 
Timetable’ however, this in itself could be viewed as either an afterthought or 
to reflect that the commissioning team (referred to within the contract as the 
‘Authority’) recognised that the pace of service change and equipment 
development was out pacing the drafting of the service standards.  However, 
later in the contract execution, many of the service additional desirable 
services were just out of the price range of the commissioners.  An example 
of this was the development by SET of the standalone technology INR – U-
Tell module which will be considered within this research project as it operated 
in parallel with the TF3 Service.  Similarly, at clause 9.17 1 the ‘future service 
implementation plan’ referenced enabled the provider to protract potential 
Chapter 1: Introduction 
Julie-Ann Walkden - July 2020   17 
charges to point of non-progress.  For example, following two years of 
development a revised on-line methodology of service referral had still not 
been completed.  A process failure first attributed to service implementation 
planning and later precluded due to extraordinarily high costings.   
Of note, is clause 9.22  
“At the same time as provision of additional and/ or future service is 
commenced, the contract shall at no additional cost to the Authority, 
implement and commence provisions of any other services, functions 
and responsibilities which are both necessary for and incidental to the 
paper performance by the contractor of their additional and/ or future 
services.”  
This is a particularly interesting clause as the research progresses the 
researcher learns from practitioners that the complexity of referring a patient 
to the service acted as a significant barrier to utilisation and uptake.  However, 
the Authority reported fees in excess of £70,000 to remedy the track and trend 
referral system; arguably clause 9.22 may have been interpreted and invoked 
to enforce service improvement by the contractor. 
Section 10 considers the service levels and quality failures.  
1.10 Description of the RVT TF3 Service 
The interpretation of the service offering is as follows: 
 
Figure 1.3: Relationship between practitioner, patient, carer and 
technology 
The patient with a Long-Term Condition (LTC), defined by the RTNI 
Agreement as, “…health problems that require ongoing management over a 
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typically led by Specialist Nursing. The practitioner will assess the patient as 
suitable for RVT and duly make a referral to TF3. The triumvirate, that is the 
power relationship shared between patient/ carer, practitioner and Managed 
Service Provider TF3 (Figure 1.3). The TF3 technology and service enabling 
data transfer between patient and practitioner to enable proactive 
intervention. The technology and service, a new interface, created a new 
digital relationship between the participants. The referral was by means of a 
fourteen-page electronic referral form and included all demographic 
information and pertinent clinical information along with a request for service.  
Upon later software releases the referral process improved as there should 
have been a reduction in manual completion of mandatory fields as automatic 
data population, for example, General Practitioner (GP) auto population and 
patient demographics with the utilisation of the Health and Care Number; 
which is a unique 16-digit number allocated to each patient within Northern 
Ireland to enable sharing of information, clinical record access, service 
scheduling, prescription management and care tracing without the risk of 
name confusion and misidentification. Of note, at this juncture, the 14-page 
referral form, with data fields specified by the Authority through the dialogue 
phase was set within a context pre-NI Electronic Patient Record (ECR) so de 
facto the GP and nurse advisor to the project were almost specifying an ECR 
within the RTNI without regard to the demands placed upon the practitioner.  
During the referral to the TF3 service the practitioner would define the level of 
service and package required in three decisions. The first decision was to 
have a service which included a triage nurse or not. The triage or triage 
service is defined within the RTNI managed service agreement as… 
“the service that assesses the patient’s alert, validates the vital signs 
when an alert has been raised, reviews monitoring data, obtains more 
information from the patient by asking questions designed to clarify or 
elicit more detail on clinical issues and deciding the action to be taken 
as a consequence including escalation to local response team;” (DLA 
Piper, 2011, Refer to Appendix 2).  
In short, a practitioner may want to be assured that another nurse, a triage 
nurse, is able to filter alerts so that only clinically significant issues are brought 
to the attention of the practitioner for action.  
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An example may be that a patient with (COPD) may have been ‘red-
flagged’ by the system having breached parameters set by the 
practitioner at point of referral. The patient may have reported that they 
are more breathless, higher temperature with a more productive cough 
and a reduced SPO2 level than normal and so the system would 
highlight the patient and their concomitant alert to the triage nurse. In 
turn, the triage nurse would enter into the patient’s TF3 electronic 
patient record, review the case history and advice recorded by the 
patient’s practitioner and telephone the patient. The triage nurse would 
then follow an agreed algorithm/ pathway of telephone triage as well 
as utilise their own professional nursing skills to assess the patient’s 
condition. The triage nurse may ask the patient to retake their 
readings, ask questions, discuss symptoms and rescue medication 
and decide to escalate the case, as appropriate, back to the 
practitioner/ specialist team for action.  
Equally, the referring practitioner may decide not to avail of the triage service 
so that the patient simply takes their own readings when prompted to do so 
by the system and the practitioner concomitantly takes all responsibility for 
managing the data. Typically, patients with diabetes mellitus would be placed 
onto the TF3 service without triage so that the practitioners can more readily 
track and monitor blood glucose levels over time. This facilitates telephone 
consultations between practitioner and patient so that the need for a 
practitioner to physically review a patient’s handwritten logbook of blood 
glucose readings is reduced or negated. The triage nurses only intervene with 
the monitoring of these patients where the patient is failing to upload readings 
into the system. In both the triage and non-triage service, known as track and 
trend, the patient records and results are available on-line to the practitioner 
through safe-guarded log-in credentials and also to patients who opt to gain 
access through a web-portal service. The RTNI project agreement defines 
track and trend as “a tabular and graphic report of individual patient monitoring 
data against monitoring parameters”; with monitoring parameters defined as 
“the tolerance levels that are set for the identification of which monitoring data 
are referred to the triage service.” Monitoring data are defined as “the data 
items that are collected and reported to the managed service” (Refer to 
Appendix 2). 
The practitioner secondly decides upon the clinical data requirements for a 
patient and concomitantly the devices a patient may be required to capture 
the data. Within the TF3 service these devices are referred to as peripheral 
devices, meaning “an item of patient equipment or client equipment (as 
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relevant) other than the hub;” with the hub defined as “the item of patient 
equipment or client equipment (as relevant) to which monitoring ata are sent 
by peripherals and which transmits the monitoring data to central solution.” 
(Refer to Appendix 2). 
The practitioner’s third decision when referring a patient onto the system 
relates to the frequency of monitoring and the monitoring parameters. To 
simplify matters for practitioners the system had default settings for both and 
prompted a patient to take readings each morning. However, the practitioner 
can adjust parameters as required, and may choose to do so to change the 
tolerances at any stage in the TF3 service provision. The patient at their ‘norm’ 
may trigger excessive alerts which may lead to unwanted habitual behaviour 
with a disregard of alert or experience nuisance or raised anxiety or create 
unnecessary work for the triage service. Indeed, monitoring parameters may 
be disregarded entirely for track and trend patients as the key requirement is 
to observe clinical data trends. 
The RVT systems underpin new data flows between patients, their clinicians 
and the system. The TF3 system was designed to connect patients with their 
clinicians who would enhance knowledge both of the health status of the 
clinician’s patients and also at a patient level to take responsibility for 
measuring and uploading onto the system their vital sign readings. TF3 
supplied the technology and training for all participants and users which 
supported data exchange and the clinical undertaken by practitioners. 
However, as patient readings were transmitted there were two modes of 
review either direct practitioner review, track and trend, or a first level non-
specialist nurse screening, triage. The output of both modes of data 
availability meant the clinical practitioner was able to target care as 
appropriate. The information flow to influence activity of service participants 
is illustrated Figure 1.4. 
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Figure 1.4: Showing the flow of information through an RVT service 
structure 
The RVT system designed and delivered through the regional RTNI contract 
by TF3 was hardware reliant with little use of internet and no use of smart 
phone technology. The patient possessed a home hub which collected data 
from the prescribed peripheral devices and transferred via a ‘plain old 
telephone’ system (POTs) to the central server. The RTNI contract specified 
restrictive security safeguards and strict governance to protect patient data, 
identity and integrity. Whilst the hub scheduled reminders and transmitted 
data it collected data from Bluetooth enabled technology (peripheral devices 
such as scales) and also the responses to psycho-social questions relating to 
well-being and symptoms. The data would either be made available directly 
to the patient’s clinical practitioner (track and trend service) or first be 
screened by a triage nurse. This nurse would contact a patient if a problem 
was suspected, take appropriate action and an intervention might be simple 
advice, reassurance, through to an immediate contact with the SET 
practitioner or in emergency situations an emergency response. The data 
flow, management, security and schematic architecture were designed by 
TF3 in responses to the regional RTNI tender (Figure 1.5).  
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Figure 1.5: Schematic Architecture of TF3 System 
Following the referral to the TF3 service a new relationship between patient, 
practitioner and managed service provider is created and has previously been 
described as being a triumvirate. The triage nurse will initially undertake a 
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‘welcome’ telephone call and ensure that the patient is competent and 
confident in the utilisation of their equipment, including the hub and tailored 
peripheral devices. The purpose was to put into place a community service to 
cost-effectively manage patients by reducing acute admissions and enabling 
an earlier discharge. The patient changed behaviour, which enabled urgent 
clinical intervention to take place following an alert and the practitioner to 
utilise their time more effectively in caring for an ever-growing cohort of 
patients with LTC. Within the RTNI Project Agreement, ‘Alert’ was defined as 
“an electronic message from an item of Patient Equipment that a Monitoring 
Parameter has been breached” (Refer to Appendix 2). Once referred, TF3 
ensure the patient receives a service within a defined contracted period.  
 
At the stage of Best and Final Offer (BAFO) within the procurement of the 
RVT system the two service offerings varied in several respects. Firstly, the 
BT offering had a simple and intuitive electronic referral system when 
compared to a series of 14 screens presented to practitioners through the TF3 
service and secondly the equipment on offer for the patient. The BT offering 
included a catalogue style whereby a practitioner could tailor actual 
requirements for peripheral devices to meet a patient’s need versus the TF3 
offering which had fixed equipment prescription packages for simplified 
standard packages of care and invoicing. There were 16 different packages 
proposed within the TF3 BAFO albeit that by contract year 2014/5 only 13 
were utilised and priced.  
The packages of care, tailored to particular LTCs, included peripheral devices 
that would capture only the required vital signs. Therefore, if a patient, post 
stroke, required their blood pressure to be monitored then they would be given 
a home hub and a blood pressure cuff whereas if a patient with diabetes 
required both blood pressure and blood glucose monitoring then they would 
receive a home hub, blood pressure cuff and a glucose meter. 
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Table 1.1 To demonstrate the equipment utilised in the TF3 including 
hub and peripherals, model, connectivity and expected lifespan. 
Item 
Description 







Hub MyMedic Tunstall POTS 6 years Advanced 
Mobile Hub MyMedic+ Tunstall GSM/GPRS 6 years Advanced 






Lifescan Cable 2 years 
Low Mid 
Range 





 Onyx 9560  Nonin Bluetooth 10 years 
High Mid 
Range 
BP cuff with 
Pulse meter 
UA-767 A&D Bluetooth 6 years 
High Mid 
Range 

















 (Refer to Appendix 2, derived from RTNI contract: The equipment as listed 
within BAFO Contract excel spread sheet ‘35107840_1_UKMATTERS) 
 
Although during the term of the contract there were modifications made to 
certain products, mainly the glucose meters, the basic equipment remained 
the same and the initial products are recorded in Table 1.1. 
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Table 1.2 Peripheral devices within each package type. 
 
 (Refer to Appendix 2, derived from RTNI contract: The equipment grouped 
into the 13 Packages of care as listed within BAFO Contract excel spread 
sheet ‘35107840_1_UKMATTERS ) 
 
Therefore, if a practitioner is caring for a COPD patient with a co-morbidity of 
CHF the practitioner would routinely order a ‘Package I’ which consists of a 
Hub and four peripheral devices, including scales, blood pressure cuff, pulse 
oxymeter and thermometer. Table 1.2 was issued to practitioners so that they 
were clear regarding the available packages. Moreover, the practitioners were 
at liberty to order the individual packages for as long or as short as required 
but typically the routine operational time was blocks of 13-weeks so that if a 
patient remained on the system for 52-weeks, they would receive four 
sequential blocks of service provision and the Trust achieved 365 MPD 
against their performance target. 
The charging mechanism for Remote Vital-sign Telemonitoring Northern 
Ireland (RTNI) consisted of two elements, a standing charge to cover service 
overheads, for example staff costs of Fold (the TF3 consortium member 
operating the call-centre) and decontamination services and a variable 
charged for installation, de-installation, consumables (for example, batteries 
and test strips) and MPD. Information relating to initial contract costs and 
charges can be observed in Appendix 2 Tables 12.2, 12.3, 12.4 and 12.5. 
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From a practice perspective, within the service across Northern Ireland in 
general and in particular within SET there was little or no agreement with 
regard to which subset of patients should avail of the service. For example, 
the Respiratory Service within the Ulster Hospital developed a Care Bundle 
to ensure that practitioners consider RVT as an option for each patient; this is 
illustrated in Figure 1.6. Care Bundles were not universally accepted by all 
practitioners, some of whom prefer to use other approaches. Within the 
context of RVT the Institute of Health Improvement (IHI) (2015) Care Bundle 
definition was accepted… 
 “An evidence-based Care Bundle is a structured way of improving the 
processes of care and patient outcomes: a small, straightforward set 
of evidence-based practices… (generally three to five)…that, when 
performed collectively and reliably, have been proven to improve 
patient outcomes.”  
 
All other services utilising RVT took a less formal approach to application 
permitting practitioner preference and freedom.  
 
 
Figure 1.6: Flowchart to illustrate RVT ‘care bundle’ as a process for a 
patient with a chronic disease as used within the Ulster Hospital by the 
Respiratory Specialist Team 
1.11 RVT/ TF3 Performance Monitoring for South Eastern 
Trust and Northern Ireland 
 
With the introduction of the regional service came a degree of monitoring to 
ensure compliance with the contract. This is included to show how the 
















TF3 analysis & 
‘alert’ if problem 
detected




notified if patient 
has a issue
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obtained from SET via the research protocol. Accountability and performance 
monitoring were reported by SET to the Public Health Agency (PHA) with 
primary performance data being derived from activity reports accompanying 
the variable contracts issued by TF3. The European Centre for Connected 
Health (ECCH) was moved from being based within the Department of Health 
and Personal Social Services and Public Safety (DHSSPS) to being within the 
PHA; at the same time there was a name change to the Centre for Connected 
Health (CCH). 
Due to differing perspectives on performance, early on the service 
performance within SET failed to attain the targets established by the CCH. 
The CCH set MPD targets based upon annualised MPD potential associated 
with the maximum number of patients cared for within budget. Failure to attain 
the expected outturn was due, in part, because practitioners tended to utilise 
the service purposefully with short term intervention and that the baseline 
patient cohort was smaller than three of the other Trusts.   
As explained in Appendix 1, the SET RVT 2008 pilot had been undertaken by 
Home Telehealth Ltd, (later became Alere). This was a triage service and at 
the close of the service in November 2011 there were very few patients who 
practitioners considered suitable for transfer to the TF3 service. Indeed, it was 
the COPD patients from the community service in Lisburn who were amongst 
the few to receive the new service. Many of the original triage nursing staff 
transferred to TF3 under Transfer of Undertakings (Protection of Employment) 
TUPE; under UK law protection was afforded to the previous subcontractor’s 
staff. This afforded staff protection but importantly the TF3 service 
commenced with experienced RVT triage nurses. Three of the other NI Trusts, 
the Northern, Western and Southern had all undertaken RVT pilots (with Fold 
Telecare), albeit not a triage service, rather track and trend. Fold, being part 
of the TF3 consortium, was able to facilitate a transfer of long-standing routine 
monitored patients, most of whom were track and trend service users that 
were mainly diabetic patients monitoring blood glucose. Therefore, at 
performance reviews SET fared poorly against target particularly at the initial 
stages. The three Trusts which were previously served by Fold performed well 
and the fifth Trust, Belfast, had limited engagement. The failure to engage 
was caused by tension between staff who expected Trust specialist nursing 
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services to be augmented to enable proper deployment of RVT without 
negative impact upon service provision.  
 
During the first four months of the service the Regional Target for SET was to 
refer up to 41-patients per month with the actual number of patients enlisted 
on the service during that time representing 47% of target. In total 85-patients 
were referred to the service with 75 installations being made before 31 March 
2012, which was the close of a Trust’s financial year. There were no migrating 
patients from pilot Fold projects and the initial use of the service is illustrated 
in Table 1.3. 
 
Table 1.3 The SET referrals to TF3 during the first 4 months of the TF3 
service showing uptake by disease. 
 Referrals Proportion 
COPD 31 36% 
Heart Failure (CHF) 5 6% 
CHF 1 1% 
COPD with BP 9 11% 
COPD/ CHF 6 7% 
Diabetes 33 39% 
Total 85 100% 
 (TF3 Service Management Report December 11 - March 12 v0.2) 
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By 2015 the annual target had increased, and the outturn for contract year 
2014/5 is demonstrated in Table 1.4. 
Table 1.4 The actual MPD against target 2014/15. 
   








2014/15 MPD MPD MPD 
April 6500 6048 -7% 4274 1774 
May 6500 6131 -6% 4465 1666 
June 6500 5965 -8% 4284 1681 
July  6500 6103 -6% 4418 1685 
August 6500 5821 -10% 4243 1578 
September 6500 5410 -17% 4010 1400 
October 6500 6111 -6% 4406 1705 
November 6500 6410 -1% 4642 1768 
December 6500 6835 +5% 5009 1826 
January 6500 6948 +6% 5095 1853 
February 6500 6304 -3% 4519 1785 
March 6500 7174 +10% 4981 2193 
Total 78,000 75,260 -3.5% 54,346 20,914 
 (TF3 Service Management Report March 15 v0.1) 
 
By contract year 2014/15, service in 3rd year of operation, that the lag created 
by a zero baseline of SET patients within the TF3 service system should have 
been eliminated so that attainment of the MPD target was more likely than in 
the first four or twelve months of operation. However, the Trust still failed to 
attain the regional target by 4% of the expected MPD, which equated to 8 
patients on the system for 12 months or rather 33 patients each receiving RVT 
for a single package period of 13-weeks. By considering the metric of MPD, 
SET failed to attain regional targets and, by inference, failed to maximise the 
use of available, commissioned RVT service capacity. 
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In the same year the performance against the metric of MPD of other four 
Trusts was benchmarked against SET. The Trust did not compare favourably 
when compared to the other Trusts. 
Table 1.5 The 2014/15 TF3/ Trust performance metrics. 
Month 2014/15 
 Target 
MPD Actual MPD 
Variance 
against 
Target Triage MPD 
Track & 
trend MPD 
Belfast 50004 64376 +29% 23785 
4059
1 















6 115236 +9% 43831 
7140
5 
 (Data compiled from TF3 Service Management Report March 15 v0.1) 
Table 1.5 is interesting in that at a stage that behaviour should have become 
embedded and reflected in practice it appeared that Belfast Trust was over 
performing by almost a third. However, at the time when Belfast Trust 
clinicians were refusing to engage, and the CCH reallocated funds from 
Belfast Trust to the Northern, Southern and Western Trusts along with a 
concomitant share of MPD. The Belfast Trust’s reduced funding share meant 
it was over-performing against an artificially deflated target. The original target 
distribution was based upon the population sizes within each of the five Trusts. 
The key point here to note is that it was clearly behaviour and stance, within 
one cohort of staff that drove application of RVT or not. It illustrates the ‘Gate-
Keeper’ role of the practitioners. 
It also raises questions as to why the Northern, Southern and Western Trusts 
attained or exceeded their MPD Performance target, particularly as the 
service targets were raised to mitigate against overall regional failure of 
contracted targets or to artificially create a situation whereby some Trusts 
required additional revenue resources to fund overuse whilst Belfast Trust 
remained significantly underspent and in credit. The CCH agreed in 2013/14 
with SET not to adjust baseline funding, instead SET committed to endeavour 
to attain MPD Targets. 
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Examination behind the target figures illustrated a complex pattern of 
utilisation behaviour across the Trusts. With data compiled from TF3 Service 
Management Report March 15 v0.1, was created which illustrates some key 
service pattern differences.  
The Trusts are represented by their initials, BT is Belfast Trust, SET is South 
Eastern Trust, NT is Northern Trust, ST is Southern Trust and WT is Western 
Trust. The disease groups are an aggregation of services with the lead 
condition where co-morbidity exists accounted for in main overall reason for 
being in receipt of the RVT service. The LTC groupings are COPD, albeit in 
SET patients with Bronchiectasis are part of the respiratory patient cohort 
utilising RVT, diabetes mellitus (Types 1, 2 and in the Western Trust 
Gestational Diabetes), stroke and CHF. SET had a 70/30 split between the 
TF3 triage and the track and trend provision higher than the other Trusts along 
with the highest proportion of patients utilising the system for COPD. 
Moreover, unlike the other Trusts, at that time there were no CHF or Stroke 
patients on the system in SET (see Table 1.6). 
 











BT 38 62 37 49 13 0 9 10 166 
SET 70 30 67 30 0 0 23 14 233 
NT 51 49 40 44 5 10 24 20 330 
ST 69 31 52 30 1 17 18 14 270 
WT 38 62 36 51 12 1 0 20 277 
 (Data compiled from TF3 Service Management Report March 15 v0.1) 
The Western Trust, a high user of RVT, did not have any new referral patients 
enrolled onto the service in March 2015 because there was a 9% over 
performance of the MPD metric and therefore spend on the variable element 
of the contract had to be controlled. With reference to the Western Trust’s 
target having previously been inflated due to Belfast Trust’s 
underperformance indicates that Western Trust Management may, at this 
time, have attempted to contain costs by not permitting referrals to be made 
or for the equipment to be installed into patient’s homes during the last month 
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of the financial year to ensure affordability and cost containment. Budgetary 
pressures within CCH prevented a further easement or bailout due to cost 
pressure. This retraction of service also illustrated the power of management 
control to the extent that services can, in effect, be turned on and off at will in 
a Trust rather than necessarily reflecting clinical practice or patient need. 
The dominance of provision of service for diabetic patients in the Belfast, 
Northern and Western Trusts may also reflect both the commissioning of track 
and trend and a lack of alternative technologies to monitor glucose control or 
better engagement of diabetes practitioners than within SET. 
Therefore, the 2014/15 TF3 performance data for the region appears to 
indicate a variance between Trusts relating to patterns of service type uptake, 
patient access and attainment to the MPD metric. However, the reporting of 
this metric is binary, with either a succeed or a fail result without the acquisition 
of understanding of actual benefit, disbenefit, utility or meaningful outcome. 
However, the regional TF3 report, had been positively skewed by SET 
reporting RVT MPD that were derived from another system, a Trust based 
system U-Tell. (Table 1.5) 
1.12 TF3 and U-Tell:INR Combined Monitored Patient Day 
Activity for South Eastern Trust Demonstrates a Different 
View of Target Attainment 
 
Of note, for the overall assessment of SET’s relative RVT performance 
success in relation to MPD is the effect of adding the U-Tell:INR MPD to the 
TF3 MPD; CCH permitted the variation. This could be marked as a turning 
point in outlook of the CCH as they were accepting data from a service that 
was not end-to-end as had been specified in the RVT documentation; the 
medical and nursing advisors to CCH who had insisted upon electronic data 
transfer had both retired from service. A mind-set of change as well as 
increase in performance had occurred with the CCH acceptance of the U-Tell 
RVT MPD data in addition to the TF3 MPD performance data. 
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Table 1.7 The MPD 2014/15 as at 31 March 2015 for SET splitting 
standard TF3 and U-Tell data. 







SET TF3 78333 75260 -4% 54346 20914 
SET U-
Tell:INR 
 0 14600 0%  0  16600  
SET Total 78333 89860 15% 54346   37514 
 (Data compiled from TF3 Service Management Report March 15 v0.1 and U-
Tell:INR activity) 
Table 1.7 demonstrates the effect of including a stratified approach to RVT for 
appropriate patients and both modes of RVT, TF3 and U-Tell, will be 
considered in the thesis. The 15% over-performance of SET when compared 
to the other Trusts may demonstrate more effective utilisation of RVT as the 
cost of service did not over run requiring a cessation of service in the final 
month of contract year 2014/15. Equally, it may demonstrate a lack of 
adoption of the TF3 or a targeted approach to care regimen for patients. It 
does indicate a mixed use of different RVT solutions within SET. 
 
1.13 Stratified Provision of RVT and First Consideration of 
Model in Thesis 
 
Access to alternative forms of RVT must not be ignored particularly as the 
Regional RVT service, RTNI, provided by TF3 was to be the only service 
provided and indeed to be end-to-end. During the specification design stage, 
the two clinical advisors were concerned by risk of variation in service 
provision; in particular risks posed by patient self-reporting as errors, 
deliberate or accidental, were possible. At the time of specification design 
Trust representatives argued that patients with diabetes already had an ability 
to inappropriately record their readings in their logbook for practitioners. It was 
further argued that experienced practitioners could discern when 
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inappropriate recording was occurring most particularly with the utilisation of 
the HbA1c blood test which demonstrates control over time. SET argued that 
patients should be trusted, and self-reporting permitted but this view did not 
prevail, and the regional service specification only reflected end-to-end and 
automated data reporting. Moreover, during the design of the specification 
SET argued for the development of portals and apps for data capture, 
particularly for simple single data capture, for example, blood glucose 
readings. During negotiations one potential provider’s Chief Executive 
explained that income for them was derived from the sale of hardware and so 
would not compromise high volume sales for low cost alternatives. Therefore, 
from the outset of the RTNI contract, SET did not share the strategic view as 
to how RVT should be developed as the opinion maintained by CCH and TF3.  
If the attainment of Trust’s MPD target within the TF3 contract alone was the 
measure of relative success or failure of RVT within SET, then as shown SET, 
may be considered as failing or not optimising RVT. However, SET RVT 
management and some clinicians took a different approach to RVT than the 
other Trusts and the construction of a pyramid of cost versus volume was 
proposed by the researcher. (Figure 1.7) 
 
Figure 1.7: Stratified provision of RVT 
In order to expand this, SET decided to seek alternative provision and go 
beyond the RTNI TF3 service. One service in particular is U-Tell and this RVT 
tool was included when the research question of optimisation of RVT was 
explored. 
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1.14 South Eastern Trust Creation of an Alternative Low 
Value/ High Volume RVT 
 
In 1998 during the time of the Path.Finder Medical committee early work 
commenced between the Ulster University Computer Science Department 
and a Consultant Endocrinologist, based within the Ulster Hospital. The 
practitioner had wanted to be able to review his diabetic patients blood 
pressures without the need for clinic visits and so a PhD Student, Ulster 
University, created and tested a new technology utilising Voice Recognition 
Technology (VRT) called ‘Di@l-log’. At that time most patients were not 
comfortable nor had access to the internet and so VRT offered a simple 
alternative. 
Essentially, the practitioner gave to the patient a blood pressure (BP) cuff to 
take home along with a unique patient identifier and pass code. With a small 
amount of training the patients were able to record their own BP and upload 
data to be viewed by the practitioner via an internet portal. The patient would 
dial the Freephone number, identify themselves utilising a four-digit pin, 
confirm identity and record their blood pressure via VRT or the use of a Touch 
Tone keypad. The practitioner could then contact the patient via the phone to 
adjust medication. 
In 2009, during the RVT pilot phase, SET agreed a grant contract with Ulster 
University Computer Science Department (UU) to develop the next 
generation; U-Tell for diabetes was created. Here the system could record the 
patient’s reading via VRT or via a web portal and patients could both record 
BP and Blood Glucose readings. A problem was soon encountered as the 
time of Blood Glucose reading and in relation to time of day was not available 
and practitioners would have preferred the functionality to exist so they could 
track blood glucose against a meal schedule. However, U-Tell was unique in 
that patients would receive instant feedback and advice. This was achieved 
by having pre-set/ algorithm-based responses programmed into the system. 
Functionality was dependent upon practitioners recording into U-Tell, when 
patients were being registered, the clinical parameters tailored to the 
individual. Responses therefore ranged from a ‘well done, keep up the hard 
work’ to pointing out the parameter breach and asking patient to make urgent 
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contact with their practitioners or clinic. The rudimentary decision making 
innate within the system gave U-Tell new utility. 
1.15 Description of the RVT U-Tell:INR Service 
 
The Trust in partnership with Ulster University developed a RVT solution 
which operated in parallel with the TF3 service. Whilst the original iteration 
was designed for patients with diabetes, the system was proactively utilised 
for patients who took the anticoagulant and who had poor control, often failing 
to stay in therapeutic range. The RVT system in use was known as U-Tell. 
The overarching utility of U-Tell was considered within other clinical areas, 
most notably for patients prescribed warfarin. Warfarin is a commonly utilised 
anticoagulation therapy but unlike many medications it is metabolised 
differently by different individuals. Some patients are able to break down 
warfarin more quickly in the liver and clear the medication from the system, 
variance between individuals is known as pharmogenomics; how genes affect 
medicines. Moreover, particular food substances affect the action of warfarin, 
for example alcohol will increase the anticoagulation or blood ‘thinning’ effect 
of warfarin whereas foods high in vitamin K, (e.g. spinach), will counteract its 
action. Therefore, unlike many drugs, most notably modern alternative 
anticoagulation medications (known as direct oral anticoagulants DOACs), for 
example dabigatran, apixaban, dabigatran and rivaroxaban, a standard daily 
dose of warfarin is not given. Indeed, warfarin dosage may vary not only 
across patient groups but also over short periods of time for individual 
patients. This means that a system of measurement and dose adjustment has 
been developed. The International Normalised Ratio (INR) is an assay which 
is used to determine anticoagulation; a measure of extrinsic pathway of 
coagulation.  
Most patients within the SET geography who receive warfarin therapy had 
their INR measured and warfarin dose adjusted within the GP Primary Care 
environment whilst a number of high risk or difficult to control patients were 
monitored and cared for by hospital based out-patient services. It is crucial for 
the dosages to be correct as an INR reading that is too high may lead to 
internal life-threatening bleeding, for example causing a haemorrhagic stroke 
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and equally an INR that is too low will demonstrate reduced efficacy and the 
patient may form a blood clot or thrombus causing a blockage which equally 
may be fatal through an ischaemic stroke or pulmonary embolism. Most 
patients are required to maintain an INR range within 2.0-3.0; this is higher 
than a normal person who may have an INR range between 0.8-2.1 and 
indeed, some patients at very high risk of clots, for example those with 
Thrombophilia Factor V Leiden may be required to maintain an INR range 
between 2.5 and 3.5. 
The blood sample is most commonly collected by a venous sample at a 
frequency dependent upon results but may typically range between weekly up 
to 6-weekly for patients who maintain control well. However, there are some 
near patient testing devices that would enable the assay to be undertaken 
utilising capillary blood from a ‘finger prick’. The blood is absorbed into a test 
strip and inserted into a device for the data to be readable by the patient and 
or practitioner. These near patient testing devices first started to become 
available in the mid to late 1990’s but there was reluctance to use them due 
to the catastrophic consequences for patients if they were not appropriately 
quality assured or calibrated. Despite the Path.Finder Medical Committee 
wanting to trial near patient testing the significant lack of assurance of device 
calibration meant that inherent risks could not be balanced by potential 
benefits. In 2009, SET commissioned U-Tell:INR and by 2011 a consultant 
haematologist within SET’s Ulster Hospital, was convinced of efficacy from a 
clinical governance perspective and was trialling a multi user INR meter 
device, [Roche CoaguChek XS], within the Outpatients Department to cross-
check venous sampling results from the Laboratory with capillary samples. 
Within the control process, once the INR result was known the result was 
transcribed by the haematology nurse into a computerised dosing system, 
called DAWN (within Primary Care RATS). Both systems guide the 
practitioner to advise vis-à-vis the next dose of warfarin and when the next 
INR test is required to be undertaken. 
Therefore, an opportunity was recognised to utilise the single patient use INR 
monitor with a U-Tell:INR system. In 2011, collaborative work between the 
SET, UU and the technology supplier Roche, commenced to design a version 
of U-Tell specifically for INR. The patient received a unique identifier and 
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passcode, dialled into U-Tell:INR to utilise VRN technology, a touch tone 
phone or entered an on-line portal to upload their readings. The patient’s 
expected INR range was set by the practitioner if it was outside the default 
parameter of normal therapeutic range. The patients were also asked two 
simple yes/ no questions to indicate if there was an increased risk of bleeding. 
As soon as the patient confirmed and sent their data instant feedback and 
advice was given. The data were then available on a clinic-based computer 
for the practitioners to review, put the data into DAWN dosing system and 
message the patient back. The U-Tell:INR system was designed to be a low 
cost/ high volume service where the only cost was the original grant 
investment by SET with UU, circa £20,000, along with the purchase of the INR 
meter and the test strips; this was funded through year end RVT slippage 
funds in 2011.  
The U-Tell system connected the clinician to the patient and enabled direct 
intervention by the clinician in response to a reading the patient has taken 
responsibility to upload themselves. U-Tell facilitated multiple metrics to be 
reported such as blood pressure or blood glucose but from 2011 there was a 
reduction of diabetic patients utilising the system and the focus shifted 
towards the interchange of INR data between patients warfarinised and their 
haematology nurses.  
The data flow between patient and clinician was managed through the U-Tell 
system via the internet with clear data flow as illustrated within the 
architectural schematic (Figure 1.8). As with TF3 data governance and system 
security is an essential feature. 
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Figure 1.8: Schematic Architecture of U-Tell System 
 
The INR Meter and U-Tell:INR system were designed to be simple for a 
patient to use as the following sequence of figures demonstrate: 
a. Patient’s U-Tell:INR website login screen 
b. Patient’s home-based equipment for monitoring INR and near-patient 
testing device showing an INR reading of 3.7 (above patient’s safe 
level) 
c. Patient uploads reading into the website 
d. Patient confirms that their responses are correct and can be sent to 
practitioner 
e. System responds automatically to patient to inform them that the 
reading is outside their parameter and causing concern 
f. Later in the day the patient logs back into the U-Tell system to read a 
response from their clinical practitioner. In this example reducing dose 
and instructing a retest. 
Steps ‘a’ to ‘f’ are illustrated in Figures 1.9 to 1.14. 
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Figure 1.9: a) Screenshot to illustrate patient login for U-Tell 
 
  
Figure 1.10: b) Photograph to demonstrate INR Meter with INR reading 
to be recorded in patient log book and U-Tell 
 
Chapter 1: Introduction 
Julie-Ann Walkden - July 2020   41 
 
 




Figure 1.12: d) Screenshot to demonstrate U-Tell verification  
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Figure 1.13: e) Screenshot to demonstrate U-Tell feedback; programme 
recognised INR was out of range and alerted patient 
Patient is then given instant feedback. In this illustration the INR has breached 
expected parameter for patient. (Normal range for this patient 2.5 – 3.5 and 
reading being too high at 3.7) 
 
 
Figure 1.14: f) Screenshot to show Haematology Nurse’s dosing 
instruction to patient on U-Tell 
The SET then established a clinical trial, a Randomised Controlled Trial (RCT) 
involving 80 participants, 40 randomised to test the U-Tell:INR intervention 
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and 40 traditional care within the SET Ulster Hospital’s Outpatient 
Department. The results indicated that patients utilising U-Tell:INR maintained 
better control of their INR and were more satisfied with the care they received 
with RVT than traditional services. (El-Agnaf, 2014). (Refer to Appendix 1 for 
brief overview of RCT findings). The view of participants is important in the 
consideration of optimisation of RVT and will be revisited later in this thesis 
(Chapters 4 and 5). 
1.16 Description of the RVT Design for Mainstream Service 
 
The design of both the TF3 system and U-Tell:lNR took much effort to ensure 
that by 2011, with known available state of the art RVT technologies, the two 
systems could be rolled out to scale within SET with the basic understanding 
of efficacy. The basic roll out and how the systems were to be utilised was 
well developed on paper, building upon the learning acquired by practitioners 
during the pilot project phases. Collaborative working across professions, 
commissioners and providers to understand and agree service specification 
had been undertaken. The pre-deployment collaborative design and 
specification was important to set the context for this thesis. In some studies, 
the stance taken by researchers has been to demonstrate clinical utility and 
relative value or effectiveness of RVT and yet the specification and 
deployment was often ill-conceived. Pinnock et al. (2013) intended to 
demonstrate clinical effectiveness of RVT, through RCT methodology, for 
patients with COPD living within Edinburgh; clinical efficacy was not 
demonstrated. Unlike the ECCH’s RTNI, where every element of service was 
planned, the Edinburgh project utilised donated equipment and did not 
demonstrate consideration as to which vital signs should be monitored, so 
that the basic peripheral device, the thermometer, to indicate infection in 
respiratory patients was not utilised. Furthermore, a plan for uniformity of 
service was not considered so that delays of many weeks for deployment of 
RVT equipment post hospital discharged was a frequent occurrence. 
Therefore, the context for RVT in SET was to deploy a well thought through 
service to augment usual care regimes. The effect of which, beyond the MPD 
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metric was unknown and the case to determine if there was benefit was made 
within this thesis. 
1.17 Purpose of study 
 
A new political focus upon healthcare reform illustrates the timeliness of the 
study (Bengoa, 2016). Patient-centric care derived from self-management 
could be of potential benefit for the wider system of management for those 
with chronic conditions (Grady and Gough, 2014). Previous studies have 
signalled an early indication that technology may enable self-management 
(Calvillo et al. 2013) but little evidence that RVT could deliver a patient-centric 
ethos. Indeed, the context of the TF3 service evaluation hinted of a possibility 
of patient personal utility but the research methodology was not constructed 
to explore or test the hypothesis (McElnay et al. 2016); a conclusion echoed 
in the findings by McDowell et al. (2015).  
The working title for this research study was the ‘Optimisation of Vital Sign 
Remote Telemonitoring’. The Participant Information Sheet interpreted this for 
patients and carers to mean that the purpose of the research was to examine 
the ‘best way we can use Remote Telemonitoring equipment and services to 
help our patients’, and for clinicians and managers ‘we can try to improve the 
care and support offered to patients in the future’. The Participant Information 
Sheet described how the researcher was interested to learn about the 
participant’s experience to improve the care. This purposeful approach was 
adopted as the researcher did not want to influence opinion of participants by 
suggesting any particular utility or benefit. Therefore, the purpose of the study 
was to examine the experiences of service users to determine if a consensus 
emerges indicating the real benefit of RVT. Thus, it revolved around a patient-
centric ethos. Additionally, the study aimed to understand how to maximise 
the effect of RVT, contribute to knowledge, and influence how future 
technology can be purposefully designed and deployed.  
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1.18 Aims and Objectives 
 
The Aim of the thesis was to critically assess whether RVT is perceived to 
have derived benefits for patients.  
This will be achieved through four objectives, to understand the context, to 
gain RVT knowledge, to understand benefit and to evaluate and engage. 
The Objectives are:- 
1. To describe, summarise, critically evaluate and clarify the current state of 
knowledge on implementation of RVT.  
2. To identify and describe service data trends from service user and 
practitioner perspectives.  
3. To determine the factors of patient benefit which are enabled using 
Remote Vital Sign Telemonitoring (RVT), taking the views of practitioners 
and senior managers into account and identify service benefits and risks.  
4. To devise recommendations to enable future deployments for optimal 
patient care.  
 
1.19  Hypothesis 
 
The identified gap in knowledge revolves around the understanding of a 
possible linkage between RVT and patient outcomes; thus, this research is 
designed to examine and test the hypothesis that: 
If the healthcare system successfully integrates remote vital sign 
telemonitoring into the treatment regimens for patients with chronic disease, 
then the effect will be that patients will feel better supported, in ways yet to be 
determined. 
1.20  Research Design 
 
Owing to the complexity of RVT implementation it was necessary to adopt a 
mixed methods research design in a post-positivist stance using a broad 
methodology of programme evaluation.  
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1. Review of available literature focused search criteria 
2. Use of baseline service data 
3. One-to-one interviews with health service practitioners, managers 
and commissioners. 
4. Application of a service user and carer questionnaire.  
Prior to engagement with research participants the prerequisite research 
governance and ethics approval was obtained: 
1. Ulster University Research Ethics Committee (Project No: 15/0065).  
2. The Proportionate Review Sub-Committee of the Health Research 
Authority, NRES Committee South Central – Oxford C (July 2015) gave 
permission for the research to be undertaken. IRAS project ID 155990 
3. SET Research Governance approval was attained on 11-Aug-15 REC 
15/SC/0424 Trust reference SET/15/17 
There were four main stakeholder groups identified who interacted with the 
RVT services; engagement with all groups was determined appropriate in 
order to examine data from all perspectives, to balance bias and interpret 
convergence and/ or divergence of opinion. However, engagement and data 
collection could not be designed to be conducted utilising a single 
methodological paradigm; instead, both qualitative and quantitative data 
collection methods were designed. Tables 3.1 and 3.3 in Chapter 3 illustrate 
the framework of data collection. It was estimated that at time of survey there 
would be circa N=280 service users/ patients and an unknown number, 
estimated as up to N=90, carers would receive questionnaires by post. The 
approach with health and social care staff, both clinical practitioners and 
operational or commissioning senior managers is qualitative. It was estimated 
that N=12 practitioners and N=8 managers would attend one-to-one semi-
structured interviews which would be scheduled to last up to 60 minutes. Then 
after high-level analysis of the qualitative data the practitioners would be 
invited to attend a validatory workshop. 
1.21  Risks and Inconveniences 
 
There were no serious risks associated with participation or data 
collection. Any potential for harm, such as through data breaches, were 
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mitigated through planning but it will be seen that none occurred during 
the data collection phase. 
1.22  Data Analysis and Interpretation Framework 
 
A quantitative analysis, of data held within the (IBM-SPSS version 25) data 
base has been undertaken and concomitantly the analysis of the qualitative 
data held within the (NVivo 12) database, for overall analysis. The data, 
regardless of type, was considered of equal value and was further analysed, 
blended, compared and considered complementary when reviewing RVT in 
SET from multiple perspectives. The process, known as triangulation can be 
undertaken from different stances but within the RVT Research, the equal 
weighting, the parallel data collection and handling enables the approach of 
Concurrent Triangulation (Creswell, 2003). (Refer to Chapter 3, Figure 3.17) 
However, before data can be triangulated each paradigm requires data 
collection, handling and analysis in parallel and two independent data 
analytics software were utilised to manage large volumes of data within 
independent databases and assist with the quantitative calculations and with 
the order, classification, interpretation and as appropriate the ‘quantitizing’ of 
qualitative data (Creswell and Plano Clark, 2007, P138). 
The Primary data analysis, prior to triangulation of findings, is summarised: 
1. Quantitative (statistical) analysis of numerical data from the patient and 
carer questionnaires were undertaken: - descriptive, exploratory and 
explanatory; (IBM-SPSS version 25 to be utilised). 
2. Qualitative analysis of narrative data obtained through semi-structured 
interviews on the topic of RVT with health professionals at all levels; 
a. One-to-one semi-structured interviews with practitioners with 
experience of utilising RVT and senior health and social care 
managers.  
b. Validation workshop with practitioners following high-level 
completion of quantitative analysis of the interview transcripts. 
c. Qualitative analysis of interview transcripts following a descriptive 
thematic approach. The stages and process involved within (NVivo) 
12 will be based upon Krippendorff (2004).  
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1.23  Assumptions, Limitations and Scope 
1.23.1 Sample Size 
 
It was decided that the entire RVT active user patient population would be 
invited to voluntarily participate in the study and be sent a questionnaire pack. 
Sampling was not employed as a data collection strategy was to maximise the 
power and meaning of the data from one service setting; given the maximum 
number of participants was less than 300 and contained at least seven 
disease sub-groups and two RVT technologies with three service deployment 
models, sampling was considered counterproductive. This approach was 
accepted by the three-research governance and ethics committees as no 
statistical rationale or ethical benefit would be gained by sampling the patient 
population. Equally, all clinical practitioners trained in the use of RVT would 
be invited to voluntarily participate in the study. 
1.23.2 Participant Bias 
 
It was accepted that those who choose to participate are more likely to view 
RVT from an individual perspective whether positive or negative. However, 
statistical analysis of the quantitative data should determine if there was 
validity and an expected distribution of responses. To balance this, the mixed 
methods approach should enable the issue to be viewed from four different 
positions with the participant groups interacting with RVT. That is to 
understand the perspectives of patients, their carers, clinical practitioners and 
the managers.  
1.23.3 Researcher Bias 
 
The adoption of a post-positivist stance ensures and accepts that the 
researcher utilises the underlying knowledge in a balanced way ensuring that 
the interpretation of findings will encompass the researcher’s own values and 
background when describing observations and analysed data. Equally, there 
is a potential for bias as there was a single reader during the literature review 
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process. Of note midway through the research the researcher moved 
employment from SET to the Health and Social Care’s central administration 
provider, the Business Services Organisation. It is likely that this move helped 
to achieve neutrality in later stages of the work.  
1.23.4 Scope 
 
Strict project management techniques, Prince II (Office of Government 
Commerce, 2009), were utilised to ensure that the research remained within 
parameters and executed data collection and analysis as planned and an 
approach duly approved by the research governance and ethics committees. 
Moreover, constraining the project to SET practitioners, despite approaches 
from practitioners from other Trusts, reduced scope-creep.  
1.24   Definition of Terms 
 
Within the strategic context, a detailed definition of terms is referred to 
Appendix 2, which was derived from the regional TF3 contract. However, for 
ease of referencing the most common terms utilised within the thesis are 
documented in ‘List of Abbreviations and Acronyms’ section, prior to Chapter 
1.  
1.25 Statement of Purpose 
 
Currently there is a gap in knowledge where the benefits of digitally 
transferring vital sign readings from patients at home to their practitioners are 
not well understood. There have been pilot projects but changes in 
professional practice are unclear and this contribution will attempt to address 
the knowledge gap. The aim and objectives have been defined and the 
research designed to test the hypothesis, resolve the questions and address 
the gaps. It is anticipated that the findings of the research will contribute to the 
knowledge, understanding, application and potential future application of 
RVT. 
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1.26 Summary 
 
The context for the research thesis was within a health and social care climate 
of a rapidly increasing elderly population with associated healthcare 
demands, increase prevalence of chronic diseases and a limited health 
resource. The sample population was that within the SET’s boundary and the 
technology being studied was a subset of telehealth, known in this research 
as Remote Vital-Sign Telemonitoring (RVT). There are two distinct services, 
one commissioned regionally from TF3, which was a higher value technology 
permitting both triage and track and trend models of care and the second, U-
Tell, was an in-house low value solution for warfarinised patients whose 
control was complex and so were managed through secondary rather than 
primary care. The regional strategic direction for eHealth was to harness 
possibilities afforded by telehealth whilst a service review commissioned by 
the Public Health Agency concluded that, set against the health economics 
metrics associated with reduced secondary care utilisation, the TF3 service 
had largely failed to show those benefits so was decommissioned (2018). 
There were management instruments such as service performance currency 
monitored patient days (MPD). This metric encouraged Trusts to put patients 
onto a monitoring system and to keep them on the service rather than 
genuinely enable technology to change healthcare delivery models and 
enable real patient benefit and improved outcomes to be discovered. 
However, clinical practitioners were, for the first time, given continuous access 
to patient level data to suggest healthcare status. This information that had 
not been made available before, had not been taught in educational 
institutions and where the meaning, benefit and practical use was yet to be 
understood. 
The value of this research is centred upon patient benefit derived from the 
RVT technology; it is to observe and determine if RVT adds value to and 
facilitates care or not beyond the simple performance management metrics 
associated with reduced utilisation of secondary care services. The research 
methodology is a mixed methods research design in a post-positivist stance.  
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The data are derived from multiple sources including strategic context, 
literature, qualitative data from patient and carer participant questionnaires 
and qualitative data from practitioner and manager participant one-to-one 
semi-structured interviews. Data are handled and analysed using standard 
methods packages (IBM-SPSS version 25 and NVivo 12). Equal value is 
placed upon data captured within a quantitative paradigm with that captured 
within a qualitative paradigm; triangulated using a concurrent strategy. The 
thesis articulates synthesised data, interpretation and created meaning; 
demonstrated perceived benefit for patients and made recommendations for 
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2 LITERATURE REVIEW 
2.1 Introduction 
 
A plan to undertake the review of literature pertaining to Remote Vital Sign 
Telemonitoring (RVT) was created to address the aim to critically assess 
whether RVT is perceived to have derived benefits for patients. The review of 
literature enabled horizon scanning, policy framework and synthesis of papers 
which tested a relevant hypothesis. It was believed that there was a broad 
base of material that could be reviewed and synthesised in order to contribute 
to the knowledge and understanding of effective technology deployment. In 
addition, it was recognised that not only should published academic papers 
be considered but also a scanning of local public media sources for anecdotal 
media reports of relevant subject matter. Whilst rigour was built into review 
system, topical horizon scanning was also undertaken with some non-peer 
review reports considered so as to track commercial innovative technology 
developments which may give an early indicator of the future of RVT.   
2.2 Review Methods 
 
A framework for a review was developed (Table 2.1). Literature Search terms 
included telemedicine/ telehealth, remote vital sign monitoring, 
implementation and success factors. When reviewing abstracts for relevance 
the degree of relevance was considered by reviewing the study’s context 
including the type of technology/ telemedicine/ telehealth, the environment, 
practitioners, practice development, service users/ clients/ carers/ patients 
within the aspect of chronic disease management. Given the novelty of 
concept and technology the rationale for the search period was restricted to 
the most recent period back to 2000 as prior to this date telemedicine was 
limited by the state of the art and was not akin to RVT. 
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2.2.1 Literature Search Plan included the following themes: 
Rationale for Literature Search Plan and Paper Selection 
Table 2.1 The rationale for literature search plan and paper selection. 
DATABASE (available at 
Ulster University) 
PROVIDED BY  
Medline Ovid Wolters Kluwer Health Ovid Technologies 
CINAHL Plus EBSCO Host 
Cochrane Library Wiley Online Library 
PubMed PMC-US National Library of Medicine 
Scopus Elsevier BV 
Search Criteria 
STRUCTURE APPLICATION TO STUDY 
Publications English Language, Peer 
Reviewed Journals, 2000-
2014 inclusive and research 
based 
Type of Service Telemedicine/ Telehealth 
Aspect Specific to Service Chronic Disease 
Client Groups All 
Decisional Factors (refined) Implementation, critical 
success factors, service 
measures/ outcomes, practice 
development and practitioner 
involvement 
Inclusion and Exclusion Criteria 
INCLUSION 
Publications in English between 2004-2014 inclusive in Peer-reviewed Journals 
Empirical Research Design 
Studies primarily relating to Remote Vital Sign Telemonitoring/ Telehealth/ 
Telemedicine 
Studies primarily relating to Chronic Disease Management 
Patients living in their own home/ tenancy within the community 
Practice/ Clinical Development demonstrated 
Implementation or deployment factors/ conditions/ issues described 
Health/ Medical Based Publications – Health Sector Rigour  
EXCLUSION (Review of abstract) 
Public opinion or views of non-health care professions/ groups 
Patients living in nursing homes or hospitals 
Where devices utilised are implanted into patients 
Where devices do not require patients to upload or send data 
Non-health Publications 
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The initial search results, based upon the above Rationale, are tabulated in 
the Table 2.2. It can be seen that the key search topic areas were refined in 
a phased approach so that an initial review of the topic of telemedicine/ 
telehealth suggested that there were 38,546 papers that matched the search 
criteria; chronic disease 762,160 and health plan implementation 184,662. 
These raw figures do not consider duplicated documents. The next cycle of 
searches reviewed success factors/ further development, then practice 
development, practitioner involvement, patient involvement and finally 
outcome measures. This led to a more manageable number of potentially 
pertinent papers (662). 
Table 2.2 Illustrates the numbers of research papers identified showing 
the reduction of available papers as exclusion review was undertaken. 
  
The 662 possible research papers matching the search criteria where then 
electronically de-duplicated and a manual review of abstracts concluded that 
there were 50 relevant research papers to analyse. The 50 papers were 
obtained in full and a first read then eliminated 7 as not relevant to the study 
and were disregarded. There was then a review of the search process and 
the analysis, and the initial search findings confirmed. However, prior to 
analysis of individual research papers the criteria for future searches was 
further refined, as illustrated in Table 2.3, in order to extend and update the 
review. 
The final Literature Search terms included: telemedicine/ telehealth, remote 
vital sign monitoring, implementation and success factors. decisional factors 
considered type of service: - technology/ telemedicine/ telehealth, the 
environment, practitioners, practice development, service users/ clients/ 
carers/ patients within the aspect of chronic disease management. 
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2.2.2 Updated Literature Search Plan included the following themes: 
Updated Rationale for Literature Search Plan and Paper Selection 
Table 2.3 The updated rationale for literature search plan and paper 
selection. 
DATABASE (available at 
Ulster University) 
PROVIDED BY  
Medline Ovid (all 3 data 
bases) 
Wolters Kluwer Health Ovid Technologies 
CINAHL Plus EBSCO Host 
Cochrane Library Wiley Online Library 
PubMed PMC-US National Library of Medicine 
Scopus Elsevier BV 
Embase Elsevier 
Updated Search Criteria 
STRUCTURE APPLICATION TO STUDY 
Publications English Language, Peer Reviewed Journals, 
2014-date of search inclusive and research 
based 
Type of Service Telemedicine/ Telehealth 
Aspect Specific to Service Chronic Disease (Stroke, Diabetes, 
Hypertension, COPD, Chronic Obstructive 
Pulmonary Disease, Bronchiectasis) 
Client Groups All 
Decisional Factors (refined) Implementation, critical success factors, service 
measures/ outcomes, patient centred (cent*) 
care/ practice development and practitioner 
involvement 
 
Updated Inclusion and Exclusion Criteria 
INCLUSION 
Publications in English between 2011-date of search inclusive in Peer-reviewed 
Journals 
Empirical Research Design 
Studies primarily relating to Remote Vital Sign Telemonitoring/ Telehealth/ 
Telemedicine 
Studies primarily relating to Chronic Disease Management 
Patients living in their own home/ tenancy within the community 
Practice/ Clinical Development demonstrated 
Implementation or deployment factors/ conditions/ issues described 
Health/ Medical Based Publications – Health Sector Rigour  
EXCLUSION 
Public opinion or views of non-health care professions/ groups 
Critical Appraisal of Remote Vital-Sign Telemonitoring 
56  Julie-Ann Walkden - July 2020 
Patients living in nursing homes or hospitals 
Where devices utilised are implanted into patients 
Where devices do not require patients to upload or send data 
Non-health Publications 
 
In addition, local Northern Ireland Policy documents, European Union Policy 
Documents and service user engagement documents were obtained from the 
Health and Social Care Trust, Health and Social Care Board, Public Health 
Authority, Patient Client Council and the European Commission’s website. 
Some consideration was also given to an on-going scanning of on-line news 
feeds such as for innovative commercially available technologies being 
deployed and where anecdotal findings may be indicative of a trend or 
opinion; such sources included the BBC, InnovateUK, GovTech and 
Knowledge Transfer Network. It was recognised that there was a distinct value 
difference between papers obtained following a formal literature review 
methodology and those that are newsworthy anecdotes so the researcher 
developed a framework within which each publication could be consistently 
classified. Moreover, email alerts from Elsevier.com were received and 
reviewed within the broad topic of telemedicine fields, chronic disease and 
published in English only. The PRISMA flow diagram (Moher et al. 2009), 
Figure 2.1 summarises the literature review. 
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Figure 2.1: PRISMA Flow Diagram to show literature review search 
The framework was developed, synthesising the work of Pope et al. (2007), 
Spencer et al. (2003) and Aveyard (2010) (Table 2.4). 
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2.2.3 Publication Review Framework: 






EVIDENCE TYPE EVIDENCE 
CONSIDERED AS: 
a. Systematic reviews and meta-analysis 
b. RCTs 
c. Quasi experimental designs – cohort studies, case control 
studies 
d. Surveys 
e. Case Reports 
f. Qualitative methods 
g. Anecdote/ expert or user opinion 
h. Public policy/ Public Consultation/ Statement 
 
 APPRAISAL QUESTIONS FINDINGS 
1 Who is the Author?  
2 What was the purpose of 
writing the report? 
 
3 How credible are the 
findings? 
 
4 How well is scope for wider 
inference explained? 
 
5 How well was data collection 
carried out? 
 
6 How well are the links 
between data, interpretation 
and conclusion? 
 
7 How clear is the reporting?  
8 What evidence is there to 
attention to ethical issues? 
 
9 How adequately has 
research process been 
documented? 
 
10 Is the report relevant to the 
research topic? 
 
Issues of note: 
Quotation: 
2.3 Literature Review Findings 
 
Following the extended review of literature there were a total of N=71 papers 
formally reviewed against the Publication Review Framework. Of note, papers 
classified as Public Policy/ Public Consultation/ Statement – evidence 
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classification ‘h’ were identified from public sector/ National Health Service 
(NHS) or European Commission (EC) sources rather than through the 
application of the Tabulated Rationale for Literature Search Plan and Paper 
Selection (Table 2.1). It was found that the numbers of types of publication 
were classified as tabulated (Table 2.5). 
Table 2.5 The summary of total number of literature review search 






























1 3 0 4 5.6   



















0 6 5 11 15.5 15.5 
  TOTAL 2 49 20 71 100 100 
 
The extended literature review, as tabulated (Table 2.5) and further groupings 
recognised for relative importance or power. Letter classifications were 
assigned to types of evidence and the relative weighting given to the power 
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of the author’s message. Such that types of research studies and concomitant 
findings were classified by letters ‘a’, ‘b’ and ‘c’ were considered, by the 
researcher, to be credible and most trusted. It can be seen that a third of 
research studies analysed were in the top weighted findings. In general policy 
statements and regional strategy, classification ‘h’ which were produced by 
the Departments of Health for Northern Ireland, UK Government and the 
European Union’s Commission were based upon expert knowledge and local 
research and so contributed to overall understanding and knowledge. 
Published public policy, or consultation or statements gave a strategic context 
for the application of technology within the public health and social care 
sector. Without the support of state funders and affirmation of support for 
healthcare technologies the context for the research would be abject. 
Classification ‘h’, public policy, in itself added a further 15.5% to trusted 
evidence. In summary of all documents included within the literature review 
were considered as meaningful; contributing to the development of the 
research study.  
The researcher placed greatest value upon findings articulated within 
classification types ‘a’ ‘b’, ‘c’ and ‘h’. However, it will be demonstrated that 
each study needed to be considered on its merits. Of the 71 papers reviewed 
the greatest value grouping with 15.5% being systematic reviews and meta-
analysis, classification ‘a’. The researcher placed lowest value upon findings 
articulated within classification type ‘g’ but it was recognised that the 
anecdotal evidence, expert opinion or user opinion could act as an early 
barometer for the future of technology in a rapidly changing environment and 
as such were included for analysis if relevant. Equally, 26.8% of papers were 
evidence type classifications ‘d’ to ‘f’, including surveys, case reports and 
qualitative methods.  
Of all non-policy papers (all literature excluding classification ‘h’) reviewed, 
the three highest value classifications (‘a’, ‘b’ and ‘c’) accounted for a total of 
40%, and the lowest value classification (‘g’) accounted for 28.3% of the non-
policy papers reviewed.   
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2.3.1 What the literature suggested regarding the use of RVT. 
Each type of evidence is reviewed separately and documented by 
classification to consider the relevance to the purpose of the literature review. 
2.3.1.1 Classification ‘a’ – Systematic reviews and met-analysis 
 
Within the framework of critical appraisal of literature reviewed (Table 2.4) the 
most significant studies were classified as ‘a’, systematic reviews and meta-
analysis. The eleven studies considered were published between 2008 and 
2017 and synthesised the findings of previous studies within the fields of 
telemedicine for the support of self-management, professional practice and 
support of family caregivers. 70% of the studies considered the telemedicine 
support for general chronic disease management, 20% the respiratory 
condition, COPD, and 10% heart failure. All the disease topics were relevant 
to the application of RVT service for those with LTC. The systematic review 
of literature undertaken by the World Health Organisation (2013) was focused 
upon the reduction of the overall burden of non-communicable disease 
(NCD). Whilst least relevant to the research question it was retained as it set 
the strategic context for the overarching topic. However, Hanlon et al. (2017), 
cautions that findings could be outdated due to technology advances and 
nature of meta-analysis. 
The eleven studies were published by authoritative academics, with seven 
teams based within the UK, two from international groups, one from USA and 
one European. All documented systematic review methodologies in detail and 
two studies were produced specifically for the Cochrane Collaboration. All 
reports were well explained, clearly structured with links between findings and 
source reports, well-articulated but only one of the ten expressly discussed 
ethical and research governance considerations.  
The importance of addressing the global impact of chronic disease was a 
theme connecting all research in the field acknowledging the overall 
pressures within the healthcare systems. In essence, the concept of 
telemedicine was articulated to assist in addressing the care for those with 
chronic, or rather, NCD. It was reported that circa 38 million deaths per year 
were due to NCD, albeit cancer accounted for 8.2 million; the Global Action 
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Plan for the prevention and control of NCDs 2013-2020 aimed to “reduce the 
number of premature deaths from NCDs by 25% by 2025” (WHO, 2015). 
Moreover, the global organisation focusing research upon COPD equally did 
not solely focus their systematic review upon the utilisation of RVT but did 
conclude that  
“Accumulating data from a variety of studies indicate that telehealth in 
any of its current forms has not shown benefits for patients with COPD; 
thus, telehealth is not recommended for use with COPD patients” 
(Gold, 2014, pxi).  
 
The lack of strong evidence, further reflected by Currell et al. Cochrane 
Review (2010), “Establishing systems for patient care using 
telecommunications technology is feasible but there is little evidence of 
clinical benefit.” A view echoed by McClean et al. (2011), observing that 
“Telemedicine is a complex intervention as defined by the MRC and …difficult 
to pin down exactly what is the "active ingredient" of the intervention.” Their 
meta-analysis suggested further studies be undertaken to understand how 
“effect is delivered”. The analysis did describe opportunity within the field of 
telemedicine to provide patient education, connect remotely and improve 
medicines adherence and did positively indicate that  
“research suggests that telehealth care has the capacity to reduce 
exacerbations and may improve the quality of life of the people using 
it in comparison to usual care.” (Ibid.)  
Whilst indirectly this is suggestive of benefit it must be recognised that the 
meta-analysis was based upon experience of technology that is now in excess 
of 10 years old. 
An analysis of studies reviewing the UK’s multiple RVT Dallas Projects 
highlighted many and several issues relating to varied RVT services (Wylie, 
2015). The review applied the theory of Normalisation Process Theory (NPL) 
to the meta-analysis and Devlin et al. (2015) articulated the implementation 
issues and highlighted resistance to change.  
“Flexibility, adaptability and resilience are key implementation 
facilitators when shifting to new digitally enabled modes of care 
...complex nature of implementing digital health and well-being in 
practice” recognising the “…tension between embracing innovative co-
Chapter 2: Literature Review 
Julie-Ann Walkden - July 2020   63 
design and achieving delivery at pace and at scale” (Devlin et al., 
2015).  
In summary, RVT is a complex intervention which is difficult to successfully 
implement and requires agility to change practice and enable co-creation. 
Taylor et al. (2014) further supported McClean’s (2011) assertion regarding 
patient education and self-management suggesting that: 
“Supporting self-management is inseparable from the high-quality care 
for LTCs… promote a culture of actively supporting self-management 
as a normal, expected, monitored and rewarded aspect of care”  
Again, echoing a call for additional research in this area. The definition of self-
management was offered by Wylie (2015):  
“the tasks that individuals must undertake to live with one or more 
chronic conditions.  These tasks include having the confidence to deal 
with medical management, role management and emotional 
management of their conditions”  
…positively upholding RVT as an intervention. Moreover, beyond self-
management the need for RVT to be integrated within the healthcare system 
rather than as an adjunct to care was thematic. The self-care collaboration 
between practitioner and patient was also considered by Nolte and McKee 
(2008) within the context of RVT and offered the suggestion that self-
management was patient-centred and promoted “patient activation, education 
and empowerment.” The theme of lack of evidence, in relation to patient 
involvement and satisfaction was extended by Kraai et al. (2011) calling for 
better questionnaire construction as it is “underexposed in telemedicine 
research and the measurement of patient satisfaction with telemedicine 
underappreciated”. Of note, the analysis of Nui-Ching Chi and Demiris (2015) 
observed an additional beneficial dimension; the idea of a benefit of RVT 
going beyond the purely therapeutic gains of the patient stating that, 
 “Technology can support caregivers and facilitate better coping.  
Caregivers believe that technology can help them to make caregiving 
more efficient, effective, safer and less stressful when delivering care 
to the patients.” 
In summary, whilst the need for more research in the field was articulated 
there was early evidence that RVT was capable of affording some benefit for 
patients and carers. 
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2.3.1.2 Classification ‘b’ – Randomised Controlled Trials (RCT) 
 
Wyatt (2012) suggested that Randomised Controlled Trials (RCTs) are not 
necessarily the optimal methodology to utilise when reviewing the use of new 
complex telehealth technologies as there may be multiple variables and “… 
risks of interpreting study results ignoring the context.” However, to utilise a 
control group, within the context of healthcare is frequently viewed as a ‘gold 
standard’ by clinicians with the determination of effectiveness being important. 
Within the parameters of the literature search there were ten papers. 
However, the findings of a promising crossover RCT study, Lewis (2011), 
were not published (reason unknown); so only nine papers were considered.   
 
In England and Wales, the Department of Health operated a programme 
called the ‘Whole System Demonstrator’ which was designed to implement to 
scale a range of remote telemonitoring services for service users in their own 
homes. The programme consisted of a cluster of individual projects which 
attempted to integrate telecare and telehealth into practice. As part of the post 
project evaluation several academic teams were commissioned to review the 
outputs. Stevenson and Bardsley (2012) examined hospital utilisation via 
emergency admissions and mortality. The study concluded that the 
introduction of telehealth should be considered as there  
“were statistically significant differences in rates of emergency 
admission and mortality during the twelve months of the trial between 
control and intervention groups”;  
the findings suggested a 20% reduction of emergency admissions and there 
was a statistically significant difference with deaths with 4.6% of participants 
in the intervention arm versus 8.3% of control participants.  
Henderson et al. (2013) undertook a study to examine the cost effectiveness 
of the same Whole System Demonstrator programme. The review considered 
the economic differences between usual care and participants who received 
the intervention. The conclusion did not favourably make the case for 
telehealth albeit it did report that the ‘back office’ costs were high which may 
indicate that there was a diseconomy of scale i.e. (disproportionate cost 
burden for a lower volume service) as clearly provision was over laid rather 
Chapter 2: Literature Review 
Julie-Ann Walkden - July 2020   65 
than built to the same scale as usual care. Interestingly the study suggested 
that cost was borne by community services whereas cost benefit was realised 
by secondary care. The study findings concluded that  
“QALY gain by patients using telehealth in addition to usual care was 
similar to that by patients receiving usual care only, and total costs 
associated with the telehealth intervention were higher.  Telehealth 
does not seem to be a cost-effective addition to standard support and 
treatment.” (Ibid.) 
An influential study, arguably slowing progress of telehealth, examined the 
effectiveness of telemonitoring as defined by the admission rates when 
compared to usual care for COPD patients in Edinburgh, (Pinnock et al., 
2013). The report, did not give a direct indication of patient benefit through 
quantifiable data but nested qualitative analysis demonstrated participants 
had understanding of condition and appreciation of the intervention, ergo 
arguably demonstrated patient benefit (Ibid.p6). The study methodology itself 
was robust and was focused upon the reduction of hospital admissions as the 
key metric of success. The study did not show effectiveness against the key 
metric and hypothesised that earlier studies finding an opposite result could 
have been due to enhancement of underpinning care provision rather than 
telehealth. There were difficulties associated with poor telehealth solution 
design which were not considered, and recruitment was a challenge as so 
many people were ineligible. Recruited patients may have experienced long 
delays between discharge and equipment installation which may have 
affected patient outcome or benefit. The lack of relevant vital sign peripheral 
devices in the study would be a significant difference from other RVT service 
for respiratory patients (Pinnock et al. 2013 and McDowell et al., 2015). 
However, it was found that the service had been valued by both service users 
and carers alike. 
One Northern Ireland trial of RVT services reported performance of warfarin 
management service (El-Agnaf et al., 2014). Forty patients were randomised 
to usual care and forty to the intervention which included self-testing and 
reporting to the anticoagulation nurse’s office via a web portal. The metrics 
utilised to review the intervention included health related quality of life, cost-
effectiveness, satisfaction and therapeutic benefit. The cost of the intervention 
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was high as all initial hardware commissioning and software design had been 
included. Participants were satisfied with the RVT but most interesting was 
that the Therapeutic Time in Range (TTR) was significantly better than usual 
care;  
“mean difference (SE) in time in therapeutic range (%) was -13.1 (3.5) 
using traditional method and -13.7 (3.5) using Rosendaal method.  
These results suggest that those in the intervention arm had a 
substantial improvement in TTR” (Ibid.). 
 
Equally, another RVT service was a triage service for COPD which was 
subject to an RCT (McDowell et al., 2015). The study was designed to assess 
if care was improved through the use of RVT to determine if there was a 
benefit provided. The scope for wider inference was not widely elaborated but 
the economic review in itself informs the debate. Whilst the technology was 
found to be effective and the study contributes to the context.  
“In selected patients with COPD, telemonitoring was effective in 
improving health-related quality of life and anxiety but was not a cost-
effective intervention,” and it was “…possible that the reassurance 
provided through these regular contacts reduced anxiety and 
increased confidence, enabling patients to feel more in control of their 
symptoms and more able to carry out activities of daily living.  This is 
reflected in the enhanced quality of life and suggested by the 
satisfaction questionnaire, with 84% of patients feeling more in control 
of their health with telemonitoring” (McDowell et al. 2015) 
Moreover, 84% of participants utilising RVT agreed that it enabled them to 
feel more in control of their health, (Ibid.) an important indicator of potential 
value. 
Greenwood et al. (2015) considered telemonitoring and triage nursing care 
for patients with diabetes mellitus; this is interesting as the RVT service 
offered in SET for those with diabetes mellitus included the technology in a 
‘track and trend’ provision and did not offer the nurse triage component to 
care. In particular, the study maintained an emphasis upon self-care and 
behaviour change. The findings of the RCT was meaningful indicating the 
usefulness of the intervention as in particular, 
 “complete feedback loop in the primary care setting, supported by 
telehealth remote monitoring and paired glucose testing, improves 
HbA1c and self-management behaviours in adults with type 2 
diabetes.” (Ibid.) 
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Another Northern Ireland based study, RVT for those with Gestational 
Diabetes Mellitus (GDM) (conducted as part of a PhD study) and given the 
technology tested was supplied by the same TF3 service utilised by SET, it 
was considered relevant (Given et al. 2015). Of note, in the GDM study there 
was a suggestion that RVT should integrate into existing care whereas within 
SET there was more of an emphasis upon service redesign which may in turn 
enable practitioners to have dedicated RVT analysis sessions and therefore 
dedicated time. The GDM study reported, 
 “there was also a suggestion that telemedicine assisted the women to 
take more control of their own health such as ensuring that the blood 
glucose tests were actually performed "instead of just skipping them" 
(participant B20)” (Given et al. 2015).  
The study also found a high proportion of participants were satisfied and staff 
participants recognised the reduced burden of travel for participants was an 
important dimension of quality. Again, this GDM study echoed findings from 
the COPD study (McDowell et al. 2015) with clinical staff recognising that 
protected time for RVT was required and that RVT has a complementarity with 
standard care. 
 
Fitzsimmons et al. (2016) reported upon a qualitative study examining COPD 
patient perceptions of telehealth (and the findings were very relevant). The 
findings were published five years after the data were collected but the 
conclusions remain consistent with qualitative findings in the RVT review. The 
COPD study articulates statements from participants who expressed personal 
views including feelings of being less confident since the technology was 
subsequently removed and that they felt they were being kept safe when on 
the system; it was reported that  
“Our study shows that this benefit is derived even when patients were 
initially resistant to the concept of technology-enabled care for their 
condition… Beneficial feelings of comfort and safety from the 
Telehealth service” (Ibid.) 
Therefore, most of the RCT papers, relating to telehealth, supported the initial 
proposition that there may be benefits to patients. 
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2.3.1.3 Classification ‘c’ – Quasi experimental design – cohort studies, case 
control studies 
 
Some of the papers described projects undertaken in the ‘real-world’, and 
followed the ‘nature of quasi’ experiments, although lack control, they were 
more akin to actual service delivery. Within the literature review methodology, 
four papers classified as quasi experimental designs, cohort studies or case 
control studies, one of which was published in 2004 [some four years before 
early experimentation with RVT commenced in the South Eastern Trust]. The 
study methodology was not well explained, technology basic, primarily being 
a Plain Old Telephone System (POTS) and the cohort of participants were 
younger children who received a psychiatric report. However, it was thought 
provoking as Young and Ireson (2004) intimated that the remote care 
delivered through technology was particularly beneficial for families 
suggesting financial incentives. 
Ure et al. (2011) reported a mixed methods exploration within a COPD pilot 
study that was well designed and executed. The subject matter was 
articulated and considered pertinent except the technology used was limited 
to pulse oximetry, spirometry and questionnaires. Patients were asked about 
self-care; they reported abrogation of responsibility for self-care and looked to 
practitioners for support. The findings indicated that both service users and 
practitioners were positive about the technology in particular addressing a 
common problem of early identification of exacerbations to enable early 
intervention with the provision of “… a tangible symptom score, both validated 
the decision to seek help and ensured a prompt appointment.” (Ibid.) 
Moreover, Ure et al. reported, “…access to readings and emergency supplies 
of antibiotics at home gave them confidence to respond to deteriorating 
symptoms themselves.”  
The study by Bower et al. (2011) was the only study found that articulated a 
difficulty with randomisation and so methodology was changed mid study and 
compared telehealth and telecare across two nested groups to test five 
themes. There were two lines of enquiry that were considered pertinent, 
“Theme 2: Clinical effectiveness.  Does the introduction of telehealth 
or telecare result in improvements in quality of life, well-being, self-
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care and carer burden? …and…Theme 4: Patient and professional 
experience.  What is the experience of service users, carers and health 
and social care professionals during the introduction of telehealth and 
telecare?” (Ibid.)  
Whilst the study was clearly reported, the findings were inconclusive. 
The fourth research paper within classification ‘c’ demonstrated more promise 
and studied a group of patients with hypertension; being relevant to RVT and 
was compelling although suggested patient compliance was emphasised 
highlighting the need for nurse support. Indeed, the Italian telemonitoring 
efficacy study stated that  
“When the patients realize that their adherence is constantly and 
carefully checked, they acquire a feeling of greater control and 
consequently higher compliance which contributes to positive effects” 
(Bernocchi et al. 2014).  
These in-service studies indicated that there was patient level benefit and 
encouraged utilisation and further research. The suggestion that the act of 
being monitored, drove patient behaviour to be compliant or adherent with 
therapy was a new benefit. 
 
2.3.1.4 Classification ‘d’ – Surveys 
 
The value of the reports formulated around surveys had utility as they gave to 
patients a voice and enable reflection on user experience. Five reports 
published between 2013 and 2016 which were classified as providing the 
evidence type of ‘surveys’, classification letter ‘d’; equating to 7% of 
documents considered. Two reports were results of remote vital sign 
telemonitoring (RVT) user satisfaction surveys over two consecutive years 
(SET, 2013 and 2014).  
Kennedy et al. (2014) for Long Term Conditions, the integration of self-
management in primary nursing care was considered but the details of study 
methodology and results were not reported in detail so that inference could 
not be determined. However, a reported finding was that unless staff are 
committed there would not be effective implementation and benefit would not 
be demonstrated.  
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An interesting approach to surveying General Practitioners (GPs) in England 
was reported by Chambers (2014) in an examination of how GP 
Commissioning Groups viewed Telehealth. There were 176 questionnaires 
issued and 108 returned. The Freedom of Information legislation was used to 
seek a response to survey questions. Of note, Chambers identified,  
“‘Telehealth’ as if the technology is a clinical intervention in itself, when 
in fact it is no more than a means of conveying healthcare-related 
messages and information” (Ibid.)  
This was the only report to suggest such a finding. It was also noted that GPs 
were offered an enhanced service rate for telecare in April 2013 whereas such 
encouragement was not documented within 2014/15 contracts. Chambers 
made some specific recommendations that, if followed, would lead to greater 
use by GPs and Trusts of telehealth. These included telephone or video 
consultation, highlighting convenience for patients and that workforce 
competence was required at three levels which were basic understanding, 
higher knowledge including ‘digital health assessment’ and expertise in ‘digital 
health modalities’ (Ibid.).  
These specific findings did not resonate with the findings and 
recommendations of a review undertaken in Belfast as a general review of the 
Northern Ireland Remote Telemonitoring Service. 
In 2016 McElnay et al. returned a report to the Centre for Connected Health 
(CCH), the Commissioners in Northern Ireland responsible for Remote Vital 
Sign Telemonitoring, the RTNI service. The report was aimed to address 
effectiveness of the RTNI and be a formal post project evaluation. From the 
report there was a focus upon the articulation of success in relation to 
economics and effect upon secondary care. Service uptake data available 
and a limited number of surveys directly with service users and practitioners 
formed the data. The clinical participants were mainly GPs and community 
pharmacists, neither profession groups had experienced the regional RVT 
service with less than a third of interviewees having used RVT. When 
examining the regional RTNI Service review 15 patients and 8 carers were 
surveyed through a total of 5 focus groups including 2 patients and 1 carer 
from within South Eastern Trust (SET) Area.  
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The report gave an interesting service account of activity by long term 
condition and district over time but with a low response rate from service 
users. It could be argued that there were insufficient participants to provide a 
conclusion but the observation that patients felt reassured was a patient-
centric benefit. This suggestion was consistent with the findings across a 
range of studies as articulated which suggests RVT technology acceptance 
and receptivity is important and yet such a benefit is frequently not interpreted 
as a benefit of RVT rather as a secondary observation. 
2.3.1.5 Classification ‘e’ – Case reports 
 
The case study is a fundamental approach to basic evidence gathering and is 
useful at early stages giving potential value to this category and are of benefit 
when preparing for further trials or research (Bowling, 2002). Within the 
second tier of evidence type there were 9 publications categorised as ‘e’, case 
reports. At the turn of the century there was an optimism suggesting that 
healthcare could be enhanced by new technologies. Lorenzi and Ripley 
(2000) do not directly relate to RVT but do raise the issue of change 
management when IT is introduced into the healthcare environment and that 
it would be the people who enable effective use of technology - they need 
themselves to be empowered. This publication clearly articulates that 
technology adoption and behaviour change with practitioners “…starts with 
creating a vision for change and then empowering individuals to act as change 
agents to attain that vision” and in turn the leadership of change to inculcate 
new information technologies into healthcare is essential (Ibid.). 
 
At these early stages, practitioners were enabled to experiment with small 
scales tests or RVT. For example, the respiratory team (within the locality of 
Lisburn) commenced a trial of RVT with a cohort of COPD patients. The 
service was evaluated against metrics which were measured through detailed 
analysis of GP records of patients who participated in the pilot and also gained 
direct feedback. Not only did the respiratory team establish their own pilot and 
determine mode of utilisation of technology, but their findings concluded that 
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“…patients felt empowered and there was an overall improvement in their 
quality of life” (Hanna. 2008) 
 
The COPD RVT pilot in Lisburn (SET) was also a case study evaluated by 
BDO Stoy Hayward (2008) in order to determine if remote telemonitoring 
showed promise and should move from pilot phase into a regionally 
commissioned service. The auditors won a contract to evaluate all telehealth 
projects across the five Health and Social Care Trusts in Northern Ireland. 
These reports were not made public, were marked ‘Commercial in 
Confidence’ and the European Centre for Connected Health (the Department 
of Health body which was the predecessor to Centre for Connected Health 
and Care). The report was relevant given it was the antecedence to the RTNI 
regional programme but could only be classified as a case study. This report 
reviewed several early SET RVT projects during 2007/ 2008. Arguably the 
most interesting observation highlighted was that 
“… there are differences in perception between clinicians and patients 
in respect of the use of clinical triage – over 80 % of clinicians are not 
confident that clinical triage is suitable for monitoring patients from a 
distance where the nurse has not met the patient in person.  This 
compares to 90% of patients who are satisfied with clinical triage” 
(BDO, 2008). 
The reported apparent disagreement about the advantages of triage service 
between patient and practitioner was reported. Several studies have muted 
the receptivity of service users and the reticence of practitioners when others 
note the need for practitioners to be enabled to inculcate technology into 
practice (rather than to have it mandated by management). In the early studies 
the theme of implementation appeared to preoccupy researchers and the e-
Health Research Unit, Kings College, London undertook to evaluate the e-
Health Implementation Toolkit (e-Hit). Whilst, no impact of RVT upon service 
users was documented the impact for practitioners was explored with themes 
documented. It was highlighted that the  
“narrow focus on organisational issues related to implementation, with 
little attention paid to the impact of new technologies on workload, 
inter-professional relationships, and communication between health 
professionals and patients.” (Murray et al. 2010). 
Chapter 2: Literature Review 
Julie-Ann Walkden - July 2020   73 
A case study undertaken by the Kings Fund (Sonola et al., 2013) considered 
telehealth in a virtual ward environment in Devon for patients with long term 
conditions. The report focused upon the need to have a community integrated, 
Virtual Ward, approach to improving care for those with chronic diseases. By 
adopting the Virtual Ward approach with a lead nurse, community matron, to 
engage patients; a change in care with technology alone did yield benefit. The 
researchers suggested that  
“Perhaps not so evident from the impact data is the extent to which 
patients themselves are empowered to manage their own care and the 
degree to which they, or their carers, are expected or able to play a full 
part in the care planning.” (Sonola et al., 2013). 
In a single site extended case study, Llewellyn et al. (2014) investigated how 
the gap in organisational factors that did not enable technology uptake and 
was contextualised as a search for benefit from an organisational stance, not 
from the perspective of patients. The role of a practitioner to integrate 
technology into pathways of care and adapt care regimes is not defined in job 
descriptions but it was reported that there had been a bottom-up approach to 
technology adoption. Evidence showed enthusiasm for adoption was 
juxtaposed with their finding that there was “no evidence of benefit over 
existing technologies” (Ibid.) 
Conversely in 2014, a review of the RTNI focused upon patient and service 
user experience, with crucial conversations with 9 patients. The Patient and 
Client Council (2014) recorded the findings of their anonymous face-to-face 
interviews. A number of participants reported feeling better connected with 
practitioners, better informed and had better understanding of their condition. 
Indeed, the Patient and Client Council’s reported six benefits (Table 2.6). 
  
Critical Appraisal of Remote Vital-Sign Telemonitoring 
74  Julie-Ann Walkden - July 2020 
Table 2.6 The patient reported benefits of telemonitoring service. 
Benefits of the telemonitoring service that patients reported 
1. Less travel/ visits to clinics or the hospital for routine appointments 
2. Patients feeling that healthcare professionals would be kept well informed about 
their condition over the monitoring period 
3. Reassurance, feeling of being well supported 
4. Better channel of communication with healthcare professionals 
5. Greater understanding of their condition and how it affects them 
6. Improved self-management of their condition 
(Patient Client Council, 2014) 
However, not all case studies reviewed focused upon direct benefit for service 
users, rather focused upon technology itself. Vladzymyrskyy et al. (2016) 
charted the history of telemedicine over a century. A series of case reports 
within their textbook tracked the evolution of telecommunications and 
adaption and deployment into health care up to and including polar and space 
exploration. From a reflexive stance RVT, as an extension of 
telecommunications, is a means by which clinical practice can evolve to both 
empower practitioner to care and patient to participate. The narrative also 
reminded and demonstrated the accelerating pace of change.  
2.3.1.6 Classification ‘f’ – Qualitative methods 
 
The benefit of qualitative methods is the contribution to understanding of those 
involved in service delivery as providers, patients or carers. The final 
classification of the 2nd Tier is described as qualitative methods, classification 
‘f’, which equated to 5.6% of the papers considered in the review of literature 
with 4 papers published between 2009 and 2014. Sandberg et al. (2009) 
utilised telephone interviews with practitioners, referred to in the study as 
‘telemedicine providers’ when interviewing healthcare providers about their 
experience of utilising telehealth.   
Sanders et al. (2012) undertook a qualitative analysis of the English 
telehealth, Whole System Demonstrator (WSD) examining the barriers to 
adoption and participation. The findings were credible with comprehensive 
one-to-one interviews highlighting resistance to the intervention; relevance 
demonstrates an emerging picture of the requirement to enable practitioners 
to be part of solution development with co-creation rather than a management 
instruction; “…the need for closer proximity between innovation design and 
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evaluation, so that critical insights might usefully feed back into design and 
implementation.” (Ibid.) 
A European Commission evaluation also examined barriers and enablers in 
acceptance of new technology.  However, the technology blended ambient 
technologies, guidance systems and limited vital sign monitoring. With the 
 “Difference between experiencing and understanding the benefits of 
technology and acknowledging a need and wishing to adopt the service” 
being highlighted for consideration when planning ICT for Older People at 
home. (Georgantzi et al. 2014). 
The theme of requiring an enabling environment for technology 
implementation whereby the new ideas, services, products, practice, policies 
and processes, skills, competency and the translation from theory in 
academia into practice was discussed by Silva et al. 2014. The Brazilian study 
was not particularly easy to decipher nor was it entirely related to telehealth, 
rather the wider family of technology into healthcare but the key concepts 
resonated with the interpretation of feedback.  
2.3.1.7 Classification ‘g’ – Anecdote/ expert or user opinion 
 
The third tier of reports considered, included both expert opinion and anecdote 
and was given the classification of ‘g’ with 17 papers reviewed contributing to 
23.9% of the literature review content. The decision to include the third tier 
was made on the basis that much of technology in RVT is fast moving, quick 
paced in development, agile in design and today it appears that no sooner 
has a technology been tested it is superseded. Therefore, although lacking 
academic rigour in study design, data collection and execution, classification 
‘g’ was considered to be a barometer of opinion to include.  This classification 
is considered to contribute the lowest value findings to the overall review. 
The emergent theme of environmental factors influencing technology 
development and integration was articulated by Gardener et al. (2007) 
“leaders in the global health community… articulate a broader and more 
inclusive vision for health innovation” and makes the case for a link between 
the variety of view of the manager and the practitioner and highlights authority 
to influence tech innovation. The paper is relevant in so far as it shows the 
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link between policy and social environment and the power of leaders and 
practitioners to influence adoption. May and Finch (2009) reaffirmed utility and 
relationship between the study of normalisation and the implementation of 
RVT; the theory of normalisation processes can explain why putting into 
practices new ways of working and embedding the change can be complex 
and time consuming.  Murray et al. (2010) discussed the issues relating to 
adoption of technology and normalisation in practice; use of complex 
intervention and ensuring relevance for practitioners to ensure widest 
adoption into practice, in particular they highlight the  
“…substantive problem is the gap between research evidence and 
practice…Translational gap is also evident: that of using the results of 
such health services research to inform wider health-related policy and 
practice.  Such implementation failures are often attributed to slow 
behaviour change by professionals” (Ibid.).  
Deloitte (2012) detailed staff engagement being crucial to success, 
highlighting lack of expertise, lack of evidence and perceptions about high 
cost.  
The need for a strengthened base of evidence upon which future development 
can be anchored and that telehealth in general lacked underpinning theory. 
With “…theories that are well validated with empirical work and scholarly 
review hold the greatest value,” (Brennan.2008). However, the complexity of 
gathering such empirical evidence in complex interventions, multiple variables 
and new telehealth technologies is in itself complex “…and the risks of 
interpreting study results ignoring the context” (Wyatt. 2012) is recognised. 
The willingness to test new technology by practitioners can be linked to 
evidence to support practice and in turn the level to which clinicians become 
involved. (McKinstry et al. 2013) 
The concept of patient involvement, self-care, empowerment and benefit 
emerge within papers allotted the classification ‘g’. In 2011, Wyatt believed 
that “Technology can empower…. We need to shift towards a new model in 
which the patient is treated as a partner in medical care” and by 2013 Wismar 
and Greer extended the concept further suggesting patients should be 
participants in co-creation and involvement in decision making. The support 
of people with complex health care needs through telehealth was recognised 
by Ham and Walsh (2013) and its ability to change behaviour and benefit 
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service users suggested by Scott (2013). Compliance with treatment regimen 
is well understood in healthcare as a critical success factor; Bruzek (2014) 
suggested that (anecdotally) the use of RVT in self-management could 
provide better outcomes by encouraging patients to participate in care and be 
compliant. Farr and Nayak (2014) demonstrated a growing interest by public, 
media and industrial funders of healthcare in technology for self-care and 
management suggesting there is a future space for self-management in cost 
reduction and compliance. The journalist Wall (2016) suggested that a 
general trend of self-monitoring of a greater range of conditions will be 
supported by NHS senior staff with the advancement of sensor technology. 
Fellow journalist Smyth (2017) highlighted the need for both tailored health 
care and that patients and carers consider information as a key dimension in 
health care delivery with information as a power component for the patient or 
carer. 
 
Within the classification ‘g’ there were two dissenting writers. Scullion (2014), 
a leading respiratory specialist nurse in the UK expressed a view that did not 
support the utilisation of RVT albeit there was a suggestion the system may 
work well where deployment is thought through and integrated. However, 
contrary to benefit the risk of abrogation of responsibility by patient remained 
too high a risk; the stance was maintained based upon personal clinical 
experience. In 2017 the BBC reported the emergence of ‘Cyber-Chondria’ 
following research undertaken by Imperial College, London, where patient use 
new technologies created anxiety which led to "over-investigation by 
clinicians". 
In summary, most papers suggested that when integrated into practice RVT 
had the potential to be beneficial whilst two warned of risks. 
2.3.1.8 Classification ‘h’ – Public policy/ public consultations/ statements 
 
The eighth and final classification within the literature review included material 
which could be described as public policy, public consultation or published by 
the public authorities at regional, national or European level; classification ‘h’. 
Such documents could have had a political bias but in general were based 
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upon best practice and translation of academic research or local experience 
into guiding principles rather than based upon direct findings of research 
undertaken by civil or public servants.  However, these documents should set 
the context for the services being delivered and in turn direct impact upon the 
delivery of RVT. Arguably, low value when the metric of academic rigour is 
applied but were considered of high value given the impact upon health and 
social care services. The 11 papers equated to 15.5% of the papers reviewed, 
(equal to that of classification ‘a’), all published between 2011 and 2017, set 
the strategic direction for healthcare delivery which included the integration of 
novel technologies to engage the service users. 
One of the most significant commissioning documents to trigger systemic 
change in and to set the strategic direction for the Health and Social Care 
system in Northern Ireland was the 2011 publication ‘Transforming Your Care 
a Review of Health and Social Care in Northern Ireland’ (HSCB). It 
demonstrated a strategic willingness to enable technology development within 
service.  However, whilst the use of technology is listed as number 11 of 12 
major principles (HSCB, 2011) it was not illustrated in a diagrammatic 
representation of the future of integrated health and care.  Moreover, the 
model could be construed as paternalistic with patient perspectives being 
conspicuous in their absence. 
A year later the Department of Health in Northern Ireland produced a 
comprehensive policy framework for Long Term Conditions. The policy 
demonstrated referencing to best practice, National Institute for Health and 
Care Excellence (NICE) guidance. Indeed, the policy discussed the potential 
role for RVT in self-care. It is highly relevant and described the involvement 
of people with chronic conditions in self-care. Most particularly, it referenced 
technology, stating that  
“People with long term conditions should have a personalised care 
plan which recognises the expertise, experience and knowledge of all 
parties, but particularly the individual themselves.” (DHSS&PS, 2012).  
The policy context, which enables the strategic engagement of those with a 
long-term condition in their own self-management and care, was established. 
The following year the World Health Organisation (2015) updated the Global 
Action Plan for Prevention and Control of Noncommunicable Disease, (also 
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known as Long Term Conditions or Chronic Conditions) in order to contribute 
to management of preventable deaths. The Action Plan referenced data as a 
global aggregation. The Action Plan is fundamental to the research topic as 
the primary use for RVT is with patients with long-term conditions.  Emphasis 
was placed upon chronic disease as an international issue, prevention is the 
focus; “People and communities should be empowered and involved in 
activities…including… monitoring.” (WHO.2013) 
The National Health Service (NHS) for England and Wales documented the 
use of data and technology to improve the outcome of care for service users. 
Whilst, the basis of the strategy was the adoption of technology and setting 
strategic direction the consideration of vital sign data was omitted. The 
strategic drivers were essentially the transformation of care and reduction of 
variation through technology enabled care (NHS, 2014, p7). The policy was 
framed within the context of knowledge cascading from higher tiers of 
healthcare professions down through to lower skilled staff and service users.  
“The skilling and empowerment of the service user are the result of a 
skill transfer process, which moves skills from the highly skilled to the 
less skilled and ultimately to the consumer” (NHS, 2014, p11). 
The European Commission’s Green Paper documented the emergence of 
mobile health (mHealth) technologies; mHealth, was defined as 
encompassing,  
"medical and public health practice supported by mobile devices, such 
as mobile phones, patient monitoring devices, personal digital 
assistants (PDAs), and other wireless devices" (EC, 2014).  
The underpinning research was articulated and the broad and meaningful 
purposes to which mHealth could be applied were articulated. Crucially, these 
included a change in the role of a service user from passive recipient of care 
to proactive participant and encouraging service users to improve their own 
health. 
 
The importance of the concept of patient utility and benefit was further 
documented by the European Commission encouraging services to develop 
whereby service users should be enabled to be active participants in care and 
decision making suggesting that an enhanced understanding of condition 
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would encourage compliance with therapeutic interventions. (EC, 2015) The 
strategy for active and healthy ageing is relevant to the research study and 
highlights personal information, self-care, empowerment, technology and sets 
a context.  
The use of innovative technology to promote self-care was promoted in the 
NHS (2015), encouraging healthcare commissioners to consider a range of 
technologies at different stages of a patient’s care journey and for a broad 
range of conditions including maternity and child health, mental health, long-
term conditions, urgent and emergency care, post-operative care and post-
discharge. The use of Apps was encouraged for self-care (NHS, 2015) to “… 
promote understanding of the condition and better self-management” (NHS, 
2015). 
In Northern Ireland the Health and Social Care Board published a 
commissioning plan focusing upon eHealth and Care in order to improve 
health. The base data to create the document was derived from stakeholder 
engagement rather than a detailed review of contemporary research. 
Importantly the policy set the direction for the development of health and care 
improvement supported by integrated technology for the region against which 
all technology enabled innovation should be benchmarked. The 
commissioning priority recognised the contribution and participation of service 
users in their own care;  
“Through eHealth, we will empower people to be more active in their 
own care and support health and social care staff to achieve real 
change that delivers the best possible health and wellbeing for 
everyone” (HSCB, 2016, p5). 
The Commissioning Plan was congruent with the regional policy ‘Health and 
Wellbeing 2026 Delivering Together’ which highlighted the requirement to 
change models of care to meet growing demands upon service given 
demographic and morbidity trends; it predicted that by 2039 25% of people 
will be aged 65+. Person-centred approach to supported modes of service 
delivery was an imperative factor with home-based services and service user 
engagement essential. Whilst the narrative of ‘empowerment’ was utilised in 
relation to staff, the strategy extended to technology with “…information 
technology to improve outcomes for service users and free up time for front 
line staff” (DOH, 2016). 
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Northern Ireland’s Assembly ceased operation in January 2017 which 
impacted upon the role and ability to execute functions of Civil Servants. The 
last regional document within the Department of Health to be published under 
the leadership of a Minister was in October 2016 and sent out a 10-year plan. 
The policy ‘Systems, Not Structures: Changing Health and Social Care’, 
colloquially referred to as the ‘Bengoa Report’ highlighted four main themes: 
‘better healthcare experience, better population health, lower cost per capita 
and better staff experience’. The report expressly recommends that 
investment in e-health technology should continue in order to improve “self 
management, care at home” (Bengoa et al. 2016. p79). The report repeated 
the EC’s narrative (EC, 2015) calling for patients to be active not passive in 
their care and that they should be “…empowered to stay healthy and care for 
themselves” (Bengoa et al. 2016, p84). 
Policy at the European, National and Regional levels indicated a future model 
of care which integrated novel technologies into direct patient care. Most 
suggested that through technology, patients would be able to be active in their 
care and derived benefits were suggested. 
2.4 Literature Review Summary 
 
The rationale for the search of literature including search terms, inclusion and 
exclusion criteria were developed (Table 2.3) and the literature search was 
undertaken. N=71 papers were collected and were reviewed against a 
Publication Review Framework (Table 2.4). The Framework was created by 
synthesising the work of Pope et al. (2007), Spencer et al. (2003) and Aveyard 
(2010). In particular, the framework enabled the publication/ literature to be 
classified as a type of evidence whereby, the concept of weighting of opinion 
was constructed based upon research methodology employed by the author. 
So that the more rigorous a research methodology utilised and described, the 
more important and likely to be valid their findings and recommendations were 
considered. 
Evidence types ‘a’ systematic reviews and meta-analysis, ‘b’ randomised 
controlled trials, ‘c’ quasi experimental design – cohort studies, case control 
studies and ‘h’ public policy/ consultation and statement were considered of 
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most intrinsic value as rigour was applied within the methodology and 
contributed 49.3% of the literature reviewed.  However, all literature within this 
section could be viewed through a prism of a historic journey of technology 
adoption, trial and development. Technology reported in a meta-analysis or 
RCT in 2010 would, from a technology evolutionary perspective, be outdated 
in comparison to the technology utilised in the SET RVT service (2011 to 
2018). Therefore, balance vis-à-vis currency and contemporaneous 
experience is required when considering the overall review. The second tier 
of literature reviewed, ‘d’ surveys, ‘e’ case reports and f ‘qualitative methods 
was recognised as important and indeed acted as a barometer for user 
perception; accounted for 26.8% of the literature reviewed. The third tier of 
literature, ‘g’ anecdote/ expert user or user opinion, 23.9% of the literature 
reviewed, was considered of lowest value and also included public interest 
journalist reports which indicated trends in technology adoption or user 
experience. This classification was only included as it was an early indicator 
of changes in the technology environment, several of which may well be too 
new to have been reviewed by academics. 
It can be seen that there was much early optimism reported regarding an 
opportunity remote telemonitoring may afford the healthcare system whereby 
it could reduce pressure on acute services. There was a general consensus 
that the reality of service delivery was such that there was little or no evidence, 
from a health economics perspective, that such a system-based benefit or 
outcome was realised. There were also indicators that the integration of 
technology into healthcare, to the point where the application of telemonitoring 
was normalised and routine, was a hurdle to overcome. Several 
implementation issues were highlighted including lack of practitioner 
involvement or knowledge and the lack of an enabling environment created 
by the healthcare system. Indeed, commentators suggested implementation 
consideration including co-creation and design of new pathways of care with 
technology. There was a theme which expressed a degree of reluctance to 
adopt remote telemonitoring by practitioners with suggestions that it may 
enable service users to abrogate responsibility for self-care. This finding 
within the literature was tested through the analysis of the SET practitioner’s 
qualitative data. However, where users of remote telemonitoring services 
Chapter 2: Literature Review 
Julie-Ann Walkden - July 2020   83 
were considered as participants and reported upon in the literature there was 
a sense that remote telemonitoring was almost universally well-received.  
Literature indicated that whilst practitioners are trained to apply evidence-
based practice there were issues as the new technologies did not have a 
beneficial clinical track record; there was little or no evidence to support 
application and this may create a sense of clinical anxiety or reticence. There 
was evidence to suggest that benefits realised, when set against the principles 
of health economics, were insufficient to justify system and care regime 
change to enable large scale technology adoption.  
A common theme, particularly in policy documents, is the requirement to care 
differently, recognising the demographic shift that is occurring with an ageing 
population, increasing numbers of people with chronic diseases/ 
noncommunicable diseases along with the concomitant health burden; with 
local policies advocating disruption to the conventional care system. 
Transformation of care using health technologies emerged as a strategic 
direction. Equally, the need to engage service users with long-term conditions 
to participate in self-care, adherence to therapeutic interventions, modify 
behaviours and to become informed, experts in their own condition was 
evident with a drive to relieve burden from the state. It was muted that eHealth 
technology per se, and remote vital sign monitoring in particular, could enable 
service users and patients to be educated, compliant and engaged 
participants. The policy-based literature indicated a need to embolden service 
users and there were suggestions that remote monitoring may yield this 
benefit. 
The potential benefit or utility for the service users through remote vital sign 
telemonitoring appears to have been overlooked as a metric of success in the 
literature classified in the first tier, classifications ‘a’, ‘b’ and ‘c’ and so the 
extent to which the patient, carer, practitioner and manager perceived benefit 
or utility as a critical success factor, emerges in the data within the South 
Eastern Trust’s Remote Vital Sign Telemonitoring services was explored. 
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3 METHODOLOGY 
3.1 Restate Aim and Objectives 
 
To critically assess whether RVT is perceived to have derived benefits for 
patients.  
This will be achieved through four objectives, to understand the context, to 
gain RVT knowledge, to understand benefit and to evaluate and engage. 
Objectives:  
 
1. To describe, summarise, critically evaluate and clarify the current state 
of knowledge on implementation of RVT. (Understand Context) 
2. To identify and describe service data trends from service user and 
practitioner perspectives. (RVT Knowledge) 
3. To determine the factors of patient benefit which are enabled using 
Remote Vital Sign Telemonitoring (RVT), taking the views of 
practitioners and senior managers into account and identify service 
benefits and risks. (Experience and Benefit/ Outcome Determination) 
4. To devise recommendations to enable future deployments for optimal 
patient care. (Evaluate and Engage) 
 
3.2 Exploration of Potential Research Methodologies 
Initially the exploration of potential research methodologies to study the 
subject was problematic in nature given the complex nature of the 
intervention, new digital medium, multiple contextual variables, patient 
participants with varied medical conditions and time constrained clinical 
participants. The determination of the methodology to explore the subject was 
a challenge in the context of fluidity in the development of technologies to 
capture data, report findings, highlight difficulties and enable effective care. 
The context is complex as practitioners frequently experience pressure from 
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an ever-growing presenting need, complexity of care demands and mixed 
opinion vis-à-vis the efficacy of RVT per se. 
The research methodology decision making process, to enable the research 
question to be answered, was extensive in order to test for efficacy within the 
research field and context. The topic was initially broken down into sectors 
and constituent parts to understand possibilities and limitations of data 
collection techniques. Several key observations were made which included, 
inconsistent technological ‘prescriptions’ deployed to a range of patients by a 
range of different professions specialising in different LTC clinical areas. As 
already described within the research context, clinicians included doctors, 
nurses, physiotherapists, a pharmacist and a dietitian; there were two RVT 
systems the U-Tell: INR and the TF3 service. The TF3 service was further 
divided into a service with or without nurse triage; the package of peripheral 
devices was issued to patients based upon the referral request of lead 
practitioner. The referring practitioner also typically worked within a specialist 
field and cared for patients with at least one LTC which included diseases 
such as diabetes, heart failure, COPD, bronchiectasis, hypertension, post-
stroke stroke hypertension and anticoagulated haematology (patients 
prescribed warfarin). There were many interested stakeholders who may have 
insight into various dimensions of relative success of RVT and these include 
patients, their carers, practitioners and also decision makers within the 
Northern Ireland health care system. It was important to adopt a definition of 
a carer within the study; it has been selected from National Institute of Health 
and Care Excellence (NICE) definition, 
“A person who provides unpaid support to a partner, family member, 
friend or neighbour who is ill, struggling or disabled and could not 
manage without help. This is distinct from a care worker, who is paid 
to support people.” (NICE, 2018, p26).  
The inclusion of the lay recipients and supporters of service within the 
research was considered an important aspect of the research as the 
encouragement of patients to self-care and carers to support is recognised to 
enable health care systems to manage a growing demographic burden 
(European Commission, 2015). The contribution of lay people to build 
understanding was argued by Popay and Williams (1996). 
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3.3 Five Potential Research Methodology Options 
Considered 
3.3.1 Option 1 – Randomised Controlled Trial and Obtain Evidence 
of Effectiveness 
The local practitioners considered Randomized Controlled Trial (RCT) as the 
‘gold’ standard but as an approach to conduct the study it was problematic. 
The first observation described a research field with many and diverse 
variables which could not easily be controlled. Moreover, Wyatt (2012) 
suggested that RCT was not the methodology of choice within the field of new 
RVT technologies. During the planning phase of the research methodology 
the researcher was frequently told by medical staff that there was ‘…no 
research to support the use of telemonitoring’ however, the researcher 
interpreted that to mean that there was little empirical RCT findings to support 
the use of technology in general.  Within SET there were two previous service 
based RCTs executed to test RVT, one to examine the use of the TF3 triage 
service for COPD patients (McDowell, 2015) and the other a test of U-Tell:INR 
(El-Agnaf, 2014). These trials were not without difficulty, not least objection by 
practitioners when potential RVT beneficiaries were enrolled as research 
participants and were randomised to the control groups, which is to receive 
usual care without RVT intervention. Furthermore, the research could only 
provide insight as to whether it was better to augment care with RVT or to 
treat patients utilising established standard care packages without RVT. RCT 
design could not then determine if there was an optimum deployment 
technique to maximise care benefit or to understand the benefit derived by 
patients and carers. Of note, the two studies endeavoured to answer health 
economics questions, so that economic efficiency was a key factor of 
examination. Whereas, the economic benefit or disbenefit of RVT within this 
research was not of primary interest. Therefore, giving consideration to six 
dimensions, (i) there had been two previous RVT RCTs conducted within 
SET, (ii) there was no need to consider effectiveness or economic value and 
efficacy, (iii) the RVT service deployment was beyond feasibility study of 
translation from laboratory technology into the field, (iv) lack of support from 
local practitioners, (v) inability to control variables and (vi) deeper meaning 
and experience required examination. The need to secure a broad 
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engagement from participants was driven by an objective to discover 
experience-based opinion which may influence or optimise future deployment. 
In order to implement RVT into routine practice the need to discover if there 
is a potential for disbenefit/ harm or adverse incidents, perceived and 
observed benefit and patient’s motivation to utilise RVT, impact and 
experience. Such less tangible and patient-centred metrics may be invisible 
to a researcher if RCT was to be utilised as a research methodology. 
Therefore, RCT was excluded as a methodology to be considered. 
 
3.3.2 Option 2 – MRC Framework for the Evaluation of Complex 
Interventions 
 
Extending beyond RCT was the opportunity afforded by the Medical Research 
Council framework for the evaluation of complex interventions (MRC). RVT 
systems have multiple inputs, actions, outputs and outcomes. Therefore, 
consideration was given to a logical systems approach considering the MRC 
(2008) framework for the evaluation of complex interventions (Craig et al. 
2008). Variability and inability to fix key dimensions of the service hindered 
research design and the replication of study environments where smaller scale 
comparative studies were to be undertaken. The Edinburgh based split site 
comparative study was well designed and executed (McKinstry, 2013) but 
again whilst findings could be construed as robust,  the research design could 
not be replicated to consider RVT in SET as clinicians were reluctant to 
participate in such research and there was an uneven distribution of specialist 
services. This study was designed to ascertain if there was benefit, from a 
health economics stance, with the use of telemonitoring when compared to 
usual care and did not determine if there were patient-centred metrics of 
success to be described. The MRC framework could not satisfactorily address 
the research topic and the methodology could not robustly suggest optimal 
deployment of RVT, consider patient-centric metrics or suggest relatively 
better deployment techniques for consideration. The methodology, as applied 
in the Edinburgh study was influential in suggesting RVT lacked utility. Equally, 
the lack of homogeneity across SET, with broad range of conditions, different 
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models of deployment and broad spectrum of clinical practitioners meant that 
trial design and deployment could not be sufficiently anchored and could be 
hinder the MRC. However, Gosling (2014) suggested the MRC principles had 
utility in eliciting expert opinion and articulated methods for engaging with 
experts. Therefore, elements of the MRC Framework were considered when 
constructing the overarching research design, but the methodology was not 
selected. 
 
3.3.3 Option 3 – PARiHS Framework for Successful Implementation 
 
In seeking a methodology there was an examination of data collection techniques 
that were more focused upon qualitative data collection and analysis rather than 
quantitative data and an emphasis upon finding a more engaging approach. In 
order to describe and understand enabling factors it was useful to review practice 
development approaches such as the Alberta Context Tool (Estabrooks et al. 
2009) and PARiHS framework (Kitson et al. 2008). These offered a structure to 
help identify success factors but had not been tailored to the deployment of RVT. 
The Alberta Context Tool described structural elements, resourcing, and 
interactions between staff, while the PARiHS framework identified clear evidence, 
strong facilitation and positive context as critical success factors. An underlying 
theme in practice development, within the concept of PARiHS is the need to make 
change based upon the principles of ‘evidence-based practice’ (Kent and 
McCormack, 2010) which can be problematic within RVT given the novel nature 
of the technologies being deployed. Both tools suggest elements to consider 
when changing practice and there was a tentative alignment to the BDO Stoy 
Hayward (2009) recommendation relating to ‘support’ change in practice. When 
observing ‘success’ from a perspective of a health environment where care work 
is more open-ended with longer timeframes where the notion of an enabling or 
supportive style of environmental leadership could be viewed as a critical success 
factor (Handy, 1985, p212) and merited further investigation. However, owing to 
the lack of RVT service evidence, efficacy testing and applying PARiHS within 
the SET context of RVT was eliminated.  
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3.3.4 Option 4 – Cycles of Action Research 
 
It was proposed that action research would be utilised given that the thoughts, 
feelings and behaviours of research participants were of interest within a context 
of patient centred care. Action research, and most particularly transformational 
action research, was initially selected as the methodology to be applied. It was 
assessed that through action research, the specific framework for success in RVT 
deployment could be synthesised to demonstrate alternative value and the 
expressed opinions of research participants. Early indications suggested a 
degree of correlation between a model for optimisation of RVT with the Alberta 
Context Tool but recognising the need to extend beyond to encompass 
purposeful application, multi-professional learning, support with specific training, 
enabling environment and supportive leadership. Transformational action 
research recognised the softer more creative metrics and allowed the clinical 
practitioners to analyse, interpret and personally develop themselves. 
The transformational action research could add creative ecological and spiritual 
dimension to practice development, essentially permitting practitioners to develop 
their service and modality of care.  As a methodology it was considered useful in 
the context of RVT as there were many variables, fluidity within a developing 
arena and the need for on-going iterative improvement and experimentation. It 
was believed that for this to happen the current context must be evaluated to 
inform programme development. Essentially when transformation action 
research commences practitioners would be proactively encouraged and enabled 
to make iterative improvements, but the context should be known to promote 
innovation and freedom to practice. A significant feature of the action research 
was the development of practitioners, within the context of adoption of 
technology, and the improvement of patient care.  
 
Whilst the methodology of transformational action research was initially favoured 
to determine the answer to the overarching research question, a decision was 
taken to terminate the plan and change methodology. There were two key drivers, 
the first was that the methodology was far too complex and although compelling 
was not well proven. The second driver for change of research methodology was 
a serious lack of willingness to participate if action research was utilised. Given 
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that action research as a methodology is structured to embolden the practitioner 
to direct the research the methodology and data collection tools, methods and 
activities were shared with potential research participants. The response was 
such that the researcher decided that pursuing the approach would be 
unproductive; 80% of the practitioners confirming that they would feel 
uncomfortable, were sceptical, decided it was too demanding of their time and 
resources and so could not consider consenting to participate. Therefore, whilst 
the researcher believed there were significant merits to the methodology the 
research design process would have to be reconsidered as without willing 
voluntary participation the outcome of research would be weak and findings 
inconclusive.  Despite the methodology being planned to an advanced stage 
there were too many barriers to proceed. (Refer to Appendix 5 for greater detail 
describing the initial Action Research Plan.) 
 
3.3.5 Option 5 – Mixed Methods 
 
Option 5, Mixed Methods, was considered as an option owing to the 
complexity of RVT implementation. The methodology of mixed methods in a 
post-positivist stance using a broad methodology of programme evaluation 
was proposed (Creswell, 2003). The sources of data which were accessible 
were:  
1. Use of literature 
2. Use of baseline service data 
3. One-to-one interviews with participants who would be health and 
personal social services staff; practitioners, managers and 
commissioners. 
4. Application of a service user and carer questionnaire.  
 
An illustration of which data collection methods to contribute to specific 
research objectives has been included in the Table 3.1:  
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Table 3.1 To illustrate which data collection methods contributed to 
addressing specific research objectives. 
















METHODS           
1. Literature x x       
2. Baseline Data x x       
3.1-to-1 
Interviews  
x x x x x 
4. SU & Carer 
Questionnaires 
  x x x x 
 
Therefore, with such available material it was believed that a triangulation of 
findings could be effectively studied, and resultant findings interpreted. 
Moreover, to validate findings and enable a cross practitioner learning 
opportunity a final half-day group discussion/ workshop with participants was 
offered to practitioners who shared anonymous case studies and personal 
experiences at one-to-one semi-structured interviews. The data analysis 
required the combination of the findings of both data of a quantitative and 
qualitative nature to reach a conclusion. 
The researcher challenged the metrics of success for RVT; some modes of 
evaluation fail to recognise the benefit of patient self-management and the 
ability of practitioners to successfully manage greater caseload numbers 
targeting their care in a timely manner. However, such assumptions could only 
be tested and examined with data analysis, digital analytical databases and 
tools (QSR International’s NVivo Version 12 and IBM-SPSS Version 25) to 
determine outcome or benefit which may enable the optimisation of future 
deployments to be created upon a foundation of new knowledge, learning and 
direct participant experience.  
The researcher examined beyond a concept of RVT as a ‘bolt-on’ service 
option and acknowledged more complex factors to achieve service 
integration; the examination of critical success factors allowed the experience-
based benefits and issues to emerge. This recognised the opportunity for 
Critical Appraisal of Remote Vital-Sign Telemonitoring 
92  Julie-Ann Walkden - July 2020 
reform and practice development as integral to effective deployment of RVT. 
Through a process of both qualitative and quantitative data analysis, 
synthesis, refinement and development the researcher defines the new 
knowledge. For example, the findings may address a range of issues, as yet 
unknown, which may include factors such as barriers to access; enhanced 
communication and training. The utilisation and interpretation of existing 
qualitative and quantitative data were proposed as a method of enquiry to 
augment practitioner case study analysis. 
In addition, by involving service users and carers, through the application of a 
questionnaire it was determined as likely to maintain the patient centric focus, 
as previously suggested within Transformational Action Research; service 
user perception utilised to encourage and harness practitioners to change 
practice thus permitting patients to contribute to the findings. Indeed, it was 
determined that by comparing the responses of service users collected within 
a research framework with the opinion of HSC staff there may be variance of 
opinion found. The questionnaires were sent to SET RVT service users, 
N=240, with responses sent via freepost to SET’s Safe and Effective Care 
team to compile the returned documents. The team undertook an initial 
collation of results with the application of SPSS software with the early high-
level findings being given to the questionnaires author, the researcher, in 
order to publish a brief report which was shared with participating carers and 
patients via the Trust’s website, as per the research protocol. It was 
recognised that it may not be possible or even necessary to eliminate all 
researcher-bias but this process with the questionnaire was designed to 
reduce the risk of bias or influence by the researcher. Moreover, it was 
recognised that there was a possibility that perhaps only those potential 
participants who had a positive opinion of RVT may be inclined to respond so 
a risk of bias is also acknowledged.   
The modes of enquiry included the utilisation of a questionnaire and direct 
engagement of practitioners and commissioning managers through one-to-
one semi-structured interviews with practitioners being given the time and 
space to share their personal case studies and experiences. Whilst the 
research was conducted from an evaluative stance there were aspects from 
the transformational action research methodology that may have enabled the 
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personal development of those clinical practitioners who volunteered as 
research participants which were adopted within the study design. 
Practitioners, regardless of discipline or disease area, were enabled to 
participate in a safe environment, where they were given the opportunity to 
expressively share, learn, flourish and create with the semi-structured 
interviews being conducted purposefully and it was anticipated that it enabled 
practitioners to innovate, change, reform, develop and enable time for 
reflective practice in a similar mode as they may have experienced were they 
to have engaged with action research (Titchen, McCormack and Manley. 
2013). However, the focus of the research, whilst dependent upon personal 
experience, was focused upon lessons learned from the perspective of 
evaluation.  
Therefore, balancing the strengths and weaknesses of the methodologies 
considered, it was decided that the mixed methods would be most effective 
and was chosen. 
3.4 Selection of Research Methodology Summarised 
 
The five recognised methodologies considered for use in the research were 
evaluated (Table 3.2). In summary, option 5, was selected as the most 
appropriate strategy to answer the research question. 
Table 3.2 To illustrate summary assessment undertaken to select the 
appropriate research methodology. 
 
 
OPTIONS NEGATIVE ISSUES POSSITIVE ISSUES REJECT/ 
ACCEPT 
Option 1  
– RCT 
a/ Too many variables to 
be controlled 
b/ Practitioner objection to 
limiting access where 
patients could benefit 
c/ Economic analysis not of 
interest 
d/ Would not determine a 
broad base of experience 
or opinion 
a/ Considered the ‘gold’ 
standard 
Rejected 
Option 2  
– MRC 
a/ Inability to fix variables a/ Reviews complex 
interventions 
Rejected 
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b/ Economic benefit not of 
interest 
c/ Softer metrics may not 
be explored 
b/ Recognised standard 
Option 3  
- PARiHS 
a/ Requires evidence-
based practice to be 
evaluated and RVT was 
not an evidence-based 
modality of care 
a/ Structure to identify 
success factors 
b/ Facilitates qualitative 
data collection through 
engagement 
Rejected 
Option 4  
– Action 
Research 
a/ Researcher bias may be 
exaggerated 
b/ Cycles of research too 
time demanding of clinical 
practitioners 
c/ Potential clinical 
practitioner participants 
refused to participate as 
they did not feel it was a 
methodology, they could 
comfortably engage with 
a/ Engage to seek opinion 
of research participants 
b/ Purposeful application 
of multidisciplinary 
learning 
c/ Can accommodate 
variability, broad 
functionality and differing 
ecology 
Rejected 
Option 5  
– Mixed 
Methods 
a/ A study in two 
paradigms, i.e. collecting 
and analysing qualitative 
and quantitative data can 
be complex and difficult for 
the researcher to manage. 
a/ Broad base of data and 
evidence can be 
managed 
b/ Triangulation of data 
from multiple sources  
c/ Robust supportive 
technology to enable data 
analysis (SPSS & NVivo) 
c/ Permits data, 
regardless of paradigm, 
to be collected and 
analysed simultaneously 
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3.5 Research Design – Mixed Methods 
 
The simultaneous planning of data collection, parallel design of both 
quantitative and qualitative data analysis and the equal status of data 
collected in either paradigm, were mapped. Figure 3.1 illustrates the 
collection, handling and interpretation of data to find meaning has been 
adapted from Creswell (2003). 
 
 
Adapted from (Creswell.  2003. Pp 212-214). 
Figure 3.1: Illustrates the design structure and flow of mixed methods; 
the parallel nature, the digital tools and equal value of qualitative and 
quantitative data captured 
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3.5.1 Mixed Methods Theoretical Underpinning  
 
Parahoo (2014) suggested that there may be six reasons why a researcher 
may choose to utilise mixed methods with the one that applies in this study 
being a study that evaluates “different aspects of the same topic”. The 
underpinning philosophy for the mixed methods study was founded within the 
stance of postpositivism with a pragmatic world view adopted by the 
researcher. Whereby, the researcher attempted to collect data in as 
unbiassed approach as possible, utilising instruments designed to capture 
data from several perspectives, and independent participant groups, to 
answer the research question and to fail to reject or reject the hypothesis. 
(Creswell and Plano Clark. 2007). A definition adopted by Greene, Caracelli 
and Graham 1989 included the core tenant that the research must include at 
least one set of data collected in each paradigm, that is both qualitative and 
quantitative data. Creswell and Tashakkori (2007) suggested mixed methods 
research could be conducted from four different perspectives, or even 
blended to address the research topic; within the research the fourth 
perspective, that of ‘the practice perspective’ was selected. This allowed a 
pragmatic bottom up approach to building the evidence. The dynamic 
approach to mixed methodology research afforded the opportunity to remodel 
understanding within RVT (Guba. 1990). 
 
The researcher, in triangulating data from various sources, undertook enquiry 
utilising mixed methods, to determine validated findings from multiple 
perspectives (Robinson, 2002, p370). The triangulation of data was then 
further discussed following the explanation of data collection and the 
management of quantitative data through the utilisation of standards methods 
packages (IBM SPSS version 25) and qualitative data through (NVivo 12). 
3.5.2 Approach with Clinical Practitioners  
 
A descriptive approach was taken, in the form of semi-structured one-to-one 
interviews with staff. It was agreed that the researcher would also ensure that 
participants did not feel obliged to participate in the research and through the 
Chapter 3: Methodology 
Julie-Ann Walkden - July 2020   97 
Participant Information Sheet and Consent Forms ensured that only 
practitioners open and willing to confidentially share their experiences were 
enabled to participate. (Albeit the request for participation may have introduce 
some bias, as there is a risk that only those with positive opinions may be 
motivated to engage.)   
 
The participants were self-selecting, and it was assumed likely that those who 
were enthusiastic about utilisation of RVT were more likely to join the 
research. Whilst, this may have risked the introduction of bias, the nurses, 
allied health professions and medical personnel, Band 6 and above (senior 
experienced practitioners) were enabled to contribute to the study and 
possibly influence future application of RVT. Whereas, those with a less 
favourable disposition, may have excluded themselves from reflective 
practice focusing upon RVT. Whilst, early voluntary self-nomination to 
participate had N=12 potential participants from across a range of 
practitioners and clinical fields it was determined to be necessary to trawl 
further until the one-to-one interviews had reached data saturation of topic 
and no new material is forthcoming. However, if it had been found that there 
were widely divergent views, the interpretation of the data would express the 
views of practitioners from across the spectrum. Only once the practitioners 
were able to articulate their patient’s outcomes and their experiences could a 
determination be made about the nature of success factors or potential for 
patient benefit which may optimise the RVT intervention. 
 
All relevant practitioners were initially invited to participate in the research but 
only self-selecting, consenting respondent practitioners were invited to 
participate in one-to-one semi-structured interviews in a safe environment. 
They were given the opportunity to express their views from the stance of 
developing future practice based upon their personal direct experience of 
RVT.  
 
The mixed-methods methodology enabled the researcher to seek from the 
practitioners their qualitative data. The one-to-one interviews were piloted with 
two senior nurses in May 2014 and the outcome of the meeting used to create 
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the semi-structured interview plan for the research. Practitioners, each a self-
selecting participant, were given the opportunity to share with the researcher 
their experiences of learning to use RVT, within the semi-structured interviews 
structure. The practitioner participant became a specific case study within the 
overall data collection phase and contributed qualitative data. The observation 
of the phenomenon from the stance of the practitioner participant was 
undertaken through listening and prompting discussion which was recorded 
as a case study (Saks and Allsop, 2008). It was planned that they would be 
given the opportunity to describe their view of how to enable effective future 
deployment and consider all elements of experience to date. The semi-
structured interviews were conducted purposefully to enable the practitioners 
to describe their personal experience of changing and developing care 
through RVT (Titchen, McCormack and Manley, 2013). From the perspective 
of evaluation of experience, this research was dependent upon personal 
practitioner experience and enabled practitioners to reflect upon the lessons 
they have learned from using RVT in the natural clinical environment and also 
allows new knowledge to emerge.  
 
The semi-structured interviews (case studies) permitted the practitioners to 
reflect and share their views and experience. This approach was selected 
because it permits a degree of freedom of expression for practitioners and for 
the researcher to encourage the participant to share knowledge; to express 
real experience of new way of care delivery. It was planned that the researcher 
would share the written-up findings to the practitioner participants if requested 
to enable them further opportunity to comment and sense check. In order to 
minimise the risk of interviewer bias the broad themes emerging from the data 
were presented to the practitioner participants to discuss in a half-day group 
workshop.  This activity further enabled reflection upon clinical practice, 
analysis and validation of theory being built and if RVT could be appropriately 
embedded into clinical practice. The results of quantitative analysis and 
findings from qualitative analysis were synthesised to determine the emerging 
factors required to perhaps achieve effective future deployment or reveal 
benefit or disbenefit. This was undertaken by coding qualitative data to enable 
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tabulation and comparison (Oppenheim, 2003). Themes in comments were 
reflected and articulated within the narrative of analysis.  
3.5.3 Approach with Commissioning and Operational Managers 
 
To explore in detail environmental issues, the most senior executives, N=8, 
within the Health and Personal Social Services (HPSS) with an influencing 
position in RVT were interviewed to reflect on their RVT experience of the 
service, system, environment and management factors. These semi-
structured one-to-one interviews were intended to contribute to reflection upon 
and interpretation of prior findings. The short working title of, ‘Optimisation of 
Vital Sign Remote Telemonitoring’ was used within the participant information 
sheet with the purpose describing how the ambition is to improve care and 
support in the future.  
 
It was planned that the data would be sorted into common themes in order of 
magnitude and consistency of opinion, with findings compared with the directly 
reported experiences of practitioners. It was recognised that within the study 
the complex intervention, RVT, would be examined from several perspectives. 
Simply taking a quantitative approach to data collection would have been likely 
to omit the psychosocial dimensions associated with the application of 
innovative technologies from the perspectives of patient, carer, practitioner 
and manager. Equally, only examining the issues from a purely qualitative 
perspective, the study may not have been as inclusive and lacked objectivity. 
Within the context of ensuring a comprehensive review, mixed methods, was 
selected and aimed to ensure “…complementarity, completeness, 
confirmation” (Parahoo, 2014, p88).  
3.5.4 Approach with Patients/ Service Users and Carers 
 
Henderson et al. (2013) evaluated the English RVT Whole System 
Demonstrator (WSD) Sites using a questionnaire. Whilst, this questionnaire 
was tested to scale it focused upon service user acceptability and did not allow 
the patient to share opinion of experience and personal benefit, so it was not 
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chosen for use but the principle of using questionnaires as an instrument with 
patients was applied. Indeed, the WSD research utilised the questionnaire-
based study to determine economic benefit with three main dimensions being 
examined, acceptability, effectiveness and cost effectiveness. This SET 
based RVT research was concerned within the context of determining 
effective use of the system and if perceived benefit could be derived. The 
method of data collection from the service user was undertaken using a 
tailored questionnaire which offered the ability to engage with many 
individuals and assess relevant elements of accessibility, benefit, experience 
and effectiveness. In the design of research methods and instruments to be 
applied included an examination of other studies considering the optimisation 
of healthcare systems.  
3.5.4.1 Development of Patient and Carer Questionnaires 
 
Initial service user satisfaction questionnaires were undertaken by SET in 
2013 and 2014 and a pilot service evaluation in 2009 by BDO Stoy Hayward. 
These contain a rich narrative, particularly in the form of open responses. The 
2013 and 2014 questionnaire had been developed by the researcher to 
assess service user RVT service satisfaction for the Trusts was agreed for 
use across the Region by the five Trusts, Public Health Agency and the 
service provider. Distribution of the survey tool across all service users within 
Northern Ireland was, periodically, undertaken by the service provider, TF3, 
but SET directly issued the questionnaire to all its service users on the annual 
basis; N=204 in 2014. The 2014 service evaluation questionnaires were 
analysed and from 184 anonymous questionnaires 127 service users 
contributed and further survey responses were received from 47 carers and 
nine practitioners. This experience demonstrated that a questionnaire was a 
practical instrument to engage service users and obtain data effectively. 
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Figure 3.2: Flow diagram to demonstrate the development of the 
questionnaires, starting from an original source used by BDO to inform 
commissioning of RVT. 
The researcher duly designed the survey instrument and the series of 
improvements to the questionnaire were made following an iterative process 
of refinement and peer review, refer to Figure 3.2, which illustrates the stages 
of questionnaire development.  
The survey was designed to have both quantitative closed questions where 
the respondent had choices to indicate and open questions where the 
respondent could respond using free text with the narrative forming qualitative 
data (Saks and Allsop. 2008). However, whilst the patient and carer 
questionnaires were designed for self-completion the open questions were 
utilised conservatively so that analysis and interpretation could be undertaken 
efficiently. The design of the self-completion survey instrument was such that 
complexity was avoided and that there was a clear flow of questions being 
asked with the questionnaire broken down into subject area (Robson. 2005). 
As an understanding of attitude toward and perceived benefit of RVT was 
required a unidimensional survey was constructed which permitted 
comparison of and association with particular variables. Whilst there were 
some binary questions to identify attributes of the respondents, a Likert scale 
was consistently applied to the remaining closed questions. The scale 
consistently applied was four to one, with strongly agree rated four, agree 
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to be grouped broadly around attitudes (Oppenheim. 2003). Planning and 
texting of the instrument was a vital component of instrument design (Bowling. 
2006) and was undertaken in an iterative process as illustrated in Figure 3.2. 
Indeed, pilot testing and the modification through experience refined the 
survey tool increasing the likelihood of reliability (Creswell. 2003). 
Whilst initially based upon the BDO Stoy Hayward questionnaire, the second 
trial questionnaire underwent a process of content challenge by the five Trust 
telehealth managers from across the region, the Patient Client Council and 
Ulster University academic staff (not related to the research project) and 
through the Research Ethics and Governance Filter Committee.  
The service user and carer questionnaires were modified to enable further 
enquiry and enable tracking of service perception, both current experience 
and reflecting a patient’s view of potential future application. The researcher 
garnered support from stakeholders and incorporated advice and feedback 
received following independent review from the Patient Client Council. The 
data from the earlier service evaluation questionnaires was reviewed for 
commonality in theme, analysed and examined for development of 
experience and was only used to shape the tool for the research.   The 
research questionnaires retained key questions from earlier iterations but 
were enhanced to elicit deeper opinion regarding the effect of RVT upon self-
care and utilisation of technology. The plan was for the questionnaire to be 
issued within the context of voluntary participation in evaluation and seeking 
more in-depth opinion rather than service satisfaction. The questionnaire was 
designed to enable Personal and Public Involvement (PPI) activity so that 
patients, as well as practitioners, could be enabled to inform development and 
deployment. The questions, for use with service users, in the prospective 
questionnaires were designed to direct them to respond to themes focused 
upon benefits and harm. It was anticipated that there may be an opportunity 
for service user recommendations to influence practitioner behaviour and 
there was freedom through free text for feelings and opinions to be recorded 
thus creating an open journey of discovery to enable emphasis upon the 
transformation of practice, care and application of technology; albeit elements 
of satisfaction were retained to determine if RVT adds value and generally 
met with approval. The plan for the data collection instrument was to permit 
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patients to be able to influence practitioner behaviour, responses or actions 
and RVT Programme design, embracing the regional strategy of user 
engagement, PPI and enabling Transforming Your Care, (HSCB, 2010). The 
focus of the study remained the future deployment of service through the 
effective optimisation of care, the deployment of technology and enabled the 
emergence of discovery of the real effect of RVT beyond original contract 
intentions of keeping people out of hospital.  
3.5.4.2 Distribution of the Questionnaires 
 
Engagement was fundamental to elicit the service user’s voice of experience 
of RVT. It was planned that all service users within the SET, at a point in time 
which was determined to be mid-August 2015, would be given the opportunity 
to complete the pseudonymised questionnaire.  The entire patient base was 
surveyed as pilot questionnaires applied to the whole group have been 
successful and also the N=280 patients were known to be a heterogeneous 
group living with co-morbidity or one of several LTC. SET had many service 
users experiencing several combinations of RVT. Some service users had a 
track and trend service, whilst others self-entered data on PC and others were 
in receipt of a full triage service. Also, there was a broad range of medical 
conditions that meant they may have been offered different peripheral devices 
so that the vital signs reported were relevant to their personal treatment plans. 
The differing conditions meant that practitioners selected different RVT 
peripheral devices to meet clinical observation needs. Therefore, with so 
many variables, the entire patient population actively who interacted with RVT 
was included. This contained seven disease sub-groups and two RVT 
technologies with three service deployment models. By the inclusion of the 
entire SET RVT caseload, it was assumed that the findings would be less 
likely to be skewed or inadvertently unrepresentative of participants’ views; 
whereas, sampling may have introduced such difficulties. The short working 
title of, ‘Optimisation of Vital Sign Remote Telemonitoring’ was used within the 
participant information sheet with the purpose describing how the ambition is 
to improve care and support in the future.  
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All completed patient and carer questionnaires were returned to the Trust’s 
Safe and Effective Care Team via free-post envelopes, were basically 
compiled and results entered into a database (IBM-SPSS) to profile high-level 
summary data to enable the researcher to conduct a rapid superficial analysis 
to report back to the participants via the Trust’s website. The questionnaire 
material was then returned to the researcher, was coded and compiled in a 
new (IBM-SPSS Version 25) data base for analysis; the resultant report 
contained both narrative and numeric articulation of findings. Coded 
questionnaire templates were used to collect data (Appendix 3). Commonality 
in theme of service user’s free text was collated and reviewed to assess 
relative benefit or perceived risk of harm, both through statistical analysis of 
coded text (Oppenheim, 2003) and researcher interpretation of narrative.  
3.6 Development of Questions 
 
The clinical practitioner, manager/ commissioner, patient and carer perceived 
benefit questions were developed to specifically answer the research 
question, which was to ‘critically assess whether RVT is perceived to have 
derived benefits for patients’ (Robson.2005). They were designed to offer 
subtle insights rating attitude through the consistent application of the Likert 
scale (Oppenheim. 2003). The questions were all piloted prior to final data 
collection instrument production through small scale tests with practitioners or 
service user engagement and underwent peer review and iterative 
modification. The service user questions were closed and asked through a 
self-completed questionnaire whereas, the HSC staff questions were all open 
and administered utilising a semi-structured one-to-one interview technique. 
Refer to Table 3.3 to review the questions designed to answer the research 
question. 
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Table 3.3 Questions designed to enable reflection of perceived RVT 
benefit. 
 QUESTIONS 
 SOURCE CLINICIAN & MANAGER SEMI-STRUCTURED INTERVIEW 
1 
Describe your experience with RTM and feel free to illustrate your 
experiences with reference to anonymous case studies – please remember 
not to disclose patient or carer details… 
2 What are our lessons learned from your perspective? 
3 What are your thoughts on this service? 
4 
Is there anything else you would like to tell me about RTM or technology in 
healthcare in general? 
 SOURCE PATIENT QUESTIONNARE 
5 
The telemonitoring system assisted me in managing my health on a day to 
day basis. 
6 I believe the telemonitoring system has reduced the number of my GP visits. 
7 
I believe my own monitoring of my condition has reduced the number of 
nurse/community team/health professional visits. 
8 
I believe that during the telemonitoring period, the system has prevented the 
need to attend Accident & Emergency Department and /or GP Out of Hours 
services. 
9 
I believe that during the telemonitoring period, the system has prevented or 
reduced the need to attend outpatient appointments. 
10 
I believe that during the telemonitoring period, the system has prevented my 
admission to hospital. 
11 
The telemonitoring system has enabled me to better manage my own 
condition and become more involved in my health care. 
12 I believe telemonitoring has given me peace of mind. 
 SOURCE CARER QUESTIONNARE 
14 
I believe telemonitoring has improved the overall level of health and social 
care given to the person I care for. 
15 
I believe telemonitoring has helped prevent the person I care for being 
admitted to hospital. 
16 
When assisting the person to operate the telemonitoring equipment, I found 
it easy to use. 
17 I think the use of telemonitoring as part of a care package is generally helpful. 
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3.7 Ethical and Research Governance Approval 
 
Prior to engagement with participants there were three steps that were 
considered and undertaken, (i) identification of actual ethical issues, (ii) ethical 
approval and (iii) research governance. 
Prior to the consideration of the methods of data collection or obtaining of any 
patient level information the researcher had to satisfy the Ulster University’s 
Research Governance and Ethics Committee that all relevant ‘Good 
Research Governance’ and research ethics training had been successfully 
completed.  
SET Research and Development Team advised that if the study was to 
engage SET practitioners then full ethical approval was not required simply a 
basic Trust approval to conduct the interviews mandated through the local 
Research Governance Policy. It was not believed the line of enquiry to be 
undertaken by the researcher would be contentious or personal and was 
unlikely to cause Trust staff distress. Moreover, there was a requirement for 
the researcher to gain access and review RTNI TF3 Service Agreements/ 
Contract material, have access to performance management material and 
also to review and utilise the findings of historic RVT questionnaires 
completed by patients over time in order to inform the research, shape the 
design of the research methodology and future data capture methods. On 11 
October 2013 the Trust formally approved the release of data for ‘service 
evaluation’ and research protocol design.  
The requested material assisted with the refinement of both the research 
focus and the methodology by which the data would be collected to determine 
new findings. One-to-one recorded interviews were required with practitioner 
participants and also the opinions of patient participants so that a comparison 
could be made. As a 360-degree review of perspectives was required from a 
variety of stakeholder participants mixed methods was deemed to be the most 
appropriate methodology. Given the required participation of service users full 
ethical approval was then required for the data collection to proceed, albeit 
that a proportionate review was determined to be an appropriate route of 
approval. 
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The researcher then registered the project with the Integrated Research 
Application System (IRAS). With revisions made to the research protocol and 
support material with appropriate University approvals and certifications in 
place, the research proposal was submitted to the Trust’s Research Ethics 
and Governance committee where consent was given. (Refer to Appendix 6 
for protocol materials). 
The formal approval to proceed enabled a series of two data capture methods 
to proceed to collect both qualitative and quantitative data. The first method 
approved, gave permission to issue a questionnaire to all current SET RVT 
patients, with the only exclusion criterion being that no service user under the 
age of 18-years would be sent a questionnaire. The second data capture 
method approved was to interview a cohort of practitioner and manager 
participants and to deliver a validation workshop for practitioners to review 
findings. 
Research participation, was explicit and understood by participants that at all 
points along the research journey for the service user, carer, practitioner and 
senior managerial officer would be voluntary with the participants being free 
to withdraw at any stage up to data entry; withdrawal after data collection 
meant that they would not take any further part in data collection or review of 
findings. It was planned that material submitted to the date of withdrawal 
would be analysed and form part of the research findings albeit no participant 
withdrew from the research and data collection phase. The questionnaires 
posted to service users and carers were accompanied by a stamped 
addressed return envelope along with a cover letter to explain, study purpose, 
ethical consideration, confidentiality and consent.  The questionnaires were 
sent to approximately N=280 service users with the option of them being able 
to pass a supplementary questionnaire on to further potential participants; that 
is the service user’s carer, if available; their responses were also be returned 
in a separate sealed envelope. The management of sensitive issues was 
considered so that the safeguards were in place to protect vulnerable adults 
if issues were identified through a ‘red flag’ system which ensured such 
matters were addressed through the Trust governance administration; there 
were no issues identified.  (Refer to Appendix 4). Patients were not identified 
in the research findings and their contribution retained securely and 
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confidentially for 10 years in line with the Ulster University standards, the 
Code of Practice for Research Integrity and the Data Handling procedures 
and the Data Archiving procedures. However, not knowing patient identity 
also meant that patients who had not responded could not be targeted and 
encouraged to participate.  Pseudo-anonymity was achieved through the 
coding of the questionnaires so that, should the need arise to identify a 
particular service user, appropriate action could be taken. The file containing 
participant study identification codes and personal details were kept under 
secure conditions by the chief investigator, in a password-controlled computer 
system with access for the researcher.  Any hard copies of data were kept 
under locked conditions, designed for the purpose. The chief investigator was 
the custodian and had control of the data generated from the study. 
Confidentiality was respected but not guaranteed.  Any disclosure of poor 
practice would have followed normal management protocols; there were no 
issues identified. (Refer to protocol instrument documents Appendix 4 and 
research governance and ethics approval in Appendix 6) 
In summary, the research governance and ethics approval was a stepped 
process whereby three committees sanctioned progression: 
1. Ulster University (Project No: 15/0065).  
2. Proportionate Review Sub-Committee of the Health Research 
Authority, The National Research and Ethics Service (NRES) 
Committee South Central – Oxford C (July 2015). The Integrated 
Research Application System (IRAS) project ID 155990  
3. SET Research Governance was attained on 11 August 2015 REC 
15/SC/0424 Trust reference SET/15/17 
Table 3.4 documents the list of version control documents that constituted the 
suite of research protocol documents as submitted to and approved by the 
Research Governance and Ethics Committee. These covered all dimensions 
of the data collection (see Appendix 6). 
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Table 3.4 To summarise the suite of documents approved by the 
research governance and ethics committees. 
Protocol v6 040615 
a ox optimising remote TM Response to Filter Committee v5 140715 
b ox Subject Information Sheet patient v5 140715 
c ox Letter User Questionnaire TF3 v7 140715 
d ox Letter User Questionnaire UTEL v6 140715 
f ox Service User Questionnaire TF3 v4 140715 
g ox Service User Questionnaire UTELL v3 140715 
h ox Carer Questionnaire TF3 v4 140715 
i ox Carer Questionnaire UTELL v3 140715 
ia ox Staff member consent form v4 140715 mckinstry walkden 
ia ox Staff member consent form v4 140715 
j ox Subject Information Sheet staff v4 140715 
k ox Invitation letter practitioners v2 140715 
l ox Invitation letter Managers v2 140715 McKinstry 071015 
I ox Invitation letter Managers v2 140715 
m ox semi-structured interviews with healthcare professionals v2 140715 
n ox semi-structured interviews with healthcare managers v2 140715 
15 SC 0424_(PRS)_Favourable_opinion_on_further_information_20.07.15 
15SC0424 - Favourable Opinion 
Final Permissions Letter from SET 
ox a 15 SC 0424_(PRS)_Provisional_opinion_09 07 15 
ox b response to NRES Committee South Central 
Re Outcome from Research Committee Meeting - SET.15.17 
SET.15.17 Notification of Valid Application 
SL-AR2 Non-CTIMP Standard Conditions v5.2 
(Relevant documents are available in Appendices 3 and 4) 
Following the systematic review of literature and with reference to the Ethical 
Approval given by Ulster University, the Proportionate Review Sub-
Committee of the Health Research Authority, NRES Committee South Central 
– Oxford C and SET, it was proposed that the relevant data were obtained 
and managed utilising Mixed Methods within a broad-based programme 
evaluation.  
1. Analyse existing service contract material and data at Trust and 
Regional level; 
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o This includes service statistics and reports relating to previous 
service evaluations and customer surveys  
o Evaluation of existing Regional service use data. 
2. Confirming this prospectively through service user and carer surveys;  
o Questionnaires were sent to all current South Eastern Trust 
RVT service users, N= 280 patients were on the system at any 
given time), with responses returned for collation and analysis.  
o Where an informal carer plays a role in RVT, they were invited 
to provide data from their perspective (From experience of pilot 
studies it was anticipated there are approximately 30% of RVT 
Patients who are assisted by carers); N=90.  
3. Interviews on RVT with Health professionals at all levels; 
o One-to-one semi-structured interviews with practitioners with 
experience of utilising RVT and Senior Health and Social Care 
Leaders; N=20  
o Workshop for Trust practitioners; N=12 
o Quantitative (statistical) analysis of numerical data (from 1 and 
2, above): descriptive, exploratory and explanatory;  
4. Qualitative analysis of transcripts (from 3) following a descriptive 
thematic approach. 
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3.7.1 Framework of Data Collection: 
To summarise the expected data collection methods linked to participants and 
the associated outputs for data analysis a table was produced (Table 3.5) 
Table 3.5 To illustrate the framework of data. 
Data Collection  Data Analysis  
Designed four tailored 
questionnaires: - a service 
user and a carer 
questionnaire for each of the 
two services (TF3 & U-Tell) 
– These were based upon 
BDO Stoy Hayward 2009 
RVT questionnaire, then 
piloted and reviewed by 
Patient Client Council 
 
To Patients (Pa) 




analysed using SPSS 
(final version utilised by 











Case Study narrative 
[E,Pr] analysed using 
NVivo (final version 





Technique for Cognitive 
Mapping used to help 
Practitioners review initial 
findings, group issues and 
find common meaning and 











Consideration was given to the comparison between disease specific groups 
versus a single disease area. The enquiry comprised of groups of practitioners 
who were of varied professional backgrounds and specialising in the care of 
patients with various chronic illnesses whilst having commonality in possessing 
the ability to access the TF3 RVT service. This approach enabled greater 
opportunity of a transferable framework of success factors, enabled cross-
fertilisation between professional areas and maximised the number of eligible 
practitioners. Criteria for selection was defined as participants must be of HPSS 
Band 6 or above with a professional clinical background (defined as someone 
with a medical, nursing, pharmacy or allied health professional registration).  
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3.9 Autonomy 
 
Consideration was also given to the parameters within which the researcher 
was permitted to operate. The research governance and ethics approval 
process safeguarded the participants and through a process of audit and 
supervision the correct execution of the protocol was assured whilst the 
activity of the researcher occurred independently. The Trust enabled access 
to data and participants without hindrance.  
3.10 Benefit 
 
There was no direct benefit for the participants. Potentially future patients may 
benefit from appropriately designed and targeted RVT and improved care for 
those with LTC. Being able to engage with service users and give early 
feedback, via the Trust’s website, contributed to Public and Patient 
Involvement and an engagement agenda for the region. However, if benefit is 
found or if a mode of effective deployment is identified to optimise RVT then 
the potential benefit is to improve the care for those with LTC and manage 
resources more effectively.  
3.11 Risk 
 
No serious risk attached to participation nor to data collection. There were five 
systemic risks identified with the research project and these include: (1) 
service capability of provider restricting operation of remote monitoring, (2) 
technology advancement providing new alternatives to service under review, 
confounding findings, (3) engagement with clinical participants being limited 
by other service requirements, (4) high risk of inconvenience for the 
participants associated with data capture and (5) separate, Public Health 
Authority commissioned service evaluation to judge if the service should be 
re-commissioned (in 2017). Each risk was reviewed with regard to possible 
impact and affect upon both research progress and the participants. None of 
the identified risks were anticipated to be likely to seriously conflict with the 
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research project or negatively affect research participants; burden was kept 
to a minimum as far as practicable. 
3.12 Project Planning 
 
A project flow chart, (Figure 3.3), illustrates the steps of the research 
programme associated with data collection.  Permissions were granted to 
access relevant Trust data. The researcher commenced the personal 
development training programmes and undertook training specifically related 
to Human Subjects, Ethics and Research Governance.  Application for ethical 
approval was received for survey work and interviews. In line with the original 
project plan the service user evaluation questionnaires were issued in the third 
quarter 2015 and one-to-one interviews undertaken at the end of the second 
quarter 2016 as illustrated by the Gantt Chart, Figure 3.4.  From start to finish 
this process took 5.5 years.  
 
Figure 3.3: Flow chart to illustrate the steps within the data collection 
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(M1 = Month 1, etc.) 
Figure 3.4: Gantt chart to demonstrate the data collection and analysis 
phases timeline of study 
3.13 Methods of Data Capture 
 
There were two methods for data capture. As there were two distinct types of 
research participants, (1) those who were practitioners or who have a strategic 
influence over the development or deployment of RVT in Northern Ireland and 
(2) those who were in active receipt of the RVT service. 
3.13.1 Practitioner and Manager Participants 
 
Staff were given an opportunity to opt into the research in two-stages. (1) a 
recorded and transcribed interview with the researcher and (2) a workshop to 
consider overall findings and challenge common themes relating to 
optimisation of RVT. The experience of RVT for each of the practitioners was 
articulated in a case study for each participant and data from all participants 
combined utilising a descriptive thematic approach. Practitioners discussed 
the synthesised findings.  
 
A descriptive approach was taken, in the form of questionnaires and 
interviews with staff. It was recognised that a manager within SET conducting 
interviews of staff may have introduced bias into the process and skew 
findings. Therefore, the researcher proactively moved out of the SET to join 
the BSO and no longer was in a position to influence operational service 
outcomes for staff. The researcher ensured that potential participants did not 
feel obliged to participate in the research and through the participant 
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information sheet and consent forms ensured that only practitioners open and 
willing to confidentially share their experiences were enabled to participate. 
Practitioners were given the opportunity to express their views from the stance 
of developing future practice based upon direct experience of RVT. 
 
Each potential participant practitioner was sent, by post, a cover letter, the 
Participant Information Sheet for staff, a consent form, a sample of possible 
discussion topics and a stamped addressed envelope to return the consent 
form should they wish to participate. A month later, the Safe and Effective 
Care Team, SET, forwarded completed consent forms to the researcher. The 
participants were given clear guidance about the intention, method of 
participation and personal time commitment along with the understanding as 
to why they had been asked to consider participation. Included within the 
Participant Information Sheet the Trust practitioners received the researcher’s 
contact details and general details (Appendix 4).  
Practitioners were also given information regarding likely, guiding, questions 
to be utilised during the one-to-one interviews. However, there was some 
modification between those discussion-guided questions for Clinical 
participants and those who undertake a management role (Appendix 4). 
3.13.2 Patient and Carer Participants 
 
Patient and carer participants were given an opportunity to participate in the 
research via questionnaires. By returning the completed questionnaire, in the 
pre-paid and addressed envelope to the SET Safe and Effective Care team, 
they were assumed to have consented to participate.  
 
Each potential patient participant was sent, by post, a cover letter, the 
Participant Information Sheet for patients and carers, two questionnaires and 
a stamped addressed envelope to return the completed questionnaires form 
should they wish to consent and participate. The patient was also sent a 
shorter questionnaire to give to their carer, as appropriate, and a second 
envelope for it to be sealed into and returned within the main stamped 
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addressed envelope. Of note, whilst there are similarities between the two 
RVT systems being utilised they are not the same and so the questionnaires 
were appropriately tailored to the recipients. Questionnaire design was 
discussed but for ease of review they are available within Appendix 4. Of note, 
the questionnaires were colour coded; The TF3 Patient Questionnaire being 
printed on white paper, the TF3 carer questionnaire printed on yellow paper, 
the U-Tell patient questionnaire printed on blue paper and the U-Tell carer 
questionnaire printed on pink paper. 
 
After a month the Safe and Effective Care Team, SET, transcribed the 
completed questionnaires onto IBM-SPSS, a software package utilised for 
statistical analysis, transcribed into typed Microsoft word document the 
responses to more narrative focused comments boxes. The Safe and 
Effective Care Team did not interpret the data; the electronic and paper 
documents were forwarded to the researcher for management as per the 
research protocol and data governance. The first step and high-level review 
was only to enable early feedback to patient and carer participants via the 
SET website by 31 March 2016 (Appendix 8). 
 
The patient participants were given clear guidance about the purpose of the 
research and the understanding as to why they had been asked to consider 
participation. Included within the Participant Information Sheet the RVT 
patients received the researcher’s contact details and general details 
(Appendix 4). 
3.14 Patient Confidentiality and Duty of Care 
 
As part of this study the management of patient level information was strictly 
governed; the patient participants in receipt of the questionnaires were all ‘live’ 
on either the TF3 or U-Tell RVT systems at the time of recruitment (August 
2015). Not only would the researcher be privy to the patient’s demographic 
details but also the reason for the RVT service they receive. For example, all 
but one of the recipients of the U-Tell patient questionnaire would have been 
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medicated with warfarin and would already have been participants in an 
earlier Trust RCT. Moreover, not only would the careful management of 
patient information and their concomitant responses be conducted in 
accordance with both Trust and University Data Governance policies, but the 
principles of Adult Safeguarding were adopted. This recognised the duty of 
care at all levels within the study to address issues of safety, handle data 
confidentially and protect the identity of the patients and carers. If a 
respondent to a questionnaire alerted the researcher to an adult safeguarding 
issue or poor clinical practice issue it was possible to act to safeguard a 
potentially vulnerable adult or address a matter of clinical governance. 
Therefore, the questionnaires were pseudonymised, and a confidential record 
kept of which patient was allocated which alphanumeric code. A protocol was 
specifically created for the research and was as shown (Table 3.6): 
Table 3.6 Study Protocol for dealing with clinical and social care issues. 
Study Protocol for dealing with Clinical and Social Care Governance Issues that might arise during the study 
It is recognised that during the course of the investigation research participants may disclose material of a 
concerning nature. For example, these may include topics such as: - 
• Adult Safeguarding 
• Unprofessional conduct of staff 
• Failure to act upon data provided by Remote Telemonitoring Service – act or omission of Trust or 
Service Provider’s practitioners 
• Discovery of Complaints against the Trust or Trust Staff or Service Provider 
If the disclosure has been made through the questionnaires the following steps will be taken, in line with 
Trust escalation policy- 
• The incident as documented will be transcribed 
• The coding on the questionnaire will be accessed to note the demographic details of the participant. 
• The details will be passed to the Trust’s Research Governance Manager who in turn will follow the 
Trust’s Clinical and Social Care Governance Policy to ensure matters are addressed by Trust 
managers. 
If the disclosure has been made through the staff one-to-one interview process the following steps will be 
taken: - 
• The incident as disclosed will be transcribed 
• The details of the participant, patient and staff member involved will be recorded as disclosed. 
• Participant who made the disclosure will be reminded of the duty of care held by the researcher to 
uphold Clinical and Social Care Governance standards as previously explained and documented 
within the Participants Consent form informed of the expected steps to be taken by the researcher. 
• The details will be passed to the South Eastern Trust’s Research Governance Manager who in turn 
will follow the Trust’s Clinical and Social Care Governance Policy to ensure matters are addressed by 
Trust managers. 
The researcher will also brief the Supervisor/ Chief Investigator of the actions taken. 
Julie-Ann Augusto (20:02:15) 
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3.15 Quality Assurance and Compliance with Research 
Governance and Ethics 
 
Quality Assurance and Compliance with Research Governance and Ethics 
was assured by the chief investigator, principal investigator and researcher. 
The study was randomly selected for audit by the Ulster University’s Research 
Office Team. At short notice the research governance controls file was called 
into the University for a Compliance Audit. In November 2017 the research 
project was found to be compliant and with the researcher having followed all 
the research governance and ethics instruction and protocols. 
In addition to the random audit of compliance, quality was considered 
separately in quantitative and qualitative approaches to ensure accuracy of 
data capture, transcription, handling and analysis. 
3.16 Methodology: Building the Quantitative Database 
 
The process of data analysis, when utilising the software IBM-SPSS Version 
25, was recognised as reliable software for quantitative data analysis. From 
the decision to collect data to undertake quantitative analysis to enable an 
answer to the research question to be analysed there were seven overarching 
Steps. 
3.16.1 The Seven Steps within the Data Analysis  
 
Step 1 – To plan the structure and content of a new database. 
Step 2 – Assigning of codes and consistent values.  
Step 3 – The auto-coding of the database. 
Step 4 – Numbering of the pieces of data and governance check. 
Step 5 – Construction of the two Databases. 
Step 6 – Quality Assurance of Database entries to validate accuracy. 
Step 7 – Finalise the report of findings of qualitative data. 
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3.16.1.1 Step 1 
 
The first step was to plan the structure and content of a new SPSS database 
based upon the data contained within completed service user and carer 
questionnaires. There were four different questionnaires which had received 
Research Governance and Ethics approval (July 2015). In accordance with 
the Protocol, the version-controlled questionnaires were issued to all 
recipients of the RTNI service and their carers and to recipients of the u-Tell 
service and their carers.  
 
Next the RVT service users were sent the appropriate questionnaires, 
Participant Information Sheet (PIS) and freepost return envelope through the 
post if they had been a recipient of a SET’s RVT service the previous month. 
The returned questionnaires were managed by SET’s Safe and Effective Care 
Team. Trust Officers safeguarded the material and compiled the response 
data into an initial database. These databases were reviewed and disposed 
of and not utilised for the research as the structure and format was insufficient 
to interrogate data and some responses had not been appropriately coded. It 
was useful to review an early iteration of 4 separate databases, one for each 
type of questionnaire. Early review demonstrated weaknesses in the structure 
and inaccuracies in data input, but it was a useful exercise to review; from an 
informed position, and so two new data sets were planned and concomitantly 
two databases compiled. It was decided that the carer questionnaires were to 
be combined regardless of RVT service experienced and that data contained 
within all service user responses similarly be grouped.  
It was determined that the service level nuances in data could be 
disaggregated from the overall data set if appropriate coding was developed 
and refined.  
Equally there had been limited quantity of free text and a determination was 
made to retain the more qualitative data separately so that only the 
quantitative data was recorded in two data bases (patients and carers). 
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3.16.1.2 Step 2 
 
The step of assigning of codes and consistent values to each possible 
response, to each question, across the four questionnaires. A ‘nickname’ or 
abbreviation was decided upon for each question asked of a respondent. For 
example, the question under the ‘Patient Benefit’ topic, question 1, “The 
telemonitoring system assisted me in managing my health on a day-to-day 
basis” was given the abbreviated code, “b1helpmeman” so that there would 
be a logic to follow for the researcher whilst analysing the data. Moreover, 
numbers to represent non-response or not applicable were allocated. For 
some yes or no, or rather binary on or off type of questions the numbers 1 and 
2 were used and where there were agree or disagree responses a scale of 4 
to 1 was applied with 4 representing a response of ‘strongly agree’ and 1 
representing a response of ‘strongly disagree.’ The Figure 3.5 demonstrates 
assignment of codes and values to a questionnaire template whilst Appendix 
3 contains coding details. 
 
Figure 3.5: Demonstration of assignment of codes and values to 
questionnaire template 
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3.16.1.3 Step 3 
 
The auto-coding of the database; the data were then merged where miscoding 
had occurred which had been caused through software header variation. This 
process was designed to format and structure consistently. 
 
3.16.1.4 Step 4  
 
Numbering of the pieces of data and Governance Check. 
Each of the completed and returned questionnaires were sequentially 
numbered and ordered so that one set of responses in a questionnaire could 
be cross-checked or referred to when quality assuring data entry in the 
database or when adding qualitative narrative to a particular finding or 
anomaly.  
During this process the researcher visually examined the returned 
questionnaire in order to determine if any respondents had raised a clinical 
governance or safety issue. [There were no comments to cause concern and 
so there was no need to follow the Research Project’s Clinical Governance 
Policy and no questionnaire required to have the respondent identified]. 
3.16.1.5 Step 5 
 
Construction of the two SPSS Databases. 
Following the structural plan decided upon in Step 1, in turn, each of the two 
SPSS data bases were constructed. Then each set of responses to an 
individual questionnaire were entered into the database in ascending 
numerical order. The responses were grouped by RVT service; all the RTNI 
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3.16.1.6 Step 6 
 
Quality Assurance of Database entries to validate accuracy. 
Once the preliminary data base was constructed every cell rule and 
construction was cross-checked to ensure accuracy and all individual data 
entries, i.e. the transcription of questionnaire-based data into an electronic 
database, cross checked twice for validity. Therefore, a detailed quality 
assurance process was undertaken thus validating and ensuring data 
accuracy. This then meant that the databases were ready for data analysis to 
be undertaken, confident quantitative findings would accurately represent the 
views as expressed by RVT service users and carers. 
3.16.1.6.1 Data Cleansing: 
 
Preparation of the Patient Questionnaire responses recorded in the 
quantitative database included the transformation of the condition data so that 
it could be manipulated and counted more easily. The coding was scored ‘one’ 
for ‘yes’ to a condition, (14 possible condition options), and ‘two’ for ‘no’. The 
transformation was to change all score ‘two’ to score ‘zero’. There were two 
steps in the process first to transform all scores of ‘two’ in the Data View 
against the conditions and then to change the meaning within the Variable 
View so that N/S equals zero instead of N/S equals two and that ‘yes’ equals 
one remains.  
In examining the data there were nine respondents who recorded a condition 
in the cell ‘other’; eight of those participants recorded a secondary condition 
that would be classified as the main condition that they recorded in their 
response to the questionnaire, i.e. recorded emphysema ‘other’ and also 
recorded that they were being monitored for COPD as both would be 
classified as ‘respiratory’. One participant recorded ‘other’ as pregnancy and 
had equally responded to maternity and weight management both of which 
would be classified as maternity as the primary reason for use of the RVT. 
One participant recorded that they had Parkinson’s and one participant 
recorded arthritis; neither of these conditions were managed through RVT and 
both participants recorded primary conditions managed through RVT, so the 
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entries recorded under ‘other’ were not considered. Only one participant 
recorded ‘other’ without any primary diagnosis for the purpose of RVT. 
Therefore, there were two options to pursue, the first being that no assumption 
could be made about condition so it would be accepted that their opinion 
would only be considered where specific conditions were specified as a 
required variable. The second option was to go back to the original narrative 
submitted by questionnaire of respondent number 47 to seek further 
indicators of condition. Upon examination there was evidence, on the 
completed questionnaire, that the respondent had chronic asthma, used a 
triage service and of note asked never to be taken off the system in a 
comments box. Therefore, the decision was taken to record the respondent 
as a respiratory patient with a most likely condition as COPD, concomitantly 
the response for the variable COPD was manually changed from 0 to 1 to 
show that they were using the system for a respiratory condition.  
In the process of analysis of conditions, the analysis variable ‘data reliability’ 
relating to conditions excluded the ‘other’ variable and only reviewed the core 
conditions. Equally, one respondent, number 51, received the TF3 service 
and recorded that they were receiving RVT for dementia care but equally 
recorded RVT COPD, COPD and GDM. This could not have been the case 
as the respondent was a 78-year-old male. Gestational Diabetes Mellitus 
(GDM) is a condition only found in pregnant females and so the participant’s 
data was amended to reflect that they did not have GDM rather had DM; this 
recognised that having dementia, the questionnaire may have caused 
confusion and that he may have intended to indicate ‘diabetes’. Similarly, a 
74-year-old lady with Parkinson’s recorded her purpose for management 
within the TF3 service as GDM and so again her response was changed to 
diabetes mellitus. The change of these two respondents’ health conditions 
meant that no respondents were recorded in the results as having just GDM 
which is entirely consistent with how the service TF3 RVT was being 
operationalised within SET. In turn, the responses recorded by the 
participants indicating that they received TF3 RVT for maternity care were 
three. Within SET RVT, policy indicated that the only patients who were 
prescribed the service and were pregnant, would be referred by the Dietitian 
and so received RVT to assist with weight management throughout their 
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pregnancy. One recorded maternity as a reason to use RVT but it is difficult 
to determine if this is genuine as the participant recorded their age as 61-
years. Given the absence of other indicators of ill-health, an assumption was 
made that their age was incorrect, and the participant’s responses was 
analysed as if they were receiving the TF3 RVT service during the pregnancy. 
Their responses were excluded from analysis where the opinions of those with 
chronic diseases or rather long-term conditions were considered and there is 
a note that this respondent may skew the related means.  
One respondent, number 81 failed to identify the service being utilised and so 
a review of their overall questionnaire demonstrated it was the U-Tell service, 
so the data was changed from ‘zero’ to ‘two’ for the response; this removed 
one for missing data for the ‘which service?’ variable.  
The questionnaire did not seek to clarify if patients suffered from a condition 
but were not monitored for it and so an assumption was made that when a 
participant responded positively to the presence of a condition by ticking a box 
associated with the question… ‘What is your health condition being monitored 
through TF3 (or U-Tell)? Please tick all that apply’, that they reported that 
multiple conditions were being monitored. It is accepted that there is a margin 
of error as some respondents may choose to report all their conditions and 
not only those which are being monitored through an RVT service, e.g. an INR 
patient not on U-Tell could not be monitored through TF3 for INR; N=18 
participants reported INR/ warfarin but only N=16 received the U-Tell service. 
However, it is known that some participants, N=unknown, were genuinely 
monitored on TF3 by several Trust practitioners given the presence of co-
morbidity; COPD patients with diabetes would be managed by both the 
respiratory team and the separate diabetes team; patients with COPD, 
diabetes and CHF would be cared for by the Virtual Ward community nurses. 
Therefore, an assumption was made that the co-morbidities reported are valid 
and being monitored and reported through the TF3 RVT service.   
3.16.1.7 Step 7 
Finalise the report of findings of qualitative data. 
The summary of results, the application of statistical analysis tools and the 
description of findings is undertaken in step 7 and the report of the findings of 
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the quantitative data held within SPSS and is documented in later chapters. 
This step included an initial review of the data held within SPSS and decision 
making with regard to the focus of the data analysis. The overarching 
principles of the data analysis were then designed (described 3.15.2). 
3.16.2 Overarching Principles of Quantitative Data Analysis 
 
Once the two quantitative databases (patient and carer) had been constructed 
the process of analysis began.  
 
A. The "conditions of interest" for the primary analyses was conditions 
combined but without weight management, paediatrics, maternity, 
gestational diabetes, dementia and renal. 
B. Primary analysis for an indicator of self-care and was for analysis of 
question 32 
C. Important secondary analyses were for questions within the topic range 
sections for patient benefit, telemonitoring equipment and technology and 
nurse triage (TF3 Service). 
D. Answers to questions that could be strongly agree, agree, disagree, 
strongly disagree were analysed as the proportion who gave an answer 
and were strongly agree plus agree versus disagree plus strongly 
disagree, if found to be the case. 
E. Subgroup analyses was undertaken for: 
a. Men versus women 
b. Service use with or without nurse triage so that a comparison 
between service users who have respiratory (bronchiectasis plus 
COPD) and cardiovascular (stroke plus CHF plus hypertension) 
versus those diabetes mellitus 
c. Different age groups  
F. To determine if service users felt more or less able to self-care if they 
received the TF3 service or the U-Tell service.  
a.  Variation of opinion of service users, e.g. if there was a difference 
in opinion between patients with different conditions in relation to 
question 32  
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G. To contrast responses of various groups to determine if RVT gave service 
users peace of mind (question 34). 
a. Contrast TF3 and U-Tell 
b. Contrast Gender 
3.16.3 Statistical Analysis to be Undertaken 
 
A plan to methodically analyse the data to determine if there was variation 
between patients with different conditions, gender or technology was created. 
Equally, the opinions expressed by responders relating to patient benefit such 
as self-care were planned. 
1. Tables showing the number of each response to each question for all 
respondents in order to confirm response rate per item. 
2. Tables for the conditions of interest combined for the questions noted in B 
and C, showing the proportions noted in D in order to determine the variation 
in respondents (from section 3.13.2). 
3. Tables for men and women separately for the conditions of interest 
combined for the questions noted in B and C, showing the proportions noted 
in D to determine if gender affected opinion and if sample represented 
population. (from section 3.13.2). 
4. Tables for INR, respiratory, diabetes and cardiovascular separately for the 
questions noted in B and C, showing the proportions noted in D to determine 
if there was variance in opinion based upon RVT technology used (from 
section 3.13.2). 
5. Tables for self-care and triage (F from section 3.13.2) to determine opinion 
and if patient level benefit emerges. 
6. Validity and reliability. The statistical analysis software (IBM-SPSS) can be 
utilised to test the internal reliability and consistency within the data. The 
statistic of Cronbach’s coefficient alpha will be calculated to test the average 
correlation between the elements constituting the scale. Higher values, within 
a range between 0 and 1, will indicate stronger reliability. (Pallant, 2016). 
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Equally, if the measure, actually measures what it was intended to measure 
this is described as validity and indicates research quality. 
Following interrogation and analysis of data, where data were found to be of 
interest it was recorded within Chapter 4. 
3.17 Methodology: Building the Qualitative Database 
 
The process of data analysis, when utilising the QSR International software 
NVivo Version 12 is both methodical and disciplined. The activities were 
broken down into eight steps. The eight-step framework was developed, 
Meehan (2016) and Krippendorff (2004). 
3.17.1 The Eight Steps within the Data analysis  
 
Step 1 - Transcription of digitally recorded semi-structured interviews with 
participants.  The structure was laid out in a word processor and uploaded 
NVivo. 
Step 2 – Assigning of characteristics and attributes to the participants i.e. 
profession, background and decade of qualification. 
Step 3 – The auto-coding of the transcripts, using the formatting provided by 
a framework of semi-structured questions.  The data were then merged where 
miscoding had occurred. 
Step 4 – Break down further the narrative into themes, sub-themes and 
develop code to enable interpretation and understanding. 
Step 5 – Further refinement and consideration of codes to create a structure 
of codes. 
Step 6 – Documentation of findings. 
Step 7 – Validate the interpretation and findings with a group of clinical 
participants. 
Step 8 – Finalise the report of findings. 
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3.17.1.1 Step 1 
 
First step was to create a new database named ‘RVT Interviews’ and 
established rules for data back-up and file recovery.  All data were formatted 
and prepared within a word processor and spreadsheet to simplify data 
comparison, review and enable auto-coding. The data were then uploaded to 
create the ‘Sources’ of data. Initially the RVT Interview database was 
populated with source data creating three main folders, ‘Interview 
Participants’, ‘Interviews’, and ‘Questionnaire Free Text’.  Then import the 
relevant documents into the appropriate source folders. 
 
The creation of cases within the nodes was then required of which there were 
two sets of survey respondents within the semi-structured interviews, 
practitioners and managers. Identity was given to a case through the use of 
case nodes.  The case node then contained all of the qualitative data relating 
to the cases. 
3.17.1.2 Step 2 
 
The classifications were then created for the data and were labelled as ‘Case 
Profiles’ and expanded adding further detail by creating attributes and values.  
The attributes assigned to the cases were Gender, Profession, Decade 
Qualification, Disease Group and RVT Service being utilised by practitioners 
as appropriate (Table 3.7). The next step was to link classifications to each 
case, each of which contains the qualitative data.  On a case by case basis 
all of the 24 semi-structured interview participants’ data were created. 
The Attributes and Values were added to each Case as shown (Table 3.7): 
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Table 3.7 To illustrate the attributes assigned within NVivo to the 
participant demographic data. 
No# ATTRIBUTE VALUES 
1 Gender Male or Female 
2 Professions Nurse, Allied Health Professional (AHP), Doctor, 
Pharmacist, Manager 
3 Decade of 
Qualification 
1970, 1980, 1990, 2000, 2010 
4 Disease Group Diabetes, COPD, INR, Stroke, Weight, All, 
Indirectly Overview All 
5 RVT Service TF3, U-Tell, TF3 & U-Tell 
6 Background Medical, Nursing, Dietetics, Physiotherapy, 
Pharmacy, Business Studies, Law, Information 
Technology, Hotel Management & A Levels 
 
Accuracy of assignment of Attributes and Values was cross-checked, further 
refined and cross-checked again ensuring accuracy. 
Moreover, all values for the 24 cases were assigned.  Ensuring the accuracy 
of data to protect the integrity of the research, as errors in assigning attributes 
and values undermines assertions (Meehan, 2016, p25.). 
3.17.1.3 Step 3 
 
Having built the framework of the database for the qualitative data a degree 
of auto-coding was planned.  In order to plan, in advance, for auto-coding the 
typed transcripts of the digital voice recorded interviews had been formatted, 
prior to upload, so that topics, guide questions and narrative were formatted 
using different styles of header types.  ‘Auto-coding’ was the pre-ordering of 
data prior to manual interpretation and coding. 
Auto-coding of each group of interviews was initiated by header and 
paragraph style and then each section saved to a new folder within nodes 
under ‘Clinicians by Topic’ or ‘Managers by Topic’.  At this stage under nodes, 
within the database, were two node folders ‘Clinicians by Topic’ and ‘Manager 
by Topic’ and case folder ‘Qualitative Data Individuals’. Table 3.8 profiles the 
type of participant by professional grouping, year of primary qualification, 
designation, which RVT service they were most familiar with and the patient 
group who were given RVT. 
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Table 3.8 To illustrate the attributes of the research participants. 
 
 
Following the creation of high-level auto-coding, further quality assurance was 
undertaken within each of the ‘Manager by Topic’ and ‘Clinician by Topic’ 
nodes so duplication caused by word document variation in formatting was 
eliminated through the merging of nodes. The auto-coding enabled the 
collecting of qualitative narrative around the topics for discussion as set out, 
to guide discussion, originally within the semi-structured interviews.  It creates 
a framework for detailed analysis within a methodical and well organised 
format. However, data within the RVT (NVivo) databases that revolved around 
service user comments did not readily lend itself to auto-coding but then the 
low volume of qualitative narrative volumes was manageable for a pen-and-
paper or word processor-based analysis.  The free text submitted by patient 
and carer participants was narrative in response to open questions within a 
questionnaire for example ‘Is there anything else you would like to tell us?’ 
was not analysed using a database. 
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3.17.1.4 Step 4 
 
Step 4 is a process of analysis and was explained through the coding and 
analytical strategy.  The methodology described within this section has been 
interpreted from both approaches to Meehan (2016) and Krippendorff (2004). 
Whilst the initial structure of the database was formulated based upon the 
structure and content of the guiding questions within the interview framework 
there was no auto-coding that could be applied to the participants’ responses.  
Their responses were captured as open-ended free text statements and so 
within the coding of this narrative, meaning and relationships had to be utilised 
to determine the categories.  The approach to the creation of categories was 
based upon the topic of research enquiry, i.e. to assist with answering the 
research topic, “Patient Empowerment through the use of Remote Vital Sign 
Telemonitoring”.  The (NVivo) software holds the data categories and codes 
created by the researcher and does not undertake any of the cognitive 
activities of considering, understanding and interpreting data.  NVivo adds 
rigour and order to the process and at any stage permits an audit of activity 
and steps undertaken.  
3.17.1.4.1 Coding and Analytical Strategy included the Auto-coding Structure: 
 
Auto-coding Structure for the semi-structured interviews created a framework 
which enabled detailed analysis. The software auto-coding function reordered 
the semi-structured interview questions, and associated responses, into 
sections, albeit not following the original question order, Table 3.9). 
  
Critical Appraisal of Remote Vital-Sign Telemonitoring 
132  Julie-Ann Walkden - July 2020 
Table 3.9 To illustrate the NVivo auto-coding process and how subject 






Interview Question used in auto coding 
1 9 Are your thoughts and feelings generally positive, 
neutral or negative about RTM?...  
2 1 Describe your experience with RTM and feel free to 
illustrate your experiences with reference to 
anonymous case studies – please remember not to 
disclose patient or carer details… 
3 10 Do you choose to use RTM or are you given a quota 
by management to use the service? 
4 5 Do you tend to use track and trend or triage? 
5 11 Do you think RTM is value for money?...  
6 2 Have you received training in RTM?  
7 3 If so please could you describe it and your views 
relating to RTM training… 
8 12 If we now think just about the HPSS commissioned 
end-to-end service provided by the supplying 
consortium TF3 or U-TELL (Depends on practitioner’s 
experience – will be one or the other)  
9 14 If you think the service could have been delivered more 
effectively please describe this? 
10 19 Is there anything else you would like to tell me about 
RTM or technology in healthcare in general?.... 
11 4 Please tell me about how you use RTM 
12 8 Please tell me what you have found works best for your 
patients and in what circumstances 
13 16 What are our lessons learned from your perspective? 
14 17 What are the barriers to RTM from your perspective?... 
15 13 What are your thoughts on this service? 
16 15 What do you believe are or would be the key factors to 
make deployment of this type of service most 
effective? 
17 18 What is the future for RTM from your perspective?... 
18 7 Which peripheral devices do you tend to choose and 
why? 
19 6 Why do you make this choice? 
3.17.1.5 Step 5 
 
Following the refinement and deduplication of the auto-coded data a process 
of manual interpretive coding of data was adopted; the auto-coding had 
essentially sorted the data by semi-structured interview question and had 
grouped all responses to the discussion topic under a node. Auto-coding 
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made available compiled sources highlighting the relevant paragraph or 
section by nickname of respondent. This initial sift of data, through auto-
coding, enabled a high-level review but a significant issue with the 
participant’s response data was that, whilst themes were emerging, they were 
not consistently emerging within a single auto-coded node which detracted 
from interpretation and determination of meaning. Therefore, overlaying the 
folder within nodes under ‘Clinicians by Topic’ or ‘Managers by Topic’ with a 
new refined structure was devised. In creating refined topic nodes, at point of 
data saturation, after the detailed review of four manager/ commissioner 
participants and so whilst no new nodes were created for the remaining data 
coding greater detail and sub-nodes were articulated. Similarly, for the 
practitioners, topic or node saturation was achieved after five practitioner 
participants. 
 
Following the creation of a new range of nodes or topics within the responses, 
a new structure for the nodes within each folder was created. In order to 
compare the views of the two main groups of participants the high-level nodes 
were duplicated across the two ‘Clinicians by Topic’ or ‘Managers by Topic’ 
folders. There was variance in the child node topics and a divergence of 
opinion began to emerge. The articulation of findings did not occur in Step 5. 
 
With the manual coding of data, it was determined that there would be eleven 
main nodes within each folder and the child nodes from the initial manual 
coding of data was sorted again into the new nodes. Whilst these were 
decided upon through initial data analysis, the nodes themselves, at this step, 
were not findings rather a structure to enable data sorting, coding and 
analysis. However, it must be noted that in any further analysis the M or P ‘z 
Original auto-coding’ was not undertaken as it would be a duplication of data. 
In effect, this became a storage node of all the original data, as originally auto 
coded by the (NVivo) programme, and to be kept as both a step in the data 
base audit trail and for future reference should a query arise. 
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There were ten additional manual nodes created each with a unique name, 
definition, nickname and colour; with ‘M’ representing a manager/ 
commissioner node whereas ‘P’ representing a clinical practitioner. These 
were not findings, rather a structure to enable detailed analysis. The second 
letter was to give a reasoned structure to the list of nodes as the software 
displays nodes in alphabetical order and the last part of the title was to explain 
overarching node or topic content.  
The details of the eleven-node structure, including node title, definition, and 
‘nickname’ was documented as follows: 
• MP a Experience as a manager or commissioner practitioner. 
o Background of or experience with RVT from the perspective of 
being a manager or commissioner practitioner. Comments may 
be about experience, qualification or advice gained from 
observation that does not fit within another Superior Hierarchical 
Node. 
o MP a Experience (no text highlight colour or coding stripe) 
• MP b Feelings towards RVT 
o Where the participant expressed their feelings towards any 
aspect of RVT. 
o MP b Feelings (red text highlight colour or coding stripe) 
• MP c Opinion expressed RTNI 
o Opinion expressed by manager or commissioner practitioner 
about the Regionally Procured Service and the comments could 
include reflections regarding any area from commissioning 
process to RTNI; from process of service design and 
procurement to end service. 
o MP c Opinion RTNI (blue text highlight colour or coding stripe) 
• MP d Opinion of models of RVT 
o Opinion expressed by manager or commissioner practitioner 
about the models of RVT, that is the two main types of provision 
triage or track and trend. Both TF3 and U-Tell include track and 
trend.  
o MP d Opinion RVT (green text highlight colour or coding stripe). 
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• MP e Training 
o This describes the RVT training received, any deficits or 
recommendations. 
o MP e Train (purple text highlight colour or coding stripe) 
• MP f Staff Engagement target 
o This considers staff engagement from the perspectives of 
clinical freedom versus performance targets and mandates 
o MP f Staff Eng (no text highlight colour or coding stripe) 
• MP g Value for Money 
o This considers aspects of value for money and the perceptions 
and knowledge expressed by manager or commissioner 
practitioner 
o MP g VfM (orange text highlight colour or coding stripe) 
• MP h Outcome and Benefit 
o This considers the aspect of outcome or benefits of the service 
expressed by manager or commissioner practitioner, whether 
actual, demonstrable, hypothetical or imagined. 
o MP h Outcome (yellow text highlight colour or coding stripe) 
• MP i Clinical Service Issues 
o This considers any Clinical service issues beyond those 
documented within the node MP c Opinion expressed RTNI. It 
is more focused upon views, or perceived views (if made by a 
manager) of practitioners, service users, the change of practice 
and research evidence. 
o MP i Clinical (pink text highlight colour or coding stripe) 
• MP j Future of RVT the next generation 
o Considers all aspects for the future of RVT, looks forward to the 
future or articulates what next for RVT in Northern Ireland, 
including policy, equipment, models and engagement 
regardless of a pessimistic or optimistic stance taken by 
participant. 
o MP j Future (no text highlight colour or coding stripe) 
• MP z Original auto-coding (These initial data sorting nodes are to be 
ignored and not analysed to avoid duplication) 
Critical Appraisal of Remote Vital-Sign Telemonitoring 
136  Julie-Ann Walkden - July 2020 
o Contains all the original (NVivo) Nodes that were generated 
through the auto-coding of discussion guide questions. The 
N=16 for practitioners and N=8 for managers/ commissioners 
o MP z Auto (no text highlight colour or coding stripe) 
The Figures 3.6 to 3.13 illustrate the screen shots of the node topics being 
rebuilt within (NVivo) to their final structure. Screen to demonstrate the 
formulation of new nodes. 
 
Figure 3.6: Illustration of practical formulation of new nodes in 5 
manager screen shots of nodes 
 
 
Figure 3.7: Manager node topics j, a, b and c 
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Figure 3.8: Manager node topics c, d and e 
 
Figure 3.9: Manager node topics f, h, z, g and i 
 
 
Figure 3.10: Practitioner screenshot of nodes topics a, b and c 
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Figure 3.11: Practitioner node topics of d, e, f and g 
 
 
Figure 3.12: Practitioner node topics h and i 
 
Figure 3.13: Practitioner node topics j and z 
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3.17.1.6 Step 6 
 
Step 6 is where the researcher documented high level findings. In Step 5 the 
nodes were described in order for both the practitioner participants and the 
manager participants to enable both a high-level review and a comparison 
between two groups. The Step 5 node topic areas were alphabetically 
recorded so that the thoughts and comments across the two participant 
groups could be compared and contrasted, thus creating Step 6. The 
information was transferred into a spreadsheet with clear illustration of 
expanded high-level subjects further dividing nodes/ topics into sub nodes 
and sub-sub nodes (parent, grandchild and great grandchild nodes). Although 
still high level the node/ topics were captured indicating the number of sources 
where a node/ topic was referred to (with a maximum number of sources for 
practitioner participants as N=16 and for manager participants N=8). Then the 
final column demonstrated the frequency a participant made reference to the 
particular topic and gave a notional indication of the power or strength of 
feeling towards a particular node/ topic area. In the first column the letter M 
denoted manager and P the practitioner. The topics were sorted into 
alphabetical order whereas they are not necessarily displayed in order to 
illustrate the process steps and activities undertaken in step 6. (Tables 3.10 
and 3.11 illustrate the summaries).  
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Table 3.10 To illustrate manager participants sample summary reports 
which were produced 
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Table 3.11 To illustrate practitioner participants sample summary 
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3.17.1.7 Step 7 
 
Validation of the interpretation and findings with a group of clinician/ 
practitioner participants. The practitioner participants were offered the 
opportunity to validate the findings but equally the participants were under no 
obligation to undertake this activity and were free to withdraw from the study 
at any stage. There were N=16 practitioner participants who had been 
consented into the research, had taken part in the one-to-one interviews and 
so were eligible to participate in validation. The original plan had been to use 
the Bryson Technique of Cognitive Mapping in a workshop environment, but 
concerns were raised vis-à-vis the length of time required to undertake the 
activity and the activity demanded a single question be considered by a large 
group (Bryson et al., 1995). The researcher decided that an activity which 
relied upon a single question was not appropriate as there were at least eight 
descriptive topics/ nodes and associate sub and sub-sub nodes for the 
practitioners to consider and validate. Moreover, as the practitioners all had 
on-going direct patient care responsibilities and clinical commitments to 
undertake, a protracted event was unduly onerous and not appropriate. 
 
Therefore, printed high-level descriptive findings in summary form were given 
to the practitioner participants in a validation meeting that was scheduled to 
last a maximum of an hour. The date and venue for the validation meeting 
was set two months prior to the event to enable scheduling of practitioner’s 
time given the frequent practice of rebooking patients into appointments 6-
weeks ahead. The meeting was arranged for the convenience of most 
practitioners with the proximity to the main hospital campus. The practitioner 
participants were sent an email inviting them to participate, enclosing a further 
copy of the Participant’s Information Sheet (PIS); simultaneously a Microsoft 
Office Outlook appointment invitation was issued. A month later, a letter was 
posted to the practitioner participants who had not responded to the initial 
invitation to stimulate a response. Then finally, five days before the meeting 
an electronic meeting reminder was issued to those practitioners who had 
responded with either ‘yes’ or ‘tentative’ N=7. Packs were then prepared for 
the participants including the agenda, original PIS, original consent form, the 
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Interview Guide from their original one-to-one interview, and one single-sided 
and compiled copy of each of the two Microsoft Excel NVivo Summary Tables 
to describe the responses of the participants, both managers and 
practitioners. The profile of the practitioner participants, refer to Table 3.12. 
Table 3.12 To illustrate practitioner participants’ attendance 26 January 
2018 validation meeting. 
 
 
Upon arrival the practitioners, (N=4) were offered refreshments, signed an 
attendance form and given a pack. After introductions the researcher 
reminded the Participants of the purpose of the study, data collection activity, 
definitions of acronyms used and requested consent for digital voice 
recording. Four Participants gave verbal consent in support of their original 
written consent permitting the activity to be recorded by audio digital means. 
The Participants understood that the researcher and supervisor would record 
brief notes as the meeting progressed and that the meeting would be digitally 
recorded but not transcribed. The recording was to assist the researcher to 
review discussion in Step 8, as required.  
 
The Steps of data analysis using NVivo were explained as was the format of 
the data presented in the Microsoft Excel NVivo Summary Tables. The 
information header columns and first two topics, ‘a’ manager or practitioner 
Critical Appraisal of Remote Vital-Sign Telemonitoring 
144  Julie-Ann Walkden - July 2020 
and ‘b’ Feelings towards RVT were explained by way of a working example 
and all practitioner participants confirmed understanding and meaning of 
headers and information given and equally how the information had been 
derived from the original interviews. The practitioner participants confirmed 
understanding of the Header ‘Sources (Participants)’ to mean that the topic 
was mentioned by N=’x’ practitioners throughout the entire one-to-one 
interview process. Also, the practitioner participants confirmed understanding 
of the Header ‘References (Frequency)’ to mean that the topic was mentioned 
by N=’y’ number of times throughout the entire one-to-one interview process 
regardless of under which original guide question a response was given to 
(understanding the ‘Quantitization’ of qualitative data). It was assumed that 
the higher the frequency of referral to a topic the greater power or weight of 
importance the topic held for the participant respondents.  
Having affirmed understanding of the format and contact of information 
presented, the group of practitioner participants were then taken through each 
of the eight topics labelled as topics ‘c’ to ‘j’. The role of the practitioner 
participants was to discuss, challenge or affirm and validate the high-level 
findings. One typographical error was found and subsequently corrected and 
following a robust discussion N=4 practitioners explained and confirmed 
agreement with the findings and verified the outcome of the data collection, 
compilation and then Step 1 through to Step 6 of data management using 
NVivo. With final validation in place the researcher was permitted to proceed 
to the Step 8.  
 
3.17.1.8 Step 8 
 
Finalise the report of findings of qualitative data. 
The final step is to report the findings of the qualitative data and in order to 
achieve this objective; query tools were applied to generate reports. During 
the process of creating the database and the subsequent activity of coding 
the text there was the construction of abbreviated definitions for each node 
and sub-node etc. as described in Step 5. At the analysis stage, Step 8, the 
formal generation of the definitions book, an important action to ensure the 
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description of narrative was anchored to the nodal framework. Figure 3.14 
illustrates a screen shot of the first page of the node code book. The Code 
book for the practitioner participant and manager participant RVT interviews 
were produced separately. Whilst, the highest-level codes broadly read 
between both sets of interviews there were subtle sub-node and sub-sub-
node attributes by dint of the fact the groups viewed and spoke about RVT 
from very different perspectives, so emphasis and issues varied.  
Then each of the Coding reports was generated. The coding report for the 
manager interviews was 97 pages long and for the practitioners were 122. 
Each of the coding reports grouped, in alphabetical order, the nodal topics 
and each sorted narrative coded to each node. The participant’s code, name 
and date were included to the left of each statement which enabled attribution 
and an understanding of the context for the perspective offered by the 
participant. Figures 3.15 and 3.16 illustrate example text and formatting to 
demonstrate the structure and presentation the software, (NVivo), is capable 
of presenting (respondent’s names are obscured). This then in turn enabled 
analysis within a structured framework of the outputs of the interviews, i.e. the 
qualitative data. It can be seen that the names of participants have been 
masked in Figures 3.15 and 3.16 in order to maintain anonymity. 
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Figure 3.14: Screenshot of the first page of the node book to illustrate 
an output for the researcher to refer to the node definition book created 
during the manual coding process 
 
Figure 3.15: Screenshot of coding report pages 1 and 2 with practitioner 
participant’s names obscured 
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Figure 3.16: Screenshot of a page of coding report at greater 
magnification with practitioner participant’s names obscured 
 
In writing the report, when the verbatim words of respondents were quoted, 
the names of the respondents were not disclosed. The individual coded 
narrative quoted was expressed inside speech marks and a pseudonymised 
alpha-numeric reference is used so that, if required, attribution can be 
checked. The number represents the date order the participant interview 
occurred and the letter either ‘P’ for practitioner participant or ‘M’ for manager 
participant. Following the production of the node code books and the coding 
report, analysis was undertaken with interpretation and meaning being 
documented and later discussed. The 8 Steps, and tool of (NVivo) as an 
approach, enabled rigorous analysis of larger volumes of text; there were 
93,051 typed words following the 24 face-to-face interviews and so (NVivo) 
enabled a structure to handle large volumes of data and facilitate the 
researcher to give meaning through analysis. The number of participants 
within the qualitative data collection was within the normal range of between 
1 and 30 (Bengtsson, 2016). 
Critical Appraisal of Remote Vital-Sign Telemonitoring 
148  Julie-Ann Walkden - July 2020 
3.18 Approach to qualitative analysis – for NVivo 
 
Hsieh and Shannon (2005) identify three approaches to the qualitative 
analysis of content within narrative, conventional, direct and summative 
with the first approach being adopted in this study.  The tool used provided 
the framework and backdrop for the researcher’s analysis of narrative.  
The software displayed the narrative and recorded the data coded by the 
researcher, but the approach taken to analysis was the,  
 
“subjective interpretation of the context of text data through the 
systematic classification process of coding and identifying 
themes and patterns”. (Hsieh and Shannon, 2005) 
 
Indeed, conventional content analysis was selected as there was little 
existing theory or literature available for RVT regarding experience of 
clinical users.  NVivo facilitated the researcher to build a framework of 
themes, categories, attributes and nodes; building knowledge and context 
directly from the expressed experiences of the participants.  The 
framework afforded the creation of a sustainable and robust structure to 
enable realistic content analysis. 
 
3.18.1 Utilising numerical counts when analysing text 
 
 “Numeric counts of instances of a theme within unstructured 
text are sometimes used as a proxy indicator of the importance 
of that theme for qualitative analysis” (Bazeley, 2010).   
 
Albeit, it can be argued that a relationship between importance and 
frequency may be tenuous and that meaning derived from content and 
context has to be understood.  Therefore, care was taken when counting 
was applied to the narrative data as indeed the researcher’s coding may 
introduce influence on the number of comments, phrases, references, 
codes and nodes to be included in a tally.  The counts were used as a 
basic proxy for relative importance and were utilised with caution.  
However, the table and matrix of relationship between theme, node, sub-
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nodes and corresponded with associated tallies, was a very useful proxy 
indicator of emphasis, broadness of viewpoint experienced and to give 
structure to narrative analysis.  These models enabled connections and 
relationships to be articulated experience and form a key element of 
analysis (Gibbs, 2002, p218).  Indeed, in this study the linking of qualitative 
data, attributes, ideas and nodes was undertaken through the ‘code it’ 
approach, whereby,  
“save concept to data links require fathering of all material 
about a topic… reflect on it or explore in relation with other 
topics.  Use visual coding for rapid identification of topic, service 
etc. or to introduce another ‘layer’ of interpretation that 




Rigor was applied to both the research methodology, the data collection 
instrument design and to the execution of the research to ensure 
trustworthiness. There were four tenant characteristics within the domain of 
trustworthiness that were incorporated: - 
i) Credibility. The credibility of the research was founded upon validity and 
replicability of the research methodology; in ensuring the process was 
followed. The measures applied within both qualitative and quantitative 
paradigms of the research were stable and enabled consistent data to be 
collected. The mixed methods approach balanced the flexible and fixed data 
collection instruments and enabled the findings from both paradigms to be 
assimilated through triangulation. This ensured findings which related to the 
lived experience of RVT from multiple perspectives. 
ii) Transferability. The methodological approach ensured that the findings of 
the RVT research were generalizable across the deployment of the 
technology within the health and social care environment to enable a patient 
centred approach not, simply rigid within the RVT system, structure and 
environment within SET. Transferability is the ability to transfer findings to 
another environment. The research methodology should be replicable, with 
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the findings being more broadly relevant rather than simply within the study’s 
situation. 
iii) Dependability. This was achieved by developing a systematic approach to 
the analysis of the data and interpretation of the findings and is achieved by 
ensuring an explicit audit trail. 
iv) Confirmability. The confirmation of findings was built into the research 
methodology by observing, exploring and explaining the findings from four 
different perspectives (patient, carer, practitioner and manager) and within 
two paradigms (quantitative and qualitative analysis). It was based upon how 
the findings were checked before the triangulation of data. Within the 
qualitative analysis, the approach of quantitization of data and subsequent 
triangulation of all data, meant findings could be corroborated from different 
perspective. This allowed the research question of to be answered from all 
data sources and confirm that all the data was ‘saying the same thing’. 
(Robson, 2002) 
3.20 Methodology: Mixed Methods Data Integration 
 
The mixed methods design is a scientific aspect of drawing findings together 
which was described by Creswell (2003) “integration means that the 
researcher “mixes” the data.” This may be within a survey where both open 
and closed questions are utilised or through different methods of data 
collection and where the “mixing” occurs within the analysis and interpretation 
stage of the study.  
3.20.1 Concurrent Strategies Creswell (2013): Concurrent 
Triangulation Strategy 
 
When the full quantitative analysis, of data had been undertaken and 
concomitantly the analysis of the qualitative data completed, it was ready for 
overall analysis and interpretation. The data, regardless of type, was 
considered of equal value and was further analysed, blended, compared and 
considered complementary when reviewing RVT from multiple perspectives. 
The process, known as triangulation, can be undertaken from different 
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stances but within the RVT research, the equal weighting, the parallel data 
collection and handling enabled the approach, articulated by Creswell (2003), 
of ‘concurrent triangulation’.  
 
 
“+” “indicates simultaneous or concurrent form of data collection”.  Capitalisation indicates emphasis 
and priority. 
Figure 3.17: Illustration of concurrent triangulation strategy 
Concurrent triangulation strategy enabled the researcher to utilise data 
obtained through different methods to “confirm, cross-validate, or collaborate 
findings within a single study” (Ibid.) and the parallel activity and equality of 
value is illustrated in Figure 3.17. The approach enabled a balance between 
the strengths and weaknesses of one approach with those of the other. The 
approach with interpretation was descriptive where observations, comparison, 
complementarity or contradiction across data, regardless of source or type, 
was documented. Convergence of results occurred across multiple sources 
gave an indication that the new knowledge, whether a likely outcome, benefit 
or disbenefit of RVT, was strengthened; and it assisted with substantiation or 
validation of findings. Equally, divergent data needed explanation and was 
illustrative of the interface of the system between different participants, i.e. 
from the stance of a patient, or a carer, or a clinical practitioner or a manager. 
However, whilst the complementarity was sought, Saks and Allsop (2008) 
warned that conducting such a study could be difficult and would require skill 
to distil the results, whilst Creswell (1994) highlighted this could be mitigated 
by good project management. Although the effort within a healthcare 
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environment was beneficial as it enabled the triangulation of multiple sources 
of data to discover ‘holistic’ knowledge derived from multiple perspectives 
(Tritter in Saks and Allsop, 2008, pp301-318).  
Combining the paradigms was difficult because of required expertise, time 
and risk of scope creep although it had the potential to balance bias from one 
paradigm or data source with another. However, the utilisation of software 
facilitated the transformation of qualitative data, counting codes, themes 
which allowed the generation of “a narrative that portrays the results 
comparing “quantitized” qualitative data with the quantitative data” (Creswell 
and Plano Clark, 2007).  New perspectives were found through examining 
data that converged or offered complementarity and afforded a breadth and 
depth of results.  
 
Populations that interact with RVT were different in terms of roles and 
relationships with system accessibility and volume.  There were far more 
patients, fewer managers and practitioners with significantly different roles 
within the system.  Therefore, utilising the same method of data collection 
would not permit the richness of meaningful data.  The opportunity to 
maximise the number of patient participants was enabled through the use of 
a questionnaire.  Such a survey tool, when applied to the entire service user 
population, afforded the researcher an opportunity to reach out and engage 
with the broadest base of service users.  It was already known that sampling 
of the service user base could not be achieved to attain a representative 
sample across all disease groups, as numbers were small within some 
disease groups.  Therefore, the data collection methodology had to be tailored 
to the potential participants.  A known risk within the application of mixed 
methods included selection of different individuals to be surveyed through one 
paradigm or another; unequal samples sizes and the potential bias.  
Therefore, by recognising the differences in the potential participant groups 
different modes of engagement and data collection were devised.  In effect, 
through the utilisation of a questionnaire with closed questions, quantitative 
data could be collected from patient and carer respondents including 
opportunities for free text enabled data as they felt fit.  Therefore, whilst mixed 
data collection in the form of a questionnaire was given to the patient and 
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carer group the significant volume of data collected and analysed, in the 
overall research, would be qualitative.  Equally, the two health and social care 
staff groups to be engaged in the research were the managers and the clinical 
practitioners.  The research paradigm was that of qualitative data collection 
and analysis, and the data from both groups was kept separate, allowing an 
initial analysis of the two groups of participants independently.   
 
The data collection from Health and Social Care staff was undertaken using 
semi-structured one-to-one interviews.  The analysis was undertaken utilising 
software which enabled the generation of reports profiling, combination or 
comparison of codes by participant.  The summary analysis generated a 
report that “quantized” qualitative data and as appropriate, permitted direct 
combination or comparison with true qualitative data obtained from the service 
user/ carer participants. (Creswell and Plano Clarke, 2007). 
 
This study used mixed methods and therefore, mixed the findings to create 
an interpretation of the RVT service within the context of application within 
SET. 
“Researchers can merge the two data sets during the interpretation 
(by analysing them separately in a results section and then merging 
the two sets of results together during the interpretation or discussion 
phase)” (Ibid. p83). 
 
However, of note within the qualitative analysis one piece of information, 
narrative data, was coded only once, whereas, there is a possibility that the 
quantitative data may be coded multiple times and the distinction in counting 
of data are made (Bowling, 2002, p389). 
 
The pre-existing knowledge and experience of the researcher was considered 
to achieve balance.  Whilst there was a recognised risk of bias, which was as 
far as practicable avoided, some knowledge was an advantage.  Moreover, 
the researcher adhered to  
“a qualitative perspective and the main issue is to achieve the rigour 
and credibility that make the results as trustworthy as possible” 
(Bengtsson, 2016, p8-14).  
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All material was analysed with the purpose to organise and elicit meaning 
from data collected and draw realistic conclusions.  As a method, content 
analysis was unique in that it has both a qualitative and a quantitative 
methodology and can be used in an inductive or deductive way (Ibid.) so that 
the blended data can be interpreted and given meaning. 
3.21 Justification 
 
In exploring the options that can enhance RVT for people with LTCs, the study 
aimed to suggest how to deploy new technologies to best effect where 
technology is integrated into care packages and determine if there was patient 
benefit. It was anticipated that the by understanding optimisation and/ or 
benefits of RVT would enable technology integration into “mainstream” health 
and social services.   
3.22 Summary 
 
In order to design and apply the appropriate research methodology to answer 
the research question there were five recognised methodologies investigated 
and considered, with the high-level summary of the decision-making being 
seen in Table 3.2. Moreover, full research governance and ethics approval 
was attained following the creation of data collection tools, research protocol 
and research support materials. 
It was recognised that undertaking a mixed methods study could be complex 
and that data handling and management had to be executed with discipline 
and so IBM-SPSS Version 25 was utilised to manage quantitative data and 
QSR International’s NVivo Version 12 for qualitative data. There was no 
sampling of potential patient or carer participants with the full caseload of RVT 
participants being sent questionnaires and eligible clinical practitioners and 
managers being offered the opportunity to share their experiences through 
one-to-one semi structured interviews. The research was undertaken in 
accordance with the methodology and version-controlled documents as 
approved by the research ethics and governance committees. 
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4 ANALYSIS OF SERVICE 
USERS DATA 
4.1 Defining the Benefit of Empowerment 
 
During the analysis of data evidence emerged suggesting that benefit could 
be obtained through the application of RVT for those with LTCs. However, 
nuance of language meant that the utilisation of multiple terms required a 
broad understanding of an overarching emergent theme. There were 
repeated concepts or language which were interpreted and considered as 
proxies for, or dimensions of, the overarching benefit of empowerment. 
Therefore, the researcher’s interpretation of empowerment considered the 
knowledge, skills, attributes and abilities of a patient to be an active participant 
in their own self-care or management of their condition to be constituent 
elements. Moreover, language associated with patient-centredness was 
considered as a central tenant of empowerment. The benefit was not one 
where a practitioner abrogates responsibility or expects compliance rather the 
creation of a partnership, where power passes from the practitioner to the 
patient. In affording deeper meaning to the data, where acknowledgement of 
patients expressing an ability to feel supported, to gain a better understanding 
of their LTC, was to become active participants rather than passive recipients 
of care was again interpreted as empowerment. 
The basis for defining the factors contributing to empowerment was 
articulated within the WHO Alma-Ata declaration (1978) which “…includes at 
least education concerning prevailing health problems and …individual self-
reliance and participation.”  A constituent part of empowerment was the 
dimension of person-centredness: 
“... an approach to care that consciously adopt the perspectives of 
individuals, families and communities, and sees them as participants 
as well as beneficiaries of trusted healthcare systems that respond to 
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their needs and preferences in humane and holistic ways. People-
centred care requires that people have the education and support they 
need to make decisions and participate in their own care. It is 
organised around the health needs and expectations of people rather 
than diseases.” (WHO. 2015. p19) 
Two European collaborative networks have also focused effort upon defining 
empowerment within healthcare. ENOPE (2014) defined a framework of 
seven principles where the patient: 
1. “Understands their health condition and its effect on their 
body. 
2. Feels able to participate in decision-making with their 
healthcare professionals. 
3. Feels able to make informed choices about treatment. 
4. Understands the need to make necessary changes to their 
lifestyle for managing their condition. 
5. Is able to challenge and ask questions of the healthcare 
professionals providing their care. 
6. Takes responsibility for their health and actively seeks care 
only when necessary. 
7. Actively seeks out, evaluates and makes use of information.” 
With CEmPaC (2020) extending the value base by building in person-
centredness: 
“Person-centered care is the provision of care that places the 
patient at the center ensuring that the healthcare system is 
designed to meet the needs and preferences of patients as defined 
by patients themselves.” 
McCormack and McCance (2017) argued that empowerment consisted of two 
overarching principle types, firstly of ‘structural empowerment’ where authority 
is delegated in relation to resources and support and secondly ‘psychological 
empowerment’ where powerlessness is removed. Whereas, NHS England 
(2020) only articulated empowerment from a structural perspective, i.e. 
articulating physical resources rather than system and meaningful design in 
the ‘empower the person roadmap’. The researcher acknowledges the tools 
articulated in the roadmap but considered it to be insufficient and failed to fully 
encapsulate the meaning of the narrative and ratings of the respondents 
within any of the participant groups.  
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Therefore, the concepts as described by the WHO, European collaborative 
networks and McCormack and McCance were adopted to understand and 
describe the benefit of empowerment within the research. 
4.2 Introduction of the Analysis of the Patient and Carer 
Participant Questionnaires for both TF3 and U-Tell  
 
Questionnaire packs and Participant Information had been issued, to the 
service users and carers as per the protocol. No sampling was undertaken, 
instead the entire cohort of ‘current’ RVT service users were sent a 
questionnaire along with a questionnaire for their carer, if appropriate, 
requesting completion.  There were 32 patients who used the U-Tell Remote 
Telemonitoring Service and 242 patients who used the TF3 Remote 
Telemonitoring Service. Of note, the researcher could not determine how 
many carers may be likely to respond as records were not available to assess 
this, albeit an estimate of N=90 possible carers had been made which did not 
account for a possible response rate. The response rates 16 (50%) U-Tell 
questionnaires returned with one questionnaire was returned by a carer and 
for the TF3 service 242 questionnaires were issued and 81 returned, giving a 
response rate of 33.5%. In addition, there were 48 carer questionnaires 
returned for statistical analysis. Overall patient response rate was 35% with 
97 of a possible 274 returned. Consistent with the research protocol, the 
questionnaires were pseudonymised and the researcher did not have access 
to list of service users invited to participate, so there were no opportunities to 
further encourage participation or improve the response rate. However, 
external reviewers for the BMJ were satisfied with participation rate and a 
paper discussing the findings was published (Walkden et al. 2019). 12% of 
patients had assistance from their carer to complete their questionnaire. As 
described in chapter 3, all questionnaire responses were entered into SPSS 
with two data bases created, one to enable analysis of patient participant 
opinion and experience and the other for the carer participants. Not all patients 
responded to every question indeed as the U-Tell service did not afford the 
patient access to the triage nurse the patients were not asked all of the 
questions as the TF3 patients were.  Nine patients did not disclose their 
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gender and five did not report their age. Of the questions, requiring a rating of 
experience of RVT for both TF3 and U-Tell patients the mode of missing data 
was 6.  
4.3 Quantitative Analysis of Patient Data 
 
The first analysis to be undertaken was to review the high-level descriptions 
of data such as number of respondents, gender and diseases recorded. Whilst 
there were 97 respondents there were N=130 conditions reported of which 
N=123 were ‘conditions of interest’ i.e. chronic diseases and use of warfarin 
(INR reporting). This demonstrates that co-morbid non-communicable 
disease is present in the cohort. 
4.3.1 High-level Demographics 
4.3.1.1 Gender 
The response to the question regarding gender, indicated most were male 
(N=49, 56%), nine respondents did not indicate their gender. 
4.3.1.2 Service 
The great majority of responses came from users of the regional ‘TF3’ service 
(N=81, 84%), with a minority using the local ‘U-Tell’ service (N=16, 17%). U-
Tell for INR/ warfarin management and TF3 for diabetes, respiratory 
conditions, hypertension or CHF. There were N=97 valid responses overall. 
50% reported that they had a carer to help them record  
4.3.1.3 Age 
It can be seen that of the N=92 respondents who disclosed their age, the 
mean age of RVT service users is 68.6-years (Table 4.1).  
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Table 4.1 Mean age of respondents by RVT service. 
Which Service do you 
use? Mean N 
Std. 
Deviation 
0 (a) 74.0 1 . 
TF3 69.5 76 10.9 
U-Tell 64.0 15 12.1 
Total 68.6 92 11.1 
(‘a’ calculation executed prior to status of omission changed to U-Tell) 
4.3.1.4 Conditions 
Participants reported health condition(s) being monitored. There were 14 
potential options and it is recognised that co-morbidity is significant within the 
older segment of the population. Virtual Ward service users would typically 
have had multiple conditions, frequently a combination of CHF, respiratory, 
hypertension and diabetes. As the Virtual Ward patients were a small 
proportion of participants, it was assumed, that there may be minimal 
articulation of co-morbidity. Instead, it was found that the N=97 respondents 
recorded N=127 conditions (where age is disclosed) (Table 4.2) or N=130 
(where age is not a factor) (Table 4.3). Moreover, whilst the care options for 
the conditions of dementia and renal were available through TF3 in other 
Trusts they were not utilised in SET. Furthermore, the weight management 
service and maternity service in SET were in fact the same service and was 
managed by a dietitian; there is a mismatch with the data as the number of 
participants being monitored who were pregnant and over-weight should be 
the same whereas there were three more participants noting weight 
management. Such cases illustrate the behaviour of participants reporting all 
clinical conditions rather than those for which RVT was prescribed. It can also 
be noted the average age of the pregnant woman whose care is augmented 
through RVT was 44.3-years with a standard deviation of 14.9; this was 
skewed by a respondent recording their age as 61-years. Most patients (66%) 
recorded one condition, 20% recorded two LTCs and the remainder with three 
or more; one of who recorded five LTCs demonstrating 34% of respondents 
had co-morbidity of LTCs. 
In summary, the existence of co-morbidity meant the total number of 
conditions recorded exceeded the number of participants. 
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Table 4.2 Mean age profile of respondents by reported condition. 
Condition (N) Mean Age Std. Deviation 
CHF (6) 81.7 6.2 
Dementia (1) 78.0  
Hypertension (6) 72.0 10.3 
COPD (59) 71.2 8.8 
Diabetes (17) 70.2 10.9 
Bronchiectasis (9) 69.7 4.6 
Renal (1) 69.0  
Stroke (2) 67.5 14.8 
INR (18) 65.4 11.9 
Weight Man. (5) 56.2 24.1 
Maternity (3) 44.3 14.9 
 
 
Table 4.3 Morbidity profile of respondents. 
Condition N 
Chronic Obstructive Pulmonary Disease (COPD) 63 




Chronic Heart Failure 6 




Valid N (listwise) 0 
 
4.3.2 Response Ratings Recorded by Patients 
4.3.2.1 Rating given by patient respondents to experience based questions 
were categorised into four groupings, i) the RVT enabled self-care, ii) RWVT 
reduced the patient’s demand or additional direct access services, iii) the 
patient’s opinion regarding RVT technology and future use and iv) the 
patient’s opinion of RVT response. (Table 4.4) It can be seen that the majority 
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of patient’s indicated that RVT had enabled self-care defined across three 
domains of self-management, being involved in care rather than a passive 
recipient and giving peace of mind. Moreover, most patients indicated that 
RVT had reduced the demand upon primary care and outpatient services with 
66% of patients reporting a belief that RVH had reduced hospital admissions. 
Whilst 44% of patients reported being worried about technology before it was 
installed, 90% believed that increased use of technology in the future would 
be of benefit albeit that 73% were happy for that to be through increased use 
of internet-based technologies.  
Table 4.4 Rating reported by patients relating to four groups of 















Enabled Self-Care     
The remote monitoring 
system assisted me in 
managing my health on 
a day to day basis 
0 3 21 66 
Has helped me manage 
my own condition and 
become involved in 
health care 
1 4 34 54 
Given peace of mind 0 2 30 62 
Reduced demand for 
other services 
    
Prevented or reduced 
need to attend OP appts 
1 7 28 47 
The monitoring system 
has reduced number of 
GP visits 
1 5 27 55 
The monitoring system 
has reduced the number 
of health professional 
visits 
1 3 31 56 
Has prevented the need 
to attend Emergency 
Department and/or GP 
Out of Hours Service 
3 5 27 46 
Prevented my admission 
to hospital 
3 14 27 37 
Technology now & 
future 
    
Worried about using new 
tech before installed 
15 28 31 10 
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SET Practitioner 
explained system in 
enough detail before 
installation 
0 1 33 58 
Equipment easy to use 0 0 26 64 
More interested in using 
tech in general 
2 15 34 28 
Questions on Hub or U-
Tell readings page 
encouraged to think 
about symptoms 
2 6 37 42 
Internet portal to view 
readings useful 
2 2 29 29 
Happy to use internet to 
upload readings or send 
messages 
5 11 24 29 
Believe Increased tech 
in care and support of 
people at home will be of 
benefit in future 
0 1 33 54 
Consider Increased 
internet in care and 
support of people at 
home will be of benefit in 
future 
2 8 30 41 
Utility of messages & 
support 
    
TF3/ U-Tell message 
helpful 
0 1 29 50 
Clinician's telephone 
support helpful 
0 1 29 55 
Triage nurse helpful 0 0 10 53 
4.3.2.2 Patient experience of contact by healthcare staff in relation to RVT 
When comparing the data in Tables 4.4 and 4.5 it can see that the majority of 
patients reported having received contact by a healthcare practitioner in 
relation to their vital sign reading (N=76). Only a proportion of patients would 
have access to a triage nursing service and 60% reported having been 
contacted by a triage nurse and no patients reported that this service was not 
helpful. 
 
Table 4.5 Patient reported contact with healthcare staff. 
Contact with staff YES NO 
Have you been contacted by a SET practitioner in 
connection with readings? 
76 9 
Receive a TF3 nurse triage service?  56 13 
Contacted by a TF3 triage nurse? 58 4 
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4.3.2.3 Self-reported admission data 
Patients were asked to report how many times they had been admitted to 
hospital when in receipt of the RVT service. Whilst, N=64 patients believed 
RVT had prevented admissions (Table 4.4) N=44 reported having been 
admitted into hospital (Table 4.6) with two patients reporting between 11 and 
15 admissions and one patient more than 16 admissions. 
Table 4.6 Patient reported admissions to hospital data whilst using RVT. 
How many times admitted 










Number of Patients 50 36 5 2 1 
Percentage of 
Respondents 
51.5% 37.1% 5.2% 2.1% 1% 
 
4.3.3 Reported Benefit of RVT 
 
The topic of ‘Benefit’ consisted of seven questions; the most critical of which 
was, ‘The telemonitoring system has enabled me to better manage my own 
condition and become more involved in my health care’.  
In considering the groupings of conditions for participants, not only was there 
reporting of multiple or co-morbidities but there were similar conditions which 
required the same peripheral devices and service to be given to the TF3 
service users and so alternative two groupings were considered for the 
analysis of elements of the data; COPD and Bronchiectasis were classified as 
‘Respiratory’; Equally, a classification or reference group of Chest, Heart and 
Stroke (CHS) was created and participants would have reported Stroke, 
Chronic Heart Failure (CHF) and Hypertension (essentially circulatory system 
conditions). However, the mean response for both groups was the same at 
3.5 indicating high levels of agreement (Table 4.7). 
In considering the dimensions or interpretation of empowerment, the first 
question considered was Has helped me manage my own condition and 
become involved in my healthcare. Table 4.7 shows the mean and standard 
deviation for an overall positive or negative perspective of the topic with 4 
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being the high rating attributed to the value statement, ‘strongly agree’ and 1 
being the low rating attributed to the value statement, ‘strongly disagree.’   
The lowest rating was 1 and had been recorded by one participant but the 
utility is questionable as this participant recorded their diagnosis as dementia 
and the RVT services provided by SET were not designed to support the care 
of those with dementia and would not have been the reason for prescription 
of the system; this participant will have a dual diagnosis and so their attributed 
value was accounted for in the mean rating associated with their reason of 
inclusion in the program. The same is true for Stroke where the mean rating 
for two participants was 1.50 and yet again their response would be included 
in the condition; they were prescribed the service for i.e. a respiratory 
condition, diabetes or CHF etc. The utility for patients with such conditions 
could be determined as low and is consistent with their response. Conversely, 
where the service was well designed for the majority of conditions being 
monitored the respondents were more agreeable with the idea of the 
technology assisting with self-management. Equally, the one participant who 
has recorded a renal diagnosis responded with ‘4’, the highest rating and 
again as this RVT service was not given to support their condition, this single 
rating is ignored and it is accepted that their rating would be attributed within 
the condition for which they were prescribed the system within SET.  
The accepted lowest mean rating was 3, ‘agree’ and was attributed by those 
N=15 participants with diabetes, whereas those nine with a diagnosis of 
bronchiectasis had a highest mean rating of 3.78. Overall CHS N=64 
participants with CHS (which includes both respiratory conditions) was the 
largest cohort and had a high mean rating of 3.50. Of note, within the RVT 
data, the only participants to utilise the U-Tell system rather than the TF3 
system were the participants recording that they were anticoagulated; N=18 
warfarin participants with the mean rating 3.67. Therefore, it is concluded that 
there is consensus between participants believing there is a benefit to RVT 
service users from their own self-management and proactive involvement; 
indeed, one respondent wrote,  
“…because my oxygen levels can drop very quickly and suddenly, I 
can keep a check on my levels with oxymeter which keeps me from 
panicking.  I can adjust my oxygen accordingly.” 
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Table 4.7 To articulate the mean and standard deviation in responses to 
the question Has helped me manage my own condition and become 
involved in my healthcare. 
Condition (N) Mean Rating Std. Deviation 
Diabetes (15) 3.0 .845 
Stroke (2) 1.50 .707 
CHF (6) 3.17 1.169 
COPD (59) 3.49 .679 
Renal (1) 4.00  
Hypertension (7) 3.17 .488 
Weight Man. (6) 3.17 .753 
Maternity (3) 3.00 1 
Bronchiectasis (9) 3.78 .441 
INR (18) 3.67 .485 
Dementia (1) 1.0  
Total (127)   
Grouping   
Respiratory (60) 3.50 .676 
CHS (64) 3.50 .632 
4.3.4 Testing Reliability of the Service User Questionnaire 
4.3.4.1 Patient Benefit Section 
 
It is important to determine if the questionnaire itself could be considered as 
reliable to consider in turn the value of the participants’ responses. To do this 
within the data set held within SPSS a test for reliability scale was undertaken. 
Crucially for the reliability of the key metrics for empowerment within Patient 
Benefit section of the questionnaire were tested (Appendix 3). Cronbach’s 
Alpha of 0.914 for the seven items was indicated. The value of Alpha ranges 
from 0 to 1; the higher values of Alpha indicate the greater internal reliability 
with 0.70 and above being desirable. Moreover, the Table 4.8 demonstrates 
a Cronbach’s Alpha of over 0.70 for each of the seven questions within the 
section. Therefore, the seven are consistent in their performance and the 
section be regarded as reliable. 
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Table 4.8 To illustrate reliability of each of the patient benefit questions 
within the questionnaire. 
Seven Patient Benefit 
Questions 









Alpha if Item 
Deleted 
The remote monitoring system 
assisted me in managing my 
health on a day to day basis 
21.43 10.158 .722 .904 
The monitoring system has 
reduced the number of health 
professional visits 
21.61 9.241 .828 .891 
Prevented or reduced need to 
attend Out-Patient 
appointments 
21.78 9.055 .715 .906 
Has helped me manage my 
own condition and become 
involved in health care 
21.63 9.783 .699 .905 
Given peace of mind 21.51 10.405 .678 .908 
The monitoring system has 
reduced number of GP visits: 
21.58 9.308 .817 .893 
Has prevented the need to 
attend Emergency Department 
and/or GP Out of Hours 
Service 
21.72 8.843 .767 .899 
4.3.4.2 Telemonitoring Equipment and Technology 
The test for reliability of technology and equipment section followed, of these 
there were nine indicators of receptivity to equipment. The overall internal 
reliability as measured by Cronbach’s Alpha was 0.902. Similarly, the Table 
4.9 demonstrates a Cronbach’s Alpha of over 0.70 for each of the nine 
questions within the section. Therefore, the nine are consistent in their 
performance and the section be regarded as reliable. 
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Table 4.9 To illustrate reliability of each of the health technology 
questions within the questionnaire. 



















SET Practitioner explained 
system in enough detail before 
installation 
26.13 50.555 .833 .882 
Worried about using new tech 
before installed 
27.10 55.073 .320 .917 
Equipment easy to use 26.02 50.770 .803 .883 
More interested in using tech in 
general 
26.52 51.065 .531 .902 
Questions on Hub or U-Tell 
readings page encouraged to 
think about symptoms 
26.34 49.998 .717 .887 
Internet portal to view readings 
useful 
25.92 47.993 .704 .888 
Happy to use internet to upload 
readings or send messages 
26.22 47.963 .652 .893 
Believe Increased tech in care 
and support of people at home 
will be of benefit in future 
26.09 49.168 .899 .876 
Consider Increased tech in 
care and support of people at 
home will be of benefit in future 
26.20 48.367 .789 .881 
 
4.3.4.3 Use of RVT Service Section 
 
The test for reliability within the section examining the participant’s experience 
of using the RVT service including interaction with practitioners was tested. 
The three questions had a combined Cronbach’s Alpha of 0.676 suggesting 
a deficit of reliability. However, Table 4.10 demonstrates that the first question 
alone within this section, ‘Have you been contacted by a SET practitioner in 
connection with readings?’, had a Cronbach's Alpha score of 0.879 and was 
considered reliable. 
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Table 4.10 To illustrate reliability of each of the use of RVT questions 
within the questionnaire. 
Three Questions Relating 
to Messaging or Phone 
Support. 
Scale Mean if 
Item Deleted 








Have you been contacted by a 
SET Practitioner in connection 
with readings? 
7.29 .932 .128 .879 
Clinician’s TF3/ U-Tell 
message helpful 
4.70 .300 .760 .127 
Clinician's telephone support 
helpful 
4.64 .320 .754 .140 
4.3.5 Ascribing Meaning to the Use of RVT 
4.3.5.1 The Equipment 
 
The first question in this section was reliable and related to how well the 
service users were supported at the beginning of their RVT care support and 
considers the explanation given to the participants, by their clinical 
practitioner, at the beginning of the intervention. Again, the statement asked 
if the practitioner explained the system and there were five possible 
responses, from strongly agree to strongly disagree and then not applicable. 
Five patients did not respond, one participant expressed lack of explanation 
but 34% of participants agreed and 60% strongly agreed. Therefore, it can be 
concluded that practitioners explained the RVT system before installation in 
enough detail.  
 
The second question was designed to gauge service user apprehension prior 
to installation. Whilst recognising that possibly the most resistant service 
users did not accept the service, number unknown, and were not included in 
the sample, it was useful to consider a possible anxiety prior to experience. 
Again, the possible responses were rated as with the previous question but 
there was a greater distribution of responses. It was found that 44% of 
participants were not worried about using technology before it was installed 
and 42% were worried. This distribution of potential anxiety should be 
considered for future technology interventions but also it must be recognised 
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that even though 94% of participants felt the system was adequately 
explained the level of reassurance did not allay the anxiety of more than one 
third.  
The final question within the section enquired if the participant found the RVT 
equipment easy to use. There was a 94.8% response rate for this query, 
N=92, with two stating the issue was not applicable and with N=90 agreeing 
that the equipment was easy to use; overall 64% of participants ‘strongly 
agreed’ that equipment was easy to use.  
 
4.3.5.2 The TF3 Triage Nursing Response and Service 
 
The reliability of the questionnaire in relation to the use of monitoring was less 
reliable as was the experience of triage nursing service as provided in the TF3 
service alone. 
 
4.3.5.3 The Receptivity to Future Use of Technology 
 
An examination of receptivity towards the concept of future based provision, 
whereby technology or Internet-based services were developed, the findings 
across the three questions were found to be reliable; Cronbach’s Alpha 0.890. 
With the Cronbach’s Alpha for the three constituent questions within this 
section being displayed in Table 4.11. 
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Table 4.11 To indicate reliability of individual questions within the future 
use of technology in healthcare.  
Three Questions 
Relating to Future 
technologies 
Scale Mean if 
Item Deleted 
Scale Variance 





Alpha if Item 
Deleted 
Happy to use internet to 
upload readings or send 
messages 
6.85 4.195 .782 .873 
Believe Increased tech in 
care and support of people 
at home will be of benefit in 
future 
6.72 5.953 .775 .871 
Consider Increased 
internet-based care and 
support of people at home 
will be of benefit in future 
6.82 4.875 .852 .785 
 (Cronbach’s Alpha above 0.70 being considered reliable.) 
When considering the data recorded within the future data question section, 
all data were considered valid within this section and all participants 
responded to each of the three questions. The first question asked of the 
participants in this section was to consider the future use of the internet 
regarding the uploading RVT readings or sending messages; this question 
was reliable with a Cronbach’s Alpha of 0.873. Despite, the almost 
consistently positive affirmations, two responses to this topic began to diverge 
in view. Table 4.12 illustrates distribution of ratings. Of note, 17% of 
participants disagreed with the statement whereas three times as many, 55% 
of participants, were happy to use the internet for uploading readings or 
messages. However, one voice within free-text responses was cautious for 
an unexpected reason,  
“… I did not fill in the questions regarding the internet as have been in 
A&E/ward/GP surgeries, the patients who are self-centred and think 
only of themselves, and I watched them abuse staff who were trying 
to help them was a disgrace, giving them access to the internet would 
be transferring that behaviour to the internet.”  
The view, clearly being a concern that Health and Social Care (HSC) 
practitioners should be protected from possible on-line abuse. 
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Table 4.12 To illustrate distribution of patients ratings of the use of the 
internet to upload readings or send messages to their practitioners. 
 Frequency Percent 




Disagree 11 11.3 




N/a .22 22.7 
Total 97 100.0 
 
The second question, in the section considering future receptivity to 
technology by RVT service users, examined if participant respondents 
believed the increased use of that technology in care and support of people 
at home will be of benefit in the future. Only one participant disagreed with the 
statement and N=88 agreed; 56% strongly agreed. However, the third 
question repeated the enquiry but specifically asked the participants to 
consider the internet. There was a negative move away from the previous 
question with ten disagreeing with the increased use of the internet, two of 
whom strongly disagreeing. N=71 agreed with the statement with 42% 
strongly agreeing with the consideration of a greater use of the Internet based 
care and support of people at home will be of benefit in the future. Therefore, 
there is a support for greater use of technology but with some reservation 
relating to technology that is Internet based. 
 
4.3.6 Testing Normality 
 
Before applying parametric tests, as appropriate, to the data sample, tests of 
Normality were undertaken utilising the SPSS software. The nonparametric 
test, Kolmogorov-Smirnov (KS), showed significance for patients with CHF 
(0.168) and diabetes (0.001) the residual significance is greater than zero. In 
examining skewness and kurtosis, a skewness result of zero would produce 
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a symmetrical bell-curve but a range between -0.5 and 0.5 indicates 
approximate symmetry. For other comparisons relating to variables i) manage 
own condition and ii) gave peace of mind it is known that the normality is 
supported albeit being positively skewed to the right, and distribution can be 
assumed as not normal leading to utilise non-parametric tests. (Tables 4.13 
and 4.14) 
4.3.6.1 Exploration of RVT having helped participant manage their own condition 
It was found that the p-values show a significant difference from normality 
(Tables 4.13 and 4.14) 
Table 4.13 To indicate the normality of the distribution of the responses 
examining the data as a whole to the hypothesis that RVT helped the 
participant manage their own condition. 
Case Processing Summary 
 
Cases 








Has helped me 
manage my own 
condition and 









tic Std. Error 
Has helped me 
manage my own 
condition and 
become involved in 
health care 
Mean 3.52 .066 
95% Confidence 









5% Trimmed Mean 3.59  
Median 4.00  
Variance .405  
Std. Deviation .636  
Minimum 1  
Maximum 4  
Range 3  
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Has helped me 
manage my own 
condition and 




1 1 1 4 
2 2 2 4 
3 4 4 4 
4 5 5 4 
5 6 6 4a 
Low
est 
1 51 51 1 
2 76 76 2 
3 68 68 2 
4 67 67 2 
5 16 16 2 
 
a. Only a partial list of cases with the value 4 are shown in the table of 
upper extremes. 




tic df Sig. 
Statis
tic df Sig. 
Has helped me 
manage my own 
condition and 
become involved in 
health care 
.357 93 .000 .700 93 .000 
a. Lilliefors Significance Correction 
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4.3.6.2 Exploration of RVT if it has helped the participant manage their own 
condition and become involved in their healthcare  
Table 4.14 To indicate the normality of the distribution of responses 
examining the data by condition, system and gender in relation to the 
































Stroke .260 2 .000    
CHF .277 6 .168 .773 6 .033 
Diabetes .300 15 .001 .837 15 .011 
COPD .349 59 .000 .707 59 .000 
Bronchiect
asis 








































TF3  .342 77 .000 .716 77 .000 


































Male .358 46 .000 .705 46 .000 
Female .363 38 .000 .705 38 .000 
a. Lilliefors Significance Correction 
b. Has helped me manage my own condition and become involved in health 
care is constant when Which Service do you use? System not defined = 
0. It has been omitted. 
With p values showing significant difference from normality. 
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4.3.6.3 The Data expressed within a series of histograms 
 
The Tests of Normality and associated histograms express the data to 
demonstrate difference of, or consistency of, experience and opinion within 
the subgroups. The exploration considered similarity or difference between 
participants with different conditions, utilising either of the two RVT 
technologies or systems and binary gender linked responses. The initial 
review considered the statement that RVT helped them manage their own 
health and care. The second review area examining normality considered 
RVT affording the participant a ‘peace of mind’. Across the two systems the 
participants highly rated to help them with their condition (Figure 4.1). With 
participants who utilised U-Tell highly rating the system as agree or strongly 
agree (Figure 4.3), for TF3 the majority of participants agreed or strongly 
agreed (Figure 4.2). 
 
 
Figure 4.1: Histogram to illustrate the high rating of the systems to help 
the participants to manage their conditions across all conditions 
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Figure 4.2: Histogram to demonstrate rating of the system to help the 
participants manage their own condition by TF3 respondents 
 
 
Figure 4.3: Histogram to demonstrate rating of the system to help the 
participant to manage their own condition by U-Tell respondents 
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4.3.6.4 Explore if RVT gave participants peace of mind 
Table 4.15 To indicate if there is a normality of the distribution of the 
responses examining the data relating to RVT giving peace of mind. 
Case Processing Summary 
 
Cases 





nt N Percent 
Given peace of 
mind 




c Std. Error 
Given peace of 
mind 
Mean 3.64 .054 
95% Confidence 









5% Trimmed Mean 3.68  
Median 4.00  
Variance .276  
Std. Deviation .526  
Minimum 2  
Maximum 4  
Range 2  
Interquartile Range 1  
Skewness -1.033 .249 











1 1 1 4 
2 2 2 4 
3 4 4 4 
4 5 5 4 
5 6 6 4a 
Lowe
st 
1 90 90 2 
2 76 76 2 
3 89 89 3 
4 87 87 3 
5 82 82 3b 
a. Only a partial list of cases with the value 4 are shown in the table of upper extremes. 
Critical Appraisal of Remote Vital-Sign Telemonitoring 
178  Julie-Ann Walkden - July 2020 
b. Only a partial list of cases with the value 3 are shown in the table of lower extremes. 




c df Sig. 
Statisti
c df Sig. 
Given peace of 
mind 
.414 94 .000 .640 94 .000 
a. Lilliefors Significance Correction 
 
RVT has given peace of mind to participants with the KS significance being 
zero with no difference between the ratings of RVT regardless of system or 
gender. (Tables 4.15 and 4.16) 
 
Table 4.16 To indicate the distribution of the responses examining the 
data by condition, system and gender in relation to the hypothesis that 



































.414 94 .000 .640 94 .000 
SYSTEM 
(b) 
Statistic df Sig. Stati
stic 
df Sig. 
TF3  .414 78 .000 .634 78 .000 
U-TELL .439 15 .000 .606 15 .000 
GENDE
R 
Statistic df Sig. Stati
stic 
df Sig. 
Male .395 48 .000 .660 48 .000 
Female .432 37 .000 .617 37 .000 
a. Lilliefors Significance Correction 
b. Has helped me manage my own condition and become involved in health 
care is constant when Which Service do you use? System not defined = 
0. It has been omitted. 
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4.3.6.5 Data expressed within a series of histograms for RVT having given peace 
of mind  
The patient’s distribution of ratings showed that both systems were rated 
highly with regard to feeling ‘peace of mind’, regardless of the technology 
used, and can be observed in Figures 4.4, 4.5 and 4.6. Equally, the proportion 
of highly rated opinion was similar regardless of gender (Figures 4.7 and 4.8).  
 
Figure 4.4: Histogram to demonstrate the rating of peace of mind across 
patient responded to the question (N=94) 
 
Figure 4.5: Histogram to demonstrate peace of mind by TF3 respondents 
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Figure 4.7: Histogram to demonstrate rating of peace of mind by male 
respondents, showing a similar distribution to the ratings recorded by 
female patients. 
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Figure 4.8: Histogram to demonstrate rating of peace of mind by female 
respondents showing most rate RVT highly in the metric of affording 
peace of mind. 
 
4.3.7 Independent t-test 
 
T-test enables the comparison of means between two groups and considers 
purpose and assumptions. The t-test can be used where groups are small as 
long as the normality of the distribution is assumed (Hill and Lewicki, 2006).  
4.3.7.1 Empowerment – Participants using TF3 versus U-Tell System responses 
 
Independent T-Test to compare U-Tell or TF3 to responses in the question 
‘…has helped me manage my own condition’ was undertaken. t-test assumes 
variance expressed as a standard deviation and is Levene’s test F value and 
the significance of 0.5 or less indicates the variances or standard deviations. 
However, the proportionality in comparison is important as there were five 
times as many TF3 responders than U-Tell patients for this variable. (Tables 
4.17 and 4.18)  
Critical Appraisal of Remote Vital-Sign Telemonitoring 
182  Julie-Ann Walkden - July 2020 
T-Test Calculation Demonstrated – Service Group Statistics 




you use? N Mean 
Std. 
Deviation 
Std. Error Mean 
Has helped me 
manage my own 
condition and become 
involved in health care 
TF3 77 3.48 .661 .075 
U-Tell 15 3.67 .488 .126 
 
Table 4.18 To indicate the independent sample tests. 
Independent Sample Test 
 






F Sig. t 
Has helped me 
manage my own 
condition and 
become involved 
in health care 
Equal variances 
assumed 














Has helped me 
manage my own 
condition and 
















Interval of the 
Difference  
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Has helped me 
manage my own 
condition and become 


















Interval of the 
Difference 
Upper 
Has helped me manage my 
own condition and become 
involved in health care 
Equal variances assumed .171 
Equal variances not assumed .116 
4.3.8 Nonparametric Tests 
 
If a hypothesis is tested and it is null, it is possible to reject it in favour of an 
alternative hypothesis. To determine whether to accept or reject the 
hypothesis test depends on P-value proportions.  
With the inclusion of the variable ‘…has helped me manage my own 
condition’, examining the responses, (but not comparing disease, age, system 
or gender subsets), the SPSS Nonparametric test was undertaken and the 
results for the variable (Table 4.19). 
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Table 4.19 To demonstrate the findings of the nonparametric test for the 
variable RVT has helped with patient self-management. 
 
It can be seen that the variable ‘the telemonitoring system has enabled me to 
better manage my own condition and become more involved in my 
healthcare’, reject the null hypothesis was indicated. The Null hypothesis or 
rather nullifiable hypothesis is to undertake a “…reversal of the experimental 
hypothesis that your prediction is wrong and that the predicted effect does not 
exist” as explained by Field (2006). Therefore, it can be determined that the 
predicted hypothesis that patient/ service user respondents find that RVT 
enables them to better manage their own condition is accepted (Table 4.19). 
The Nonparametric Test was then repeated to include the entire 
questionnaire. 
With the inclusion of thirty-five variables statements examining the entire suite 
of responses, not comparing subsets of gender, disease, age or system, the 
SPSS Nonparametric test was undertaken and the results for the thirty-five 
variables can be seen in the Table 4.20 (a, b, c and d). Table 20a, consists of 
respondent ‘demographics’, Tables 20b, c and d describe distribution.  
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Table 4.20 To demonstrate the findings of the nonparametric test for the 
35 variables/ statements/ questions. 
Table Section 4.20a examines the initial category variables on the 
questionnaire. Variables 3 and 8 retained the null hypothesis; the data was a 
binary result with approximately equal distribution between each option. 
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Table Section 4.20b examines the distribution of ratings for the variables and 
further tests normality. Variable 13 to be ignored as relates to the number 
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Table Section 4.20c examines the distribution of ratings for the variables and 
further tests normality.  
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Table Section 4.20d examines the distribution of ratings for the variables and 
further tests normality.  
 
 
Of note: where p=0.000 means ‘absolute certainty’ 
It can be seen that in three of the 35 tests, it was recommended to retain the 
null hypothesis; the results for these variables are to be ignored - including 
numbers:  
• #3 asking if a carer assisted the service user to access the RVT service 
and submit readings which required a yes/ no response,   
• #8 which asked the responder to record gender with male/ female options 
• #13 which recorded the participant identification number.  
Therefore, in all critical variables/ questions enquiring the of service user’s 
opinion, the decision was that the null hypothesis be rejected. Which was 
interpreted to mean that the high positive rating of patient experience 
indicated benefit of RVT was accepted as meaningful. 
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4.3.9 Correlation in Dimensions of Combined Data Variables 
 
An exploration of relationships between some factors was undertaken. A new 
variable was created (within the IBM-SPSS Dataset) which described the 
concept of ‘Future Technologies’, which combined the variables of future use 
of technology in care and future use of internet base technology. It was found 
that there is a positive correlation between the age of a respondent and their 
support for the future use of technology; Pearson Correlation -0.098 and a 
significance (2-tailed) of 0.373. Therefore, as the respondent’s age increased, 
they were less likely to support an increased use of technology in future. 
A new variable was created (within the IBM-SPSS Dataset) which described 
the concept of ‘Empowerment’, which combined the three variables (refer to 
Table 4.4, ‘Enabled Self-Care’ section). This was considered alongside the 
variable of future use of technology. In examining the skewness and kurtosis, 
a normal distribution was found for both empowerment and future technology. 
The skewness for future technology was 0.257 and empowerment 0.245, 
meaning approximate symmetry.  
When considering the new variable of empowerment, against the variables of 
co-morbidity, using Automatic Linea Modelling, to determine predictor 
importance, it was found that the more conditions a patient reported the less 
empowering RVT was whereas the fewer LTC present the more empowered 
the patient reported they were (Figure 4.9). 
When extending the exploration of this finding, a univariate analysis of 
variance between the two variables of empowerment and comorbidity, further 
testing the interrelationship, between-subject effects. The significance was 
found to be 0.039 and the null hypothesis was rejected (as p value is less than 
0.05), there is a significant relationship between variables in this regression 
model. 
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Figure 4.9: Chart to demonstrate predictor importance between 
empowerment and co-morbidity. 
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4.4 Qualitative Analysis of Patient Data 
 
The service user/ patient questionnaires gave the participant respondents two 
opportunities to record free text narrative. The analysis of the qualitative data 
recorded by the service users of both RVT services, TF3 and U-Tell, were 
analysed as one data set. Service user participants were asked to record 
feedback under two separate headings, ‘Peace of Mind and Technology 
Comments’ and ‘Further Comments’. All comments were compiled, 
regardless of where a participant recorded their narrative explanations. The 
recorded comments for Peace of Mind and Technology N=27 comments were 
made by TF3 service users and six for U-Tell giving a total of N=33 comments. 
For the final comments section, TF3 N=23 comments, U-Tell N=10 giving a 
total of N=33 comments. However, of note, some participants went to great 
trouble to record extensive feedback with one participant writing a separate 
letter to review their service experience. Table 4.21 summarises the basic tally 
of sentiments expressed. 
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Table 4.21 The tally of sentiments expressed by service user 
participants in free text. 





Excellent service and staff (efficiency-based text) 13 
Staff are helpful and caring (emotional wellbeing-based text) 4 
Peace of mind 11 
Immediate response from service when there is an issue 8 
Patient taking control 7 
Independence and patient freedom 6 
Reduce anxiety 5 
Reduce hospital visits 5 
Communication  4 
Free the time for practitioners 4 
System to manage self 4 
Thank you 3 
Quality assurance checks 2 
To know someone/ help is at hand 2 
Reassurance 1 
Assist diagnosis (hypertension) 1 
Understand condition 1 
Life-saving technology 1 
 
Whilst the statistical analysis of the response ratings of the patient participants 
indicated a high level of user acceptability and technology utility regardless of 
technology package, service response or patient’s condition the qualitative 
responses give greater insight as respondents articulated their personal 
experience. The sentiment of service excellence, from both a technology and 
practitioner contribution, was positively remarked upon N=13 times with a 
further three expressing gratitude and one stated that they considered it, “life-
saving technology”. Much consideration had been given to the deployment of 
RVT before services went live so that an integrated service offering, and 
response, was delivered rather than a new RVT being overlaid onto existing 
pathways or models of care. Moreover, at the time of the survey the RVT had 
been in operation for circa four years and it was likely that system teething 
problems had been overcome with practitioners also being more experienced 
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regarding effective utilisation of the technology. The service users were asked 
to participate in the enquiry of an established RVT service; with all forms of 
technology and service response being embedded into practice. Of note, only 
patients who were active recipients of the RVT services were asked to 
participate. Therefore, responses were contemporary and current rather than 
reflective upon past experience. 
 
It was expected that service users would express their approval of technology, 
but this knowledge was expanded upon as the theme of patient empowerment 
emerged and whilst they may not have been liberated from chronic diseases 
the patient participants expressed their new level of well-being associated 
with LTC. N=11 users expressed how the technology gave them a peace of 
mind and concomitantly five wrote of their reduced anxiety. Indeed, four 
participants recognised how the technology was enabling their practitioners 
to target their time more productively towards patients most in need of direct 
care; a participant using U-Tell wrote,  
“It’s convenience and immediate response make it a vital tool in the 
assessment of patient’s condition. It freed medical staff to care for 
other patients who may be in poorer condition than myself. The patient 
is in control of his/her condition which reduces anxiety.”  
 
Dimensions of empowerment which emerged to demonstrate the well-
considered benefit from a patient’s perspective revolved around a feeling of 
connectedness to the healthcare system through technology. The five service 
users who shared a sense of reduced hospital visits did so positively, “Using 
self-monitoring has definitely given me more freedom of not having as many 
hospital visits to get venous samples taken.” Patients repeatedly shared a 
sense of being safer through more monitoring, “It is a very welcome and 
needed extra pair of eyes and ears.” Three wrote of being reassured by being 
monitored, whereas eight reported immediate services responses with four 
better communications with their practitioners. Timeliness of intervention was 
generally appreciated but Independence and freedom, six, was an important 
pillar in the empowerment of patients, “it means a lot of freedom for me but if 
I need help, they are only a phone call away”. Most importantly, seven patient 
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participants wrote that they were taking control of their condition with one 
expressing how they better understood their condition,  
“Telemonitoring has given me a better understanding of (my) condition 
COPD… independence to live at home confident that I can manage 
my health and not be a burden on the NHS and my family.”  
Patient participants, who expressed their own experience did so bringing to 
life the importance of remote monitoring in the patient’s journey, participation 
in self-care and empowerment. 
4.5 Quantitative Analysis of Service Trend Patient Data 
The intention, as articulated in objective 2 (cross reference 1.18), had been to 
analyse aggregated patient data to articulate service trend data. The TF3 
service provider did not make this data available to the Trust nor was it 
available through the regional data brokerage service. The TF3 provider data 
output was only for the purpose of performance management and billing. The 
limited data could describe broad provision of service (Tables 1.3, 1.4, 1.5, 
1.6 and 1.7) but and not offer insight into effect or benefit. 
4.6 Quantitative Analysis of Carer Data 
 
There were seven scaled variables in the carer questionnaire, possible 
responses included strongly agree (given value of 4), agree (3), disagree (2), 
strongly disagree (1), not applicable (coded ‘88’) and missing (‘99’). However, 
there were a total of 49 responses received from carers with 48 recording an 
opinion of experience with the TF3 RVT service and one with the U-Tell. The 
N=49 respondents’ data were analysed together.  Of the N=97 patient 
responses, 50% reported that they had a carer to assist them with their RVT 
service. N=36 patients stated that they would pass the carer questionnaire to 
their carer. Therefore, it was assumed that most carers, responded to the 
questionnaire. 
The initial test computed for the questionnaire was Cronbach’s Alpha for the 
seven variables, i.e. the scaled questions excluding demographics. A rate 
closer to 1 when testing reliability demonstrates more reliability, a rated value 
above 0.7 is acceptable and 0.8 or above is considered optimal. The 
Chapter 4: Analysis of Service Users Data 
Julie-Ann Walkden - July 2020   195 
questionnaire is considered reliable, such that the construction of the 
questionnaire gave relatability between questions; with a Cronbach’s Alpha 
rate of 0.866. 
A descriptive analysis was undertaken. The mean and standard deviation for 
the responses to the seven variables are set out in the Table 4.22. 
 
Table 4.22 To demonstrate the mean and standard deviation for the 
responses to the seven variables. 
Descriptive Statistics Carer Respondent Questionnaire  
 N Minimum Maximum Mean Std. Deviation 
I believe remote monitoring has 
improved the level of care given 
to the person I care for. 
46 2 4 3.72 .502 
I believe remote monitoring has 
helped prevent the person I 
care for being admitted to 
hospital. 
45 2 4 3.56 .586 
When assisting the person to 
operate the remote monitoring 
equipment, I found it easy to 
use. 
41 2 4 3.61 .542 
I think the use of telemonitoring 
as part of a care package is 
generally helpful 
47 2 4 3.66 .522 
I believe telemonitoring has 
given me peace of mind 
46 2 4 3.72 .502 
I believe increased use of tech 
will be of benefit in future 
44 2 4 3.66 .526 
I believe increased use of 
internet-based care will be of 
benefit in future 
44 2 4 3.41 .658 
Valid N (listwise) 37     
 
The mean of 3.72 for both the question relating to RVT improving the level of 
care received by a patient and the giving of peace of mind demonstrates 
support for RVT by those who care for patients with LTC. Indeed, responses 
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to the seven variables or questions demonstrated overall support with no 
mean being below 3; the lowest mean score was 3.41 and this question 
related to perceived benefit of future use of internet-based technology in the 
future; this demonstrates a general consensus of support. 
 
A review of frequency of response was undertaken to enhance understanding 
beyond mean given the overall sample size was 49. Of note, it appeared to 
consistently demonstrate one or two ‘disagree’ responses relating to six 
questions with the final question associated with future use of internet-based 
technology receiving four ‘disagree’ responses (Table 4.23). The data base 
was then examined to determine if the experience of the one U-Tell carer 
respondent varied distinctly from the 48 TF3 carer respondents.  
It was found that the one U-Tell carer respondent strongly agreed with all 
statements except with question/ statement relating to admission where they 
responded by agreeing that the service had prevented admission. It was found 
that the TF3 carer rated disagree with all statements except with statement 
relating to ease of use where they responded by agreeing that the service had 
been easy to use.  
 
Table 4.23 To demonstrate the carer respondent option frequency. 
I believe remote monitoring has improved the level of care given to the person I care for. 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Disagree 1 2.0 2.2 2.2 
Agree 11 22.4 23.9 26.1 
Strongly 
Agree 
34 69.4 73.9 100.0 
Total 46 93.9 100.0  
Missing N/a 3 6.1   
Total 49 100.0   









Valid Disagree 2 4.1 4.4 4.4 
Agree 16 32.7 35.6 40.0 
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Strongly 
Agree 
27 55.1 60.0 100.0 
Total 45 91.8 100.0  
Missing N/a 4 8.2   
Total 49 100.0   









Valid Disagree 1 2.0 2.4 2.4 
Agree 14 28.6 34.1 36.6 
Strongly 
Agree 
26 53.1 63.4 100.0 
Total 41 83.7 100.0  
Missing N/a 5 10.2   
Missing 3 6.1   
Total 8 16.3   
Total 49 100.0   
 








Valid Disagree 1 2.0 2.1 2.1 
Agree 14 28.6 29.8 31.9 
Strongly 
Agree 
32 65.3 68.1 100.0 
Total 47 95.9 100.0  
Missing N/a 2 4.1   
Total 49 100.0   








Valid Disagree 1 2.0 2.2 2.2 
Agree 11 22.4 23.9 26.1 
Strongly 
Agree 
34 69.4 73.9 100.0 
Total 46 93.9 100.0  
Missing N/a 3 6.1   
Total 49 100.0   








Valid Disagree 1 2.0 2.3 2.3 
Agree 13 26.5 29.5 31.8 
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Strongly 
Agree 
30 61.2 68.2 100.0 
Total 44 89.8 100.0  
Missing N/a 4 8.2   
Missing 1 2.0   
Total 5 10.2   
Total 49 100.0   
     








Valid Disagree 4 8.2 9.1 9.1 
Agree 18 36.7 40.9 50.0 
Strongly 
Agree 
22 44.9 50.0 100.0 
Total 44 89.8 100.0  
Missing N/a 5 10.2   
Total 49 100.0   
 
The carer participants were supportive of the RVT service. The focus of the 
seven questions was to determine if there was a general acceptability of 
technology not simply from their direct and contemporaneous experience but 
also envisaging a health service of the future which is more dependent upon 
technology to maintain and improve the quality of life or health status of 
service users. Most carers (92%) reported that RVT had generally helped to 
improve the care of the service user illustrated in Figure 4.10. The responses 
to the question, I believe telemonitoring has given me peace of mind, mirrored 
the response pattern for the first question relating to improvement of care and 
was equally reflective of the views expressed by the service user/ patient 
participant respondents. Figure 4.13 illustrates the carer respondent’s belief 
that RVT as part of a care package was generally helpful. 
N=45 participants responded to the question considering belief that RVT had 
prevented hospital admission with only two reporting disagreement. 98% of 
ratings suggested that carers found the equipment easy to operate and they 
were equally receptivity to greater utilisation of technology in future, albeit a 
degree of reticence was expressed regarding internet based future options;  
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9% of responses disagreeing that increased use of the internet would be of 
benefit in the future. 
In order to illustrate the carer respondent opinion frequency Table 4.25 a 
series of seven charts were created, each variable was illustrated by a simple 
bar chart (Figures 4.10 to 4.16). 
 
Figure 4.10: Bar chart to illustrate carer respondents belief that RVT has 
improved the level of care 
 
Figure 4.11: Bar chart to illustrate carer respondents belief that RVT has 
prevented hospital admissions 
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Figure 4.12: Bar chart to illustrate carer respondents belief that RVT 
equipment was easy to use 
 
 
Figure 4.13: Bar chart to illustrate carer respondents belief that RVT as 
part of a package of care was generally helpful 
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Figure 4.14: Bar chart to illustrate carer respondents belief that RVT has 
given peace of mind 
 
 
Figure 4.15: Bar chart to illustrate the respondents belief that increased 
use of technology in care will be of benefit in the future 
 
 
Critical Appraisal of Remote Vital-Sign Telemonitoring 
202  Julie-Ann Walkden - July 2020 
 
Figure 4.16: Bar chart to illustrate carer respondents belief that 
increased use of the internet in future will be of benefit 
 
Six of the seven variables/ questions were grouped into three groups of two 
as they could be considered as testing the same dimension. The data were 
then charted to reflect the data triangulation (Table 4.24). 
Table 4.24 The group and chart variable questions and statements. 
Graph to illustrate Variable/ Question/ Statement Variable/ Question/ 
Statement 
RVT Improved Health & 
Care 
I believe remote monitoring has 
improved the level of care given to 
the person I care for. 
I believe remote monitoring 
has helped prevent the 
person I care for being 
admitted to hospital. 
RVT is Helpful & Gave 
Peace of Mind 
I think the use of telemonitoring as 
part of a care package is generally 
helpful 
I believe telemonitoring has 
given me peace of mind 
Increased Use of 
Technology in Future 
Care 
I believe increased use of tech will 
be of benefit in future 
I believe increased use of 
internet-based care will be of 
benefit in future 
  
The IBM-SPSS function ‘Ggraph’ was applied to variable data to illustrate the 
relationship between variables (Figures 4.17, 4.18 and 4.19). The series of 
three 3D graphs illustrate the depth and strength of opinions expressed by the 
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carer respondents and suggested correlation between variables. The first in 
the series, Figure 4.17 the overall improvement in care as a result of RVT, the 
second, Figure 4.18, the helpfulness and peace of mind and the third, Figure 
4.19, the prospective receptivity of technology to support care in the future 
with the lack of support for internet juxtaposed to support for technology to 
assist in general. 
 
 
Figure 4.17: Graph to illustrate variable data - RVT improved health and 
care 
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Figure 4.18: Graph to illustrate variable data - RVT is helpful and gave 
peace of mind 
 
Figure 4.19: Graph to illustrate variable data - increased use of 
technology in future 
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4.6.1.1 Test of Normality 
A one-sample Kolmogorov-Smimov Test, was calculated for each of the 
seven carer variables and all demonstrated evidence to reject the null 
hypothesis.  The nullifiable hypothesis was to undertake a “…reversal of the 
experimental hypothesis that your prediction is wrong and that the predicted 
effect does not exist” as explained by Field (2006). Therefore, it was 
determined that the predicted hypothesis that carers would support RVT was 
confirmed.  Consensus coalesced around general support for RVT to help 
support the care of the patient/ service users.  
4.7 Qualitative Analysis of Carer Data 
 
There were 23 written comments added to the carer participant 
questionnaires; 21 related to the TF3 service and two to U-Tell. For this brief 
descriptive analysis, the two RVT service responses were considered 
together. In considering the U-Tell two comments submitted relating to the 
RVT service were recorded by both the patient participant and carer 
participant. The patient stated that she only had a carer to remind her to 
undertake the test and so her husband spoke highly about the opportunities 
RVT afforded them to improve their lifestyle by allowing travelling abroad and 
reduced clinic visits,  
“If my wife did not have telemonitoring, I would have to take her to be 
tested, as she cannot drive. As we travel a lot in Europe, I would also 
have to locate somewhere to do the testing, so my wife’s 
telemonitoring is a significant help to me as her carer.”  
Of note, the U-Tell service would instruct a user when to retest, for example 
on a date in a weeks’ time, if forgotten the haematology nurse would contact 
the patient by telephone the patient to prompt whereas the TF3 service had a 
scheduled reminder integral to the home hub technology and failure to upload 
a reading would trigger a triage nurse response to prompt action. The 
comments were positive when reflecting upon the 23 qualitative data 
statements; there were only two comments with negative connotation, both 
were in relation to the TF3 service. The TF3 concerns related to technology 
was a burden to utilise albeit whether that concern was a proxy for the 
management of the chronic disease being a burden or technology 
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idiosyncrasies was not determined. The qualitative rating expressed by the 
majority of both carer and patient participants was that the technology was 
intrinsically simple. When considering the potential increased use of 
technology in the future one felt the increased use of the internet would make 
the situation worse and one shared that technical issues experienced with 
TF3 would need to be overcome. It was suggested by one carer respondent 
that,  
“Idea is good, but many older people do not have the technical 
capability and …attendant stress in how to use it correctly i.e. use of 
the internet could make some people opt out because of this.”  
However, it is suggested that as the majority of RVT users are elderly, i.e. 
over 65-years, and the majority found RVT a simple and helpful solution, the 
concern may be a personal perception rather that to be an ongoing concern 
for RVT. Moreover, it could be postulated that as the generations progress, 
as the middle-aged become elderly, they will be more technology attuned and 
receptive, with one carer respondent suggesting, “I am not a fluent user of 
internet but know it will be useful to younger people in the future.” 
There were five main positive topics expressed by carers across the TF3 and 
U-Tell surveys and these have been tabulated (Table 4.25). 
Table 4.25 To summarise the positive opinions shared by carer 
respondents. 
Primary Topic Number of Carer 
Participant 
Responses 
Time and travel as without RVT they would have to use a 
building-based service 
5 
Rapid access to help 5 
Someone to talk to 2 
Safety and peace of mind 7 
Efficient and helpful 1 
 
It is important to note that many comments contained multiple issues as 
respondents had taken the time elaborating upon their gratitude and support 
for RVT. Indeed, one respondent wrote,  
“I took care of my husband … until he passed away …  He used 
Telemonitoring himself but I did it for him.  For last two weeks we both 
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find a great sense of having help at your fingertips… I was able to look 
after James at home.”   
It is judged that this single testimonial articulates true empowerment as the 
choice to remain at home was enabled, in part, by RVT.  Across carer 
participants, the key messages of peace of mind, being able to manage at 
home, being integrated with care and that assistance was available when 
required were iterated. Not only does this demonstrate patient centred care 
and the empowerment of the patient and their carers but it demonstrates a 
system that is working, i.e. that technology had been appropriately inculcated 
into care. It is difficult to find support for this as a benefit in the literature to 
justify the application of RVT, by policy makers. Indeed, the agreed metric of 
success or end goal by policy makers was simply to demonstrate by the use 
of remote tele-monitoring to reduce requirement for secondary care services, 
providing an economic benefit. Whilst the health economic literature does not 
support RVT, nor was it an area of examination in this study, it has been 
suggested through the questionnaire that patients and their carers perceive a 
positive benefit of reducing admissions. One carer wrote at length her 
explanation of a positive improvement in care,  
“Prior to his using RTS [their name for TF3 RVT], my father was being 
admitted to hospital on a monthly basis.  Since RTS catches chest 
infections so early, he has not once been rushed to A&E or admitted 
to hospital.  This has greatly improved his health and “recovery” and 
has improved both our stress levels and quality of life.  A specialist 
nurse is just a phone call away and can prescribe drugs previously 
requiring a GP visit.” 
4.8 Summary of the Analysis of the Service User Participant 
and Carer Respondent Questionnaire for both TF3 and U-
Tell 
 
Questionnaires were analysed from 16 patients who used the U-Tell Remote 
Telemonitoring Service and 81 patients who used the TF3 Remote 
Telemonitoring Service. In addition, one questionnaire was returned by a 
carer of a patient who utilised the U-Tell service and 48 carer participant 
questionnaires related to the TF3 Service. Two SPSS data bases built and 
analysed, the patient questionnaire data base containing the responses from 
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97 participants and the other data base being for 49 carer questionnaire 
responses. 
In the RVT patient quantitative data collection, there were 25 questions, of 
which there were seven which indicated healthcare utility and patient benefit 
and three key issues which examined the patient’s involvement, participation 
and feelings which were interpreted as indicators of empowerment. (Table 
4.4) These were: 
1. The remote monitoring system assisted me in managing my health on a 
day to day basis 
2. Has helped me manage my own condition and become involved in health 
care 
3. Given me peace of mind 
Descriptive statistical analyses were undertaken for both data sets which 
demonstrated that the two questionnaires could be considered as reliable and 
the null hypothesis was rejected for all critical questions. There was no notable 
difference between the responses given associated with gender, age, remote 
vital sign telemonitoring (RVT) technology used or LTC. It has been 
determined that patient and carer participants are supportive of the use of 
technology and that it gives them peace of mind and empowers them to ‘better 
manage their own condition and become more involved in their healthcare’. 
Of note, whilst some apprehension was expressed by the patient participants 
when first asked by their practitioners to use RVT, the ease of use and 
reliability of technology was demonstrated. 
 
Both patient and carer respondents included extensive narrative in ‘additional 
comments sections’ which provided a deeper appreciation and value for RVT 
in their lives. Qualitative analysis was undertaken and again there was 
consistency across respondents regardless of whether they were patients or 
carers and very few negative sentiments expressed. The respondents 
expressed their ability to live more freely being in control of their condition and 
being less anxious; given peace of mind. A general expression of being better 
connected to their practitioners through technology which was counter 
intuitive as an intention in the design of RVT was to reduce the number of 
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clinical face-to-face visits. It was clearly articulated that patients were being 
empowered to better manage their own conditions in a home environment 
supported by technology connection with their healthcare practitioners. 
Moreover, the receptivity of predominantly elderly patients to technology, and 
to a future with greater levels of technology enabled care was articulated. 
Whilst there was support for technology enabled care there was a low level of 
reticence regarding internet-based technologies and so these should be 
considered when designing easy to use, reliable healthcare technologies to 
support the care of patients with LTC at home by the healthcare system 
providers. However, U-Tell is primarily an internet-based technology and 
those patients accessing RVT through the internet expressed positive 
opinions of benefit just as the users of TF3, which is a direct hub to server 
system without the requirement of a patient to access the internet and enter 
data themselves. 
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5 ANALYSIS OF 
PRACTITIONER DATA 
5.1 Analysis of Qualitative Data  
5.1.1 Introduction 
 
Results of qualitative analysis of practitioner interviews are presented by 
reference to eight main topics they raised: some negative, some positive. 
They referred to training needs that if addressed may help to ameliorate 
concerns over their many clinical issues. Targets for implementation were a 
mixed blessing – not always useful. In future they predict success through 
integration. This chapter will explain the experience of the practitioners and 





In 2015 there were 37 acute and community practitioners, including a GP, 
Allied Health Professionals (AHP), consultant physicians, nurses and a 
pharmacist trained in the use of remote vital sign telemonitoring technology 
all employed by the SET. The majority of practitioners were acute hospital-
based staff linked to multidisciplinary teams extending into the community 
having ongoing responsibility for care of patients diagnosed with chronic 
diseases and residents at home. Only those practitioners who worked with 
patients receiving long term anticoagulation/ warfarin were purely outpatient 
based and the pharmacist within the diabetes service was purely ward based.  
It was known that some of those trained in the use of the systems in 2011 had 
moved into service areas outside direct contact with RVT. 
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All practitioners were invited to participate in one-to-one interviews with the 
researcher and provided with material to ensure they were fully informed of 
the study purpose, data management, governance and methodology. It was 
estimated that, of the total, 29 practitioners were active users of RVT. Of those 
16 practitioners responded positively to the request to participate, that is, 55% 
of the RVT practitioners volunteered to participate. Over a period of four 
months in the summer of 2016 these 16 practitioners were individually 
interviewed for approximately one hour. The data followed the semi-structured 
interview process with the participant’s narrative captured through notetaking 
by the researcher and digital voice recording, then subsequently transcribed. 
The researcher delivered the semi-structured interview in such a way as to 
enable the practitioner to describe their experience, thoughts and feelings. As 
far as practicable the conditions for each interview were standardised and the 
approach to transcription was verbatim and was analysed in a positivist view 
being open and transparent (Lapadat, 2000). The spoken word was 
systematically transcribed into the standard semi-structured interview 
template so that the original framework for questioning was maintained. The 
narrative was transcribed in factual topic areas, following the semi-structured 
interview plan rather than considering the conversation, flow and tone of 
discussion; transcription was without interpretation of conversation (Edwards, 
1991). Within qualitative analysis there is a possibility for inattention regarding 
the process of transcription (Davidson, 2009) and so care and planning were 
undertaken with approach so as not to introduce error or bias at point of 
transcription. In gathering data and evidence, it was known through traditional 
grounded theory, it was likely that at some point no new evidence would 
emerge in subsequent interviews that the qualitative data was said to have 
reached saturation so data collection could be concluded. It was estimated 
that at interview N=12 that new data would not emerge. However, the 
researcher decided to fulfil the commitment and interview the remaining four 
practitioners, most particularly given the broadness of the clinical experience 
being represented in the final four volunteer practitioners. 
The professional spectrum of the N=16 practitioners covered a broad range 
of healthcare professionals and is set out in the Table 5.1 
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Allied Health Professions 3 
TOTAL 16 
Eligible Clinicians in SET (trained) (%) 37 (43%) 
Eligible Clinicians in SET (trained & actively practicing using RVT) (%) 29 (55%) 
 
The 16 practitioners also cared for people with a full range of diseases being 
managed through RVT (Table 5.2).  
Table 5.2 To demonstrate the disease management groups. 





Virtual Ward/ General 2 
Maternity/ Weight Management 1 
 TOTAL 16 
 
There was a broad range of practitioners who were experienced within 
particular clinical specialties but also in the length of time as qualified 
practitioner. Each practitioner was asked to give their year of graduation, the 
most newly qualified practitioner was a respiratory physiotherapist, who 
qualified in 2011 and the first recorded clinical qualification was of a diabetes 
specialist nurse in 1980. The mean year of graduation was 1990, with 
qualifying decades, eleven in the 1980s, two in the 1990s, two in the first 
decade of 2001 in the subsequent decade.  One practitioner, a consultant 
physician, utilised both TF3 and U-Tell systems with eleven practitioners 
utilising only TF3 and four the U-Tell system. A broad spectrum of experience, 
clinical backgrounds and clinical understanding of the use of all the RVT 
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system in the care of people with chronic diseases had been captured through 
the data given through the semi-structured interviews.  
The group was 25% male and 75% female. Of note, none of the practitioner 
respondents reported having been formally educated about the presence or 
use of RVT at undergraduate level or attended post-graduate training prior to 
the commencement of the RTNI contract. Indeed, the AHP who graduated in 
2011, the youngest participant, did so 3-years after the first remote 
telemonitoring pilots commenced in Northern Ireland and the year the RTNI 
contract went live, reported that it was still his understanding that the subject 
was not part of the curriculum in his school of physiotherapy. 
The 16 transcripts were uploaded into (NVivo), the mean word count length 
of each was 3,403 words with the range being from 1,881 to 5,416 words, a 
total of 54,443 words. Therefore, the assistance of (NVivo) in permitting the 
researcher to create topic notes and concomitantly code narrative to the 
appropriate note for sorting, reporting and methodical analysis was beneficial. 
A high-level summary report was tabulated within (NVivo) to demonstrate the 
distribution of opinions and perspectives shared by participants and can be 
seen in Table 12.6 Appendix 9. This expresses the topic code, the descriptive 
title of the topic area, up to two tiers of more focused response descriptive 
titles, the number of participants who expressed a view within the topic area 
and then the number of times that description was repeated. Therefore, if each 
participant expressed an opinion in a descriptive topic title area the number of 
practitioner respondents would be represented as N=16 and if each of those 
respondents mentioned the topic twice, the frequency would be 32. 
 
5.1.3 Analysis of Practitioner Narrative by Descriptive Topics 
 
Each descriptive topic area was tabulated with the number of participants who 
expressed an opinion and the number of times the topic was repeated or 
reinforced by them. The descriptive topic tables also include the working 
definition assigned to the description (by the researcher) to further enable 
understanding, grouping of sentiments and concomitant interpretation. (The 
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practitioner participants had been given assurances that their individual 
identities would not be discussed, nor their comments attributed to them).  
5.1.3.1 Practitioner experience of RVT 
 
With reference to practitioner responses in Topic Area Coded ‘a’, the topic 
area of Experience of the practitioner only referred to their experience of RVT 
prior to the TF3 or U-Tell services being in operation (Table 5.3). This topic 
area did not consider the formal professional qualification of the individual 
practitioner rather RVT experience. Three practitioners discussed this topic 
area with one making reference to the subject on four occasions. The clinical 
areas of stroke and respiratory were referenced and the practitioners shared 
their experience over 9 years of RVT including a period in advance of the 
regional services where they were involved in pilot projects. In essence, whilst 
reference was made to service implementation training the practitioners 
discussed their learning through trial and error, experiential learning. 
Table 5.3 Practitioner responses in topic area coded ‘a’, examining the 
participant’s experience of RVT. 
Name Description Files References 
P a Experience as a 
manager or commissioner 
practitioner 
Background of or experience 
with RVT from the perspective 
of being a manager or 
commissioner practitioner. 
Comments may be about 
experience, qualification or 
advice gained from observation 
that does not fit within other 
Superior Hierarchical Node 
3 6 
long term service Before the current RVT service 
there was a previous pilot 
service and patients from 




5.1.3.2 Practitioner feelings towards RVT 
 
With reference to practitioner responses in Topic Area Coded ‘b’, the topic 
area is the personal feelings the practitioner expressed about RVT (Table 
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5.4). The open question within the semi-structured interviews had been 
designed to start conversation and to in effect initiate reflective thinking. All 
practitioners answered the initial topic with N=49 references made to general 
feelings throughout the N=16 semi structured interviews. Whilst the majority, 
N=15 expressed positive feelings about their experience of RVT there were 
practitioners who expressed mixed feelings. 
Two practitioners spoke about their concerns regarding the intrusively of 
technology particularly where a non-public sector supplier was managing the 
end-to-end service with references to shocked reactions of potential service 
users with the narrative of ‘big brother’ being expressed. The negative feelings 
expressed by five practitioners when reflecting upon RVT frequently revolved 
around the failings of technology or infrastructure including inability to 
prescribe and install TF3 when a service user did not have a plain-old-
telephone (POTS) land line and was in a 3G ‘black spot’ as mobile remote 
access was also highlighted as a negative issue. Both medical practitioners 
independently expressed the same fundamental system criticisms whereby 
the TF3 RVT had failed to expand to scale, was not user friendly for clinicians 
with disappointment expressed regarding lack of progress over the term of the 
service. Of particular note was the inability to link the TF3 RVT to the Northern 
Ireland Electronic Care Record (NIECR). A complaint of practitioners mirrored 
those who referred to the TF3 service and was the length of time the electronic 
referral form took to complete and then if POTS or mobile signal could not be 
obtained by the supplier the nugatory effort to refer amounted to an 
unacceptable waste of time; a practitioner expressed discontentment of a ’13-
page referral form’, a complaint echoed by a further five. One practitioner 
expressed serious concern about the level of training and concomitant 
knowledge of the triage nurses associated with the TF3 service. Linked to that 
was a concern that the triage nurses were insufficiently connected to the Trust 
specialist services and an improved service response may have been 
possible with better systems of working together. Also, the lack of basic local 
knowledge held by the triage nurses was another cause for concern with 
contact calls with Trust specialist nurses being made so late in the day that 
direct clinical responses by the patient’s lead practitioner would be poorly 
planned and inconvenient. A negative feeling in one practitioner expressed a 
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concern about patients being capable of using the equipment and one 
considered a risk of patients becoming dependent upon RVT an issue. Three 
reflected that RVT had indeed increased workload with a view that this had 
not been highlighted as a risk to clinicians before they engaged with the 
system. 
When considering the general orientation towards or against RVT the majority 
of practitioners, N=15 articulated feeling positivity; 63.2% of sentiments 
expressed being positive. There were key themes that demonstrated the 
overall benefit of RVT with the most common theme being that technology 
enables care and is the way forward as the four following quotations from four 
separate practitioner participants illustrate: -  
 “I think technology is the way we are going in the Health Service.  I 
don’t think that they will ever find anything to replace our team of 
nurses here, computers or otherwise but I think it is a brilliant system 
and it is allowing patients a lot of freedom.  We have found particularly 
in the anticoagulation and haematology our patients are getting 
younger, they’re working and have busy lives so something like this is 
ideal for them as they’re not having to take time off work to come to us 
here at the clinic and having to be at a specific point and cancel 
different things as they have to have their blood checked.  So, I would 
be very positive about it.” (P8) …”it is really the way forward and I think 
we really should be using technology more and more.” (P12) … “Way 
forward, I think links with ECR for anything really successful and 
integrated.” (P13) and “I think technology is the way forward.  I don’t 
know that Telehealth is quite where it should be yet, but I think it’s 
moving in the right direction.” (P2)  
Practitioners expressed initial reticence but felt generally very positive when 
they experienced the benefit of having accurate, digitally transferred results 
rather than standard self-reporting. The speed of intervention was shared, 
particularly for those patients with respiratory conditions as RVT was 
described as a good 
“platform for monitoring of infections” (P10) and “…gives us a very 
good idea of how well or unwell they are.” (P2) Equally, the real 
purpose of RVT was challenged with a view expressed that RVT is not 
a mechanism to keep people out of hospital but in fact it can be 
“…promoted as a way of improving quality of life for patients.” (P2) 
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Table 5.4 Practitioner responses in topic area coded ‘b’, to express their 
general overarching feelings towards RVT. 
Name Description Files References 
P b Feelings towards RVT Where the participant 
expressed their feelings 
towards any aspect of RVT 
16 49 
Feel Negative Where a participant does not 
feel positive about their 
experience of using RVT 
5 13 
Obtrusive Staff are concerned about 
obtrusive nature of RVT 
2 3 
System can't be installed Patients can’t access the 
system due to lack of phone 
lines or internet 
3 3 
Feel Neutral Where a participant feels 
neither positive nor negative 
about their experience of using 
RVT 
4 5 
Feel Positive Where a participant feels 
positive about their experience 
of using RVT 
15 31 
 
5.1.3.3 Practitioner expressed opinion of RVT 
 
With reference to practitioner responses in Topic Area Coded ‘c’, the topic 
area is Opinion expressed by practitioner about the Regionally Procured 
Service and the comments could include reflections regarding any area from 
commissioning process to RTNI; from process of service design and 
procurement to end service (Table 5.5). All practitioners shared experience 
and qualitative data in a very practical explanatory topic area. There were 144 
data points recorded with fourteen defined. The topic area with most opinions 
expressed was, ‘what didn’t work, with 11 practitioners discussing the solution 
difficulties thirty-four times.  
Whilst the negative issues seem many in number, they follow consistent areas 
of concern, which may be resolved through technology evolution e.g. 
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thermometers not functioning correctly, technology being ‘clunky’ and not 
effective for younger mobile patients, lack of connectedness to other 
Healthcare Information Technology Systems and date time stamps for blood 
glucose readings in relation to meal times. Two further issues need 
consideration if further development of RVT were to occur. The first being 
added workload for practitioners and linked to that erroneous alerting. Such 
alerts could be caused by a respiratory patient undertaking their daily remote 
vital sign check too early; their actual vital signs may be within tolerances, but 
they may answer the wellbeing questions indicating that they feel worse than 
the day before. The second is the lack of practitioners working and training 
together; shared learning was not demonstrated and so issues such as 
management of patients who had become dependent upon RVT couldn’t be 
considered. 
Practitioners also reported upon what worked well for RVT. Whilst some had 
previously reported an increased workload, others reported that if the system 
was utilised properly then the workload could be relieved. As clinicians they 
felt their patients were safer and more supported and that the system could 
be promoted to improve a patient’s quality of life and was seen as a worthwhile 
expenditure in the long run. However, the same practitioner reported that they 
would not prescribe the system on the first intervention and would then explain 
the system at length to increase the opportunity for acceptance and benefit. 
Practitioners reported that the systems were simple to use, and the end-to-
end service provided by TF3 meant that the worry associated with the setting 
up of equipment was taken away. Whilst practitioners raised a concern 
regarding the health status questioning of patients’ others reported that these 
questions worked well and help give a clearer clinical picture especially for 
respiratory patients. There were other positive attributes with practitioners 
reporting that it was particularly useful to access data about health status on 
the computer to review progress, the empowerment of warfarin patients in 
being able to go on holiday and still report back to the anticoagulation nurse 
for medication dose management. Albeit the anticoagulation nurses day-to-
day working experience with U-Tell could be improved if there was a direct 
feed from U-Tell to DAWN (clinical software) for warfarin dosing. Therefore, 
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there was a balanced approach by the practitioners with regard to their 
reflections upon what did not work so well in RVT and what worked well. 
However, the element of working with RVT that exercised N=10 of the N=16 
practitioners was the issue of the RVT service creating work. The work 
created is where patients breach their clinical parameters or tolerances and 
an alarm is raised that the triage nurse believes is best dealt with by the 
specialist practitioner. It was reported that this can lead to 1 to 2 calls a day 
that were not appropriate. Indeed, one practitioner reported a situation where 
the patient was confused, and the triage nurses would raise an alert which 
would mean the patient may mistakenly believe the practitioner would visit. 
Dedicated time to review RVT patients was an issue and it was noted that 
 “…you need to be careful of what you ask for. If you get patients to 
record loads and loads and loads of health-related data you’ve got to 
be able to deal with it.” (P5)  
Indeed, lack of integration with other systems and no ‘single sign-in’ meant 
that the data were printed by the nurse for the consultant physician at a review 
clinic. 
There were N=10, 62.5%, practitioners who expressed their feelings about 
their input into design. Practitioners acknowledged engagement and being 
able to see the equipment by possible suppliers to the regional RVT project 
but in general were not meaningfully engaged and expressed that more senior 
ranked officers were the ones who made the actual decisions. However, one 
supportive practitioner observed that those who would be the users of the 
equipment should have been involved in the process and were not; the 
patients. It was suggested that practitioners should have been offered the 
opportunity to be more engaged particularly those who had been part of the 
pilots. Of note, one practitioner who was familiar with the U-Tell system 
praised the implementation as the right approach but as it was part of a 
Randomised Controlled Trial, felt there were people randomised to the usual 
care group who missed out on a real opportunity to utilise a service that would 
have been of benefit to them. 
There were 22 comments made by seven of the practitioner participants and 
all were universally concerned by the referral process. None of the practitioner 
participants who used the U-Tell service passed comment, primarily as the U-
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Tell referral process was short, fast and straightforward. Therefore, 64% of 
TF3 practitioners discussed the referral process in very negative terms. 
Essentially the practitioner participants described a lengthy and slow process 
of completion with 13 pages of text to upload, with a page completed before 
the practitioner could move onto the next. Only a Diabetes Specialist 
practitioner had found a system to bypass data entry as they were simply 
requiring a ‘track and trend’ service and did not require TF3 triage nurse 
Intervention. However, this participant still described the referral process 
created by TF3 as the “…biggest deterrents” (P14). The practitioner, P4 
described how the referral; process was the “… first issue that we had” 
describing it as “… long and tedious” exclaiming that, “…that sort of 
inefficiency really annoys me.” P4 contrasted the process to the referral 
process to give patients 24-hour blood pressure monitor where “…30 seconds 
to order and put a sticker on a piece of paper and scribble my signature on it.” 
Whereas, P5 suggested auto-population as most data was already in digital 
formats and P1 suggested administrative support. Linked to the referral 
process was that of discharge but only two practitioners considered this area 
suggesting that timeliness of discharge was important. 
There were five practitioner participants who unitised the respiratory care 
peripheral devices with the TF3 service. All were very positive about the 
equipment finding SPO2, pulse oximetry, temperature with occasional blood 
pressure of use, particularly in highlighting those patients who were 
exacerbating. A further two practitioners were complementary with regard to 
blood pressure monitoring for Stroke patients and on the Virtual Ward. 
Equally, three of the diabetes practitioner participants discussed the 
peripheral devices and technologies supplied by TF3. Universally they were 
critical of the limited range of glucose meters and stated that it was not 
appropriate for most patients to be retrained on a new glucose meter; it would 
have been a more effective service with more referrals if a broader range of 
frequently used devices had been available. The lack of “patient choice” (P11) 
in glucose meters was an issue but also a service deficit where multi-specialty 
working was impossible. It was reported that when the same patient was to 
be monitored by two separate clinical specialties, in a situation of co-morbidity, 
where two groups wanted to use the TF3 RVT service with the same patient 
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e.g. diabetes team with weight management/ dietetics team or diabetes team 
with respiratory team. With the increased prevalence of co-morbid long-term 
conditions this limitation was not welcome. Conversely, two of the INR U-Tell 
practitioners were complementary about the peripheral device utilised. 
Further issues were unnecessary monitoring and remoteness leading to 
failure of connectivity. Both these related to TF3 service inadequacies and 
inefficiencies whereby technology was insufficiently developed or had 
limitations.   
Table 5.5 Practitioner responses in topic area coded ‘c’, to express their 
wide-ranging opinions of the regional RVT service deployed in SET and 
U-Tell, as appropriate. 
Name Description Files References 
P c Opinion expressed 
RTNI 
Opinion expressed by 
manager or commissioner 
practitioner about the 
Regionally Procured Service 
and the comments could 
include reflections regarding 
any area from commissioning 
process to RTNI; from 
process of service design and 




Administrative support Administrative support may 
help practitioners to be more 
efficient 
1 1 
Blood Pressure Cuff To measure blood pressure 
2 2 
Clinicians feeling about 
input into service design 
and technology 
Whether practitioners felt 
they had influence or not 
10 14 
Contact by email The main interface with the 
service provider is by email 
2 3 
Diabetes equipment Issues and comments raised 
about equipment used for 
patients with Diabetes 
Mellitus 
3 9 
Discharge The discharge of patients/ 
service users from the 
system 
2 2 
Critical Appraisal of Remote Vital-Sign Telemonitoring 
222  Julie-Ann Walkden - July 2020 
INR Roche Coagucheck (INR 
Meter) and test strips only 
given to patient – near patient 






Monitoring of too many vital 
sign parameters when 
perhaps the practitioner 
requires a single reading, but 
system forces a range or 
peripherals to capture data 
2 2 
Referral Process The referral process 
practitioners found inefficient 
and cumbersome 
7 22 
Respiratory equipment describes equipment chosen 
by practitioners in respiratory 




Rural remoteness combined 
with technology frailty meant 
that some patients cannot be 
connected to the service. 
3 7 
Service creating work Where service could have 
been delivered more 
efficiently but instead it 
caused work 
10 17 
what didn't work When tested with some 
groups of patients it did not 
seem to work particularly well 
11 34 
What worked well What worked well so that 
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5.1.3.4 Practitioner opinion of models of RVT 
 
With reference to practitioner responses in Topic Area Coded ‘d’, it can be 
seen that the topic area is opinions of models of RVT (Table 5.6). 88% or 
rather 14 cited all availability of the models of RVT available 38 times. 
Essentially there was RVT with the support of a TF3 nurse and this is referred 
to triage and then there are RVT models where a central operator or triage 
nurse does not review the data of patient activity rather all recordings are 
solely reviewed by the Trust’s specialist practitioner or patient/ service users 
lead practitioner (model known as track and trend). The TF3 service offered 
both types of service model albeit to differing condition groups and the U-Tell 
RVT was solely track and trend. 
Nine practitioners had sixteen of their comments assigned to the node of track 
and trend. It was reported that it depends upon the condition, frequency and 
meaning of reading as to whether track and trend is appropriate or not. Track 
and trend was not deemed appropriate for respiratory patients as it was 
believed that it would generate far too much work. It was helpful that the TF3 
triage nurse would screen alerts and non-contacts so as to reduce the burden 
on the clinical respiratory team. The converse was true for weight 
management and diabetes mellitus. Participant P1 stated that triage “…was 
unnecessarily complex… for something non-clinically urgent as weight” and 
5R reported that in diabetes care Triage was “…tricky so because we were 
track and trend, we had to take more responsibility for closing the loop…” and 
“triage would generate a lot of work”.  Although another diabetes practitioner 
P11 aired concern that “…on occasions you could have forgotten about it...” 
continuing that to reduce this known risk that they would try to access results 
on a “… day when I wasn’t very busy at clinic.” In this topic area the U-Tell 
practitioners were silent as their way of working is a standard practice but 
there is variance with practice with regard to the use of track and trend 
provision across the professions and clinical areas. The risk associated with 
a lack of oversight and lack of dedicated sessions to ensure safe and effective 
care is of concern. There is an issue that the patient’s security and belief that 
they are being looked after by a healthcare professional and yet it is now 
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known that even remembering to look at vital signs, blood glucose readings, 
may be an issue for some. 
Four practitioners reviewed track and trend and triage together exploring their 
own practices and questioning their own way of working. P10 reported within 
the context of a respiratory triage service and said that they were also 
disciplined to go through readings as a team a session a week. However, that 
practice was only possible when numbers were low and once, they moved up 
from15-to-20 patients per week to 51-to-60+ then the practice became too 
demanding. P11 reported that they tested triage with diabetes and changed 
as it led to patient calls. 
Three practitioners reiterated triage was not available in U-Tell RVT and five 
practitioners expressed triage fifteen times in relation to their standard use of 
RVT and these practitioners work in either the respiratory service or the virtual 
ward. P7 reported how well the triage nurses worked, a view echoed by P13 
from a patient safety perspective who stated that “…it gives me that security 
that I know patients are being checked up on” continuing that patients are at 
high risk of being admitted onto a ward due to deterioration. However, P10 
gave seven distinct brief respiratory patient context responses including case 
histories and an audit that emphasised the essence of RVT with triage nurse 
intervention was so vitally important to ensuring fast access to interventional 
care as required up to rapid escalation to GP and onward emergency 
admission into hospital. P10 reported having received triage escalations 
during a 4-week period and so conducted an audit of cases. It was found that 
the majority of cases were associated with low oxygen saturation which is an 
expected pattern of disease within COPD. Upon more detailed review the 
saturation levels were within the normal ranges for each of the patients and in 
fact it was the patients’ self-reporting not feeling well through the Respiratory 
questions on the home hubs and concomitantly triage nurses passing the 
information on to the team. Of the 30 case reviews there were three home 
visits and three escalations because the triage nurse was unable to contact 
the patient.   
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Table 5.6 Practitioner responses in topic area coded ‘d’, to express their 
opinions of the models of RVT delivered. 
Name Description Files References 
P d Opinion of models of 
RVT 
Opinion expressed by 
manager or commissioner 
practitioner about the models 
of RVT, that is the two main 
types of provision triage or 
track and trend. Both TF3 & U-




Track & trend Track & trend service is the 
RVT of choice 
9 16 
Triage Triage service is the RVT of 
choice 
9 18 
Triage and track & trend Triage and track & trend 
services are the RVT of choice 
4 4 
 
5.1.3.5 Practitioner opinion of training 
 
With reference to practitioner responses in Topic Area Coded ‘e’, the topic 
area of Training was referenced 32 times by all N=16 practitioners (Table 5.7). 
Four practitioner participants spoke about training and awareness of RVT and 
technology in general at university. Two of these practitioners were nurses by 
profession and the other two physiotherapists in the clinical areas of 
respiratory care and diabetes mellitus. They expressed concern by both the 
absence of undergraduate training or awareness of technology and also the 
lack of interest. Five other practitioners of a range of professions, including 
physiotherapy, pharmacy, dietetics and medicine spoke about the need for 
more people being trained and that much training had been delivered ‘on the 
job’ by those more senior experienced practitioners. Indeed, a broader range 
of team members who support the patients should be trained; it was 
suggested administrative staff so that the burden of the referral process be 
removed from clinician practitioners. N=14, 87.5% of practitioner responders, 
including 100% of U-Tell practitioners spoke about their experiences and 
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opinions of training at the time of service initiation. The U-Tell practitioners 
spoke about their experience very positively which included specialist training 
in England on the use of the INR metre, the U-Tell peripheral and also training 
by the programme developers from Ulster University (UU). The UU team were 
commended for spending much time to train the anticoagulation nurse 
specialists in the use of the U-Tell programme and with follow-up site visits to 
support practice were appreciated. However, the opinions of the ten TF3 
practitioners varied in range and opinion and certainly were not as 
complementary as the U-Tell practitioners expressed. Of these practitioners 
two referred to training they had received on the use of a forerunner service, 
a pilot supplied by a company called Home Telehealth which perhaps gave 
the cohort for the new regional RVT a foundation knowledge. However, there 
was a general consensus that the training for both user and ‘train the trainer’ 
was poor, only ameliorated by having good Help Desk support once the 
service commenced.  
P4 stated that, “…all quite excited about it going over but it quickly 
became clear that it wasn’t as user friendly as we would have liked. 
We were trained in the IT training room.” 
TF3 training included instruction of the on-line referral system, viewing of 
cases and the patient on-line portal in a mocked-up digital environment in a 
Trust computer training suite in the Ulster Hospital but training did not meet 
practitioner’s expectations.  
 
Table 5.7 Practitioner responses in topic area coded ‘e’, to explain the 
participant’s experience or opinion of RVT training and education. 
Name Description Files References 
P e Training This describes the RVT training 





More People Trained Would assist take up of service 
or understanding if more 
practitioners are trained in use 
of RVT 
5 5 
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RVT Training at time of 
service initiation 
The training the staff member 
received was at the time of the 
service implementation 
14 22 
Train at University as 
Student 
Was trained in use of RVT as a 
student or at least told about the 
technology. 
2 2 
Training in RVT not on Uni 
curriculum 
Instances where clinicians 
specifically referenced that RVT 
training or awareness not 





5.1.3.6 Practitioner opinion of encouragement they may have received from 
managers 
 
With reference to practitioner responses in Topic Area Coded ‘f’, it the topic 
area is staff engagement with RVT, considering if practitioners had the clinical 
freedom choose to use the system or not or if they were driven by 
management to use it through Trust or Centre for Connected Health 
performance management (Table 5.8). All practitioner participants responded 
to this topic with twenty-six references being made. The largest cohort, nine 
responded with regard to their personal choice to participate or even to 
proactively seek out an opportunity to test the RVT technology. One 
participant in this group utilised an older version of U-Tell for diabetic patients 
and felt they wanted to test the system to see if the patient’s hypertension 
could be monitored and driven downwards rather than risking ‘white-coat 
hypertension’, the practitioner participant clearly articulated a personal drive 
and motivation. All other respondents, eight, utilised TF3 across three 
specialty areas respiratory, diabetes mellitus and the Virtual Ward so were 
using the full TF3 triage service. The respondents positively affirmed their 
choice to utilise TF3 RVT. One spoke about how they were the newest 
member of the specialist service so was simply inducted into a way of working. 
Another articulated how they felt they could have reviewed the entire caseload 
and found patients that could have benefited from RVT, but their team’s 
resources were such that they could not have had the person-time to address 
the concomitant workload. However, a more senior practitioner from within the 
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same specialty but in a different location commented, “I know management 
have figures to hit, we can’t do anything bar the patients we have…we can’t 
go looking for people.” (P7). In hypertension management the practitioner 
participant shared their personal motivation to reduce the need for clinic 
attendance; a view echoed by their colleague P4, “…we were potentially very 
excited about it for our stroke patients as high blood pressure is a big risk 
factor… no pressure to use it… we were excited about it and wanted to use 
it.” Within the Virtual Ward the practitioner reported initiating the service as 
there was, “…one-person case managing the entire locality.” (P13). The free 
choice was still echoed within diabetes mellitus practitioners except other 
perspectives lessened the impact with one reporting that “…personally told 
that I had to put X on, yes numbers initially… I just never took it personally as 
I just knew myself, I was referring”. (P14) Whereas, P5 disclosed that “… in 
the beginning we did chose to use it, when we identified major constraints, we 
became a bit disappointed… disillusioned”. Therefore, in general, 
practitioners were aware of targets but articulated that they made the choice 
whether to use RVT or not. 
Eight practitioners reported being encouraged to utilise RVT by peers or 
management. The four users of U-Tell, three with INR monitoring and one 
with blood pressure monitoring with patients with diabetes mellitus reported 
involvement because of research studies but they were interested. Within 
weight management the practitioner had no contention and within respiratory 
care there was a feeling expressed of enthusiasm for new innovative 
technologies which offered the opportunity of positive outcomes for patients. 
P16, within Virtual Wards, expressed having been encouraged but there was 
a chasm between what the clinicians believed was possible and the inflated 
idea of management. P2 reported that they never had a choice but that if they 
had, they would choose to use the system. 
However, five practitioners reported feeling that they had no choice and were 
instructed to use RVT by management clearly articulating RVT usage by 
performance management targets. These were understood as having been 
set by the Minister and Department of Health and they understood the need 
to utilise resources effectively but the action of management to performance 
manage had a far more damaging and negative effect. Being told to increase 
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quota by management was unwelcome especially where it was to 
compensate for another service areas underperformance. Frustrations were 
expressed when targets were not met and P12 reported  
“…was where my negative attitude came from at the time because you 
were told that you were doing this, and you were wondering why am I 
doing it and then actually I set the quota at the very beginning... I set 
too high a target.”  
The irony in that scenario was that the practitioner considered the total 
number of patients and was assessing a reasonable proportion, which was an 
impossible task as they had never been involved in RVT and there was no 
literature to suggest an ideal number of cases for entire caseload for planning 
purposes. One practitioner observed that technology had moved on but that 
the “…service provision was stick in a deal, in a contract.” (P5). In summary, 
where practitioners perceived freedoms to act there was receptivity but where 
management performance managed target attainment the resistance waxed, 
and the positivity waned.   
Table 5.8 Practitioner responses in topic area coded ‘f’, to show the 
opinions expressed regarding the encouragement of practitioners to 
engage in particular the use of performance targets by managers. 
Name Description Files References 
P f Staff Engagement 
target 
This considers staff engagement 
from the perspectives of clinical 
freedom versus performance 




Chose to use RVT Where a practitioner proactively 
chose to seek out and use RVT 
9 10 
Encouraged to use 
RVT 
Practitioners were encouraged to 
use RVT by peers or 
management. 
8 9* 
Management target The practitioners had no choice 




 (* = data reclassified from management target to encouraged) 
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5.1.3.7 Practitioner opinion of RVT in relation to value for money 
 
Whilst this thesis is not concerned about the health economics associated 
with RVT all practitioners discussed the concept of value for money and the 
quantitizing the narrative associated with value for money is Topic Area 
Coded ‘g’; this is only a perception (Table 5.9).  Most practitioners did not 
know whether RVT was value for money (VFM) or not. Several expressed 
how they had no idea about cost of contract or even costs or value to service. 
P4 suggested that if they thought about it then there was doubt it was not 
value for money given the length of time it took practitioners to complete the 
referral form or be interrupted by unnecessary calls from triage nurses. 
However, two practitioners reported the value for patients and these 
quotations summarise the views on RVT VFM.  
“I honestly would be undecided, but the value is in the patients and the 
self-management of their conditions, that is where the value is and 
then you would have better health outcomes.” (P16) and “…from the 
patient point of view, the patients aren’t losing time off work, they’re 
not having to pay car parking fees…I think in the long run I think it 
would be very good value for money” (P8).  
This latter opinion was echoed by three further practitioners as they expressed 
an opinion that they perceived RVT was value for money. 
That said, five practitioners expressed an opinion that RVT was not good 
value for money. A U-Tell practitioner reflected that others may perceive it as 
poor value for money but did not express their own view. The remaining four 
practitioners were familiar with the RVT service provided by TF3 and were 
extremely negatively vocal in their belief of poor value for money albeit none 
had an idea of the actual financial cost of the TF3 contract to the Northern 
Ireland Health and Social Care system. One practitioner felt it was not money 
well spent and was under-utilised with another suggesting that local budgets 
for RVT for local teams would have been more cost effective.  One practitioner 
had spent time reviewing the costs and values and said that there was a 
principle that an acute admission was very expensive so that if RVT could 
avert such admissions then the value would be clear but that the objective 
was not met. The practitioner continued that the value was based elsewhere 
with 
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“…value for money in healthcare utilisation or in terms of quality of 
life… just look at quality of life then it did improve that, so maybe it was 
an expense worthwhile in the long run.” (P2). 
 
Table 5.9 Practitioner responses in topic area coded ‘g’, to illustrate the 
perceived value for money of RVT. 
Name Description Files References 
P g Value for Money This considers aspects of value 
for money and the perceptions 
and knowledge expressed by 





Don’t know if Value for 
Money 
The practitioner does not know 
if the RVT is value for money 
11 13 
No not Value for Money The practitioner believes the 
RVT is not value for money 
5 9 
Yes Value For Money The practitioner believes the 




5.1.3.8 Practitioner opinion of outcome 
 
With reference to practitioner responses in Topic Area Coded ‘h’, the topic 
area is outcome and benefit of RVT with fifteen of the sixteen practitioners 
making eighty-nine comments, this quantitizing of qualitative data 
demonstrates power of sentiment (Table 5.10) and (Creswell and Plano Clark, 
2007). 
One of the coding nodes considered the outcome and benefit from the 
perspective of hospital attendances. Seven practitioner responders 
mentioned this topic area sixteen times. This node considered if RVT had any 
affect upon hospital utilisation, admission, readmission or outpatients. 
Practitioners were from four therapeutic groups, (diabetes mellitus, INR, 
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Virtual Ward and Respiratory). The two diabetes practitioners said they were 
not trying to keep patients away from hospital, but it did mean that there were 
reduced numbers of out-patient appointments. The U-Tell RVT for INR had a 
“…huge impact on our workload because patients don’t physically come to 
see us because they are doing it at home, and it has worked out fine” (P15). 
The Virtual Ward practitioner’s role was to provide an alternative in the 
community for care rather than an acute hospital admission and the 
practitioner suggested the use of RVT by the district nurses would further 
relieve their pressures of home visits to monitor Blood Pressure and weight 
monitoring in chronic heart failure patients. The two respiratory practitioners 
had most to say on the topic with one not believing RVT reduced clinician 
contact, did not reduce Emergency Department (ED) attendances or 
hospitalisations. P10 observed that when their patients transitioned from their 
chronic disease phase to a palliative phase that the role and utilisation of RVT 
subtly changed away from “…on-going acute monitoring to try and then 
disengage from that to more of a symptom management rather than actual 
clinical parameters.” Practitioner P2 spoke at length on this topic with a 
particularly clear minded view that the purpose of RVT had been to reduce 
the expense of hospital admissions but that was not realised and went on to 
say that there were some groups where a hospital admission would never be 
prevented; if the patient had asthma a hospital admission is unavoidable. This 
practitioner did propose that a more moderate patient could have a reduced 
hospital admission if RVT was deployed. P2 recounted a situation where a 
hospital admission had been averted as an exacerbation was detected early 
and emergency antibiotics administered. P7 supported such an assertion and 
case example suggesting that without the all-encompassing RVT and clinical 
team response patients may have delayed reporting the onset of an 
exacerbation and concomitantly been at higher risk of an admission.  
Two practitioner participants reported their view that RVT had a negative 
impact upon readmission or outpatients articulating it as knowing what a 
patient’s desired outcome is but that it couldn’t be achieved through RVT. One 
practitioner described how a poor experience with TF3 peripherals and hubs/ 
equipment lead to a patient feeling quite stressed and the majority of RVT 
work was time consuming. The other practitioner rated outcomes as negative 
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when the patient is unable to use the peripheral device correctly or they fail, 
and this leads to additional work for the practitioner and a negative outcome 
for the patient. The two consultant medical practitioners reported neutral 
patient outcomes, one critical of a lack of user engagement and testing during 
the RVT design phase and the other (P5) reporting that the TF3 RVT service 
did not “… really impact much on the younger folk”.  
Eight practitioner participants reported a positive outcome for patients. In the 
‘Way to a healthy pregnancy project’, patients monitored their weight and if 
during the course of the pregnancy an obese lady lost weight or remained 
neutral then the outcome was deemed as positive; P1 reported that the 
majority achieved that, so the outcome was successful. Two of the U-Tell 
practitioners reported positive outcomes as long as patient safety and a single 
point of contact was maintained for the patients. In the Virtual Ward P16 
reported being “…able to hold on to the over 65’s that have complex needs 
that don’t fit under anybody else’s remit.” A practitioner within diabetes 
mellitus observed that the TF3 service was not so reactionary and worked 
better over time but because of technology it was better suited to the life styles 
of older people, part time worker or the retired. There were better outcomes 
reported for older type 2 patients with complex treatment regimes, poor 
control, hypos and variability in blood sugar.  
“… our initial evaluations of the results were really very spectacular, I 
think the drop in HB1C was nearly 2%, lower than 5% anyway, which 
is a very clinically significant improvement but the price we had to pay 
for this was great. Patients liked it definitely, patients loved it.” (P5) 
Three respiratory practitioner participants reported positive outcomes. 
P6 reported early deterioration detection, P2 emphasised the positive 
effect upon “… their quality of life and affected their healthcare 
utilisation” but the most detailed explanation was made by P10 who 
explained the multi organ and system disease that was COPD and the 
effects of medications long-term upon the person’s health, it was within 
that context that they said, “…I am trying to optimise their health with 
Telehealth it has a positive impact on their general well-being.” 
All four of the U-Tell Practitioner participants and three quarters of the TF3 
Practitioner participants reported within the node ‘Help people keep track of 
their condition Empower’. Moreover, of all the nodes formed through the 
(NVivo) powered analysis of the N=16 Practitioner interviews, it had the 
second highest frequency of references, N=58 references made by the 
practitioner participants. The topic area of Empowerment is patient centric 
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whereas the other two high frequency comment areas are RTNI process 
based or references to needing to pursue further innovation. Therefore, it is 
assessed as the single most important patient centred observation made by 
12 of the 16 practitioners.  
The interpretation of empowerment broadly encapsulated the direct use or 
reference of the word ‘empower’ by five practitioners and also included 
concepts of ‘patient centred’, ‘patient orientated’, ‘independence’, ‘self-
management’, ‘control’ and ‘individualised’. Therefore, this topic area 
essentially considered the wider benefit derived from the use of RVT that was 
not part of the initial regional programme design. The intention of the RTNI 
had been to keep people out of hospital and exert a downward pressure upon 
the hospital utilisation costs; benefit for the service user where not considered 
as a metric of value or a feature to articulate in the specification. However, it 
is argued that the real value of RVT did not rest with economic gain rather 
quality of life and benefit of well-being at the human level. Albeit, the metric of 
worth was not measured utilising methodologies such as Quality-adjusted life 
year (QALY) rather the interpretation of narrative reflections of clinical 
experience and observation. 
When considering the practitioner participants of the U-Tell service, 75% 
utilised the service for the management of anticoagulation therapy, warfarin, 
measuring Blood INR and 25% for the management of blood pressure where 
patients had a diagnosis of diabetes mellitus. All four practitioners, three 
specialist anticoagulation nurses and one clinical pharmacist were consistent 
with their opinion of U-Tell in terms of patient, service user and carer benefit. 
Moreover, a consultant physician/ endocrinologist who had experienced both 
U-Tell and TF3, echoed the views of the fellow U-Tell practitioners in relation 
to that service. The generalised opinion of practitioners who used U-Tell RVT 
was that their patients were empowered by RVT and the summary benefits 
derived from practitioner data suggested the following seven key reasons: 
1. The patient could reduce commitment to attend the Hospital as an out-
patient which means they did not have to pay for car parking or have 
difficulty seeking a parking place. 
Chapter 5: Analysis of Practitioner Data 
Julie-Ann Walkden - July 2020   235 
2. The patient could reduce their travel time particularly if their condition was 
too difficult or complex for their local GP to manage and they were 
compelled to attend a regional service. 
3. The patient could monitor themselves at a time that was convenient 
4. The patient could increase monitoring and reporting if they felt unwell 
rather than having to wait for a scheduled appointment or seek an earlier 
out-patients appointment. 
5. The patient could reduce the effect of their ill-health upon their 
employment so that they did not need to take time off work in order to 
attend hospital. 
6. The patient could be mobile or travel freely abroad whilst maintaining their 
monitoring and dosing advice. 
7. The patient learned about and understood their own condition, putting 
them in control. 
Such benefits were expressed as having very real and tangible importance in 
the lives of patients taking warfarin as a means of anticoagulation. It was 
explained that the effect of warfarin could be significant upon the body and so 
the maintenance of a patient’s INR within therapeutic range was vital. It is 
possible for patients to form thrombi where the INR is below therapeutic range 
or indeed suffer a haemorrhage if above therapeutic range. Some extraneous 
factors can have a significant effect upon the warfarin levels or metabolism 
within the body; these may include, heat, ill-health, alcohol, foods containing 
high vitamin K levels, a general change in diet and medication. Therefore, 
when a patient goes abroad on holiday, they may be at particular risk of their 
INR control becoming erratic. P15 when referring to U-Tell in such a scenario, 
“… definitely empowered them. I think that they are now controlling their lives 
instead of their condition controlling them.” 
The practitioners who reported that their patients utilising the TF3 RVT service 
were being empowered supported patients with the broad range of conditions 
the regional service was designed to address including weight management, 
respiratory medicine, diabetes mellitus and the Virtual Ward. Of note, neither 
the specialist stroke nurse nor the consultant geriatrician believed RVT in its 
current state of development benefitted the Stroke patients, a finding 
consistent with TF3 post stroke hypertension reported experiences. P12 had 
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reported the use in the Stroke service for RVT was short term blood pressure 
monitoring to exclude the effect of ‘white coat hypertension’ (cross reference 
anxiety coded narrative section ‘i’). Therefore, there was probably not the 
opportunity for practitioners to observe, consider or even enable 
empowerment in such a limited functional application of RVT. 
Within the Virtual Ward team, the views of the two specialist nurses were 
positively supportive of the service dimension and outcome of empowerment 
with P13 stating it “absolutely” empowers patients and continued with several 
case examples where patients’ lives had been very positively impacted from 
this perspective. P13 was the first to expressly detail the benefits and effect 
of patient empowerment through becoming ‘expert-patients’. P13 explained 
how patients changed not only their understanding of their conditions but also 
their language so at a time when they needed to seek medical attention, they 
were empowered to speak with authority rather than as a passive recipient of 
healthcare unable to articulately explain clinical observations. Concomitantly, 
this then affected how patients were received by their General Practitioners 
(GP);  
“I suppose from the GP’s perspective they love it that patients have 
given them a complete clinical breakdown. It makes their lives so much 
easier” (P13).  
In another example case P13 described how patients were independent as a 
result of RVT but that carers were helped considerably. A case was cited 
whereby a frail patient with both dementia and respiratory disease could be 
cared for by their family as they were able to understand vital signs that may 
indicate deterioration when the patient did not have the capacity to share how 
they felt. It could also be argued that this example demonstrates safety but 
also that carers are empowered to continue caring, having a proactive role in 
the maintenance of the patient’s well-being. P16 equally supported this view 
within the context of a Virtual Ward and stated that the RVT had the “…patient 
at the centre.” 
The two remaining clinical areas had different approaches and technologies 
for RVT; respiratory with full triage TF3 RVT and diabetes mellitus with track 
and trend TF3 RVT. Whilst, again describing empowerment, the different 
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professional groupings and service responses triggered a response from 
differing viewpoints.  
Two of the four respiratory practitioner participants contributed observations, 
one practitioner being a specialist physiotherapist and the other a specialist 
nurse. P2 clearly articulated “…empowerment and patient quality of life” 
setting into context the tangible benefit and value of patients being able to 
have “better control of their disease”. P7 gave case examples where patients 
and their carers were empowered to be independent and manage early signs 
of infection describing the support provided by RVT as “phenomenal” which 
enabled them to “…just manage themselves better”.  
Within diabetes a specialist nurse observation, made through experience, 
commented that patients could become dependent upon RVT and so they 
had the time limit set from the outset of the prescription and an occasional 
extension enabled. The dependence was interpreted as a security issue and 
so the nurses ensured emphasis of purpose changed to reflect the need to 
understand diabetes and the effect of certain behaviours upon the body; an 
education tool. The reframing did not detract from the security patients 
expressed knowing that they were being monitored. The physician took a 
different approach to the articulation of empowerment through RVT of the 
diabetic patient. Indeed, from P5’s perspective there was no doubt that RVT 
empowered patients, “…we were trying to improve their self-management 
skills and their overall diabetes control.” Furthermore, P5 extended discussion 
to the wider and future opportunities that RVT could afford within the concept 
of patient empowerment.  There was a vision of extended empowerment for 
the future with dynamic patient support groups through dedicated portals, 
“semi-automated” (P5) analysis of RVT data particularly where therapeutic 
intervention is through injectable medicines especially when considering 
difficulty when face-to-face access with practitioners is likely to become more 
limited. 
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Table 5.10 Practitioner responses in topic area coded ‘h’, to illustrate the 





P h Outcome 
and Benefit 
This considers the aspect of outcome or 
benefits of the service expressed by 
manager or commissioner practitioner, 













Consider if RVT has affected the hospital 






Know what the Patient's desired outcome is 





Know what the Patient's desired outcome is 





Know what the Patient's desired outcome is 
and achieve that through use RVT 
8 10 
 
5.1.3.9 Practitioner opinion of clinical issues 
 
With reference to practitioner responses in Topic Area Coded ‘i’, the topic area 
of Clinical Service Issues extended the thinking of practitioners beyond the 
high-level general feelings towards RVT as described in topic section ‘b’ or 
opinions as expressed in topic section ‘c’ (Table 5.11). The topic section ‘i’ did 
not discuss purely mechanical service clinical issues but explored wider 
concepts, the feelings and behaviours of others and technology in general. 
There were sixteen subheadings within the topic areas with two subheadings 
further divided into sub-subheadings. All practitioners discussed RVT within 
the context of the wider topic of Clinical Service Issues. The subheadings 
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considered by the researcher as most significant and impactful will be 
discussed. Of the N=24 sub-nodes and sub-sub-nodes, analysis was 
undertaken under three overarching themes, professional opinion of patient 
interaction with RVT, RVT System and RVT Technology.  
When considering professional opinion of patient interaction with RVT, there 
were two main nodal topics anxiety and patient identification.  Anxiety is 
described at length by six practitioners. It is a particularly interesting area as 
the practitioners who raised patient anxiety as an observation were almost 
split with an opinion that RVT had the potential to increase anxiety with others 
recognising an ability to reduce anxiety but there was consensus regarding 
knowing the individual patient. Through experience practitioners had built into 
their own personal unwritten assessment criteria for RVT whether or not they 
would have anxiety controlled or exacerbated by the use of RVT. From 
experience it was reported that post stroke patients were particularly prone to 
anxiety, a fear of the next stroke and the devastating consequences. On one 
hand RVT had been observed that RVT could reduce ‘white-coat 
hypertension’ (high blood pressure caused by clinicians) by self-managing at 
home and on the other elevate anxiety. In stroke care it was the experience 
of practitioners that the anxiety issue was unpredictable, and an example was 
given of a post stroke patient who was discharged from hospital with RVT. 
The individual was a highly qualified bank manager but very shortly after 
discharge be became ‘fixated’ upon his blood pressure, increasing frequency 
of measuring and concomitantly increased contact with the stroke specialist 
nurse. The same descriptor, ‘fixated’ was utilised by a dietitian who described 
RVT as unhelpful where individuals were obsessed with weight as in their 
experience they could not condone over monitoring of weight as it “heightened 
people’s concerns.” Within the general discussion about anxiety, situations 
were described where an overly anxious patient would create more anxiety 
and would “manipulate the system to make them worse than they are” (P16) 
particularly where the subjective psychosocial questions confuse the patient 
as they are unable to compare well-being from one day to the next and “over 
analyse the questions” (P13) where a question enquires if they would describe 
themselves as better or worse today than the day before. However, within 
respiratory and virtual wards there was a consensus the system can reduce 
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anxiety where the patient is quite unwell, is home alone and can be given a 
lifeline to the triage service and more anxious patients would tend to contact 
the practitioners more than less anxious patients and so by prescribing RVT 
they were given assurances. Situations where practitioners know their 
patients are socially isolated RVT can afford reduced anxiety. In summary, 
RVT can have both a positive and negative effect upon patient’s anxiety levels 
and the key is to know the patient. There was a consensus that RVT had been 
found by practitioners in virtual wards and respiratory medicine to reduce 
anxiety and in post-stroke care and weight management to heighten anxiety. 
N=13 practitioner participants referenced the topic of patient identification 
process fifty-eight times making it the second highest ranked topic across all 
of the one-to-one practitioner interviews and very much focused upon 
process.  The opinions and recommendations of the practitioner participants 
are tabulated; demonstrates a summary of patient identification factors (Table 
5.12). 
 
Table 5.11 Practitioner responses in topic area coded ‘i’, which 
examines the clinical service issues as observed or perceived by the 
respondent. 
Name Description Files References 
P i Clinical Service 
Issues 
This considers any Clinical service 
issues beyond those documented 
within the node MP c Opinion 
expressed RTNI. It is more focused 
upon views, or perceived views (if 
made by a manager) of practitioners, 
service users, the change of practice 




Anxiety Observed a change in patient anxiety 
as a result of RVT 
6 16 
Increases Anxiety Patients who utilise RVT experience 
increased anxiety 
4 7 
Reduced Anxiety Patients on RVT experienced a 
reduced level of anxiety 
3 5 
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Clinicians are 
reluctant 
Some clinicians are reluctant to 
engage with the technology 
5 6 
Contact by Phone Contacted by the service provider by 
Phone 
8 13 
Duration Length of time patients utilise RVT 
5 6 
Extended Range of 
Conditions 
Where practitioners have chosen to 
extend the range of conditions, they 




The practitioners have purposefully 
decided to monitor a patient, their vial 
sign, so as to adjust care e.g. 
medication dose 
5 10 
Need for better 
research 






Patient behaviour with regard to 
technology, the learning of new skills 
and use of technology 
7 12 
Patient Honesty If patients record own reading and 
communicate directly with practitioner 





This describes the decision-making 
steps and process a practitioner 
described and in most cases was 
developed in service following the 
experience of practitioners testing the 
system. 
13 58 
Patients fear of 
technology 
Some patients are fearful or nervous 





where the patients were asked to 
upload readings from their own home, 
un-calibrated equipment e.g. scales, 
BP cuff, glucose monitor 
1 2 




How frequently patients are asked to 
submit readings 
5 6 
Ad hoc submission Reading submission is variable based 
upon previous reading and need 
0 0 
Frequent Once a day submission of readings 
1 1 
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Less than 3x per 
week 
Patients are asked to submit readings 
less than 3 times per week but more 
than once a week 
0 0 
Once a week Patients are asked to submit readings 
once a week 
2 2 





Patients are asked to upload readings 
Monday to Friday 
1 1 
Time The Time associated with RVT can be 
problematic 
5 11 
Work in a new way Practitioners proactively changed 




5.1.3.10 Practitioner opinion for patient inclusion and exclusion criteria 
 
The tabulation of use case application of RVT across the professional and 
disease groupings demonstrates that only Respiratory reference a local set of 
referral criteria and that all other practitioners tend to utilise their clinical 
judgement and trial and error modified over time by experience. There are 
common themes such as anxiety reducing chances of referral and that all 
practitioners have a therapeutic purpose to enrol their patients onto the 
system; it appears to be purpose driven even if agreed evidence-based 
guidance was not driving clinical practice. 
Further consideration of professional opinion of patient interaction with RVT 
included the nodal topic of ‘Patient Honesty’ which was raised by four 
practitioners working across weight management, diabetes mellitus, INR and 
Virtual Ward and in summary the practitioners experienced patient dishonesty 
as a critical factor. In fact, one practitioner gave a case example where a 
patient had her RVT removed as she was manipulating the data to cause an 
alert and receive attention and a home visit. The data from the peripheral 
devices would be transmitted to the Home Hub and on to the TF3 service 
without the requirement of a patient to self-record data. However, the psycho-
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social well-being questions could be manipulated by the patient in order to 
elicit a response. Unusually, in INR there was a subtle difference associated 
with failure to upload data, sometimes due to forgetting and other times as the 
patient feels in control of their INR and feels fine. In addition, practitioners 
shared opinions that the range of practitioners and conditions RVT could be 
deployed with could be extended with P10 suggesting pre and post-operation 
transplantation patients. Four practitioners, across as many different 
professions emphasised the need for better research. There was a consensus 
that scepticism and apprehension existed amongst professionals as little 
evidence was available to support the Government’s investment. However, it 
was recognised that would be the case with new technologies and so it was 
not a “reason to stop trying” (P4). 
A salutary message was delivered by five practitioners across four clinical 
areas. Concerns were voiced that there were many practitioners who were 
reticent of technology and generally unaware of RVT. A positive message of 
engagement and motivation was required. A further two practitioners 
articulated the new way of working from a positive stance with P8 proclaiming. 
“…embrace technology… accept things are moving forward and we have to 
move with them.”  
The RVT System was a set of nodes that were discussed by all practitioners 
and covered a range of practical dimensions of RVT including duration, 
telephone contacts, method and frequency of uploading data and time. The 
narrative did not significantly move beyond the known planned type of service 
delivery. Practitioners did share how they engaged with the practical 
mechanistic operationalisation of the regional RVT contract, TF3. There was 
no contribution to knowledge beyond the known context of service. 
Personal RVT Technology experience was an important reference point for 
practitioners to anchor their thoughts of technology utilisation moving forward 
to the future. The TF3 RVT project supported a Patient’s Portal which was not 
universally accessed by patients and was only referenced by one practitioner 
whereas three supported the practitioner’s portal for accessing the data 
associated with their patients. Patient owned devices were not utilised as part 
of either of the RVT systems and whilst it could be an option the lack of 
calibration was highlighted by one practitioner. Interestingly, a finding which 
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did not emerge to any great extent from the patient participant data was the 
consideration to be given to patient’s fear of technology. Nine practitioner 
respondents across nursing and AHP, across all clinical areas, except weight 
management expressed the observation. It was recognised that some people, 
possibly older, with mental state issues and having had no experience of 
technology were afraid of technology. P13 gave a case example whereby a 
patient asked for the equipment to be removed after 3-days as it “…reminded 
him that he was ill.”   
 





Stroke Hypertension/ blood pressure that is 
difficult to reduce 
Cognitive 
impairment 
 Suspected ‘white-coat’ hypertension Anxiety 
Care of Elderly 
(CoE) 
Following experience with Stroke – 
consideration to monitoring CoE with 
weight in Heart Failure 
 




 Avoid exacerbations  
 Looking for a trend  
 Frail with dementia if family could support  
 Young adults transitioning from paediatric 
services. 
 
 Mixed clinical pictures with co-morbid 
Congestive Heart Failure with COPD 
 
Diabetes Mellitus Speech impediment as giving blood 
glucose information over the phone can be 
difficult 
 
 Patients that need extra support and 
Encouragement 
 
 Pre-surgery patients to get them to target  
 Where we want to make major therapeutic 




Patient safety where stable  
 In future move to unstable INR for frequent 
monitoring 
 
 Only anticoagulated with warfarin  
 Live a long distance from the Acute Out 
Patients Clinic 
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 Patients who work and would not have 
much time available to attend for clinic 
appointments 
 
 Computer literate and capable of utilising 
the Roche CoaguChek (INR Meter) 
 
 Mental Capacity  
Respiratory Two exacerbations in previous 12-months Asymptomatic 
patients 
 Patients with poor family support Patients who are 
very well 
 Reassurance to patients on good days as 
the patients know there can be hospital 
admissions and serious consequences if 
observations are off. 
Patients who are 
very ill e.g. lung 
cancer or 
pulmonary 
fibrosis who are 
deteriorating 
 High healthcare utilisation in line with 
some locally agreed guidelines 
Not where a 
patient tends to 
be poor in the 
morning 
generally unless 
RVT can be 
scheduled for 
later in the day 
i.e. after lunch 




 Locally agreed guidelines and team 
decision making 
Anxiety 
 When on a domiciliary visit always thinking 
if RVT would help in the situation 
Independent 
and no infection 
over the past 
two-years 




would not use a 
machine 
 
5.1.3.11 Practitioner opinion of the future of RVT 
 
With reference to practitioner responses in Topic Area Coded ‘j’, the topic area 
of Need More Innovative Technology was the single most thought-provoking 
topic across all practitioner one-to-one interviews with N=14, 85.7% of 
practitioner respondents referencing the nodal topic sixty-one times (Table 
5.13). Of note, the two practitioners who did not articulate issues about the 
future utilisation of technology were the two most inexperienced both having 
worked with a few patients and on a solely track and trend TF3 service. 
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In summary, the fourteen practitioners who offered thoughts on the future of 
technology utilisation in healthcare were universally supportive and 
encouraging. A common theme was that with the staffing resources not 
keeping pace with demand for care, “…we are seeing doubling rates of maybe 
10-15-years in terms of prevalence in diabetes, and we’ve got to do something 
different” (P5). Practitioners believed that there were no other opportunities in 
healthcare to address burgeoning demand other than to look to technology to 
support care. There were common practical themes shared by the 
practitioners, when they expressed their thoughts and feelings, within the 
context of the future for technology, particularly in relation to RVT. Across the 
narrative recorded under this node, based upon their experience of RVT, there 
were nine common predictions shared and these have been distilled as 
follows considering the future of technology:  
1. Mobile technologies that automatically send data, in the background, that 
are easy for patients to use and do not require dexterity with cables and 
ports. 
2. Technologies where there is a single sign on Electronic Patient Record 
that can be accessed by all Trust staff and GPs which includes the 
patient’s own daily readings from RVT. 
3. Technologies which are automated or semi-automated responses to 
patients generated by the technology embedded with data analytics to 
create a “Doctor-in-my-pocket” (P5) 
4. Technologies which communicate automatically in an integrated way e.g. 
the INR reading transferring from U-Tell to the Dawn Dosing system (P5) 
5. Technologies which include patient access such as internet Patient 
Portals. These should become interactive so that patient interfaces and 
technology enable push and pull information to enable training, health 
promotion, lifestyle, function, exercise and treatment compliance. 
6. Technologies which are calibrated so the accuracy of peripheral devices 
and battery life are more reliable. 
7. Technologies which enables two-way messaging between practitioner and 
patient for more timely personalised care and intervention. Including the 
option for video calling. 
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8. Technologies which permits the recording and transmission of new metrics 
e.g. carbohydrate counting and the date, time stamps included 
9. Wider technology adoption across the services and professions not only 
the domain of a limited number of specialist practitioners. 
Whilst there were calls for better collaborative working between practitioners 
and Information Technology experts, with a request for suppliers to be more 
forward thinking, there was a resounding sense of support and enthusiasm 
for RVT and the need for more innovative technology; “…is the future and we 
need to embrace the future and we need to think to a smarter way of working” 
(P4). 
Table 5.13 Practitioner responses in topic area coded ‘j’, to enable the 
articulation of perceived vision for the future of RVT in Northern Ireland. 
Name Description Files References 
P j Future of RVT the next 
generation 
Considers all aspects for the 
future of RVT, looks forward to 
the future or articulates what 
next for RVT in Northern 
Ireland, including policy, 
equipment, models and 
engagement regardless of a 
pessimistic or optimistic 




Electronic Record Where the readings are 
collected and translated into a 
record for practitioners to 
access 
2 2 
Need more Innovative 
Technology 
Clinicians recognise the need 
for more technology, new, 





There were 37 senior nurses, doctors and allied health professionals within 
the SET who had been trained in the utilisation of RVT, 16, agreed to be 
interviewed. Over 50,000 words of data were analysed utilising (NVivo). There 
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were eight main topics, ten overarching topic nodes (two of which were more 
demographic in nature) which contained 55 sub-nodes.  
A criticism of the data may be that RVT enthusiasts had self-selected and that 
the more negative viewpoints were not expressed, and the data demonstrated 
that 15 of the 16 participants had positive feelings about RVT and were 
optimistic about future use. However, of practical application in the future 
participants were candid about what worked well, what did not, and from a 
very practical experience the inclusion and exclusion criteria the different 
clinical areas had developed.  
The key message from the practitioners had been how RVT had changed their 
relationship with patients as they found patients became empowered through 
RVT.   The summary experience of practitioners to articulate this belief 
included, self-management, reduced requirements for patients and carers to 
travel to appointments and pay parking fees, less impact on employment for 
those patients who were in work, could monitor themselves at a time that was 
convenient for them, could increase monitoring if they felt unwell, could travel 
abroad and maintain monitoring and support from clinical services and that 




Chapter 6: Analysis of Manager Data 
Julie-Ann Walkden - July 2020   249 
6 ANALYSIS OF MANAGER 
DATA 
6.1 Analysis of Qualitative Data Held within Nvivo 
6.1.1 Introduction 
 
Results of qualitative analysis of manager and commissioner interviews are 
presented by reference to eight main topics. To enable meaningful 
comparison between participant groups, that is the practitioner group with the 
manager group, the main topics are consistent with those of the practitioners, 
albeit the sub-topics demonstrate diversity and some divergence from the 
structure of the practitioners. Managers shared their experience and opinions 
of the collaborative design of RVT, implementation and then 
decommissioning. Options are varied, some favourable and some less so.  
This chapter will explain the experience of the managers and the knowledge 
they shared consolidated around the share themes.  
6.1.2 Manager and Commissioner 
 
There were eight interviews with senior officers from within the Northern 
Ireland Health and Social Care (HSC) system. The objective was to garner 
the opinions of senior officers from across a range of relevant clinical 
professionals and also non-clinical senior administrative staff. In principle, 
enough one-to-one interviews were to be undertaken until such time as no 
new evidence emerged as per the best practice within grounded theory 
(Aldiabat and Le Navenec, 2018). However, seeking participation within this 
group was time consuming as 40%, of those requested to participate, did not 
respond whilst an additional individual opposed participation as he said that 
his views of the TF3 service would be unpublishable. Within quite a broad 
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spectrum of senior managers from across the Trust, Public Health Authority, 
Health and Social Care Board and Department of Health and Social Care, 
eight senior managers were interviewed. Most of the managers did not have 
a clinical background (Table 6.1). The senior civil servant did not have a 
tertiary education and those with a business studies background classification 
had third level degrees in hospitality management, accountancy and 
accountancy with business law. Whilst these professional backgrounds do not 
naturally orientate towards remote telemonitoring, the four individuals had 
lengthy careers in the health service, and all were in experienced senior 
positions influencing and commissioning RVT for the region.  None of the 
managers had received any prior training in RVT. The gender mix of the 
manager respondents was 50% male and 50% female. The years of highest 
qualification attained ranged between 1976 and 1997, with 75% graduating in 
the 1980’s and the mean year of graduation being 1985. 
Table 6.1 Profile of professional background of managerial respondents 
showing a range of positions in the healthcare system. 
Professional Background Number 
Business 3 
IT 1 
Civil Servant 1 
Nursing 2 
Allied Health Professions 1 
 Total 8 
Eligible Regional Managers 15 
Percentage Responded 53% 
The face-to-face interviews each lasted circa 1-hour, were digitally recorded 
and transcribed into Microsoft Word. The eight documents were uploaded into 
NVivo, the mean word count length of each was 4,826 words with the total 
number of words in the narrative being 38,608. Therefore, the assistance of 
NVivo in permitting the researcher to create topic notes and concomitantly 
code narrative to the appropriate note for sorting, reporting and methodical 
analysis was beneficial. 
A high-level summary report was tabulated within (NVivo) to demonstrate the 
distribution of opinions and perspectives shared by participants (Table 12.7 
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Appendix 9). This expresses the topic code, the descriptive title of the topic 
area, up to two tiers of more focused response descriptive titles, the number 
of participants who expressed a broadly similar view within the topic area and 
then the number of times that description was repeated. Therefore, if each 
participant expressed an opinion in a descriptive topic title area the number of 
manager respondents would be represented as eight and if each of those 
respondents mentioned the topic twice during their total interview time, the 
frequency would be 16. It is recognised, in analysing the narrative that it may 
seem arbitrary to count multiple expressions by the same respondent in the 
same “unit” as if it was expressed by different respondents, but distinction and 
explanation will be made in the analysis. A unanimous view is considered as 
stronger than one person repeating a point eight times. Consideration of the 
qualitative data in this way is referred to as ‘quantitizing’ the data (Creswell 
and Plano Clark, 2007). 
 
6.1.3 Analysis of Manager Narrative by Descriptive Topics 
 
Each descriptive topic area has been tabulated to illustrate the number of 
source participants who expressed an opinion and also the frequency the 
topic was repeated or reinforced by the subset of participants who articulated 
the topic. The descriptive topic tables also include the working definition 
assigned to the description by the researcher to further enable understanding, 
grouping of sentiments and concomitant interpretation. The manager 
participants had been given assurances that their individual identities would 
not be discussed, nor their comments attributed to them. Therefore, within the 
qualitative analysis of the narrative any manager participant quotations was 
not attributed, rather recorded within speech marks. 
6.1.3.1 Experience of RVT as a manager 
 
With reference to manager responses in Topic Area Coded ‘a’, the topic area 
of experience as a manager or commissioner participant was discussed by all 
participants with all confirming that they had no personal experience of 
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actually using an RVT system (Table 6.2). Of the eight managers, only three 
had a clinical background, one dietitian and two nurses, but all had held senior 
positions without direct patient care for a number of years. The managers with 
a clinical background were able to explain their foundation knowledge, direct 
connection with their staff delivering care through RVT, exploration of 
theoretical clinical evidence base development and a strategic high-level 
overview. One manager held an Information Technology (IT) qualification and 
was able to articulate how their (expert) knowledge of technology enabled 
them to examine technology from the perspective of patient benefit. The 
remaining four managers did not have a clinical or IT foundation described 
their ‘on the job’ learning. Such activities included attendance at conferences, 
technical demonstrations, visit into the homes of patients utilising RVT, visiting 
services in other regions, learning through the pilots and learning through the 
creation of a specification of a new region RVT service, which TF3 was 
successfully awarded. One manager articulated their belief that it was an 
advantage not to be a clinician, arguing that they would not suffer from a 
perceived hierarchy within clinical ranks and that they were able to say, “look 
I’m not a clinician, what would you like?” (M2) 
Table 6.2 Manager responses in topic area coded ‘a’, examining the 
participant’s experience of RVT. 
Name Description Files References 




Background of or experience with RVT 
from the perspective of being a manager 
or commissioner practitioner. 
Comments may be about experience, 
qualification or advice gained from 
observation that does not fit within 




Experience only as a 
manager or 
commissioner 
No personal experience of actually 
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6.1.3.2 Manager feelings towards RVT 
 
With reference to manager responses in Topic Area Coded ‘b’, the topic area 
of feelings towards RVT was discussed by all manager participants (Table 
6.3). One of the participants, (M5), expressed strongly negative feelings 
towards RVT, specifically referencing TF3, the expected benefits and 
outcomes were not being realised. They recognised that RVT was useful in 
certain aspects but was not maximising opportunity. Two manager 
participants expressed neutral feelings towards RVT, one of whom was 
indecisive but also expressed positive views, so the only truly neutral manager 
participant articulated that whilst patients did express benefit there were still 
many clinicians who were sceptics alongside those who were champions. 
However, six managers expressed generally positive feelings towards RVT. 
The majority were moderately positive with the strongest affirmation being that  
“… it is the only show in town… pressures are significant, and we need 
to start understanding how to use data…technology is about giving us 
data…in terms of decision making “(M8).   
Of interest, M3’s positivity was contextualised within a concept of RVT, “… a 
patient collecting information and having a mechanism to share with health 
and care” and so framed RVT within a patient sharing data model (an action) 
rather than a fixed specific technological solution (hardware & software). 
 
Table 6.3 Manager responses in topic area coded ‘b’, to express their 
general overarching feelings towards RVT. 
Name Description Files References 
M b Feelings towards 
RVT 
Where the participant expressed 





Feel Negative  
1 1 
Feel Neutral  
2 2 
Feel Positive  
6 8 
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6.1.3.3 Manager opinions of RVT 
 
With reference to manager responses in Topic Area Coded ‘c’, the topic area 
of opinion expressed about RTNI was that, the RVT provided by TF3 did not 
include consideration of the U-Tell RVT solution (Table 6.4). All managers 
expressed opinions within this node with 84 references made. For 
interpretation and understanding there were 12 sub-nodes that grouped key 
opinions together for more detailed and focused analysis. 
Seven of manager participants articulated what the ‘Commissioners get 
wrong’, defining the sub-node in terms of mistakes made by them or the 
process; there were 27 such comments from most managers. The problems 
revolve around the Contracting/ Commissioning authority. They indicated that 
the TF3 contract had too many restrictions, was slow and change was 
extremely difficult to enable. The fitness for purpose of the contract was 
questioned and whilst it might have been considered good at the outset by 
June 2016, one manager said that it was no longer fit for purpose at the time 
of interview (June 2016). A sentiment echoed by M4 where the belief now was 
that an end-to-end service was not necessarily required by all as it was too 
restrictive of innovation and ‘lighter-touch’ solutions. They continued 
expressing that it also led to ‘finger pointing’ between the consortium partners 
when problems arose. Four managers thought that not only were analytics 
enabled or exploited to demonstrate service use, value and clinical interaction 
between patient and therapist but that the evaluation of the TF3 service should 
have been considered and built into the contract from inception instead of 
being an afterthought towards the end of the contract. An example of direct 
contract failure where the omission of evaluation was noted was with regard 
to the length of time practitioners were instructed to prescribe the TF3 RVT 
for, as one manager explained;  
“…What benefits the patient and that’s where the evaluation becomes 
really, really important because having an arbitrary cut-off date, for 
example, with no measure of effect… no definition of what a 
measurable effect is, how does that actually show value in anything?” 
(M8).  
A recurrent theme was the failure of real and meaningful engagement with 
stakeholders so that a gap existed between the strategic vision and 
Chapter 6: Analysis of Manager Data 
Julie-Ann Walkden - July 2020   255 
operationalisation leading to a lack of foresight and understanding. To 
compound that, M7 spoke about the double-edged sword that was associated 
with ‘ring-fenced money’. The benefit being that the service funds are 
protected whilst on the other hand; the Trust’s management do not really have 
the motivation or ability to mainstream the service. From a senior level, there 
was criticism of the commissioning and a clear articulation as to how 
leadership was required to act clinically, financially and strategically. 
The second most discussed opinion from the matrix of participants raising the 
topic was the sub-node of managers’ negative comments about the kit where 
six managers expressed negative opinions about the RVT equipment. They 
felt that the TF3 devices/ technologies were not state-of-the-art and that the 
technologies had not really changed over a decade. They described service 
limitations where patients were shoehorned into set packages rather than 
having peripheral devices that would fully support their needs i.e. enable the 
right vital sign metrics to be recorded based upon particular need rather than 
a ‘one-size-fits-all’ approach.  
Others were more positive comments about kit. For example, one manager 
felt the accreditation, calibration, standardisation and general quality control 
was superior in a regional RVT service, whereas others expressed a view that 
a wider variety of ‘bring-your-own’ peripherals should be utilised and be 
patient specific. One manager (M6) spoke at length about the need to enable 
patients managing their weight gain or weight loss to do so with their own 
home scales. The lack of accurate calibration was not always seen as 
important as the key was a recorded difference (reduction) in weight. Such a 
change would have enabled a scalable difference to a weight management 
programme as the digital, Bluetooth calibrated scales within the TF3 service 
were one of the more expensive pieces of equipment and yet have only been 
utilised by the patient once a week to transmit data. 
Five of the managers sought more clinical engagement in service design. 
They repeatedly said that clinicians were not engaged or involved enough in 
the design of the end-to-end managed service. Linked to this node was the 
node considering clinical engagement with service design and specification. 
The manager’s view is that (some) clinicians were engaged and were involved 
in the design of the managed service. Three managers mentioned this positive 
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engagement five times with only one manager participant making both 
positive and negative comments relating to the level of clinical involvement 
during the creation of the regional RVT service, the RTNI, which was supplied 
by TF3. Most of managers expressed the importance of clinical involvement 
and buy-in from the outset of RVT service design. The importance of 
“meaningful partnership” (M8) with clinicians was emphasised and whilst 
there was an engagement with a broad base of clinicians there was the view 
that more stakeholder engagement was required within the “…implementation 
of any significant change … clarity of vision from the outset …about having 
change champions” (M7). 
Within this node the manager participants also passed comments on the 
functional issues of the service and technical specification including tender 
process, quality of TF3 service with some critical statements, “…solution that 
was actually procured was the wrong solution” (M8) and “…we have procured 
it this time round, it is a bit of a size 9 shoe, everyone has to wear it….to some 
extent it is successful but it is still clunky” (M1). Two managers commented 
on the referral form. Both said that the referral form was too long (16-pages) 
that the lack of auto-population was problematic, and they appreciated the 
level of difficulty experienced by the practitioners. 
In summary, the managers had considered a broad range of factors when 
expressing opinions of the RVT. The managers were balanced understanding 
the commissioning and service issues that should have been addressed as 
well as a desire to support practitioners to become involved. It was a 
disappointment to the managers that there had not been more clinical 
engagement both in service design and the deployment. 
Table 6.4 Manager responses in topic area coded ‘c’, to express their 
wide-ranging opinions of the regional RVT service deployed in SET. 
Name Description Files References 
M c Opinion 
expressed RTNI 
Opinion expressed by manager or 
commissioner practitioner about the 
Regionally Procured Service and 
the comments could include 
reflections regarding any area from 
commissioning process to RTNI; 
from process of service design and 
procurement to end service 
8 84 
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Sub-Nodes  
  
Clinicians involved in 
service design 
Managers view is that clinicians 
engaged and were involved in the 





Views of managers regarding the 




comments about kit 
Managers had negative thoughts 
about kit utilised in RVT 
6 7 
Managers positive 
comments about kit 
Positive comments about 
technologies deployed 
4 5 
Managers view of 
Referral Form 




service design was 
required 
Managers view is that clinicians 
were not engaged or involved 
enough in the design of the end-to-
end managed service 
5 12 
Patient service user 
involvement in design 
of service 
Managers view is that clinicians 
engaged and were involved in the 
design of the end-to-end managed 
service 
1 3 
RVT Purpose How the manager describes their 
role/ objective in or the original 
purpose of RVT 
1 4 
RVT TF3 better Managers views that the service 
was better than hoped for 
3 4 
RVT TF3 service 
poor 
Managers views that the service 
was not what would have hoped for 
3 6 
Tech specification for 
contract 
During the specification process to 
prepare for the call for tender, there 
was effort put into specifying 





Upon reflection, issues managers 
pointed out as mistakes made by 




Critical Appraisal of Remote Vital-Sign Telemonitoring 
258  Julie-Ann Walkden - July 2020 
6.1.3.4 Manager opinions of models of RVT 
 
With reference to manager responses in Topic Area Coded ‘d’, the topic area 
is opinion of the models of RVT (Table 6.5). Seven managers discussed the 
two major types of service model as provided by TF3 with six discussing triage 
and four track and trend. Track and trend was likened to simply taking 
readings at the bedside enabling the clinician to make decisions with the 
patient about their care. It was thought to be the highest volume of activity and 
evolved to be a very low invention service whereby the originally planned role 
of the Service Provider, TF3, to intervene if a reading was missed was 
dropped as it was believed to be “too heavy handed” (M2) in practice.  
One respondent (M8) suggested that the approach to remote monitoring 
should not be “mutually exclusive but they really should be designed in and 
around the patient”. The general debate amongst six other manager 
participants agreed the general definition or intention of the triage service with 
the key feature being that the Trust’s specialist practitioner would set the 
parameters for the patient; if they subsequently uploaded a reading outside 
then an alert would be raised with the first responder being the supplier’s 
triage nurse. One manager observed that the interventional element of triage, 
the triage nurse contact was provided “…by a 3rd sector party rather than 
through the Health Sector” (M5) which further raised a concern about an 
intervention from a general nurse rather than a specialist practitioner where 
patients were generally managed by specialist practitioners. It was suggested 
that triage was appropriate for a narrower range of patients and with another 
manager (M4) contributing with thoughts about data analysis within triage that 
were not considered i.e. patterns of alerting. Another manager equally queried 
understanding of the value triage brought,  
“…because we know that many patients’ readings are in excess of 
their parameters each day, but we know that only a fraction of those 
are escalated to healthcare professionals.” (M1). 
The strongest opinion expressed by a non-clinically trained senior manager 
who blamed clinicians for alerts. 
“…trouble initially with the triage because parameters had to be set, 
clinicians would put patients on, set parameters and leave them on 
forever and a day then complain because they were constantly getting 
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alerts and I think there is a question out there as to whose fault is that 
and ultimately it would be the fault of the clinician who didn’t go back 
and view the patient and see are these true alerts or are the 
parameters not appropriate for this patient?” (M2) 
However, this statement may demonstrate the manager’s understanding of 
the mechanistic steps a practitioner may undertake in placing a patient onto 
a regime of care inculcating RVT as a modality rather than the knowledge and 
skills of a practitioner in the decision making to prescribe and planning of care.  
Table 6.5 Manager responses in topic area coded ‘d’, to express their 
opinions of the models of RVT delivered. 
Name Description Files References 
M d Opinion of 
models of RVT 
Opinion expressed by manager or 
commissioner practitioner about the 
models of RVT, that is the two main types 
of provision triage or track and trend. 








Managers will not have had direct use of 





Managers will not have had direct use of 
triage but will have a view on the solution 
6 15 
 
6.1.3.5 Manager opinion on training 
 
All managers shared opinions in Topic Area Coded ‘e’, the topic area is 
training in relation to RVT (Table 6.6). One manager reported that there was 
currently no awareness being raised at the undergraduate stage of nurse 
training and that the Trust had wanted to pursue this. None of the managers 
reported having ever been trained in RVT. It was felt that training in the system 
was not appropriate as they undertook more strategic roles. Albeit the most 
senior officer within the Health and Social Care Board attended the TF3 site 
to observe proceedings and visited patients utilising the service in their own 
home. Attendance at awareness sessions, through contract negotiations, site 
Critical Appraisal of Remote Vital-Sign Telemonitoring 
260  Julie-Ann Walkden - July 2020 
visits across the EU and England and regional service meetings M3 believed 
were sufficient in terms of the level of operational understanding required. 
Indeed, at the outset the most senior officer in the Public Health Agency 
visited sites in the USA. One manager reported that they had been directly 
involved in the design and development of a U-Tell research project and so in 
organising training and setting protocol ensured that they were personally well 
versed in the U-Tell approach to RVT but not with the TF3 service. 
Table 6.6 Manager responses in topic area coded ‘e’, to explain the 
participant’s experience or opinion of RVT training and education. 
Name Description Files References 
M e Training This describes the RVT training 







Manager received awareness 
training 
3 4 
Managers view is that 
more training is or was 
required 
The overall reflections regarding 
training are that more should have 




Manager did not receive training 
7 11 
 
6.1.3.6 Manager’s opinion of encouragement of practitioners to use RVT 
 
With reference to manager responses in Topic Area Coded ‘f’, the topic area 
is the encouragement of clinicians to utilise the RVT service; comments were 
only in relation to the regional TF3 service (Table 6.7). Most managers (N=7), 
spoke about performance management and quotas. Both Provider and 
Commissioning organisations in the Health and Social Care sector have a 
responsibility to report performance to the DoH. A theme throughout was 
summarised by one respondent,  
“…engagement of health and social care professionals is much more 
important than target setting for them. So, target setting in its own right 
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may be part of a range of engagement measures but will not be a 
solution in itself” (M3).   
Another manager practitioner did echo this sentiment but then also 
contradicted themselves by remarking, “…think managing practitioners by 
quota is really an effective way of going” (M1). One manager (who was the 
architect of the RVT TF3 performance management and quota system) 
confirmed that the clinicians should be “free to use it, in an ideal world would 
use it because it was part of the normal care pathway” (M2) Another reinforced 
a view of patient centeredness as what the patients actually needed; likening 
the prescription of technology to pharmaceutical prescription, “…you’d 
prescribe the drug that was fit for purpose” (M8). 
One manager participant shared that consideration of performance 
management and quota had been part of the managerial planning process 
and that they had recommended an outcome-based approach (M4). They 
explained the possibility of building perverse incentives into the system, 
recognising a disincentive to refer new patients as to have a currency of length 
of time on the system as it could lead clinicians to simply prescribe long 
durations of RVT and fail to review and take the patient off the service. 
Whereas a more clinically linked outcome focused metric would have been 
purpose driven; “… it would have been a lot more challenging to try and 
deploy… so in the end we opted for the target we did” (M4). The perverse 
incentives were eluded to as “a degree of sophistication” being needed in 
target-setting or else there is a risk of “…unintended consequences” (M7).   
 
Table 6.7 Manager responses in topic area coded ‘f’, to show the 
opinions expressed regarding the encouragement of practitioners to 
engage in particular the use of performance targets. 
Name Description Files References 
M f Staff Engagement 
target 
This considers staff engagement from 
the perspectives of clinical freedom 
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Encouraged 
engagement 
Encouraged engagement as a 
manager rather than mandating 
targets 
4 5 
Set performance targets Either planned or instructed with 




6.1.3.7 Manager perception of value for money 
 
Whilst this thesis is not concerned about the health economics associated 
with RVT all managers discussed the concept of value for money and the 
quantitizing of the narrative associated with value for money is Topic Area 
Coded ‘g’ (Table 6.8). All managers described VFM as useful. Two managers 
comfortably explained that they did not objectively know if RVT worked, 
specifically speaking within the context of the regional TF3 service; both 
managers were senior Trust based managers. The opinion shared was that 
this was a problem with the RVT regional TF3 service as there had been 
repeated calls at the Regional Project Board for such an evaluation 
particularly regarding the review of the TF3 service that had been 
commissioned where,  
“I think it would be fair to say disappointment with the information that 
was forthcoming as a result of that…quantifiable quantitative 
particularly monetary benefits of the use of RTM” (M7).  
A further hidden dimension articulated (by M8) was that the job plans of Trust 
practitioners were not adjusted to accommodate the implementation and 
adoption of RVT with their work associated with RVT not being credited; that 
is their work did not change, more was added and so no determination of 
maximising benefit of RVT could be assessed. 
Three managers shared a view that the TF3 RVT was not value for money. 
However, one of whom had also expressed a view of not knowing if RVT 
worked, did so to explain that RVT had many opponents who believe it is an 
“inordinate waste of money that could be spent in better ways” (M7) 
recommending this be countered by better explanations of what RVT is and 
what it can deliver. A clinically trained Trust manager explained their rationale 
for not believing it represented value for money. The manager understood the 
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peripheral device was expensive simply to upload a single reading once a 
week and so a cheaper alternative to the TF3 type of RVT was possible. 
Therefore, their assessment was based upon a narrow service offering.  One 
manager believed RVT was poor value for money service from the wider 
literature, referencing the economic reviews of the English Whole System 
Demonstrator projects;  
“… research promoted by the UK which reached the conclusion that 
on balance it did not represent good value for money as the 
conventional mechanisms of interaction” (M3) (cross reference 
Literature Review Chapter, Sanders et al. (2012)).  
Managers demonstrated uncertainty with regard to value for money as 
although they all recorded in the overarching nodal topic comments. Half 
thought RVT was good value for money. The managers from the Trust who 
believed so explained that there were fewer domiciliary visits by staff and that 
if the service was “used in the right way” (M7) continued with an anecdote of 
service users getting benefit from RVT and “…there may be an inherent merit 
in that in itself, is that true value for money?” (M7). The two commissioning 
managers who expressed an opinion that RVT was good value for money 
justified their stance by explaining that a day of RVT per patient may only be 
a small amount of money and certainly a lot less than a day as an in-patient 
so on that basis it was considered good value for money. However, there was 
less certainty when the manager questioned themselves; the conundrum the 
manager posed during their interview was that for £1.5 to £2million of 
investment had the same value of benefit been derived and they answered 
themselves  
“I am not sure that we can confidently say that we achieved value for 
money at aggregate level but I think at a unit by unit basis it still has 
the potential to deliver value for money” (M1).  
In summary, there was a hope that in future if RVT was integrated into care 
then as part of a package of care it would contribute and represent a 
perceived, if not actual, value for money. 
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Table 6.8 Manager responses in topic area coded ‘g’, to illustrate the 
perceived value for money of RVT. 
Name Description Files References 
M g Value for Money This considers aspects of value 
for money and the perceptions 
and knowledge expressed by 





Don’t know if Value for 
Money 
The manager does not know if the 
RVT is value for money 
5 7 
No not Value for 
Money 
The manager believes the RVT is 
not value for money 
3 3 
Yes Value For Money The manager believes the RVT is 
value for money 
4 5 
 
6.1.3.8 Manager opinion of benefit or outcome 
 
With reference to manager responses in Topic Area Coded ‘h’, it can be seen 
all the manager participants considered the aspect of outcome and or benefit 
of the service (Table 6.9). Participants expressed their thoughts across three 
sub-nodal topics with one considering hospital utilisation, directly suggesting 
that hospital admissions were reduced as a result of RVT.  Most managers 
discussed their thoughts about strategic system integration and the realisation 
of benefits that RVT.  
The theme within the concept of benefit realisation within an integrated system 
was that the managers said they lacked evidence of effect and lacked data to 
analyse. There was recognition of RVT being a complex intervention and 
therefore, it was likely to take longer to realise benefits whereas the funding 
and performance mechanisms within the health and social care system 
demanded a greater emphasis upon short-term gains. Of note ‘The Way to a 
Healthier Pregnancy Programme’ was an example of an RVT project service 
response from TF3 which was lighter-touch than their other disease group 
packages and was time limited had not been evaluated for evidence of 
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success or benefit. There was narrative anchoring the RVT benefit realisation 
into a framework which included the metric of citizen benefit whereby the 
system, in this example RVT, would help the patient maximise their well-
being; albeit mainly aspirational. One tangible example of titration of 
medication to help control blood pressure post stroke was described but the 
associated system of permissions to change and implement dose 
adjustments between the hospital and GP remained a barrier to full-service 
efficiency.   
There were theoretical or philosophical benefits proffered including the idea 
that RVT could be more effectively used as a preventative tool or that it could 
assist with the  
“…inexorable increase in demand …curbing the steepness of the 
trajectory upwards as oppose to causing a downward trend in demand 
and pressure” (M7).  
The concept of understanding better the effect for patients including the 
possibility of feeling safer as they have a seven-day rather than a five-day-a-
week service or are being monitored 24/7. 
(As part of the benefit and outcome section) there was the sub-node of the 
manager’s view of patient and service user empowerment with a meaning of 
patients having overall benefitted and as a result been empowered for self-
care and being better informed assigned; most participants (N=6) spoke about 
this conceptual area of RVT (a total of 17 times). They all shared a common 
view that RVT enabled patient self-management, care and empowerment. 
The language of the managers was very much perception and conceptually 
based rather than key facts and none actually utilised the terms of ‘patient-
centred’ or ‘empowered’ and so proxy indicators such as ‘self-management’ 
and ‘maintain their independence’ were utilised as an indicator in order to 
assign narrative to the sub-node.  
One participant discussed at length empowerment and noted that the 
researchers had so far been unable to evaluate that aspect of the service 
which was, “…attributed to the people conducting the evaluation, …running 
out of time to be able to recruit the necessary numbers”  (M4) She continued, 
articulating that this single factor was important and had been missed and 
suggested that people went from a position pre-RVT to one where they better 
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understood their condition, collect data on a daily basis, self-managing, make 
decisions themselves or with carers, change behaviours, lifestyles, 
medication and in general better self-care. M5 equally articulated how this 
opportunity had been missed from the beginning. However, as M4 observed 
at the beginning of the TF3 RTNI project patients did not generally have 
technologies which could assist, “…concept of people using technology to 
look after themselves was such a far-fetched idea”. Whereas, M6 pointed out 
that patients just needed to feel supported and so were better able to take 
control of weight management by sharing information with professionals and 
described patient self-management as a “big societal thing”. Even the concept 
of RVT providing a “comfort blanket” was attributed with merit by M8, whilst 
also reminding the researcher that the RVT programme should be outcome 
focused. 
 
Table 6.9 Manager responses in topic area coded ‘h’, to illustrate the 
perceived or actual outcome or benefit derived from the use of RVT. 
Name Description Files References 
M h Outcome and 
Benefit 
This considers the aspect of 
outcome or benefits of the service 
expressed by manager or 
commissioner practitioner, whether 






within an integrated 
system 
Where managers think strategically 
about system integration and the 
realisation of benefits that RVT have 
contributed to 
7 16 
Managers view of 
Patient and service 
user empowerment 
Manager has a view that the patients 
have overall benefitted and as a 
result been empowered for self-care 
and being better informed 
6 17 
Utilisation of Hospital 
services 
Managers had an opinion on the 
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6.1.3.9 Manager opinion of clinical issues 
 
With reference to manager responses in Topic Area Coded ‘i’, the topic area 
of clinical services issues was discussed by all managers, with 110 
statements coded to the node (Table 6.10). The node was divided into seven 
sub-nodes with the highest-ranking sub-node, containing narrative from all 
manager respondents with 34 statements coded, labelled as ‘change or 
changed clinical practice’.  The sub-node encapsulated the thoughts of 
managers regarding how they may consider the way practitioners have or 
could change when RVT is utilised as part of a pathway of care. 
Five participants spoke from a philosophical stance, articulating the sub-
utopian world of effective healthcare delivered with the integration of 
technology. They spoke of needing leadership to ensure the critical mass of 
practitioners and services utilised RVT in a meaningful way. The vision of 
integrated healthcare, services and clinicians across the region could utilise 
RVT as the increasingly scarce resources and demographic pressure begins 
to take hold. The concepts of ownership, buy-in and “realisation of efficiencies 
and improvements associated with using technologies” (M3) were shared. 
Four participants spoke of resistance and cynicism within the clinical staff 
groupings.  
“I get frustrated with the fact that some people don’t appear to want to 
try and improve their patient’s lives and that is what RTM essentially 
offers us, within the right mode.” (M8).  
Three spoke about tangible examples whereby clinical practice had changed 
but one participant reported an example which illustrated a success and a 
failure of an RVT COPD service simply because of staff attitudes (M2). 
Another spoke about how significant improvements in clinical practice had 
been achieved but felt that such behaviour changes needed to be forged 
ahead with Allied Health Professionals (AHPs) in general as in some clinical 
areas there had been a greater emphasis upon opportunities for nurses (M6). 
One manager shared personal experience of RVT changing practice but felt 
that a lack of leadership from the management hierarchy prevented real 
change (M8). The emphasis upon regional leadership was summarised by 
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one who stated that “we need the Commissioners to show the 
leadership…drive the changes” (M5). 
The second most cited area of comments coded to a node within the clinical 
services issues was, clinical feedback, with seven manager participants 
making a total of 28 statements that were coded to the node. However, this 
section in general was an expression of feelings, twice clearly articulated as 
frustration, towards an inability to attain positive clinical engagement for RVT. 
One Manger participant took a positive stance with regard to nurse 
involvement but articulated a broader reluctance of General Practitioners. A 
view of GPs that was also reflected by a further two managers with one 
articulating that some GPs “portraying it as additional work …seeking 
recompense” (M7). The theme of ‘extra work’ for clinicians, regardless of 
profession was described by four of manager practitioners with one explaining 
at length that for a real change in models of care to shift, busy clinicians 
needed to be given protected time and space to think through the service 
changes to make it happen. One was concerned that it “didn’t matter how 
much evidence you gave them” (M2) there was still a lack of engagement and 
explained that clinicians were unable to describe benefit of triage beyond 
liking the fact “someone else was looking at the reading” (M2). This manager 
felt unable to satisfy the demands of clinicians. When they tried, and another 
problem arose it was ‘proof’ to clinicians that the TF3 service was unsafe. He 
took the most negative stance with regard to the practitioners whereas the 
remaining six manager participants held some prospect for RVT and clinical 
feedback and engagement. 
The theme continued in a specific sub-node examining clinical staff’s 
resistance to engage with technology. Five managers spoke to this topic with 
16 comments being captured. However, only one offered new insight into the 
issue of resistance to change and inculcate technology into practice. The 
currency of TF3 contract performance management at Trust level was cited 
(by M8) as an example of a service dimension causing barriers. The Trusts, 
ergo the practitioners, were performance managed through monthly tallies of 
patients utilising the TF3 service and it was observed that the number of 
patients 
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“I have on RTM (remote telemonitoring) is not a measure of 
performance, it’s a measure of the number of patients I have on it, 
that’s it and you will face resistance at every point if you cannot show 
benefit”. (M8). 
This participant also articulated issues of silo working, protectionism and 
‘territorial paternalism’ and the TF3 RVT implementation failed to address 
these (M8). 
Two participants, who had clinical backgrounds, articulated high level issues 
vis-à-vis the identification of patients which revolved around ensuring the 
patient received the highest standards of tailored care. Linked to this was that 
staff required an infrastructure to support them in their new roles associated 
with the review of data. 
Two participants spoke at length about the role of RVT within the context of 
Primary care; their data fundamentally pointed out the disappointing lack of 
GP engagement in the regional TF3 service.  The degree of GP cynicism was 
again highlighted and the recognition that there are opportunities for GPs to 
work in a different way to enable their care of their patients to be more effective 
comparing possible current practice of a review every three weeks with a 
possible vital sign daily monitoring opportunity to provide a different and more 
meaningful picture of health. Equally, the different models of care between 
Primary and Secondary care were noted but that these should not prevent the 
use of RVT within a Primary Care environment. 
Interestingly, six participants reflected upon the importance of service user 
feedback and all pointed out that patients were positive about RVT. One 
remarked that the voices of patients really needed to be harnessed (M4) and 
another hypothesised that patients would say that the service was value for 
money due to their positive experiences (M7). 
Seven (of the eight) participants articulated many (26) issues regarding 
research within RVT, the majority of which coalesced around the need for 
more research as there were just too many unknowns. There was a hope that 
research could prove RVT was worthwhile and encourage clinicians to 
engage. One reported that whilst the RVT TF3 service in Northern Ireland, 
was successful and  
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“within Europe and in some extent globally, did establish a leadership 
position, people referenced us as a place where we were actually 
doing something” (M1).  
There was a “lack of insight” (M1) with regard to consensus, the effect of 
triage, benefits and evaluation. One participant wanted there to be an 
evaluation which gathered information to demonstrate that RVT ‘worked’ but 
did not define what a ‘worked’ metric might have looked like. Whilst another 
took a view of success was being “…measure the ability of the patient to self-
manage which was key”, M4 continuing to complain that the commissioned 
evaluation had failed to consider and measure this metric as second 
participant was equally critical of the output of this study. There was a 
consensus that the lack of evidence to support the application of RVT, lack of 
clinical engagement or co-creation activities and perceived additional burden 
of workload, drove cynicism and disengagement. Within this context, linked to 
inconclusive evaluations of projects in England, one asked if RVT was 
“…actually having an impact on efficiency and sustainability of health and care 
systems?” (M5). Two manager participants were highly critical of an 
evaluation of the TF3 service having been considered towards the end of the 
contract rather than having had a robust evaluation planned and contracted 
for from the outset.  
In summary, meaningful evaluation and understanding of RVT was deemed 
essential to ensure the right service was being delivered and that practitioners 
could undertake evidence-based practice. 
Table 6.10 Manager responses in topic area coded ‘i’, which examines 
the clinical service issues as observed or perceived by the respondent. 
Name Description Files References 
M i Clinical 
Service Issues 
This considers any Clinical service 
issues beyond those documented within 
the node MP c Opinion expressed RTNI. 
It is more focused upon views, or 
perceived views (if made by a manager) 
of practitioners, service users, the 
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resistant to RVT 
Some clinicians are reluctant to engage 
with the technology 
5 16 
Primary Care 
The engagement of GPs within Primary 
Care 
2 6 








Opinions of practitioners in general 
7 28 
 
6.1.3.10 Manager opinion of the future of RVT 
 
With reference to manager responses in Topic Area Coded ‘j’, the topic area 
of the future of RVT the next generation is the second largest nodal topic area 
of the data collected from manager participants with all participants making 
reference to this topic area a total of 74 times (Table 6.11). Managers, with 
little variation, described a service that would be more data driven and were 
technology agnostic about how or what should be used to deliver a service. 
The managers highlighted that learning had most certainly occurred over the 
course of RVT, but the consensus was that a more strategic approach to 
planning the future provision was required; M7 suggested that the Bengoa 
report (2016) should be reviewed to see if RVT was recommended and that 
“… improvement science methodology” be applied to RVT. Albeit, the 
contradictory position was also suggested by one with the suggestion that 
RVT should be normalised (M2). There was equally a debate between the 
manager participants regarding the role of triage service with a view 
expressed that it was required for those patients with heart failure or COPD 
and others minded that a ‘lighter touch’ was required. Opposing positions 
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were also observed with regard to an end-to-end service offering the 
reassurance of calibrated and maintained equipment being the responsibility 
of one supplier versus the opportunity patients may have regarding self-
purchase of small items of technology e.g. pulse oximeters and blood 
pressure cuffs. M1 articulated the changes ahead, “… massive technological 
change in digital, the internet of things, the digitisation of everyday devices in 
people’s homes…analyse data.” Consideration of data analytics was a theme 
throughout particularly in relation to the long-term support of the patient’s 
interaction with health and social care.  
In general, the manager participant’s view of the future appeared to be the 
development of and planning for a revised strategy for the application of 
technology per se, rather than a pragmatic view of actually improving care for 
the population. Whilst most managers discussion revolved around the 
experiences of contracting for a regional service, three mentioned technology 
enabling self-care in the future with one of those stating,  
“…the right data to make the right decision, at the right time for the 
patient or empower the patient to make decisions for themselves” 
(M7).  
It is suggested that the generalised abstract nature of responses could be 
related to the fact that five manager respondents did not have a formal clinical 
qualification. Strategic fit into the mixed economy of health and social care 
was not well understood and four manager participants expressly articulated 
the need for service responses to be being powered by a lower level of 
complexity, TF3 
 “…model has relatively high overhead per patient and models like U-
Tell and others I think illustrate how we might go in future” (M3).  
However, there were common practical themes shared by the managers when 
they shared their thoughts and feelings within the context of the future for 
technology, particularly in relation to RVT. Thinking about the future was 
popular with the respondents with many ideas being shared. Across the 
narrative recorded under this node there were ten common predictions 
apparent within the data having been shared by the managers and these have 
been distilled as follows, considering the future of technology:  
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1. As patients age, they will expect and demand their smart phones to be 
used in their care. 
2. The Electronic Patient Record should include RVT information.   
3. There should be automatic uploading of data, in the background, e.g. sleep 
pattern data. 
4. Technologies communicate lifestyle and smart home data e.g. nutritional 
intake. 
5. Patient portals with health promotion and lifestyle information, including 
authentication of patients to sign themselves onto and out of monitoring. 
6. Accurate peripheral devices where calibration and servicing are 
maintained for the top 4% cases e.g. heart failure and COPD and enable 
low value patient purchased peripherals. 
7. Text and email messaging from practitioner to patient, including the facility 
for patients to upload photographs of what they have eaten for nutritional 
value to be determined.  
8. Video virtual ward rounds. 
9. Routine collection of data with wearable or ingestible devices to transmit 
data. 
10. Wider technology adoption and normalisation of RVT.  
The manager participants suggested that better utilisation of data through 
data analytics would be part of healthcare for the future. The managers were 
optimistic for future technology utilisation within health care.  
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Table 6.11 Manager responses in topic area coded ‘j’, to enable the 
articulation of the perceived vision for the future of RVT in Northern 
Ireland. 
Name Description Files References 
M  j Future of RVT 
the next 
generation 
Considers all aspects for the future of 
RVT, looks forward to the future or 
articulates what next for RVT in 
Northern Ireland, including policy, 
equipment, models and engagement 
regardless of a pessimistic or 







Managers view of user engagement 
from using a range of media to share 






Through the TF3 contract experience 
has demonstrated a need to have 








Managers have a view as to what 
future service provision should be 
like 
8 41 
NIECR Managers have an opinion that 
systems should be connected and 




It was possible to elicit valuable insight in one-to-one conversations with 
senior managers regarding RVT in Northern Ireland. It was assessed that 
there were 15 eligible senior managers/ commissioners who were eligible to 
participate in the research and eight agreed, a participation rate of 53%. The 
participants were from a range of backgrounds with only three having nursing 
or AHP backgrounds, the five non-clinical managers included a career civil 
servant, Information Technology and business management qualifications. 
The researcher analysed the data and created ten overarching topic themes, 
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nodes, and sub-nodes. Managers expressed generally positive feelings 
towards RVT albeit none had practical day-to-day experience of RVT. Their 
experience was at a high-level overview with the perspective of those who 
had specified, designed, commissioned and then monitored RVT solutions. 
There was a general concern and frustration expressed by a lack of clinical 
leadership and involvement particularly from primary care. However, the 
managers were not deterred and expressed how they thought technology 
should be inculcated into care in the future noting that the current tech-savvy 
middle-aged people will demand technology in their later years, better 
utilisation of data, electronic patient records with patient portals, technology 
which are integrated into life being unobtrusive and reliable and basic 
messaging between clinician and patient. N=6 managers articulated many 
elements which can be understood to indicate empowerment of patients in 
terms such as, better self-management and care, patient better supported and 
more patient-centred care. 
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7 CONCURRENT 
TRIANGULATION OF DATA 
7.1 Sources of Data 
7.1.1 Review of Methodology: 
 
The methodology of mixed methods including concurrent analysis of data was 
undertaken. Regardless of nature of the data or method of capture, the 
qualitative and the quantitative data, was given equal value and data 
compared for significance and understanding (Chapter 3, section 3.16). There 
were six streams of data collected from participants. All types of participants 
offered qualitative comment but only the patient and carer participants 
provided quantitative data (Table 7.1). 
Table 7.1 To illustrate the summary data streams for analysis. 
Participants Qualitative Quantitative 
Patients x x 
Carers x x 
Practitioners x - 
Managers x - 
 
7.2 Triangulation of findings of both qualitative and 
quantitative data 
 
The initial step in analysis was to compare the qualitative data derived from 
the participants, looking for both divergence and convergence of opinion. Of 
note, there was disproportionately more qualitative data from the clinical 
practitioners and managers than the patients and carers. In order to ensure a 
systematic approach, the concurrent analysis of the data followed the 
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structure established within the (NVivo) analysis, which followed the nodes 
topics ‘a’ to ‘j’. In addition, the findings of the patient and carer data were 
combined with the qualitative data with contradictions and corroboration 
described.  A high-level summary of the convergence and divergence found 
within the data for nodes ‘a’ to ‘i’ was recorded in Table 7.2. Only the three 
nodal topics ‘h’ outcome or benefit, ‘i’ clinical service issues and ‘j’ future of 
RVT were considered as contributing to resolving the research question. 
Refer to Appendix 10 for the detailed narrative comparison of all data sources 
by nodal topics ‘a’ to ‘g’. 
7.2.1  ‘h’, Perceived or actual outcome or benefit derived from the 
use of RVT 
 
Arguably a beneficial patient outcome is singularly the most important 
narrative to consider within the analysis of the patient and carer questionnaire 
data and the interview narrative conducted with both practitioner and manager 
participants. However, it was within this node that the difference in stance 
between manager and practitioner emerged but there was concordance 
between patients, carers and the practitioners. The manager’s experiences of 
RVT were from the perspective of an onlooker, strategic leader, a vested 
interest in making it work, given their role. They had a theoretical and contract 
management experience of working with TF3 and practitioners. Whereas, the 
practitioner grounded their responses as clinicians immersed in patient care, 
trial and error of utilisation of RVT and repeated experience rather than 
anecdote or theory. Equally, patients and carers expressed their direct 
experience and personal beneficial outcome associated with the use of RVT. 
The manager participants had a difficulty with articulating tangible benefits 
and outcomes as at the outset of the TF3 contract the only metrics being 
collected looked at the number of cases within particular charging bands 
which then indicated the referral and utilisation rates (not any outcomes). The 
aspirational outcomes of reducing demand for secondary care had not been 
evaluated fully and a retrospective review through a formally commissioned 
evaluation was beginning to report first findings at the time of the manager 
data collection phase and there were no indicators demonstrating success 
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against the aspirational metric. Albeit, the patient and carer data suggested 
that they felt they utilised secondary care services less than they did when 
just in receipt of usual care without RVT (Table 4.4). The manager participants 
reported their opinion of benefit for the citizen, service user and patient. These 
benefits were believed to revolve around the concept of RVT enabling patients 
to self-manage. Indeed, one manager spoke at length about state-of-the-art 
technology in 2008 when the first ideas of developing a regional RVT were 
articulated. Indeed, the emergence of patient participation in self-care and 
compliance, through the use of technology, was being discussed through 
anecdotal evidence, speculation (but not formal evaluation). It was significant 
that 75% of senior health and social care managers involved in the strategic 
delivery of the RVT service TF3 believed that RVT enabled patient 
empowerment through self-management, learning about own condition, 
independence, behaviour change, lifestyle, medication management and self-
care (Chapter 6). This view was convergent with data collected from patents 
and carers. However, whilst not formally evaluated, early in the drafting of the 
RTNI contract (cross reference Chapter 1 and Appendix 1) there was some 
consideration given to the idea and possibility of the patient being an active 
participant in care. Self-Management was defined within the RTNI contract. 
(RTNI Contract, File 1 of 4, p134, refer to Appendix 2). The data indicating 
that there was empowerment of patients, through the use of RVT in 
collaboration with their clinical practitioners, emerged through utilisation and 
was expressed during data collection and subsequent analysis. The patient 
voice clearly stated that RVT empowered across three variables, i) assisted 
them to manage their own care day to day basis, ii) managed their own 
condition and become more involved in their health care and iii) they were 
afforded peace of mind.  The realisation of such a possibility was articulated 
by the practitioners who illustrated a vibrant picture of direct patient benefit 
and outcome as a direct result of RVT; this is deemed to be a most significant 
finding as 97% of patients shared the practitioners’ view that RVT helped them 
manage their own condition. 
Essentially the managers had created an environment whereby practitioners 
could work with RVT; where managers had envisaged collecting data 
remotely, providing vital sign data to the practitioners would enable patients 
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to be monitored and cared for at home (rather than within secondary care 
environments). Beyond basic mechanics of system operation, the 
practitioners had not been trained in the utilisation of such remote technology, 
nor how to work with new levels of data. Therefore, relatively diverse 
professional groupings were able to use new technologies and to weave into 
practice without constraint beyond their usual professional roles of practice. 
Clinical deployment of RVT was not considered by practitioners to pose a risk 
for patients and so new experiences became embedded into practice. 
There were benefits articulated such as weight loss in obese pregnant 
women, reduction of ‘white coat hypertension’, reduced use of outpatients and 
suggestions of reduced hospital admission for some types of patients. 
Practitioners spoke of subtly changing their monitoring emphasis as patient’s 
conditions changed beyond the initial goals of optimisation of vital signs and 
early medication intervention as soon as early signs of exacerbation occurred 
through to medication and symptom control as they slipped into the palliative 
end stages. The single emergent benefit from RVT, as articulated by specialist 
practitioners, was empowerment with 100% of the U-Tell practitioner 
participants and 67% of the TF3 practitioner participants describing how their 
patients were empowered by RVT. 
The language of empowerment was both direct and indirect with the following 
terms utilised by practitioner participants, patient-centred, patient orientated, 
independence, self-management, control and individualised. Practitioner 
participants described their intention to optimise patient care through the 
utilisation of RVT which included the education of patients and their 
empowerment to maintain their own well-being through monitoring vital signs. 
Practitioners shared, how through a patient’s greater understanding of their 
condition and interpretation of their own vital sign readings, patients were not 
only educated but empowered to converse with their GPs from an informed 
base; patients became experts in their own conditions. Whilst the overall 
quality of life improved for patients empowered through RVT, the practitioner 
participants who had utilised U-Tell ably articulated seven key features of their 
care that put the patient in control of their care and lifestyle, which above all 
empowered through freedom (Chapter 5, 5.1.3.8). This in turn, afforded the 
carers freedom also from the constraints and burdens associated with 
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frequent out-patient attendances. These views were magnified by patients 
and carers where freedom, understanding, self-management and control 
being recurrent themes in both qualitative and quantitative data; a positive 
patient evaluation rating relating to peace of mind afforded by RVT was 
recorded (mean 3.72).  
In summary, both groups of staff participants recognised and articulated the 
new and unexpected phenomenon of empowerment through RVT. 
Empowerment emerged with the insightful observation that instead of the 
conditions controlling the patients; the patients could control their own lives. 
Freedoms, safety, assurance and a quality of life returned. This was 
exemplified by the patient’s and carer free text narrative. Contributors 
articulated a reduction of anxiety, freedom from the burden of their disease, 
being better able to manage their condition and the feelings of being in control. 
Freedom was also expressed practically as they were enabled to travel; 
highlighted as a feature by U-Tell service user responders. Patients and their 
carers particularly appreciated having access to someone to talk to; with such 
access reducing hospital admissions. The sense of peace of mind and a 
sense of safety were described. With the high mean rating (3.64), most 
patients (92 of 94 who rated the variable) expressed ‘peace of mind’ was 
afforded by RVT. Whilst one practitioner had articulated that in the beginning, 
they were reticent that a distance between herself and her patients may 
develop, not only discovered that did not happen, patients and carers in fact 
articulated a connectedness with the healthcare system, with help only being 
a phone call away. 
7.2.2 ‘i’, Examination of the clinical service issues as observed or 
perceived by the respondent 
 
The nodal section of clinical service issues was designed to broadly 
encapsulate clinical issues discussed by participants beyond their feelings 
towards RVT. It was a more focused node where tangible clinical issues were 
considered along with the formal evaluation of RVT services through research 
and evidence-based practice. The managers have a strategic overview of 
RVT and were removed from the direct service provision of RVT; they were 
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well versed in strategic deployment, service design, commissioning and 
contracting for RVT particularly in relation to the regional service provided by 
TF3. Therefore, the range and depth of topics, i.e. sub-nodes and sub-sub-
nodes was larger for the practitioner participants than for the manager 
participants with the ratio of 22:8. 
The manager participants were preoccupied with two overarching clinical 
issues. The first was a failure of the service to engage with clinicians; with 
GPs being cynical about RVT and expecting remuneration for their 
participation in the scheme. Secondly, the level of failure to engage was linked 
by the managers to an unwillingness to engage with a service model or 
technology for which there is very little evidence. Evidence based practice 
was a mantra cited by the managers and so the lack of formal evaluation 
caused concern. Some managers took the position that formal training should 
have been built into the programme from the outset (instead of being an 
afterthought). The commissioned evaluation of the TF3 contract undertaken 
by McElnay et.al (2016) was criticised by the managers, who suggested that 
there had been little engagement with clinicians utilising the service or patients 
in receipt of it. 
The practitioners gave a full and varied summary of a broad range of clinical 
service issues. Indeed, they spoke at length about which types of patients and 
conditions they would and would not prescribe RVT to. A summary of patient 
identification factors; in the absence of known referral criteria for RVT, should 
assist with future service implementation and design (see Table 5.12). Whilst 
the cynical behaviours of clinicians were cited by the managers as a service 
issue, anxiety behaviours of some patients were cited as a reason to exclude 
certain patients from RVT. Equally, whilst some managers believed that 
alerting patients was as a result of practitioners failing to engage and raise 
the alerting threshold for vital sign parameters, the practitioners undertook 
investigative clinical audit to discover the meaning of alerts. It was discovered 
that most alerts were triggered not because of the breaching of the vital sign 
parameter, but alerts to the psychosocial or well-being questions, and in fact 
some patients manipulated responses to trigger contact. However, 25% of 
practitioners agreed with 88% of manager participants that better research 
and evaluation was required in order to improve RVT service delivery. 
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The patients and carer respondents recorded narrative in free text. RVT was 
appreciated as technology being inculcated into their care packages affording 
an immediate service response. One patient hypothesised that RVT could 
allow staff to focus upon their most sick patients whilst having the oversight of 
those on the system. It was clear that the improved level of communication 
was appreciated as was a gratitude for having access to triage staff. The 
patient and carer qualitative data were interpreted to indicate that the service 
users appreciated the apparent immediate response and the perceived 
‘human’ contact RVT technology enabled. 
Table 7.2 To demonstrate notable convergence and divergence of 




Convergent Findings Divergent Findings 
‘a’, Experience of 
RVT 
 
No group had experienced 
training prior to the regional 
RVT project  






towards RVT  
 
All groups were generally 
positive with the user and 
practitioner groups reflecting a 
sense of patient centredness. 
Some practitioners shared 
concerns regarding a poor 
technology referral system and 
others of intrusion. Whereas, 
managers were discontent with 
the failure to deliver expected 
outcomes. 
‘c’, Wide-ranging 
opinions of RVT  
 
Both staff groups believed co-
creation and stakeholder 
engagement were essential. 
Both practitioners and users 
shared opinions on benefit 
and utility for patients and an 
increased use of technology 
in the future. 
Managers were observers of the 
outworking’s of a contract 
whereas practitioners and users 
had lived experiences. 
Managers complained that GPs 
were not engaged, and 
practitioners complained that 
managers made the final 
commissioning decisions. 
‘d’, Opinions of the 
models of RVT 
delivered 
 
There was consensus 
regarding the integration of 
triage nursing into the RVT 
model for particular LTCs. 
Managers complained about 
practitioners not adjusting 
parameters to prevent alerts 
whereas practitioners had a 
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strategy for application and an 
understanding of alerts at a 
clinical rather than mechanistic 
level. 
‘e’, The participants’ 
experience or 




Most users and practitioners 
appreciated a comprehensive 
training programme. 
A limited number of practitioners 
were disappointed with the 
training provided by TF3. 




engage, in particular 




Service users and 
practitioners recognised 
human benefits of RVT and 
described the improvement in 
quality of life as the motivator. 
Managers were performance 
management driven with key 
performance indicators being a 
key feature. Whereas, 
practitioners were aware of this 
and dismissed the manager’s 
attempts to attain contract 
targets.  
‘g’, Perceived value 
for money of RVT 
 
All participants were unaware 
if there was a real value for 
money with RVT albeit some 
users and a practitioner 
suggested it was but only in 
relation to quality of life 
outcomes. 
 
‘h’, Perceived or 
actual outcome or 
benefit derived from 
the use of RVT 
 
There was concordance 
between user and practitioner 
with a full range of patient 
centred benefits articulated. 
The direct patient benefits 
articulated by managers were 
fewer in number and more 
limited in range but were 
clearly articulated as enabling 
patient empowerment.  
There was concordance in 
that disbenefit, or harm were 
not described. 
The perspective of the 
manager’s was different from 
that of the practitioners which 
can be explained by role and 
distance from direct care. 
‘i’, Examination of 
the clinical service 
issues as observed 
Practitioners and patients 
recognised how RVT enabled 
early intervention and a 
The managers suggested that 
GPs were cynical describing 
frustration that there had been a 
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or perceived by the 
respondent 
 
targeted approach to contact 
and therapy. 
refusal to engage with 
technology or the service. 
Whereas, the practitioners 
explained at lengths the 
application of RVT and the types 
of patients with particular 
conditions could and did benefit. 
Indeed, one practitioner 
complained that managers had 
taken the service off them. 
 
7.2.3 ‘j’, Future of RVT  
 
This was the only topic area where patient and carer participants had 
qualitative narrative, beyond gratitude and peace of mind that could be directly 
compared with the qualitative narrative derived from clinical practitioner and 
manager participants. The contrast between the views of the future was 
interesting, demonstrating divergence between those articulated by 
practitioners, patients and carers and those articulated by managers. 
Moreover, patients and carers were receptive to the increased utilisation of 
technology, (mean carer rating of 3.66), whilst some carers were cautious 
about the use of internet-based solutions (the mean carer rating 3.41); 75% 
of patients welcomed the future use of the internet to report to their clinicians. 
The practitioners took a pragmatic approach to the application of technology 
articulating a message that from a practical perspective there was no other 
option but to utilise technologies in the support of patient care and patient 
empowered self-care. The managers adopted a more conservative approach 
where use of data was more universally promoted but that a strategic review 
and planning was higher up the agenda. The practitioners were clearly more 
purpose-driven. The common practical themes shared by the managers and 
equally practical themes shared by the practitioners when they expressed 
their thoughts and feelings within the context of the future for technology, 
particularly in relation to RVT were tabulated (Table 7.3). Across the narrative 
recorded under this node there were ten common predictions shared by 
managers and nine by practitioners. Set in the third column are remarks 
recorded in free text by patients and their carers in relation to the future of 
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technology. Patient and carer free text data were considered as qualitative 
and comparable to the themes distilled from face-to-face interviews with 
Health and Social Care Staff. There was consensus from all data sources that 
the future of technology should be enabled particularly as tech-savvy people 
get older; with improved peripheral or near patient testing devices and more 
internet based supporting care. There were six themes that were shared by 
both managers and clinical practitioners. However, they can be further 
summarised to suggest a requirement for technologies which operate in the 
background automatically sending relevant data with minimal effort which, are 
then made available to practitioners via an electronic healthcare record where 
interfaces between systems are streamlined and automatic. Equally, 
innovation of technologies to extend the range of data that can be collected 
and for two-way digital communication between patient and practitioner is 
enhanced. The patients, carers and practitioners shared the vision of 
increased use of RVT in the future. 
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Table 7.3 To capture the practical themes regarding the future use of 
technology, within the context of RVT, expressed by clinical practitioner 
and manager participants set alongside relevant patient and carer 
comments (summarised from free text). 









1 Mobile technologies that 
automatically send data, in the 
background, that are easy for 
patients to use and do not require 
dexterity with cables and ports. 
Mobile technologies as 
patients age, they will 
expect and demand their 
smart phones to be used in 
their care 
 
2 That there is a single sign on 
Electronic Patient Record that 
can be accessed by all Trust staff 
and GPs which includes the 
patient’s own daily readings from 
RVT. 
That there is an Electronic 
Patient Record that 
includes RVT information   
 
 
3 Automated or semi-automated 
responses to patients generated 
by the technology embedded with 
data analytics to create a “Doctor-
in-my-pocket” (P5) 
Automatic uploading of 
data, in the background, 
e.g. sleep pattern data 
 
 
4 Technologies communicate 
automatically in an integrated way 
e.g. the INR reading transferring 
from U-Tell to the Dawn Dosing 
system (P15) 
Technologies communicate 
lifestyle and smart home 
data e.g. nutritional intake 
 
 
5 Patient Portals become 
interactive and that patient 
interfaces and technology enable 
push and pull for training, health 
promotion, lifestyle, function, 
exercise and treatment 
compliance. 
Patient Portals with health 
promotion and lifestyle 
information. Including 
Authentication of Patients 
to sign themselves onto 
and out of monitoring 
Increased use of 
technology in 
future but not 
internet based. 
6 Accurate peripheral devices 
where calibration and battery life 
are more reliable. 
 
Accurate peripheral 
devices where calibration 
and servicing are 
maintained for the top 4% 
cases e.g. Heart Failure & 
COPD and enable low 





devices and hub 
need to be 
overcome. 
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7 Two-way messaging between 
practitioner and patient for more 
timely personalised care and 
intervention. Including the option 
for video calling. 
 
Text & email messaging 
from practitioner to patient, 
including the facility for 
patients to upload 
photographs of what they 
have eaten.  
 
8 Recording and transmission of 
new metrics e.g. carbohydrate 
counting and the date, time 
stamps included 
Video virtual ward rounds 
 
 
9 Wider technology adoption 
across the services and 
professions not simply the 
domain of a limited number of 
specialist practitioners. 
 
Routine collection of data 
with wearable or ingestible 
devices to transmit data 
 
As time passes 





savvy population  
10  Wider technology adoption 
and normalisation of RVT 
Increased use of 
RVT in the 
future. 
 
7.3 Summary of Concurrent Analysis 
The concurrent analysis suggests the benefit of RVT extended beyond the 
original intentions of service at point of design, albeit the original aspiration of 
reduced admissions and length of stay was not realised (McElnay et al. 2016). 
To extend the theme of patient centred-care into a home environment through 
RVT technologies may deliver desired therapeutic benefits. Enabled by 
technology, RVT, enhanced and developed the connectedness and 
relationship between patient and clinician. RVT enabled patient 
empowerment and that it should be recognised as the beneficial outcome 
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8 DISCUSSION AND 
CONCLUSIONS 
8.1 Emergent Benefit of Patient Empowerment 
 
The RVT services were designed to yield economic benefit for the healthcare 
system with metrics of success, considered at point of design and 
commissioning of the regional TF3 service, being the reduction of hospital 
admissions, earlier discharges and concomitant reduction of length of stay for 
patients with long term chronic diseases such as diabetes, COPD and heart 
conditions. These were not observed and subsequently the regional contract 
was not renewed, and the service was withdrawn by the Centre for Connected 
Health, Public Health Agency, following the publication of a commissioned 
evaluation (McElnay et al. 2016). The Trust’s in-house RVT service for 
warfarinised patients, U-Tell, continued to operate and was not affected by 
the regional review. Concurrently, Bengoa. et al. (2016) encouraged both the 
utilisation of technology and the enhancement of better patient outcomes. 
Within this conflicted regional policy environment, the research study 
embarked to discover if RVT could yield patient benefit for people with long 
term conditions when utilised as part of a package of care. 
Examination of available literature yielded largely equivocal findings with a 
generalised scarcity of relevant research literature. However, recurrent 
themes included a requirement for more research, improved methodology, an 
emerging consensus that RVT did not add direct economic value but that 
there was a general acceptance by patients. The researcher engaged with 
four groups of participants including patients, carers and as appropriate, their 
carers and data were collected in two differing paradigms, qualitative data 
from Health and Social Care employees and predominantly quantitative data 
from service users.  
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A theme began to emerge from the data to suggest that RVT could engender 
a sense of greater involvement for the patients in their own care, ergo a patient 
centric model of care had developed through the deployment of RVT. For 
example, one TF3 service user wrote in free text,  
“give me a better understanding of condition COPD it has also give me 
independence to live at home confident that I can manage my health 
and not be a burden on the NHS and my family.” 
 
The findings of the research, echoed literature review observations in that 
patient knowledge was enhanced (Stevenson and Bardsley, 2012), patients 
felt reassured (McDowell, 2015) and that technology could empower (Wyatt, 
2011). There was no evidence to support the predominantly negative view 
expressed by Scullion (2018) that patients somehow abrogated responsibility. 
The research did describe how some patients felt better able to manage their 
own condition and yet felt able to access immediate assistance from a health 
care practitioner if required. Three patient participants wrote the following 
three comments in the free-text comments section of the questionnaires which 
illustrate a sense of a safety net giving assurance that they can reach 
professional help promptly, “…I am very happy with the Telemonitoring 
service – I know if I am worried about my condition I can seek help with them,” 
“…It is very reassuring to have this in my home both for me and my husband 
to know help and advice is always at hand” and “My mind is completely at rest 
knowing these people are able and willing to help my illness.” Equally, the 
practitioners articulated support for RVT as it enabled them to target 
intervention more appropriately and see patient empowerment be enabled.  
Many (N=58) references, made by (N=16) practitioners, were coded within the 
node ‘Help people keep track of their condition: Empower’ which supports the 
notion of patient-centric empowerment from a professional perspective. This 
is an important patient centred observation. 
For practitioners it is important for their patients to comply with the treatment 
regimen prescribed for them and practitioners however they did not equate 
compliance with empowerment. Empowerment, as defined in Chapter 4, 
includes education which affords the patient the knowledge, skills, 
competencies, attitude and self-awareness to make better informed choices 
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whereas compliance is simply an activity of following instruction (Feste and 
Anderson, 1995). The concept of empowerment as a direct benefit of RVT 
gained weight given the practitioners interpretation of the concept. As already 
stated in Chapters 4 & 5, the interpretation of empowerment broadly 
encapsulated the direct use or reference of the word ‘empower’ by five 
practitioners and also included concepts of ‘patient centred’, ‘patient 
orientated’, ‘independence’, ‘self-management’, ‘control’ and ‘individualised’. 
This topic area is considered the wider benefit derived from the use of RVT 
that was not part of the initial regional programme design. Given the 
emergence of a general theme of empowerment as an outcome orientated 
patient benefit from all research participant sources, it is believed that this new 
knowledge is likely to be transferable to other patient-centred self-monitoring 
technologies deployed in healthcare. 
McElnay et al. (2016) suggested that as RVT becomes routinised that “… 
patients are empowered to be more active in their self-care” this was set within 
the context of a background, reflecting the forms of the RTNI contract, rather 
than data analysis, findings or recommendations. Whilst participation was low, 
they reported that the patient focus groups indicated, “…unanimously positive 
about telemonitoring, with the main benefit being the reassurance it gave them 
that a health professional was monitoring them constantly.” (Ibid.)  
Pulvirenti (2012) cited Alma Ata 1977 in setting empowerment as a key 
philosophy. How empowerment is understood is important and that care 
should be taken when recognising empowerment by recognising self-
determination (Aujoulat et al. 2007). When delivered effectively, 
empowerment could yield health outcomes through education (Anderson et 
al. 1995) but by 2002 collaboration to improve the patient and carer self-
management and knowledge emerged (Von Korff et al. 2002). With Ciccone 
et al. (2010) arguing that patient empowerment within Primary Care should 
elevate the patient to the most important team member in the collaboration. 
So that the practitioner has a clinical goal to empower the patient to make 
informed decisions about their own care (Anderson and Funnell, 2010). 
Equally, complementary to empowerment in the concept of patient-
centeredness, was the ability of patients to attain empowerment themselves 
not simply an action of the system (Holmström and Röing, 2010). Kennedy et 
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al. (2007) considered self-care as essential in long-term management of 
chronic disease conditions but that practitioners needed to reconsider the 
benefits of such empowerment. (Redman, 2007) observed that patient self-
management was not without issues as there could be a lack of competence, 
suggesting that empowerment could hide a transfer of responsibility from 
clinician to patient. This ignores the possibility that such a transfer could be 
problematic and assumes it is without harm if only patient follows instruction 
and is could lack patient selection standards. Ergo there was a possibility 
suggested that the use of RVT could enable ongoing patient education, 
support and clinical access that the early principles of self-management failed 
to deliver.  
In the RVT patient quantitative data, the most important direct indicator of 
empowerment and self-care was the variable “Has helped me manage my 
own condition and become involved in health care”. The mean average patient 
participant rating for this key metric for TF3 was 3.48 and U-Tell 3.67 which 
demonstrated that most people strongly agreed that RVT empowered (Table 
4.17). 
In the UK Donaldson (2003) advocated that the “…expertise of patients could 
be harnessed” to tackle the pressure of chronic disease although this was 
interpreted by Lindsay and Vrijhoef (2009) as an opportunity for cost saving 
in the NHS. Empowerment and self-care through RVT could be viewed as 
important to challenge the traditional care models as Vadiee (2015) found 
evidence to suggest clinicians failed to engage with expert patient model and 
failed to create an alliance between patient and practitioner. Therefore, in this 
research it was accepted that there was a need to understand what 
practitioners utilising RVT were trying to achieve by enabling empowered 
expert patients; and it was argued that it is someone who has the confidence 
and knowledge to undertake key self-management activities, not a patient 
who undertakes internet searches and asks clinicians for obscure care 
regimen (Shaw and Baker, 2004).  
The wider role of eHealth technologies in empowerment should not be 
overlooked and in this research the role of RVT was critically important. It is 
argued that RVT is a mode of eHealth technology that enables empowerment 
as a philosophical benefit where ongoing collaboration between patient, carer 
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and clinical practitioner occurs in a supportive and educational way. RVT 
enabled an interconnectedness permitting access to practitioners in a timely 
manner, one TF3 user reported, “Knowing that there is someone only a phone 
call away has improved my ability to function a lot better and give me peace 
of mind,” and RVT addresses a caution articulated by Donnelly et al. (2008) 
where patients empowered by eHealth technology are concerned by reduced 
face-to-face contact with clinicians. 
For there to be success with eHealth technologies, in particular RVT, as 
measured by dimensions of patient empowerment, behaviour, receptivity and 
attitude should be considered. The evidence from the qualitative data, 
comparing the general opinions of clinical practitioners with managers 
suggested a broad variance of attitude and technology orientation. Indeed, 
one practitioner stated, “…just when we learnt how to use the technology, they 
[the managers] took it off us.” (P5). Brown Cooper (2015) observed similar 
findings suggesting that successful organisational leaders involved with 
telehealth required “…innovativeness” to yield success. Staff attitude was a 
determinant of success within eHealth initiatives (Farhaan et al. 2008). 
Townsend et al. (2015) articulated ambivalence found within healthcare 
professionals with regard to application of effective eHealth interventions 
particularly relating to three dimensions, role changes, patient collaboration 
and patient burden but these factors were not found in the RVT research 
amongst patients or clinical practitioners, albeit, managers suggested clinical 
reluctance to change. As already stated in Chapter 6, four participants spoke 
of resistance and cynicism within the clinical staff groupings.;  
“I get frustrated with the fact that some people don’t appear to want to 
try and improve their patient’s lives and that is what RTM [RVT] 
essentially offers us, within the right mode.” (M8).  
Three spoke about tangible examples whereby clinical practice had changed 
but one participant reported an example which illustrated a success and a 
failure of an RVT COPD service simply because of staff attitudes (M2). 
Hardisty et al. (2011) suggested a failure to technology integration into care 
could be overcome by co-creation which was echoed within the RVT 
practitioners. As already stated in Chapter 6, managers reported a lack of 
clinical engagement or co-creation activities and perceived additional burden 
of workload drove cynicism and disengagement. When considering similar 
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eHealth technology intervention for chronic disease management there 
prevailed the theme that interventions fail to demonstrate cost effectiveness 
or benefit (Louis et al. 2003.) and a consensus that meta-analysis revealed a 
continued lack of effective study methodologies demonstrating effectiveness 
or benefit, (Kitsiou et al. 2013 and Bolton et al. 2010). 
It is equally argued that sight must not be lost of the very positive opportunities 
information technologies can afford the healthcare system as there are ever 
increasing numbers of patients in the community who need to be cared for by 
a limited resource of healthcare clinical practitioners. As already stated in 
Chapter 5, a common theme was that with the staffing resources could not 
keeping pace with demand for care, “…we are seeing doubling rates of maybe 
10-15-years in terms of prevalence in diabetes, and we’ve got to do something 
different… there was no other opportunity than to look to technology to 
support care” (P5). Atkin and Barrett (2012) suggest technology was 
important to optimise patient outcome but could not describe the role of the 
practitioner. Whereas, without considering the role of the practitioner Storni 
(2014) proposed that self-care ICT could, in future, enable patient 
empowerment particularly for the area of chronic disease management and 
discussed ramifications for future design of technology; a view shared by three 
manager participants, as already stated in Chapter 6, they articulated 
technology enabling self-care in the future with one of those stating,  
“…the right data to make the right decision, at the right time for the 
patient or empower the patient to make decisions for themselves” 
(M7). 
Three studies, Shany and Hession (2016) a COPD RCT, Inglis et al. (2015) a 
Cochran review of non-invasive telemonitoring for heart failure and Alrajab et 
al. (2012) a COPD RVT study all reported positive clinical benefits but unlike 
the SET RVT research did not articulate a beneficial patient or carer, human, 
perspective. 
Calvillo et al (2013) undertook a literature review to identify if current 
technology could empower patients and their findings suggested that almost 
all types of technology would be capable of assisting. They proposed that 
there were factors or ‘milestones’ which, if included, would define that the 
patient was aware of their condition, i) patient participation in self-care, ii) self-
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management, iii) patient education in condition and iv) patient access to 
technology. None of the technologies studied were RVT but conclusions could 
broadly be applied to the RVT findings albeit, in RVT empowerment is 
extended. The RVT research revealed in addition that i) support by 
practitioner, ii) a safety net, iii) targeted and timely response and iv) a true 
collaboration in care to empower the patient and their carer and afford peace 
of mind and an active contribution to self-care.  
Hypothesis in Suter et al. (2011) may have predicted the outcome of the RVT 
research, as they proposed that an RVT type telemedicine could be used to 
provide self-management, improve outcomes and empower patients through 
behaviour change (assumed not proven). This was determined through a 
theoretical study based on behaviour theory rather than findings of the trial 
and whilst was interesting and supported use of technology in healthcare to 
empower, the theoretical approach was not indicated by the RVT research. 
RVT as an instrument to change behaviour was not found albeit the 
introduction of new technological equipment into normal routine care was 
disruptive and patterns of behaviour changed. SET RVT research data 
communicated a sense of having freedom, collaboration, and safety through 
rapid access to support when required but of course technology enabled this 
change and ergo behaviour change. 
Most patients (>90%) when responding to empowerment variables, believed 
that RVT assisted self-management, allowed them to become more involved 
in healthcare, and benefit from peace of mind. This was echoed in detail by 
most of the practitioners (75%) and supported by most managers. All data 
sources indicated that self-care, self-management, co-creation, better 
support, collaboration and the affirmation of empowerment as a genuine 
patient beneficial outcome and utility of RVT, which were not proven in 
previous studies. 
8.2 Limitations of the Research 
 
Within the research study there were limitations found that, if predicted, would 
have led to a change in the research methodology. Although accepted by the 
BMJ peer reviewers, the patient response rate for the questionnaire was lower 
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than anticipated. Therefore, whilst there was a pseudonymous questionnaire 
process utilised, response rates could have been improved if automatic 
reminder letters had been generated. Whilst RVT as a service model was 
explored as a whole, it was not a homogeneous service, instead having 
multiple variables. If greater volumes of patient participants had participated 
deeper understanding of the effect of each service variant may have been 
better understood and recommendations for particular conditions delineated. 
However, this was not a problem based in poor return rate rather founded in 
the overall deployment and adoption of RVT within SET. A broader base of 
potential participants could have been selected if past service users had been 
invited to participate but the research governance and ethics principles held 
by SET advised against engaging anyone other than current users as there 
may have been a risk of causing distress to family members where a past 
service user had passed away. 
Equally, access to data regarding the service utilisation and care activity or 
service delivery for the regionally commissioned service was not available. 
During the planning and development of the research methodology the 
researcher had been assured by the Trust of availability, but the data was not 
produced by the service supplier nor were extracts of data supplied to the 
regional data warehouse. This meant that one of the objectives of the 
research could not be fully explored as only high level utilisation rates were 
available expressed in a currency of monitored patient days. The metric 
lacked any depth of meaning and did not afford interpretation or insight.  
8.3 Confirmation of Aim and Objectives 
 
The Aim of the thesis was to critically assess whether RVT is perceived to 
have derived benefits for patients.  
The thesis confirmed patient benefit was derived by the use of RVT and was 
demonstrated through an articulation of patient empowerment. 
This was achieved through four objectives: - 
1. To describe, summarise, critically evaluate and clarify the current state 
of knowledge on implementation of RVT.  
Critical Appraisal of Remote Vital-Sign Telemonitoring 
296  Julie-Ann Walkden - July 2020 
a. A review of the RVT context, local approach and technologies 
along with a literature review, endeavoured to capture the 
essence of the state of the art, known service attributes and 
coalesce the common theoretic understanding or beliefs at the 
time of the RVT services being implemented. A theme emerged 
suggesting that more meaningful studies should be conducted 
within the field of RVT. 
2. To identify and describe service data trends from service user and 
practitioner perspectives. 
a.  The trend data for local RVT was found to be of limited utility, 
for the RVT research, as it was focused upon a metric known as 
monitored patient day, which was designed to measure service 
uptake (contract performance) rather than an outcome for 
patients or a healthcare system. 
3. To determine the factors of patient benefit which are enabled using 
Remote Vital Sign Telemonitoring (RVT), taking the views of 
practitioners and senior managers into account and identify service 
benefits and risks.  
a. The new knowledge emerged from all data sources with findings 
from one paradigm corroborating or challenging the findings 
from another; determining congruence or dissonance.  
4. To devise recommendations to enable future deployments for optimal 
patient care.  
a. There was support for the future implementation of service user 
technologies in healthcare and recommendations to assist 
service and technology development and deployment.  
b. Patient inclusion and exclusion criteria were documented based 
upon practitioner experience of prescribing RVT. 
 
8.4 Emergent Model of Care with RVT 
 
The new dynamic technology-enabled partnership between clinician and 
patient was able to flourish when management committed to creating an 
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enabling environment and provide the required infrastructure. The managers 
did not intend to constrain practitioners or RVT by the application of ineffective 
metrics rather they wanted to create a system where effective care was 
delivered. In 2018, when the TF3 service was terminated the real benefit had 
not been articulated. The summary RVT research findings suggest the 
triumvirate which created the opportunity for user empowerment as an 
outcome of RVT to augment care or enable practitioner intervention was 
important (Figure 8.1). RVT was found to enable an equal collaboration 
between clinical practitioner and patient, and as appropriate their carers. This 
collaboration, which challenged the past models of care where the power was 
nested with the clinician and required compliance of patients. There was a 
consensus found between all data streams which indicated that the real 
benefit and consequence of RVT was to create this new patient-clinician 
collaboration which enabled the patients to learn, self-manage and to become 
more independent whilst sharing the responsibility by accessing the timely 
support of their clinical practitioners to ensure health was optimised. There 
was consensus that RVT had been beneficial but not as the originators had 
envisaged, the (management) metrics used had not captured the real benefit 
and changing dynamic; RVT had disrupted the status quo of usual care and 
had created an opportunity for empowerment.  
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Figure 8.1: Model of RVT integration into care to demonstrate the factors 
to achieve patient empowerment 
8.5 Conclusion 
 
The demographic profile within the SET area mirrored that of the western 
world. Whilst there was co-morbidity within the primary care caseload, most 
patients who utilised RVT had LTC as COPD, heart failure or diabetes 
mellitus. Additionally, complex anticoagulated patients with a track and trend 
RVT. Literature suggested RVT had little or no economic value for deployment 
and little ability to reduce the overall cost of care by reducing hospital 
admissions and hospital length of stay. In summary, the findings of the 
literature review were equivocal. Whilst general optimism for potential savings 
to the secondary healthcare environment was speculated, no such benefit 
was articulated. Moreover, the lived experience of patients, their carers or 
clinical practitioners was not articulated beyond a general sense of technology 
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acceptance by patients. Moreover, there was little or no evidence to suggest 
thought had been given to how usual care could be augmented or changed 
through the application of RVT.  
Mixed methods study was undertaken which demanded data collection in both 
the paradigm of qualitative and that of quantitative analysis. The blending, 
synthesis of data to determine and corroborate findings was undertaken 
utilising concurrent analysis. Data were collected from patients and, as 
appropriate, their carers by the means of questionnaires. There was no 
sampling of the patient caseload given the heterogeneous nature of the RVT 
technology deployed to a range of patients with differing LTC. Practitioners 
and managers were engaged through semi-structured one-to-one interviews.  
There were N=16 U-Tell patient respondents and N=81 TF3, response rates 
of 50% and 33.5%, in addition N=49 carers participated. The data was 
uploaded into (IBM-SPSS Version 25 database) and analysed. There was no 
significant difference found between patient groups so that ratings were 
largely unaffected by condition, gender, age or RVT technology utilised; albeit, 
there was an indication that with an increased number of co-morbid LTCs a 
patient is diagnosed with, the less benefit is derived from RVT when compared 
with patients with one LTC. A new variable was created ‘Empowerment’, 
which combined the three variables (refer to section 8.1 and Table 4.4, 
‘Enabled Self-Care’). When analysed with the variable of ‘future use of 
technology’ the skewness and kurtosis indicated a normal distribution with 
approximate symmetry for both empowerment and future technology.  
It was found that the carer data demonstrated support for both RVT and 
increased future use of technology. Patients reported that RVT was easy to 
use, would support increased use of technology and that they had used 
primary and secondary care service less when their care was augmented with 
RVT when compared to usual care. Consensus coalesced around general 
support for RVT to help support the care of the patient/ service users. 
However, patient respondents went further and expressed strong agreement 
that RVT gave them peace of mind, was able to enable them to better manage 
their condition on a day-to-day basis, become more involved in their care, 
reduced use of other healthcare resources particularly in primary care and in 
recognising the benefits and ease of RVT were more receptive to technology 
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in future. Of note, the qualitative data shared by patients and their carers 
expressed, a sense of freedom afforded to them by RVT and that they felt 
able to take action in a timely manner, including accessing their clinical 
practitioners, easily. The findings not only expressed acceptance of RVT and 
unidimensional benefits but when synthesised holistically presented a picture 
of empowerment, where patients were no longer passive recipients of 
healthcare, or complied with treatment regimen, rather were supported 
through RVT to take direct responsibility and be active in self-care. 
Data were collected from N=16 senior medical, nursing and allied health 
professionals who actively utilised RVT in the care of their patients and N=8 
senior managers/ commissioners who had responsibility for commissioning 
RVT or managing services where RVT was deployed. There were 24-hours 
of digitally recorded verbal data transcribed and analysed within the 
supporting database of (NVivo). As far as practicable the high-level nodes 
were utilised to sort the data for both staff groups to facilitate comparison and 
observe and describe findings through analysis. The initial construction of the 
clinical practitioner’s data topic nodes was reviewed, quality assured and 
ratified by a subgroup of the clinical participants. Data did corroborate the 
views of patients, but it was apparent that the perception of managers was 
not driven by a lived experience or direct observation of RVT. Managers were 
frustrated by the lack of clinical engagement whereas clinical practitioners 
sought co-creation and extended use. There was an opinion that technology 
was required in the future to enable care, but the managers articulated data 
management and data analytics, whilst the clinical practitioners wanted 
practical solutions such as electronic patient records and more importantly, 
the next generation RVT.  It is noteworthy, and of real practical use for the 
next generation of RVT, that the practitioner participants shared their learning 
to enable the future optimisation of RVT in particular patient groups, driven by 
the symptom patterns and requirements of patients with varying chronic 
diseases. The relevant data was compiled into a comprehensive list of 
inclusion and exclusion criteria and duly tabulated, (refer to Table 5.13 
summary of patient identification factors).  
Both staff groups articulated patient-centric care and whilst the managers did 
not directly utilise the term ‘empowerment’ much narrative articulated 
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empowerment using proxy language, for example, self-management and 
learning. Whereas, the clinical practitioner participants directly spoke about 
the power RVT had to directly influence the clinical/ patient dynamic 
relationship. The qualitative empowerment narrative was quantitized, through 
the use of (NVivo), which demonstrated that 75% of clinical practitioner 
participants articulated concepts of empowerment 58 times. This narrative 
was recorded under the high-level node of patient benefit and accounted for 
65% of all practitioner participant data describing patient benefit. 
The overarching finding following the data analysis is a confirmation of the 
hypothesis being tested, that is RVT, when successfully integrated into the 
treatment regimens of patients with chronic disease, enabled patients to feel 
better supported, better able to contribute to their own care, understand their 
condition and therefore be empowered. 
The theoretical speculation proposed by Suter et al. (2011) that almost any 
kind of RVT type of telehealth technology could induce a behaviour change 
and empower patients is supported by this research albeit the fundamental 
difference is about the effective deployment. The clinical practitioner 
participants were granted an enabling environment by the manager 
participants within the system and then through co-creation had the freedom 
to inculcate RVT into practice. Their ‘trial and error’ approach to learning how 
to effectively integrate technology into the therapeutic regimen and 
consideration of patient selection has enabled new knowledge to emerge. 
Practitioners expressed how they were keen to practice evidence-based care 
and so needed to discover new ways of working and to create the evidence 
to indicate optimisation of RVT in treatment regimens.  
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8.6 Confirming the Hypothesis 
 
The findings of the research confirmed the hypothesis which stated: 
If the healthcare system successfully integrates remote vital sign 
telemonitoring into the treatment regimens for patients with chronic disease, 
then the effect will be that patients will feel better supported and empowered. 
8.7 Contribution 
 
The research demonstrated that whilst the initial desired economic outcome 
was not realised for the region, RVT did afford benefit. The perceived benefit 
for service users was in line with international standards for the delivery of 
primary and community care services, particularly for those patients with LTC. 
RVT was found to effectively connect practitioners and patients and enable 
effective care to be delivered. RVT was accepted by patients, carers and 
practitioners, all of whom were positive regarding a technology enabled future 
for healthcare. There were several distinct and generalisable contributions to 
knowledge found as a result of the research undertaken, including: 
1. Demonstrated that whist the original ambition for the service (reduced 
secondary care utilisation and improved cost effectiveness of care for 
LCT care) had not been realised there was clearly a perceived benefit 
for service users. 
2. Patient empowerment was found to be a perceived benefit of RVT. This 
was in line with international goals for healthcare for all, most 
particularly for people with LTC. 
3. There was high user acceptability for RVT; an enthusiasm and 
acceptance of technology, positively indicating greater future 
application and use in future. 
4. There had been fears that RVT would create a distance between 
practitioners and patients when, in fact, the opposite was articulated. 
So that in the future service users could be better connected to the 
health services using remote technology. 
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5. Practitioners not only demonstrated a receptiveness to technology but 
observed that with growing demand and diminishing resources or 
access to conventional models of care, the application of technology 
was seen as vital for service sustainability.  
6. To enable a smooth transition to a technology enabled future the 
research demonstrated patient selection criteria and clinical 
application, based on practitioner experience, and shared best practice 




1. To advise the Department of Health and Public Health Agency, within the 
context of the regional eHealth Strategy, that they should reconsider their 
position relating to RVT. The Authorities should look beyond the blunt 
instruments utilised in the past for performance management of RVT and 
instead look for real patient outcome measures to indicate value. 
2. When introducing new disruptive eHealth technologies into the system, 
consider that patient technology acceptance was not influenced by 
disease group, age, gender or the type of technology but that simplicity, 
direct benefit and fitting with lifestyle were important. The lower value 
mobile RVT technology demonstrated equal benefit to the patient as the 
higher cost RVT solution and so the Health and Social Care system must 
look to lower cost, dynamic, mobile technologies with favour to enable 
patient empowerment, particularly as the next generation of tech-savvy 
smartphone owners begin to require care for chronic diseases.  
3. To advise the Health and Social Care system to enable clinical 
practitioners to flourish and participate in systemic decision making. Care 
can be improved through the creation of enabling environments which 
allow co-creation and a meaningful clinical contribution to the improvement 
agenda. Previous reviews of the RVT service failed to engage with the 
practitioners who utilised RVT and instead the system should learn that for 
future technology introduction those clinicians responsible for utilisation 
and prescription of technology must be proactively engaged in decision 
making.  
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4. To ensure the ongoing engagement of clinical practitioners by enabling co-
creation, benefit realisation, the development of new care pathways and 
the focus upon health and well-being outcomes.  
5. The pursuit of performance management targets, which only credits 
activity and disregards clinical benefit, is counterproductive and should be 
avoided. However, evaluation of technology projects is important and 
should be planned at the beginning whereby objectives are set, and 
metrics, along with a mode of capture, are agreed.  
6. To ensure commissioners build into their contracts, with technology 
solution suppliers, the means to enable data to be open and available for 
researchers. Suppliers must not be permitted to employ restrictive 
practices, instead the capture and then the sharing of meaningful clinical 
data, in a format which is accessible, to demonstrate effect, benefit and 
outcome, should be evident from the outset. This also requires 
commissioners to set outcome measures prior to project commencement 
so that impactful post project evaluations can be undertaken rather than a 
commissioner tracking the simple delivery of units of service against a 
contract value.    
7. Equally, within the context of General Data Protection Regulation (GDPR), 
purposeful clinical data must be collected with the consent of service 
users, anonymised and then made accessible to researchers through the 
regional data warehouse.   
8. To share the new knowledge of patient inclusion and exclusion criteria, 
gained through clinical experience RVT, across the chronic disease 
networks so that future technology adoption can be accelerated and 
appropriately targeted or technology adapted to overcome barriers (Table 
5.12). 
9. To deploy RVT in scenarios which require minimal practitioner movement 
for example in a pandemic situation where reduced footfall into domiciliary 
or residential or nursing home environments reduces the risks of 
practitioners being vectors of a disease. For efficiency to enable 
practitioners to effectively target their actions to those in most need whist 
monitoring a larger patient cohort. For the development of virtual wards or 
outpatient services which are environmentally friendly reducing the use of 
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fuels for travel or where geography and transport networks are 
problematic.  
10. To allow patient-centric care to be developed with the deployment of 
technology to better support the patient in their own journey with their 
chronic disease. To enable a real collaboration between practitioner, 
patient and their carer that goes beyond the past expectation of patient 
compliance. Where a patient is liberated to undertake self-manage 
effectively their own self-care, where education and knowledge can drive 
their decisions and choices, rather than the binary option to follow or 
disregard clinical instruction. This recommendation is about harnessing 
the patient and carer resource to maximise the opportunity for healing or 
symptom control of chronic diseases. 
11. In accepting RVT empowers patients to self-manage their chronic disease, 
to undertake further research to understand the actual behaviour change 
and how an individual’s motivation can be sustained and extended over 
time as new disruptive technologies emerge. 
12. RVT and the future of technology enabled care should be included in the 
undergraduate training of a range of health care practitioners to enable the 
development of service and an improved acceptance and trust within the 
clinical community.  
The research findings are transferable and describe how to practically 
optimise RVT into clinical practice, share the crucial selection criteria, by 
disease group, and for participants to envisage the use of technology in the 
future. It demonstrates technology acceptance for the future of self-
monitoring, self-management, behaviour change and the active participation 
in self-care and wellness. It also demonstrated the benefit of RVT was not to 
realise a cost saving in secondary care, rather to develop and enhance 
patient-centred care at home.  
However, the real importance, to redefine the collaborative relationship 
between patient and their clinical practitioner, to support the patient and their 
carers to take responsibility for their own care and self-management through 
learning, shared knowledge and rapid access to support. RVT, when 
deployed effectively, does yield the benefit of patient-centric care through the 
real and meaningful empowerment of the patient. 
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APPENDIX 1 DETAILED DESCRIPTION OF SOUTH 
EASTERN TRUST, HISTORY WITH TECHNOLOGY AND 
EUROPEAN CENTRE FOR CONNECTED OPERATIONS TO 
AWARD OF RTNI CONTRACT 
 
10.1 Profile of South Eastern Health and Social Care Trust 
 
The SET was established on 1st April 2007 and as already stated is one of 
five acute and community health and social care Trusts commissioning RVT 
to enable its provision. The Trust is an integrated organisation, incorporating 
acute hospital services and community health and social services and serves 
a population of approximately 345,000 people. The Trust encompasses the 
local government districts of Ards, North Down, Lisburn, Down and part of 
Castlereagh.  The clinical facilities include Ards Community Hospital, Bangor 
Community Hospital, Downe Hospital, Downshire Hospital, Lagan Valley 
Hospital and the Ulster Hospital. Community bases are located in many local 
towns and villages from Moira in the West to Portaferry in the East and from 
Bangor in the North to Newcastle in the South. The Trust is committed to 
providing health and social care to the local population it serves, from 
conception to death, and strives to meet the needs of the community within a 
budget of approximately £500,000,000 per annum.  The population is located 
in both rural and urban communities and affords residents care within the 
domiciliary environment, primary care health centres, community hospitals 
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Figure 10.1: Map to illustrate geographic catchment area of SET 
 
In addition, to the geographical spread, graph depicted in Figure 10.1, there 
are areas of both relative wealth and deprivation. The Trust employs in the 
region of 9,100 staff across a range of disciplines:- administration and clerical, 
maintenance, ancillary and general, nurses and midwives, social work, 
professional and technical, medical and dental and the Trust is split into a 
number of Directorates as follows: Children’s Services and Social Work, Adult 
Services, Nursing, Primary Care and Older People’s Services, Hospital 
Services, Human Resources and Corporate Affairs, Finance and Estates and 
Planning,  and Performance  and Informatics. However, the utilisation of RVT 
was limited to particular staff groups including specialist nursing services or 
multidisciplinary teams including nurses, allied health professionals and 
medical staff and within the thesis will generically be referred to as 
practitioners. Moreover, only practitioners from two directorates, Nursing, 
Primary Care and Older People’s Services and Acute Hospital Services were 
included in the research as access to RVT services was not universally 
available to practitioners across all programmes of care. 
 
The five Trust arrangement in Northern Ireland (NI) has been in situ since a 
structural re-organisation in 2007 called ‘Review of Public Administration’.  
Prior to the constitution of SET, within the geographic boundary, there were 
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two historic Trusts; Down and Lisburn (DLT) and Ulster Community and 
Hospitals Trust (UCHT). Therefore, at the time of the regional contract for RVT 
the Trust was relatively new and systems of operation and culture were still 
being developed. 
10.2 Pre-South Eastern Trust Interest in RVT 
 
Ulster Community and Hospital Trust (UCHT) had a reputation for 
engagement of practitioners with new technologies and in 1997 the first 
technology based medical governance system was created, ‘The Path.Finder 
Governance Committee’.   The group consisted of Consultant Medical 
Practitioners, the Deputy Director of Nursing, General Practitioners, 
Academics from Ulster University (UU) and Senior Trust Management.  Whilst 
the majority of the Path.Finder programme had focused upon, the creation of 
clinical guidances for medical staff, and the transmission of this material via 
the intranet, early development of innovation vis-á-vis near patient testing and 
Remote Vital-sign Telemonitoring were muted. The desire to allow remote 
monitoring of warfarinised patients was of interest to the committee but 
adequately calibrated near patient testing devices and safe modes of data 
transmission had not emerged. 
   
In 2004, UCHT Path.Finder group was terminated with the Trust’s 
Governance Committee assuming responsibility for Guidelines, Guidances 
Protocols and Pathways of Care.  However, the interest in the development 
and deployment of technology resided with a core group of practitioners and 
one Consultant Physician in particular.  By the close of 2005 the Trust’s Senior 
Planning Manager had secured £100,000 of capital resources to invest in 
technology and the Trust commissioned from Tunstall a Remote Monitoring 
System for the local community.  This was designed as a pilot to care for 24 
complex dementia patients with ambient technologies and 24 patients with 
diabetes mellitus with vital sign monitoring technologies and was called a 
‘Smart Homes Project’.  However, not only was the future of UCHT halted with 
the Review of Public Administration, the project was not enabled to progress.  
The Department of Health and Social Services and Public Safety (DHSS&PS) 
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retracted further revenue funding from the Trusts which had been designated, 
by UCHT, to enable Remote Vital-sign Telemonitoring.  Whilst the UCHT 
Smart Homes Project had early plans to include remote vital-sign monitoring 
linked to ambient monitoring and early alerts, nothing could progress as 
funding was withheld. However, a key feature of both the Path.Finder Medical 
Committee and Smart Homes Project was a core group of technology 
enthusiasts, early adopters, senior clinicians and leadership with a vision of a 
technology enabled dispersed health care model. 
 
Equally, DLT had commissioned exploratory RVT from a Lisburn based Small 
to Medium Sized Enterprise (SME), Home Telehealth, which focused upon 
remote vital sign telemonitoring, with triage nurse support for patients with 
Chronic Obstructive Pulmonary Disorder (COPD). The integrated specialist 
nurse and physiotherapy community respiratory team based within the Lagan 
Valley Hospital trialled the service. In 2007/8 an internal review of service and 
care, unpublished, undertaken by lead specialist nurse concluded that their 
triage based RVT service reduced GP attendances, improved patient well-
being and assured practitioners with regard to their health status. A later RCT 
conducted by the same team, McDowell et al.  (2015) concluded there was 
little discernible difference in health outcome between patients with RVT and 
those receiving standard care from the team; but that the little difference that 
was shown indicated improved quality of life for patients who received usual 
care plus RVT. However, this team is unusual within Northern Ireland as it has 
clearly had longer to develop clinical practice of utilising RVT supported by 
nurse triage. 
10.3 SET’s Development of RVT U-Tell and RCT Findings 
The Randomised Controlled Trial (RCT) also considered cost as an indicator 
of utility of alternative RVT care and determined a Quality Adjusted Life Year 
(QALY) to cost £26,423pa (Ibid.). The test strips, box of 48, were required by 
patients who wanted to continue to utilise the RVT facility rather than to revert 
to traditional care. Patients were asked to source these through GP 
Prescription. Whilst most GPs were supportive two were not prepared to 
utilise their prescription budget to support RVT. However, excluding the 
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consumable cost, that is the test strip cost for post RCT INR patients, the 
running costs for U-Tell:INR diminished to almost zero whereas during the 
RCT the cost of U-Tell:INR per annum was £10,000 for SpeechStorm voice 
recognition technology. In 2013, it was found that of the 70 patients utilising 
U-Tell:INR for both diabetes and INR only two utilised VRT by means of data 
upload. Over the 10-year evolution from Di@l-log to U-Tell:INR the patient 
behaviour had shifted; patients preferred to access the service via the internet 
using computer or smart phone rather than VRT. Therefore, SET ended the 
contract with the technology company Kainos who hosted the VRT product 
called SpeechStorm. The two very elderly patients who were dependent upon 
VRT changed their practice in order to benefit from U-Tell:INR rather than 
traditional care, and their family members assisting with data uploads. The 
study concluded that service users were satisfied with the service and their 
quality of life improved (El-Agnaf, 2014). 
10.4 European Centre for Connected Health Schedule of 
Operations Leading to Contract Award. 
The ECCH Senior Team established a programme Schedule of Work utilising 
‘Programme Management’ and ‘Prince II’ Project Management Methodology 
(Office of Government Commerce, 2009).  As part of this, each Trust 
established a project team attended by an ECCH Director.  The inaugural SET 
Meeting occurred in August 2008.  The ECCH then hosted a Provider 
Engagement Day.  Forty companies made representation to several ECCH 
Panels demonstrating the systems and processes they were proposing to 
create the end-to-end service within Northern Ireland.   End-to-End concept 
being one whereby a service provider would undertake every aspect of 
service delivery enabling the practitioner to refer a patient and subsequently 
is given access to the recorded readings. A competitive tender was then 
launched, and bidders invited to participate in a process of competitive 
dialogue. The 40 companies who expressed an interest were invited to submit 
a tender to become part of the competitive process. The procurement was 
being undertaken by the ECCH on behalf of a five -Trust consortium. 
Innovative procurement methods were deployed as both the specification was 
unclear and ‘off-the-shelf’ solutions limited. 
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The ECCH was supported by the Regional Procurement and Logistics Agency 
(PALS) which is a division of the Business Services Organisation (BSO).  
Consultancy support was engaged and included DLA Piper (legal support) 
and an Independent Procurement Adviser. Following the first round of tenders 
the long short-list was created consisting of the top ten bidding organisations. 
Of these, three local Telecare call centre providers were partnered with ten 
multinational technology providers.  Interestingly, one local call centre 
provider was partnered with six of the lead Tenderers.  This company Home 
Telehealth Ltd, later to become a subsidiary of Alere Healthcare, was to 
become the sole provider for SET during the Pilot phase of the Regional 
Remote Vital-sign Telemonitoring Procurement.  Home Telehealth Ltd had not 
been able to bid as an independent tenderer at that time as their annual 
turnover had not been sufficient to meet the selection criteria.  In effect, Small 
to Medium-sized Enterprises (SMEs) were precluded from leading bids 
leaving only large multi-national companies to be shortlisted by the Contract 
Adjudication Group (CAG).  Significant annual capital turnover was required 
given that in 2008, the then Minister for Health, had allocated upwards of 
£40M to commission the service over 4-years.  The Procurement Advisers set 
criteria; the lead contractor must have a turnover of sufficient value to 
demonstrate an ability to deliver a contract of the value of £40M. SMEs could 
only be afforded the opportunity to act as a subcontractor or consortium 
member with a lead contractor of sufficient financial stability.  There was a risk 
with the chosen criterion as one of the initial objectives of the creation of the 
ECCH was to help with sustainable local business.  There was then a 
dissonance created between the two Governmental Departments as ECCH 
drove ahead with the procurement within two opposing sets of criteria. 
 
By the summer of 2009 a further round of shortlisting occurred with the final 
short list of four companies being created.  It was thought that four companies 
would enable competition whilst fostering productive working relationships to 
develop effectively the creation of a workable and dynamic service 
specification for an end-to-end RVT service through a competitive dialogue 
process.  The final four companies were British Telecom (BT), TF3 (a 
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consortium consisting of Tunstall as lead contractor and a connected health 
equipment provider, Fold a provider of remote Telecare, and S3 a technology/ 
programming/ service developer), Bosch and Hewlett Packard (HP). Each 
week the Trusts, ECCH, the two procurement advisors and each Tenderer 
met.  Each Tenderer had a regular defined half day session.  The meetings 
were an opportunity for the Authority (defined as the five Trusts and ECCH 
supported by Legal and Procurement Advisers) to develop thinking and 
understanding of what was actually deliverable so that the translation of vision 
into reality was pragmatic whilst enabling innovation.  Over the period of the 
following two-years the service was developed and refined, based upon 
discussion with each organisation and also service experience obtained by 
each of the Trusts during the pilot phase. 
However, running alongside the work of the ECCH was political turmoil as the 
world’s financial markets began to collapse and the full ramification of fiduciary 
management within a time of austerity began to develop within the public 
sector. Regional Governmental budgets were under increasing pressure 
which concomitantly placed the Minister for Health and Social Services and 
Public Safety under scrutiny and challenges were made to terminate 
programmes not deemed to be effective. 
In 2009, the ECCH engaged the accountancy firm, BDO Stoy Hayward, to 
undertake an evaluation of the pilot programmes canvassing the views of 
patients, carers and practitioners.  The findings of BDO Stoy Hayward study 
were embargoed until post-procurement so as not to risk giving an unfair 
commercial advantage but it is suggested that the BDO Stoy Hayward report 
gave an added impetus to the pursuit of an RVT system via procurement. 
During this time there was a hiatus within the specification development phase 
and several key members of personnel from the ECCH left, including the Chief 
Executive, a key RVT Director and Medical Advisor.   
Several influential politicians and health professionals had castigated the 
programme as without clinical foundation, without objective evidence of 
efficacy and branded RVT a luxury that could be ill-afforded when existing 
clinical services were stretched.  However, following months of doubt the 
Minister gave his imprimatur for the programme to continue albeit with a 
significantly reduced budget.  
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Indeed, the budget was cut from the anticipated £10M per annum to £4.5M.  
The four Tenderers agreed to remain in the competitive procurement process 
at that stage and the work to reinvigorate the production of the service 
specification commenced in earnest.  There were two final rounds of a 
competitive process and at the first hurdle HP fell and soon after Bosch 
leaving BT and TF3 as the last Tenderers willing to make a best and final 
offer. 
The events of November and December 2010 before final procurement 
stages were quite precarious as some Tenderers had not accepted the model 
being specified. Bosch wanted to impose their tried and tested model of RVT 
rather than tailor their equipment and service to match the commissioner’s 
required specification. Members of the Authority, commissioning team, felt 
that the complexities of NI actual requirements were such that a bespoke 
service specification was essential. HP wanted to postpone the creation of 
their technology interface to an activity post award and so was unwilling to 
respond to those elements of the tender specification.  The Authority was 
attempting to envisage every element of provision and that meant a timely 
end-to-end service encompassing technology, vital sign equipment and triage 
nurses; embedded within a transforming integrated health and care system.  
The creation of something new, for not only Northern Ireland, but the Western 
World, was on the agenda.  
By the close of December 2010, the final two Tenderers had submitted their 
proposal and concomitantly the Contract Adjudication Group (CAG) was 
convened to score the submissions.  The Financial CAG occurred 
independently for the IT Technical CAG assessment which in turn was 
separate again from the front-line Quality Service Specification CAG 
assessment. Whilst the two final bids were scored across all dimensions and 
some elements of service offering were superior to others, there was an 
overall winning bid.  The adjudication required a service Provider to not only 
commit to deliver to the service specification but also to be the Most 
Economically Advantageous Tender (MEAT) and the contract was awarded 
to the consortium TF3. 
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APPENDIX 2 SUMMARY OF RTNI REGIONAL CONTRACT 
BETWEEN THE AUTHORITY AND TF3  
 
10.5 RTNI Managed Service Agreement Definitions 
 
DLA Piper Global law firm wrote and managed the production of the 
agreement between the five Health and Social Care Trusts within Northern 
Ireland and Tunstall Healthcare (UK) Limited, relating to the provision of 
managed remote tele monitoring services in Northern Ireland. 
The agreement extended to four leaver arch volumes along with a 
supplementary binder containing the six relevant signatories dated the 16th 
March 2011.  The 5th signed file is a duplicate copy of file 1 of 4 containing the 
original signatures.  The contents of each of the four master folders will be 
summarised and the relevant content noted.  
10.6 RTNI File 1 of 4 
 
This file contains the overarching definitions of services and establishes the 
implementation of the programme.  The folder describes the standards by 
which the service is to be delivered.   
Within the definitions section of the RTNI Project Agreement there are key 
definitions to be noted and a glossary of terms to ensure any risk of ambiguity 
is minimised. 
The key definitions are quoted as follows in Table 12.1: 
Table 10.1 To illustrate the key glossary of terms as sampled from the 
RTNI contract to inform context and intended purpose of RVT. 
Page Defined Term Meaning 
109 Electronic Care 
Record. 
Means Patient’s details or Client’s details (as 
relevant) such as name, address, medication and 
GP which are held and sent electronically (rather 
than in hard copy format). 
109 Emergency. An unforeseen and /or sudden occurrence of 
danger that demands immediate action. 
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109 Emergency 
Response. 
Means immediate action to be taken in response 
to a life-threatening situation. For example, this 
may include calling for ambulance service, 
attendance and assistance. 
110 Entry level. Means the market position which is the bottom 
quartile of specification and performance 
currently available within the tele monitoring, 




The terms set out at Annex A to schedule 2-4 
(Replacement of Equipment) as updated in 
accordance with schedule 2-4 (Replacement of 
Equipment). 
116 Health and Care 
Number H&CN. 
Means a unique Health and Social Services 
identification number.  This number is used by 
both the hospital and community services in 
Northern Ireland to identify patients/clients and 
issues in the recording of their treatments/care. 
116 HSC Staff. Means employees of the Authority and other HSC 
personnel included in caring for patients or clients 
(as relevant) who are receiving the Managed 
Service.  This includes General Practitioners and 
their staff. 
116 Hub. Means the item of patient equipment or client 
equipment (as relevant) to which monitoring data 
is sent by peripherals and which transmits the 
monitoring data to the central solution.  
117 Informed 
consent. 
Means obtaining and recording consent by a 
patient or client (as relevant) to undergo a 
particular treatment or avail of a service after the 
patient or client (as relevant) has demonstrated 
an understanding of the aforementioned and any 
potential risks involved. 
118 Interpretability. Means the ability of two or more systems or 
components to exchange information and to use 
the information that has been exchanged. 
121 Local Response 
Team. 
Means HSC Staff with responsibility for 
overseeing the care of the patient or client (as 
relevant) during the monitoring period and who 
will attend to patient or client (as relevant) needs 
when an alert/alarm (as relevant) has been 
escalated.  The Local Response Team may be a 




Means questions that are displayed automatically 
by the patient equipment/client equipment for 
response as part of the patients/ clients receipt of 
Managed Service.   
112 Managed 
Service. 
Any and all elements of the services to be 
provided by the contracts under this agreement 
including as set out in schedule 2-1 (service 
description) including the pre-operational 
services, operational services, additional services 
and/or future services. 
124  Monitored Client 
Volume Change. 
Has the meaning given in paragraph 2.5 of 
schedule 7.1 (charging and invoicing). 
124 Monitored Patient 
Day. 
Means a day during which the Patient Equipment, 
installed/delivered at the request of the Authority 
is functioning in accordance with this agreement.  
The day of installation/delivery of patient 
equipment (in accordance with this agreement) 
shall be a Monitored Patient Day, but the day of 
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de-installation/removal specified by authority and 
any day of thereafter shall not. 
124 Monitoring. Means the collection and reporting of vital signs 
and other patient data or client data (as relevant) 
by the Managed Service. 
124 Monitoring data. Means the data items that are collected and 
reported to the Managed Service. 
124 Monitoring 
parameters. 
Means the tolerance levels that are set for the 
identification of which monitoring data is referred 
to the triage service. 
124 Monitoring 
period. 
Means the duration of monitoring (normally 
measured in weeks). 
124 Monitoring 
threshold. 
Means the tolerance levels that are set for track 
and trend patients to indicate monitoring data has 
exceeded those indicated in the patient plan. 
127 Out of hours. The hours after 5pm and prior to 9am each day, 
including weekends and public holidays in 
Northern Ireland. 
128 Patient. Means a person requiring health services. 
128 Patient 
equipment. 
Means equipment used by the patient to record 
and report monitoring data (including home 
based or mobile equipment). 
128 Patient plan. Means the instructions included on the Referral 
form the Authority regarding the management of 
the patient under the Managed Service.  The 
patient portal shall include: 
i. Vital signs to be monitored, monitoring 
parameters and frequency of data collection.  
ii. Machine Automated Questions including 
frequency and duration of collection.   
iii. self-reported data.   
iv. clinical information including diagnosis, co-
morbidities, contraindications, allergies and/or 
medical history. 
128 Patient  Portal Means the patients view of their patient records 
including any associated relevant information. 
129 Peripheral. Means an item of patient equipment or client 
equipment (as relevant) other than the Hub. 
130 Project. Means the project to procure and deliver the 
Managed Service pursuant to the OJEU (Official 
Journal of the European Union).  Notice 
submitted for publication on 28th August 2008 for 
this project under reference 2008/5 166-223785. 
131 Referral. Means the instruction from the HSC staff to the 
contract to commence the provision of the 
Managed Service to a Patient/Client (as 
relevant). 
131  Responsible 
clinician. 
Means the medical practitioner with overall 
responsibility for the care of the Patient/Client (as 
relevant). 




Means a person-centred approach in which the 
individual is empowered and has ownership over 
the management of their life and conditions.  The 
role of health and social care professionals, 
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services and treatment is to support the person 
journey towards living well in the presence of 
absence of symptoms. 
134 Self-reported 
data. 
Means monitoring data which is entered by the 
Patient/Client directly rather than being recorded 
by an item of patient equipment/client equipment 
(as relevant). 
127 Service user. The patients, clients and carers and authorised 
medical personnel who use/receive the Managed 
Service. 
142 Telehealth or 
Telehealth 
monitoring. 
Means the remote tele monitoring and delivery of 
support services through information and 
communication technology, using vital signs 
monitoring and /or interpreting changes to a 
Patient’s health. 
142 Telehealth Key 
Worker 
Means the person with responsibility for the 
telehealth aspect of a patients care – such person 
will be in close contact with the patient throughout 
the period of time that they are receiving the 
Managed Service. 
144 Track and trend. Means a tabular and graphical report of individual 
patient monitoring data against monitoring 
parameters.  
145 Triage or triage 
service. 
Means the service that assesses the patients’ 
alert, validates the vital signs when an Alert has 
been raised, reviews monitoring data, obtains 
more information from the patient by asking 
questions designed to clarify or elicit more detail 
on clinical issues and deciding the action to be 
taken as a consequence including escalation to 
the Local Response Team. 
146 Vital signs. Means physical signs such as heartbeat, 
breathing rate and temperature, that assess a 
Patient’s condition. 
 
10.7 RTNI File 2 of 4 
 
The definition of the RTNI per se does not appear within the definitions and is 
rather within file 2 of 4, schedule 2.1. 
“A1 overview of Manged Service. The contracts shall ensure the provision of 
an end-to-end Managed Service to facilitate the following: 
• The processing of patient referrals; 
• The delivery and/or installation of appropriate patient equipment to/in a 
Patient’s home and/or the provision of a mobile solution as determined by 
the HSC staff and be responsible for any remedial repair work as a 
consequence of installation; 
• The provision of training to the HSC staff and patients/carers; 
• The collection of accurate and reliable monitoring data; 
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• A triage service which validates monitoring data and provides patient advice 
where appropriate and/or the escalation of their care to the local response 
team as appropriate; 
• The provision of relevant monitoring data to HSC staff in an appropriate 
manner and; 
• The removal and/or de-installation and decontamination of patient 
equipment”. 
The Manged Service shall be provided to patients with Long Term conditions 
including CHD/ CHF COPD and Diabetes.   
The Managed Service shall also be provided for the management of 
secondary prevention of stroke. 
The Managed Service Agreement file 2 of 4 sets out the detail of service to 
be provided in terms of service development, implementation and testing.  The 
progress is to be measured against pre-agreed targets and the issuing of a 
‘milestone Achievement Certificate’ was documented.  Any delays and 
concomitant correction plans and remedial actions were discussed along with 
the actions of the Liaison Committee.  These elements were specifically 
designed to enable the development of an entirely new end-to-end service 
recognising that technological developments in the real-world may need more 
time to adapt than in theory or a laboratory.  Indeed, the risk of delay was well 
accounted for with reasonable actions for both parties exclusively 
documented. 
At section 9 the document begins to address directly the matters relating to 
the Managed Service with the onus placed upon the contracts to fulfil 
obligations with regard to service standards as detailed within the schedule 2-
1 (Service Description).   
At clause 9.8 reference is made to an ‘Additional Service Implementation 
Timetable’  
Similarly, at 9.17 1 the ‘future service implementation plan’ referenced 
enabled the provider to protract potential charges to point of non-progress.   
Of note is clause 9.22 
‘At the same time as provision of additional and/or future service is 
commenced, the contract shall at no additional cost to the Authority, 
implement and commence provisions of any other services, functions and 
Critical Appraisal of Remote Vital-Sign Telemonitoring 
348  Julie-Ann Walkden - July 2020 
responsibilities which are both necessary for and incidental to the paper 
performance by the contractor of their additional and/or future services.  
Section 10 considers the service levels and quality failures.  
10.8 RTNI File 3 of 4 
This file contains the service offering and commitment made by the supplier  
10.9 RTNI File 4 of 4 
This file contains special provisions within the contract including, for example, 
commercial sensitivity, software, optional services, licencing, change 
provision, exit, staff transfer, governance and guarantees etc. 
10.10 RTNI Financial Contract Information 
Table 10.2 The standing charges for the RTNI contract in 2014/15. 
Standing 
Charge 
2014-15           
        Total Month 
        £   
        883,353 73,613 
Belfast   20.9%   184,621 15,385 
Northern   24.3%   214,655 17,888 
Southern   19.6%   173,137 14,428 
South 
Eastern    18.0%   159,004 13,250 
Western   17.2%   151,937 12,661 
            
    100.0%   883,353 73,613 
 (Taken from a TF3 new charges for 2014/15 document supplied to Centre for 
Connected Health and the 5 Trusts) 
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Table 10.3 The input package charges per monitored patient day (MPD) 
in 2014/15. 
  Discount 10.4% 10.4%  
    Charge per Monitored patient day 
6-year patient 
days Package   





Band C > 
53,000 
A 
Diabetes Home Based – 
track and trend 80% 
 £                       
1.72  
 £                        
1.54  
£                        
1.38  181,418 
A 
Diabetes Home Based 
20% 
 £                         
2.83  
 £                         
2.53  
£                        
2.27  45,354 
B 
Diabetes Mobile – track 
and trend 80% 
 £                        
1.74  
 £                        
1.56  
£                        
1.40  346,382 
B Diabetes Mobile 20% 
 £                         
2.85  
 £                         
2.56  
£                        
2.29  86,596 
C COPD 
 £                         
2.45  
 £                         
2.20  
£                        
1.97  461,825 
D Heart Failure 
 £                         
2.56  
 £                         
2.30  
£                        
2.06  763,581 
E Heart Failure ECG 
 £                         
2.55  
 £                         
2.28  
£                        
2.05  24,752 
F 
Stroke – track and trend 
95% 
 £                        
1.20  
 £                        
1.08  
£                        
0.96  201,435 
F Stroke 5% 
 £                         
2.28  
 £                         
2.04  
£                        
1.83  10,602 
G Diabetes/Heart Failure 
 £                         
3.00  
 £                         
2.69  
£                        
2.41  42,315 
H Diabetes/COPD 
 £                         
2.88  
 £                         
2.59  
£                        
2.32  42,497 
I COPD/Heart Failure 
 £                         
2.66  
 £                         
2.39  
£                        
2.14  55,146 
J 
Stroke /Diabetes – track 
and trend 100% 
 £                        
1.68  
 £                        
1.51  
£                        
1.35  55,146 
K ECG only 
 £                            
-    
 £                            
-    
£                        
-    0 
Q Stroke Mobile 
 £                         
2.73  
 £                         
2.44  
£                        
2.19  75,985 
Z COPD with BP 
 £                         
2.53  
 £                         
2.27  
£                        
2.04  461,825 
L 
Hypertension – track 
and trend (Additional 
service) 
 £                            
-    
 £                            
-    
£                        




 £                            
-    
 £                            
-    
£                        
-    0 
  
INR – track and trend 
(Additional service)         
  Total 2,854,859 
  Total (excl. Track & Trend) 2,070,478 
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 (Taken from a TF3 new charges for 2014/15 document supplied to Centre for 
Connected Health and the 5 Trusts) 
Table 10.4 The additional variable charges for installation and de-
installation of equipment. 
Installation Charge (as described in Schedule 7.1) :  £33.22 
Delivery Charge (as described in Schedule 7.1) :  £33.22 
De-Installation Charge (as described in Schedule 7.1): £33.22 
Removal Charge (as described in Schedule 7.1):  £33.22 
     
Table 10.5 The calculation of installation, delivery, de-
installation and removal charges. 
Number of visits 29,659    
Direct labour cost  £         652,022   £             22   
Overhead recovery  £         260,809   £              9   
Margin  £          72,447   £              2   
Total  £         985,277   £             33   
Charge  £            33.22    
(Taken from a TF3 new charges for 2014/15 document supplied to Centre for 
Connected Health and the 5 Trusts) 
So that SET would pay a monthly standing charge of 1/12th of £159,004 plus 
the direct costs associated with all MPD. Reporting for the variable element 
of the contract was broken down by package. The annual element of the SET 
cost and contribution was expected, at outset, to be 18% of the BAFO offer 
the total cost, for a 6-year contract for the 5 Health and Social Care Trusts of 
£12,493,338. The cost of provision was not a cost pressure for SET as access 
to this service was funded via the Regional Commissioning framework for 
Trusts and the additional resource was added to Trust funding baselines. Of 
note, there were service financial penalties for breaches in quality standards, 
for example installation times and call response times and a number of key 
milestones from a performance management perspective. From the signing 
of the contract it then took a further 8-month period for the service to be fully 
operationalised; with first SET patient live on the system on 4th December 
2011. 
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APPENDIX 3 QUESTIONNAIRES 
10.11 RTNI Patient and Carer Questionnaires 
 
Service User Questionnaire – Remote Telemonitoring Service 
– TF3 
By returning the completed questionnaire you will have agreed to participate in 
the research. Your questionnaires will be kept confidential and comments will 
not be attributed to anyone but your views will help shape the future 
development of the service.  The questionnaire responses will be compiled by 
the Trust’s Safe & Effective Care Team and I will have access to the Trust’s 
summary report.  If you wish to participate please could you return your 
questionnaires by Friday 18th September 2015. Many thanks in anticipation, 
Julie-Ann Augusto 
 
(Please tick one box only for each of the questions below) 
Patient Details 
1. Do you have a carer?     Yes         No     If yes, does your 
carer help you take your readings? Yes      No  
 If yes, will you pass the Carer Survey onto them? Yes      No  
 
2. This questionnaire was completed by the: Me          
My Carer  
 
3. Are you a current user of telemonitoring  Previous User / 
Discharged from telemonitoring  
 
4. What is your health condition being monitored through TF3? 
Please tick all that apply. 
Stroke   Chronic Heart Failure  Diabetes 
 Chronic Obstructive Pulmonary Disease (COPD)     
Renal   Gestational Diabetes  Hypertension 
 Weight Management             Maternity         
Bronchiectasis  Warfarin Monitoring/INR  Dementia 
 Paediatrics                 Other                     
 
5. What is your gender?  Male      Female    
 
6. What age are you? ___________- years 
 
Patient Benefits 
1. The telemonitoring system assisted me in managing my health on a 
day to day basis. 
Strongly Agree   Agree   Disagree          Strongly Disagree  
 Not Applicable   
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2. I believe the telemonitoring system has reduced the number of my GP 
visits. 
Strongly Agree   Agree   Disagree          Strongly Disagree  
 Not Applicable   
 
3. I believe my own monitoring of my condition has reduced the number 
of nurse/community team/health professional visits. 
Strongly Agree   Agree   Disagree   Strongly Disagree  
 Not Applicable     
 
4. I believe that during the telemonitoring period, the system has 
prevented the need to attend Accident & Emergency Department and 
/or GP Out Of Hours services. 
Strongly Agree   Agree   Disagree   Strongly Disagree  
 Not Applicable   
 
5. I believe that during the telemonitoring period, the system has 
prevented or reduced the need to attend Out Patient appointments. 
Strongly Agree   Agree   Disagree   Strongly Disagree  
 Not Applicable   
 
6. I believe that during the telemonitoring period, the system has 
prevented my admission to hospital. 
Strongly Agree   Agree   Disagree   Strongly Disagree  
 Not Applicable   
 
7. The telemonitoring system has enabled me to better manage my own 
condition and become more involved in my health care. 
Strongly Agree   Agree   Disagree   Strongly Disagree  
 Not Applicable   
 
8. Since you have been on telemonitoring how many times have you been 
admitted to hospital as a result of your condition? 
None  1 - 5  6 - 10  11 - 15 
 16 or more   
 
9. I believe telemonitoring has given me peace of mind. 
Strongly Agree      Agree     Disagree   Strongly Disagree  
 Not Applicable   
If you would like to add anything here about peace of mind and technology, 
please comment here: 
 
Telemonitoring Equipment and Technology 
10. My South Eastern Trust Practitioner explained the Telemonitoring 
system to me in enough detail before installation. 
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Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable   
 
11. I was worried about using the new telemonitoring technology before it 
was installed. 
Strongly Agree              Agree              Disagree              
Strongly Disagree              Not Applicable    
 
12. The telemonitoring system equipment in my home was easy for me to 
use. 
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable   
 
13. I am more interested in using technology in general following my use 
of the telemonitoring system. 
Strongly Agree               Agree              Disagree              
Strongly Disagree               Not Applicable   
 
14. I believe the telemonitoring questions displayed on the home-hub 
equipment encouraged me to think about my symptoms. 
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable   
 
15. I have found the internet portal to view my readings useful. 
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable   
 
16. I would be happy to use the internet upload my readings or send 
messages to my South Eastern Trust Practitioner.  
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable   
 
17. I believe increased use of technology in the care and support of people 
at home will be of benefit in the future. 
Strongly Agree              Agree      Disagree   
 Strongly Disagree             Not Applicable   
 
18. I consider increased use of internet based care and support for people 
at home will be of benefit in the future.  
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable   
 
Use of TF3 Telemonitoring Service 
19. Have you been contacted by a South Eastern Trust Practitioner in 
connection with your readings? Yes        No   
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20. My Clinician’s TF3 service messages were helpful:  
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable     
 
21. My Clinician’s telephone support was helpful:  
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable    
 
22. Did you receive a Remote Telemonitoring TF3 Nurse Triage Service? 
                       Yes        No    
(If yes, please answer questions 23 to 25) 
            
23. Have you been contacted by a TF3 Triage Nurse?                                             
Yes        No   
 
24. The Triage Nurse I spoke to was helpful:  
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable       
 
25. If you had to take more than one set of readings during a day, why was 
this? (Please tick) 
Readings didn’t go through the first time    Asked to do so by Triage 
Nurse    For confirmation or reassurance  
I have a more frequent monitoring programme   Other  
 
If you would like to add anything, please comment here: 
 
Thank you for taking time to complete this Evaluation Questionnaire.   A 
summary of the questionnaire findings will be available on the Trust’s Website, 
www.setrust.hscni.net from 31st March 2016.  
 
Service User Questionnaire – Remote Telemonitoring Service 
- U-Tell 
By returning the completed questionnaire you will have agreed to participate in 
the research. Your questionnaires will be kept confidential and comments will 
not be attributed to anyone but your views will help shape the future 
development of the service.  The questionnaire responses will be compiled by 
the Trust’s Safe & Effective Care Team and I will have access to the Trust’s 
summary report.  If you wish to participate please could you return your 
questionnaires by Friday 18th September 2015. Many thanks in anticipation, 
Julie-Ann Augusto 
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(Please tick one box only for each of the questions below) 
Patient Details 
1. Do you have a carer?     Yes         No     If yes, does your 
carer help you take your readings? Yes      No  
  If yes, will you pass the Carer Survey onto them? Yes      No  
 
2. This questionnaire was completed by the: Me          
My carer  
 
3. Are you a current user of telemonitoring  Previous User / 
Discharged from telemonitoring  
 
4. What is your health condition being monitored through U-Tell?  
Stroke   Chronic Heart Failure  Diabetes 
 Chronic Obstructive Pulmonary Disease (COPD)     
Renal   Gestational Diabetes  Hypertension 
 Weight Management             Maternity         
Bronchiectasis  Warfarin Monitoring/INR  Dementia 
 Paediatrics                 Other                     
 
5. What is your gender?  Male      Female    
 
6. What age are you? ___________- years 
 
Patient Benefits 
7. The telemonitoring system assisted me in managing my health on 
a day to day basis. 
Strongly Agree   Agree    Disagree          Strongly Disagree  
 Not Applicable   
   
8. I believe the telemonitoring system has reduced the number of my 
GP visits. 
Strongly Agree   Agree    Disagree          Strongly Disagree  
 Not Applicable     
 
9. I believe my own monitoring of my condition has reduced the 
number of nurse/community team/health professional visits. 
Strongly Agree   Agree   Disagree   Strongly Disagree  
 Not Applicable    
  
10. I believe that during the telemonitoring period, the system has 
prevented the need to attend Accident & Emergency Department 
and /or GP Out Of Hours services. 
Strongly Agree   Agree   Disagree   Strongly Disagree  
 Not Applicable   
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11. I believe that during the telemonitoring period, the system has 
prevented or reduced the need to attend Out Patient appointments. 
Strongly Agree   Agree   Disagree   Strongly Disagree  
 Not Applicable   
12. I believe that during the telemonitoring period, the system has 
prevented my admission to hospital. 
Strongly Agree   Agree   Disagree   Strongly Disagree  
 Not Applicable   
 
13. The telemonitoring system has enabled me to better manage my 
own condition and become more involved in my health care. 
Strongly Agree   Agree   Disagree   Strongly Disagree  
 Not Applicable   
 
14. Since you have been on telemonitoring how many times have you 
been admitted to hospital as a result of your condition? 
None  1 - 5  6 - 10  11 - 15 
 16 or more   
 
15. I believe telemonitoring has given me peace of mind. 
Strongly Agree     Agree     Disagree      Strongly Disagree  
 Not Applicable   
If you would like to add anything here about peace of mind and technology, 
please comment here: 
Telemonitoring Equipment and Technology 
16. My South Eastern Trust Practitioner explained the Telemonitoring 
system to me in enough detail before installation. 
Strongly Agree   Agree    Disagree    Strongly 
Disagree    Not Applicable   
 
17. I was worried about using the new telemonitoring technology 
before it was installed. 
Strongly Agree   Agree              Disagree              Strongly 
Disagree              Not Applicable    
 
18. The telemonitoring system equipment in my home was easy for me 
to use. 
Strongly Agree   Agree    Disagree    Strongly 
Disagree    Not Applicable   
 
19. I am more interested in using technology in general following my 
use of the telemonitoring system. 
Strongly Agree   Agree               Disagree              Strongly 
Disagree               Not Applicable   
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20. I believe the telemonitoring questions on the U-Tell ‘Readings’ 
page encouraged me to think about my symptoms. 
Strongly Agree   Agree    Disagree    Strongly 
Disagree              Not Applicable   
 
21. I have found the internet portal to view my readings useful. 
Strongly Agree   Agree    Disagree    Strongly 
Disagree              Not Applicable   
 
22. I would be happy to use the internet to upload my readings or send 
messages to my South Eastern Trust Practitioner.  
Strongly Agree   Agree    Disagree    Strongly 
Disagree             Not Applicable   
 
23. I believe increased use of technology in the care and support of 
people at home will be of benefit in the future. 
Strongly Agree    Agree      Disagree    Strongly 
Disagree             Not Applicable   
 
24. I consider increased use of internet based care and support for 
people at home will be of benefit in the future.  
Strongly Agree   Agree    Disagree    Strongly 
Disagree             Not Applicable   
 
Use of U-Tell Telemonitoring Service 
25. Have you been contacted by a South Eastern Trust Practitioner in 
connection with your readings? Yes        No   
 
26. My Clinician’s U-Tell messages were helpful:  
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable     
  
27. My Clinician’s telephone support was helpful:  
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable    
would like to add anything, please comment here: 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
Thank you for taking time to complete this Evaluation Questionnaire.
  
A summary of the questionnaire findings will be available on the Trust’s 
Website, www.setrust.hscni.net from 31st March 2016. 
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Carer Questionnaire – Remote Telemonitoring Service 
By returning the completed questionnaire you will have agreed to 
participate in the research. Your questionnaires will be kept confidential 
and comments will not be attributed to anyone but your views will help 
shape the future development of the service.  The questionnaire 
responses will be compiled by the Trust’s Safe & Effective Care Team and 
I will have access to the Trust’s summary report.  If you wish to participate 
please could you return your questionnaires by Friday 18th September 
2015. Many thanks in anticipation, Julie-Ann Augusto 
 
(Please tick one box only for each of the questions below) 
1. I believe telemonitoring has improved the overall level of health 
and social care given to the person I care for. 
Strongly Agree              Agree      Disagree   
 Strongly Disagree            Not Applicable   
 
2. I believe telemonitoring has helped prevent the person I care for 
being admitted to hospital. 
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable   
3. When assisting the person to operate the telemonitoring 
equipment, I found it easy to use. 
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable   
 
4. I think the use of telemonitoring as part of a care package is 
generally helpful. 
Strongly Agree              Agree              Disagree   
 Strongly Disagree              Not Applicable   
 
5. I believe telemonitoring has given me peace of mind. 
Strongly Agree               Agree      Disagree   
 Strongly Disagree               Not Applicable   
 
6. I believe increased use of technology in the care and support of 
people at home will be of benefit in the future. 
Strongly Agree               Agree      Disagree   
 Strongly Disagree               Not Applicable   
 
7. I believe increased use of internet based care and support for 
people at home will be of benefit in the future.  
Strongly Agree     Agree    Disagree   
 Strongly Disagree      Not Applicable   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
Please add any further comments here:   
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Carer Questionnaire – Remote Telemonitoring Service 
By returning the completed questionnaire you will have agreed to 
participate in the research. Your questionnaires will be kept confidential 
and comments will not be attributed to anyone but your views will help 
shape the future development of the service.  The questionnaire 
responses will be compiled by the Trust’s Safe & Effective Care Team and 
I will have access to the Trust’s summary report.  If you wish to participate 
please could you return your questionnaires by Friday 18th September 
2015. Many thanks in anticipation, Julie-Ann Augusto 
 
(Please tick one box only for each of the questions below) 
1. I believe telemonitoring has improved the overall level of health 
and social care given to the person I care for. 
Strongly Agree              Agree      Disagree   
 Strongly Disagree            Not Applicable   
 
2. I believe telemonitoring has helped prevent the person I care for 
being admitted to hospital. 
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable   
 
3. When assisting the person to operate the telemonitoring 
equipment, I found it easy to use. 
Strongly Agree    Agree    Disagree   
 Strongly Disagree    Not Applicable   
 
4. I think the use of telemonitoring as part of a care package is 
generally helpful. 
Strongly Agree              Agree              Disagree   
 Strongly Disagree              Not Applicable   
 
5. I believe telemonitoring has given me peace of mind. 
Strongly Agree               Agree      Disagree   
 Strongly Disagree               Not Applicable   
 
6. I believe increased use of technology in the care and support of 
people at home will be of benefit in the future. 
Strongly Agree               Agree      Disagree   
 Strongly Disagree               Not Applicable   
 
7. I believe increased use of internet based care and support for 
people at home will be of benefit in the future.  
Strongly Agree     Agree    Disagree   
 Strongly Disagree      Not Applicable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
Please add any further comments here:   
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10.12  Coded Patient Questionnaire 
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10.13 Coded Carer Questionnaire 
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APPENDIX 4 RESEARCH PROTOCOL DOCUMENTS  
10.14 Protocol V6 040616 
Exploring the conditions for optimisation of vital sign remote telemonitoring 
in the care of people with long term conditions 
(Short Working Title: Optimisation of Vital Sign Remote Telemonitoring) 
Julie-Ann Walkden (PhD Candidate) 
Abstract: The Health and Social Care system must identify and implement new ways 
of managing chronic disease within constrained resources.  Technology has a role 
in supporting people with chronic illness but current evidence to guide decision-
making is limited.  Remote Vital Sign Telemonitoring may enable effective care but 
the mode of deployment varies and requires optimisation from the user, carer, 
practitioner, service and commissioner perspectives.  This study aims to explore and 
understand the factors required for effective deployment of Remote Vital Sign 
Telemonitoring in one large mixed Trust.  Taken from an evaluative stance, this is an 
observational study of experienced health care practitioners where Multiple Methods 
will be used in a broad-based programme of enquiry. Both qualitative and quantitative 
data will be collected by means of a Trust-wide service user questionnaire (approx. 
370) and one-to-one interviews with Health and Social care staff (approx. 20). 
Descriptive and comparative methods will be used to analyse data, to identify trends, 
relationships and themes This analysis will be used in practice development to assist 
practitioners improve patient care. 
Background 
It has been estimated that chronic illness may cost up to 7% of gross domestic 
product (Nolte & McKee, 2008).  According to the World Health Organisation, chronic 
illnesses are the main cause of deaths worldwide at 63% (WHO 2013). In Northern 
Ireland it was agreed (in 2008) to invest in a new model of care for three diseases: 
Chronic obstructive pulmonary disease, heart failure and diabetes. Several (N=16) 
Remote Telemonitoring (RTM) pilots were developed and local evaluations were 
largely positive: patient satisfaction levels were favourable whereas in general Trust 
Staff were less supportive.  Subsequently a region-wide service was commissioned 
to address care of people with one of these conditions (Tunstall. 2014). Although 
service detail and standards were developed carefully, wide practice variation has 
led to variability in uptake rates, clinical opinion, variance in care standards and 
unclear expectation of outcomes. Anecdotal evidence within SET, reported by 
Practitioners, has suggested circumstances where RTM is beneficial or can cause 
harm, however, no clear pattern has been established to demonstrate optimisation 
or RTM to best effect; the debate has moved beyond relative success or failure.  RTM 
is a home-based service whereby a computer system provides a series of functions: 
reminders, data collection, storage, processing and transfer. The patient is reminded 
to undertake daily monitoring using recording peripheral devices provided.  Then 
compiled data is transmitted via phone-line to a central data centre. If there is an 
unacceptable reading, the system will generate an appropriate alert.  Web based 
technologies enable the review of readings by patient, triage nurse and practitioner. 
The triage nurse is employed by TF3 to be the practitioner to contact the patient after 
the computer system has indicated an issue and who decides the primary action to 
take which may include raising an alert with the patient’s own specialist practitioner, 
referred to as Trust practitioner in the study. There is a shared understanding 
between practitioner, patient and carer that the proactive monitoring of vital signs 
remotely will improve the patient’s well-being. The service provider enables the 
transmission of relevant vital sign and as appropriate responses to psycho-social 
questions to the practitioner for interpretation and action. Equally, the feedback 
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process empowers the patient and carer to better self-manage and be empowered 
through understanding of condition. It is suggested that this relationship may 
influence the successful operation of the service. 
 
From a practice perspective, within the service across Northern Ireland in general 
and in particular within South Eastern Health and Social Care Trust (SET) there is 
little or no agreement with regard to which subset of patients should avail of the 
service. For example, the Respiratory Service within the Ulster Hospital developed a 
Care Bundle to ensure that practitioners consider RTM as an option for each patient; 
this is illustrated in Figure 1. Care Bundles are not universally accepted by all 
practitioners, some of whom prefer to use other approaches. All other services 
utilising RTM have taken a less formal approach to application permitting practitioner 
preference and freedom.  
 
(SEE FIGURE 1.6)  
Figure 1 Flow chart to illustrate RTM “Care Bundle” as a process for a patient with a 




To date approximately 50 studies have reported on Telemedicine deployed within 
the context of chronic disease; where key literature search words of implementation, 
outcome measures and practice development were used to seek studies with 
development of RTM to optimise service provision.  The following eight papers 
referred to “success factors” including topics such as service user perception and 
practitioner experience following deployment.  
Sanders et al (2012) suggested that implementation and deployment should be 
considered in more detailed and an explanation of the systems and technology to 
recipients be undertaken so as to overcome barriers for utilisation.   
Currell et al (2010) highlighted the need for practitioners to ensure both clinical 
rationale and clinical skills are considered when considering a clinical RTM 
intervention. Many small-scale studies have indicated positive value of RTM.   
McLean et al (2011) reported benefits for people with Chronic Obstructive Pulmonary 
Disorder: RTM yielded improved quality of life with fewer exacerbations/ deterioration 
of health related to their respiratory condition and hospital admissions.  
However, some individual studies had less favourable conclusions, where the 
outcomes were less clear. Pinnock et al (2013) conducted a large-scale study in 
Scotland and failed to demonstrate a discernible difference between hospital 
admissions rates for patients with Chronic Obstructive Pulmonary Disorder who 
utilised RTM compared with a control group.  Wyatt has argued that there are too 
many variables for an RCT to ever be conclusive (Wyatt. 2012).   
In England, a review of a trial involving 6,191 patients ‘Whole System Demonstrator’ 
suggested some benefits (DoH. 2011). Bower et al (2011) suggested benefits as 
articulated within five categories: use (applicability to condition and ease of 
operation), effectiveness both clinical and cost, user-experience and organisational. 
These benefits were later challenged by Steventon and Bardsley (2012) who 
suggested variable technology and variable mode of deployment could affect 
outcome. It has also been argued that the large trials failed to recognise system-
benefits, and some studies fail to consider the time required to enable embedded 
change (Vinegar.2013). Henderson et al (2013) concluded that the Whole System 
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Demonstrator did “…not seem to be a cost effective addition to standard support and 
treatment.”  
Therefore, evidence to date does not suggest how to optimise RTM technologies, 
rather it suggests that the technology was found to be acceptable by users, or if 
outcomes, measured in hospital admission rates, were altered. Thus there is a need 
to further explore the practice of RTM, in a systematic way, in order to achieve 
optimal performance, taking account of key influences upon outcome.  
Aim: To critically assess if the application of Remote Vital Sign Monitoring, as part 
of the package of care for people with Long Term Conditions, is appropriate and to 
determine how and when to deploy RTM to best effect.   This will be addressed 
through a series of six objectives. 
Objectives:  
Undertake a systematic literature review to achieve current state of RTM knowledge. 
Identify from (existing) service data trends: User opinion and practitioner application 
over the past three years. 
To critically evaluate the RTM service and permit public engagement and 
involvement from the service users perspective.  
Determine the factors which enable Remote Vital Sign Monitoring (RTM) to be 
optimised taking the views of practitioners and senior officers into account. 
Identify key performance indicators; quantifying service benefits and risks 
Devise a model of application to enable future deployments to be optimised where 
appropriate.  
Methodology: 
Multiple Methods will be used in a broad-based programme evaluation. Following the 
systematic review of literature, it is proposed to- ; 
Analyse existing service data at Trust and regional level; 
This includes service statistics and reports relating to previous service evaluations 
and customer surveys (Refer to appendix r) 
Evaluation of existing Regional service use data. 
Confirming this prospectively through user and carer surveys;  
Questionnaires will be sent to all current South Eastern Trust RTM Service Users, 
N= 280 patients are on the system at any given time), with responses returned for 
collation and analysis. (Refer to appendices b, c, d, g & f) 
Where an informal carer plays a role in RTM, they will be invited to provide data from 
their perspective (From experience of pilot studies it is anticipated there are 
approximately 30% of RTM patients who are assisted by carers); N=90. (Refer to 
appendices h & i) 
Interviews on RTM with Health professionals at all levels; 
One-to-one semi-structured interviews with practitioners with experience of utilising 
RTM and Senior Health and Social Care leaders; N=20 (Refer to appendices ia, j, k, 
l, m & n) 
Workshop for Trust practitioners; N=15 
Quantitative (statistical) analysis of numerical data (from 1 & 2, above): descriptive, 
exploratory and explanatory; (Refer to appendix zc) 
Qualitative analysis of transcripts (from 3) following a descriptive thematic approach. 
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Summary Framework: 
INPUT  OUTPUT  
Designed four tailored 
questionnaires: - a service 
user and a carer 
questionnaire for each of 
the two services (TF3 & U-
Tell) – These were based 
upon BDO 2009 RTM 
questionnaire, then piloted 
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help practitioners review 
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Approach with Practitioners  
A descriptive approach will be taken, in the form of questionnaires and interviews 
with staff. It is recognised that a manager within SET conducting interviews of staff 
may have introduced bias into the process and positively skew findings. Therefore, 
the researcher proactively moved out of the Trust to join the Business Services 
Organisation and no longer is in a position to influence outcomes for staff. The 
researcher will ensure that potential Participants will not feel obliged to participate in 
the research and through the Participant Information Sheet and Consent Forms 
ensure that only Practitioners open and willing to confidentially share their 
experiences are enabled to participate.   
Henderson et al (2013) evaluated the English RTM Whole System Demonstrator 
Sites using a questionnaire. Whilst, this questionnaire was tested to scale it focused 
upon service user acceptability and the instrument will not be repeated in the SET 
context but the principle of using questionnaires as an instrument with patients will 
be applied. Indeed, this was a questionnaire-based study to determine economic 
benefit with three main dimensions being examined, acceptability and effectiveness 
and cost effectiveness. This project is not concerned with cost effectiveness rather 
effective use of the system. The method of data collection from the service user is 
being undertaken by the use of a tailored questionnaire offering the ability to engage 
with many individuals and assess relevant elements of accessibility and 
effectiveness. In the design of the methods and instruments to be applied within the 
study other studies examining optimisation of healthcare systems were reviewed. 
Estabrooks et al (2009) suggested factors that would influence critical success within 
the paediatric healthcare environment which have been later tested within elder care. 
This study created the Alberta Context Tool which described the structural elements, 
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resourcing and interactions between staff. The resultant Tool was created following 
the engagement of practitioners through interviews and workshops. In turn, such 
engagement has been modified within the Optimisation of RTM research project and 
it is expected that a framework of factors will result.  
In addition, selected practitioners will be invited to participate in one-to-one semi-
structured interviews in a safe environment, they will be given the opportunity to 
express their views from the stance of developing future practice based upon direct 
experience of RTM. The researcher has written to the existing SET practitioners with 
experience of RTM to seek expressions of interest as possible participants; only 
practitioners with experience of using either the TF3 or U-Tell service will be able to 
participate. This data base of potential participants will be approached initially and if 
further participants are required all remaining SET RTM practitioners will be offered 
the opportunity to participate. The researcher will seek from the practitioners what 
works best, for whom and when. The one-to-one interviews were piloted with two 
senior nurses in May 2014 and the outcome of the meeting used to create the semi-
structured interview plan for the research. Practitioners will be given the opportunity 
to share with the researcher their experiences of learning to use RTM, within the 
semi-structured interviews. They will be given the opportunity to describe their view 
of how to enable effective future deployment. The semi-structured interviews will be 
conducted purposefully to enable the practitioners to describe their personal 
experience of changing and developing care through RTM. (Titchen, McCormack 
and Manley. 2013). From the perspective of evaluation of experience, this research 
will be dependent upon personal practitioner experience and will enable practitioners 
to reflect upon the lessons they have learned from using RTM in the natural clinical 
environment.  
The semi-structured interviews will permit the practitioners to reflect upon their 
experience and share their views and experience. This approach has been selected 
because it permits a degree of freedom of expression for practitioners and for the 
researcher to empower through allowing the practitioner to influence the direction of 
future service development and outcome of research. The researcher will return the 
written-up findings to the practitioner participants to enable them further opportunity 
to comment and sense check. In order to minimise the risk of Interviewer bias the 
broad themes emerging from the data will be presented to the practitioner 
participants to discuss in a half-day workshop.  This activity will further enable 
reflection upon clinical practice, analysis and validation of theory being built and if 
RTM could be appropriately embedded into clinical practice. The results of 
quantitative analysis and findings from qualitative analysis will be synthesised to 
determine the factors required to achieve effective deployment. This will be 
undertaken by coding qualitative data to enable tabulation and comparison. 
(Oppenheim.2003). Themes in comments will be reflected and articulated within the 
narrative of analysis. In addition, to explore in detail environmental issues, the most 
senior executives, N= 6 to 8] dependent upon voluntary participation, within the 
HPSS with an influencing position in RTM will be interviewed to specifically determine 
views relating to environmental and management factors. These semi-structured 
one-to-one interviews will contribute to reflection upon and interpretation of findings.  
The data will be sorted into common themes in order of magnitude and consistency 
of opinion with be considered with finding compared and contrasted with the direct 
experiences of practitioners. It is recognised within the study that the complex 
intervention that is RTM needs to be examined from several perspectives. Simply 
taking a quantitative methodology would be likely to omit the psychosocial 
dimensions associated with the application of innovative technologies from the 
perspectives of patient, carer, practitioner and manager. Equally, simply examining 
the issues from a purely qualitative perspective the study may lack objectivity. Within 
the context of ensuring a comprehensive review, Multiple Methods, has been 
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selected and aims to ensure “…complementarity, completeness, confirmation” 
(Parahoo.2014.p88).  
The participants will be self-selecting and it assumed likely that those who are 
enthusiastic about utilisation of RTM will be more likely to join the Research. Whilst, 
this may risk the introduction of bias, the enthusiastic Nurses, Allied Health 
Professions and Medical personnel, Band 6 and above will contribute to future 
application of RTM. Whereas, those with a less favourable disposition may exclude 
themselves from reflective practice focusing upon RTM. Whilst, early voluntary self-
nomination to participate has 12 potential participants from across a range of 
practitioners and clinical field it may be necessary to trawl further until the one-to-one 
interviews have reached saturation of topic and no new material is forthcoming. 
However, if it is found that there are widely divergent views, the interpretation of the 
data will express the views of Practitioners from across the spectrum. Only once the 
practitioners are able to articulate their outcomes and experiences, can a 
determination be made about the nature of success factors which optimise the RTM 
intervention.  
Approach with Patients and Carers 
All service users within the SET will be given the opportunity to complete the 
anonymous questionnaire.  The entire patient base will be surveyed as pilot 
questionnaires applied to the whole group have been successful and also the 280 
patients are not a homogeneous group suffering from one condition. SET have many 
service users experiencing several combinations of RTM. Some service users have 
a track and trend service, whilst others self-entered data on PC through and a then 
others are in receipt of a full triage service. Also, there is a broad range of medical 
conditions that mean they may be offered RTM for example, heart conditions, 
diabetes, respiratory, weight control, warfarin therapy, high blood pressure and 
stroke. The differing conditions mean that practitioners select particular RTM 
peripheral devices to meet particular clinical observation needs. The findings of 
including all current patients will be less likely to be skewed or inadvertently 
unrepresentative of patient views whereas sampling may introduce such difficulties. 
They will be returned to the Trust’s safe and effective care team via free-post 
envelopes and will be compiled and results entered into (IBM- SPSS) to enable the 
researcher to analyse the responses. The questionnaire material will be returned to 
the researcher and the resultant report will contain both narrative and numeric 
articulation of findings. Commonality in theme of service user’s free text will be 
collated and reviewed to assess relative benefit or perceived risk of harm both 
through statistical analysis of coded text (Oppenheim. 2003) and researcher 
interpretation of narrative.  
Initial service user satisfaction questionnaires were undertaken by SET in 2013 and 
2014 and a pilot service evaluation in 2009 by BDO. These contain a rich narrative, 
particularly in the form of open responses. The 2013 and 2014 questionnaire that 
was developed by the researcher to assess service user RTM service satisfaction for 
the Trusts was agreed for use across the region by the five Trusts, Public Health 
Agency and the service provider. Distribution of the survey tool on a quarterly cycle 
across all service users within Northern Ireland has been undertaken by the service 
provider, TF3, but SET directly issued the questionnaire to all its service users on the 
annual basis; N=204 in 2014. The 2014 service evaluation questionnaires were 
analysed and from 184 anonymous questionnaires 127 service users contributed and 
further survey responses were received from 47 carers and 9 practitioners.  
The service user and carer questionnaires have been modified to enable further 
enquiry and enable tracking of service perception over time. The researcher has 
garnered support from stakeholders and in particular incorporated particular advice 
and feedback received following independent review from the Patient Client Council. 
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The data from the earlier service evaluation questionnaires will be reviewed for 
commonality in theme, analysed and examined for development of experience and 
comment over time.   The prospective questionnaire will retain particular key 
questions from earlier iterations but will elicit deeper opinion upon the effect upon 
self-care and utilisation of technology. The questionnaire will be issued within the 
context of voluntary participation in evaluation rather than simply service satisfaction. 
The questionnaire will enable Personal & Public Involvement (PPI) activity so that 
patients, as well as practitioners, can be enabled to inform development and 
deployment. The questions directed at service users in the prospective 
questionnaires will focus upon benefits, harm, service user recommendation to 
practitioner emphasising the transformation of practice, care and application of 
technology; albeit elements of satisfaction will be retained to enable comparison over 
time. Patients will be able to directly influence practitioner behaviour, responses or 
actions and RTM programme design, embracing PPI and enabling the regional 
strategy, Transforming Your Care (TYC), HSCB (2010). The focus of the study will 
remain the future deployment of service through the effective optimisation of care 
and the deployment of technology.  
Ethical issues 
Research participation, at all points along the research journey for the service user, 
carer, practitioner and senior officer will be voluntary with the participants being free 
to withdraw at any stage up to data entry; withdrawal after data collection will mean 
that they will not take any further part in data collection or review of findings. Material 
submitted to the date of withdrawal will be analysed and form part of the research 
findings. The questionnaires posted to service users and carers will be accompanied 
by a stamped addressed return envelope along with a cover letter to explain, study 
purpose, ethical consideration, confidentiality and consent.  The questionnaire will 
be sent to 280 service users with the option of them being able to pass a 
supplementary questionnaire on to further participants; that is the service user’s 
carer, if available; their responses will also be returned in a separate sealed 
envelope. The management of sensitive issues has been considered so that the 
safeguards are in place to protect vulnerable adult issues if identified through a ‘red 
flag’ system ensuring such matters are addressed through the Trust governance 
administration (Refer to appendices o, q & p). Patients will not be identified in the 
research findings and their contribution will be retained securely and confidentially 
for 10-years in line with the Ulster University standards; The Code of Practice for 
Research Integrity and the Data Handling procedures and the Data Archiving 
procedures.  Pseudo anonymity will be achieved through the coding of the 
questionnaires so that, should the need arise to identify a particular service user, 
direct action can be taken. The file containing participant study identification codes 
and personal details will be kept under secure conditions by the chief investigator, in 
a password-controlled computer system with access for the researcher.  Any hard 
copies of data will be kept under locked conditions, designed for the purpose. The 
chief investigator will be custodian and have control of the data generated from the 
study. Confidentiality will be respected but not guaranteed.  Any disclosure of poor 
practice will follow normal management protocols. The proposal has been scrutinised 
through peer review and the Research Integrity and Ethics Filter Committee Faculty 
of Life and Health Science, Ulster University, with comments and actions undertaken 
documented. (Refer to appendices u, v, w, y, yaa & yb). The proposal was then 
scrutinised by The Proportionate Review Sub-Committee of the Health Research 
Authority, NRES Committee South Central – Oxford C reviewed the research 
proposal in July 2015. (Refer to appendices ‘ox a’ and ‘ox b’) 
Access to Regional Data: Honest Broker Service 
The Honest Broker Service (HBS), based within Health and Social Care - Business 
Services Organisation (BSO), provides aggregate anonymised or pseudonymised 
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data for research that has been ethically approved. Access to Regional anonymised/ 
non-identifiable data will be sought within the research programme in order to 
evaluate the overall use of the TF3 service.   
Scope 
Consideration was given to the comparison between disease specific groups versus 
a single disease area. The enquiry will comprise of groups of practitioners who may 
be of varied professional backgrounds and specialising in the care of patients with 
various chronic illnesses whilst having commonality in possessing the ability to 
access the TF3 RTM service. This approach will enable greater opportunity of a 
transferable framework of success factors, enable cross fertilisation between 
professional areas and maximise the number of eligible practitioners. Criteria for 
selection was defined as participants must be of HPSS Band 6 or above with a 
professional clinical background (defined as someone with a Medical, Nursing or 
Allied Health Professional registration).  
Risks 
No serious risk attach to participation nor to data collection. There have been four 
systemic risks identified with the research project and these include: (1) service 
capability of provider restricting operation of remote monitoring, (2) technology 
advancement providing new alternatives to service under review, confounding 
findings, (3) engagement with clinical participants being limited by other service 
requirements and (4) separate, Public Health Authority commissioned service 
evaluation to judge if the service should be re-commissioned in 2017. Each risk was 
reviewed with regard to possible impact and affect upon both research progress and 
the participants. None of the identified risks are anticipated to be likely to seriously 
conflict with the research project or negatively affect research participants. 
Project planning 
A Project flow chart is below, figure 2, to illustrate the steps of the research 
programme associated with data collection.  Permissions have been granted to 
access relevant Trust data. The researcher has commenced the personal 
development training programmes and has undertaken training specifically related to 
Human Subjects, Ethics and Research Governance.  Application for ethical approval 
is underway for survey work and interviews and in line with the original project plan 
that approval will be given to proceed with the issuing of the service user evaluation 
questionnaires and one-to-one interviews at the end of the second quarter 2015.   
(SEE FIGURE 3.2)  
 
Figure 2. Flow Chart to illustrate the steps within the data collection and analysis 
process.  
(SEE FIGURE 3.3)  
 
Figure 3. Gantt Chart to demonstrate the data collection and analysis timeline.  
Justification  
In exploring the options that can enhance RTM for people with Long Term Conditions, 
the study aims to suggest how to deploy new technologies to best effect where 
technology is integrated into care packages. It is anticipated the optimisation of RTM 
it will enable technology integration into “mainstream” health & social services.   
Supervision 
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JAA is a Health Professional (refer to appendix s) currently employed in a related 
field as Small Business Research Initiative Executive with the Business Services 
Organisation.  The work will contribute to a PhD being undertaken by JAA who is 
supervised by Prof George Kernohan (Nursing and Health Research) (refer to 
appendix zb) and Dr Paul McCullagh (Computer Science).  March 2015 (Revised 
following Peer Reviews undertaken by Prof Sinclair and Dr Stinson) 
References 
(SEE References in Chapter 9)  
 
10.15 ia ox Participant Consent Form - Staff 
Participant Consent Form – Staff Member 
Title of Project : Optimisation of Vital Sign Remote Telemonitoring 
_____________________________________________________________
______Name of Chief Investigator: Prof George Kernohan BSc PhD 
Professor of Health Research, Institute for Nursing and Health Research, 
Ulster University 
Shore Road, Newtownabbey. BT37 0QB 
 Please initial  
• I confirm that I have been given, have read and understood the Participant Information 
Sheet for the above study and have asked and received answers to any questions raised 
[   ] 
• I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving a reason and without my rights being affected in any way [   ] 
• I understand that my data collected up to the point of withdrawal, will still be utilised 
within the research [   ] 
• I agree for my interview to be recorded using digital audio equipment. [   ]  
• I understand that the researchers will disclose evidence of poor practice [   ] 
• I understand that the researchers will hold all information and data collected securely 
and in confidence and that all efforts will be made to ensure that I cannot be identified 
as a participant in the study (except as might be required by law) and I give permission 
for the researchers to hold relevant personal data [   ] 
• I agree to take part in the above study [   ]  
 




Name of person taking consent Signature Date:  
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One copy for the subject; one copy for the researcher. 
Contact details  
Should you require any further details about this study please contact the 
researcher, Julie-Ann Augusto, on Telephone number 07979365939 or 
walkden-j@email.ulster.ac.uk  
 
10.16 b ox Subject Information sheet – Patient 
Research Title: optimisation of Vital Sign remote Telemonitoring 
This means that I want to look at the best way we can use Remote 
Telemonitoring equipment and services to help our patients. 
 
You are being invited to take part in a research study. Before you decide 
whether or not to take part, it is important that you understand what the 
research is for and what you will be asked to do. Please read the following 
information and do not hesitate to ask any questions about anything that might 
not be clear to you. Make sure that you are happy before you decide what to 
do. Thank you for taking the time to consider this invitation. This study is part 
of an academic qualification for a current PhD candidate.  
 
What is the purpose of the study?  
I would like to learn about your experience of the U-Tell or TF3 service so that we 
can try to improve the care and support offered to patients in the future.  I am 
interested in your experiences, whether you are a current user or you have used 
Remote Telemonitoring in the recent past or a carer of someone who has used 
the system.  Your answers will be useful and will only be used for the purpose of 
this project. 
 
Why have you been chosen?  
You have been chosen to participate in this research project as you are currently 
recorded as a service user of either the U-Tell or TF3 Remote Telemonitoring 
services. All patients over the age of 18-years have been asked to participate and 
I expect about 280 patients and 90 carers to receive a questionnaire. Equally, if 
you are a carer for someone who is using the service you may be asked by the 
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Do I have to take part?  
It is up to you to decide whether or not to take part. If you do decide to take part, 
by returning the completed questionnaire you will have given consent. If you 
choose to take part, you can change your mind at any time and withdraw from 
the study without giving a reason. 
 
What will happen to me if I take part?  
If you are a patient who uses either the U-Tell or TF3 Remote Telemonitoring 
Service you will be sent a questionnaire. If you are a carer of someone who uses 
the Remote Telemonitoring Service, you may be asked to complete a separate 
questionnaire by the person you help. If you consent to participate you complete 
the questionnaire and return in the stamped addressed envelope to the South 
Eastern Trust’s Safe and Effective Care Team. This then will be the end of your 
contribution. The Safe and Effective Care Team will compile the responses to all 
the returned questionnaires and then the researcher will analyse the results. 
 
Risks and/ or disadvantages?  
There are no risks or disadvantages associated with your decision to 
participate or not. Your decision will not affect your future care or ability to 
access the service. 
 
Are there any possible benefits in taking part?  
There will be no direct benefit provided to you for volunteering to participate 
but it is hoped that your participation will help shape future services and 
provide benefit for patients.  
 
What happens when the study ends?  
At the end of the study a PhD Thesis will be published, and it is hoped that 
this will advise other people in the future how best to use remote vital sign 
telemonitoring. 
 
What if something goes wrong?  
It is very unlikely that anything will go wrong. The Ulster University has 
procedures in place for reporting, investigating, recording and handling 
adverse events and if the researcher discovers a concerning matter then strict 
processes will be followed to ensure patient safety is maintained at all times 
through engagement with Trust Management. Any complaints about this 
research project or the researcher will be taken seriously and should be made 
to Professor George Kernohan, Chief Investigator, Ulster University Shore 
Road, Newtownabbey. BT37 0QB or Nick Curry Senior Administrative Officer, 
Room 01H12, Research an Innovation, Ulster University Shore Road, 
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Will my taking part in this study be kept confidential?  
Data will be held securely and in confidence and that any identifiers will be 
removed prior to publication as required under Data Protection legislation. 
However, Freedom of Information legislation will allow access to certain non-
personal or generalised data. It might also be in a participant’s best interests 
to have certain disclosures shared with a relevant Trust manager where 
concerns regarding Patient care or safety are shared. 
 
What will happen to the results of the study?  
The results of this study will be published in professional academic journals 
to help share the findings. It is also anticipated that the findings will contribute 
to future service improvements/ changes in procedures, treatment and 
established practice. If you would like a copy of the results summary, it will be 
available on the Trust’s Website, www.setrust.hscni.net from 31st March 2016. 
 
Who is organising and funding the research?  
The research has been funded by the South Eastern Trust and by the 
researcher.  
 
Who has reviewed this study?  
The Proportionate Review Sub-Committee of the Health Research Authority, 
NRES Committee South Central – Oxford C reviewed the research proposal 
in July 2015. The Ulster University’s Research Integrity and Ethics Filter 
Committee Faculty of Life and Health Science and South Eastern Trust’s 
Research Governance Committee have reviewed the research study in 
accordance with procedures. If you are interested you can contact the 
University or Trust for further details if you require them. 
 
Contact details  
Should you require any further details about this study please contact the 
researcher, Julie-Ann Augusto, on Telephone number 07979365939 or 
walkden-j@email.ulster.ac.uk  
 
10.17 c ox Letter User Questionnaire TF3 
1st September 2015 
Dear Sir/Madam 
Re: - Remote Telemonitoring User Questionnaire 
You are being invited to take part in a research study by the Ulster University. 
Before you decide whether or not to participate in the project, it is important 
that you understand what the research is for and what you will be asked to 
do. Please read the enclosed Participant Information Sheet and do not 
hesitate to ask any questions about anything that is unclear. Please make 
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sure that you are happy before you decide what to do. Thank you for taking 
the time to consider this invitation.  
 
I would like to learn about your experience of the U-Tell or TF3 Remote 
Telemonitoring Service so that we can try to improve the care and support 
offered to patients in the future.  I am interested in your experiences, whether 
you are a current user or you have used Remote Telemonitoring in the recent 
past or are a carer of someone who has used the system.  Your answers will 
be useful and will only be used for the purpose of this project. 
 
There are two questionnaires, the service user questionnaire on white paper 
and the carer questionnaire on yellow paper. Please return both 
questionnaires in the same free return envelope but the carer questionnaire 
should be sealed in the envelope marked ‘carer questionnaire’, placed inside 
the freepost envelope provided and posted by Friday 18th September 2015. 
You do not have to answer but it will help with the project if you do.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
 
If you prefer to speak to me, please phone me on 07979365939. I will return 
your call and complete your questionnaire with you over the phone. 
 
A summary of the questionnaire findings will be available on the Trust’s 
Website, www.setrust.hscni.net from 31st March 2016. 
 
Many thanks in anticipation. 
Yours sincerely 
 
Julie-Ann Augusto (formerly Walkden) PhD Research Student 
10.18 d ox Letter User Questionnaire U-Tell 




Re: - Remote Telemonitoring User Questionnaire 
 
You are being invited to take part in a research study by the Ulster University. 
Before you decide whether or not to participate in the project, it is important 
that you understand what the research is for and what you will be asked to 
do. Please read the enclosed Participant Information Sheet and do not 
hesitate to ask any questions about anything that is unclear. Please make 
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sure that you are happy before you decide what to do. Thank you for taking 
the time to consider this invitation.  
 
I would like to learn about your experience of the U-Tell or TF3 Remote 
Telemonitoring Service so that we can try to improve the care and support 
offered to patients in the future.  I am interested in your experiences, whether 
you are a current user or you have used Remote Telemonitoring in the recent 
past or are a carer of someone who has used the system. Your answers will 
be useful and will only be used for the purpose of this project. 
 
There are two questionnaires, the service user questionnaire on blue paper 
and the carer questionnaire on pink paper. Please return both questionnaires 
in the same free return envelope but the carer questionnaire should be sealed 
in the envelope marked ‘carer questionnaire’, placed inside the freepost 
envelope provided and posted by Friday 18th September 2015. You do not 
have to answer but it will help with the project if you do.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
 
If you prefer to speak to me, please phone me on 07979365939. I will return 
your call and complete your questionnaire with you over the phone. 
 
A summary of the questionnaire findings will be available on the Trust’s 
Website, www.setrust.hscni.net from 31st March 2016. 
 
Many thanks in anticipation. 
Yours sincerely 
 
Julie-Ann Augusto (formerly Walkden) PhD Research Student 
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10.19 f ox Service User Questionnaire TF3 
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10.20 g ox Service User Questionnaire U-Tell 
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10.21 h ox Carer Questionnaire TF3 
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10.23 j ox Subject Information Sheet Staff  
Research Title: Optimisation of Vital Sign Remote Telemonitoring 
This means that the researcher wants to look at the best way we can use 
remote Telemonitoring equipment and services to help our patients. 
You are being invited to take part in a research study. Before you decide 
whether or not to take part, it is important that you understand what the 
research is for and what you will be asked to do. Please read the following 
information and do not hesitate to ask any questions about anything that might 
not be clear to you. Make sure that you are happy before you decide what to 
do. Thank you for taking the time to consider this invitation. This study is part 
of the researcher’s academic qualification as a current PhD candidate.  
What is the purpose of the study?  
I would like to learn about your experience of the U-Tell or TF3 service so that 
we can try to improve the care and support offered to patients in the future.  I 
am interested in your experiences, whether you are a current user or you have 
used Remote Telemonitoring in the recent past.  Your answers will be useful 
and will only be used for the purpose of this project. 
Why have you been chosen?  
You have been chosen to participate in this research project as you are 
currently recorded as a staff member who has access to either the U-Tell 
or TF3 Remote Telemonitoring Services.  
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Do I have to take part?  
Participation is entirely voluntary. It is up to you to decide whether or not to take 
part. If you do decide to take part, you will be given this information sheet to keep. 
You will also be asked to sign a consent form. If you choose to take part, you can 
change your mind at any time and withdraw from the study without giving a 
reason. 
 
What will happen to me if I take part?  
If you are a South Eastern Trust member of staff who uses either the U-Tell 
or TF3 Remote Telemonitoring Service you will be given an opportunity to 
contribute to the research project by participating in a one-to-one interview 
with the researcher. The interview will be conducted in a venue and at a time 
suitable to yourself. You will be able to talk freely about your views and talk 
about your experience. The interview should last about an hour and there is 
no expectation that any further contribution will be made by you. However, 6-
months after the interviews a one-off workshop will be held lasting 
approximately 2-hours in the Innovation Centre, Ulster Hospital. This will be 
to enable you to hear the anonymous views of the staff and afford you with an 
opportunity to make further comment and contribute to a group discuss.  
 
Risks and/or disadvantages?  
There are no risks or disadvantages associated with your decision to 
participate or not. Your decision will not affect your future career within the 
Trust and you are certainly not under any obligation to participate. 
 
 
Are there any possible benefits in taking part?  
There will be no direct benefit provided to you for volunteering to participate 
but it is hoped that your participation will help shape future services and 
provide benefit for patients in the future.  
 
What happens when the study ends?  
At the end of the study a PhD Thesis will be published and it is hoped that this 
will advise other people in the future how best to use remote vital sign 
Telemonitoring. 
 
What if something goes wrong?  
It is very unlikely that anything will go wrong. The Ulster University has 
procedures in place for reporting, investigating, recording and handling 
adverse events and if the researcher discovers a concerning matter then strict 
processes will be followed to ensure patient safety is maintained at all times 
through engagement with Trust Management. Any complaints about this 
research project or the researcher will be taken seriously and should be made 
to Professor George Kernohan, Chief Investigator, Ulster University Shore 
Road, Newtownabbey. BT37 0QB or Nick Curry Senior Administrative 
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Officer, Room 01H12, Research an Innovation, Ulster University Shore 
Road, Newtownabbey. BT37 0QB.  
 
Will my taking part in this study be kept confidential?  
Data will be held securely and in confidence and that any identifiers will be 
removed prior to publication as required under Data Protection legislation. 
However, Freedom of Information legislation will allow access to certain non-
personal or generalised data. It might also be in a participant’s best interests 
to have certain disclosures shared with a relevant Trust manager where 
concerns regarding Patient Care or Adult Safeguarding are shared. 
 
What will happen to the results of the study?  
The results of this study will be published in professional academic journals 
to help share the findings. It is also anticipated that the findings will contribute 
to future service improvements/ changes in procedures, treatment and 
established practice.  
 
Who is organising and funding the research?  
The research has been funded by the South Eastern Trust and by the 
researcher.  
 
Who has reviewed this study?  
The Proportionate Review Sub-Committee of the Health Research Authority, 
NRES Committee South Central – Oxford C reviewed the research proposal 
in July 2015. The Ulster University’s Research Integrity and Ethics Filter 
Committee Faculty of Life and Health Science and South Eastern Trust’s 
Research Governance Committee have reviewed the research study in 
accordance with procedures. If you are interested you can contact the 
University or Trust for further details if you require them.  
 
Contact details  
Should you require any further details about this study please contact the 
researcher, Julie-Ann Augusto, on Telephone number 07979365939 or 
walkden-j@email.ulster.ac.uk  
(Of note: Augusto was the married name of the researcher, who is now Walkden) 
10.24 k ox Invitation letter - Practitioner  
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Re: - Optimisation of Vital Sign Remote Telemonitoring (Practitioner Semi-
Structured Interviews) 
 
You are being invited to take part in a research study by the Ulster University. 
Before you decide whether or not to participate in the project, it is important 
that you understand what the research is for and what you will be asked to 
do. Please read the enclosed Participant Information Sheet and do not 
hesitate to ask any questions about anything that is unclear. Please make 
sure that you are happy before you decide what to do. Thank you for taking 
the time to consider this invitation.  
 
I would like to learn about your experience of Remote Telemonitoring Service 
so that I can understand what works for whom in what circumstances.  I am 
interested in your experiences, whether you are a current staff user or you 
have used Remote Telemonitoring in the recent past.  Your answers will be 
useful and will only be used for the purpose of this project. 
 
If you agree, I ask you to do three things: 
1. To spend some personal private reflective time, before we meet, 
considering your experiences as a practitioner of observing, directing or 
commissioning RTM. 
2. To participate in a one-to-one semi-structured interview with me. This is 
your time to share your reflections, feelings, experiences, attitudes and 
thoughts about RTM. The one-to-one interview can be conducted at a 
venue and time of your choice and is expected to last about an-hour. It 
will be your opportunity to share your experience and knowledge.  
3. To consider participating in a workshop that will last up to 2-hours to be 
held in the Innovation Centre, Ulster Hospital. If you choose to attend this 
workshop in addition to the interview, you will be able to discuss initial 
findings with fellow participants.  
 
The record of your interview and follow-up workshop will be kept confidential 
and securely. Your comments will not be attributable but your views will help 
create recommendations to shape the future development of the RTM service.   
 
Whilst you may make reference to case studies you may have known about 
to help illustrate your experience during interview session, it is understood 
and accepted that patient confidentiality must not be breached and the 




It must also be noted that if you disclose information of a concerning nature 
during interview, e.g. information relating to matters of governance, I will be 
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duty bound to report serious concerns to the Trust’s Research Governance 
Manager.     
 
I hope you remain willing to participate and I will contact you shortly to offer 
possible interview dates.  
 




Julie-Ann Augusto (formerly Walkden)  
PhD Research Student 
10.25 l ox Invitation Letter – Manager 




Re: - Optimisation of Vital Sign Remote Telemonitoring (Senior Officer Semi-
Structured Interviews) 
 
You are being invited to take part in a research study by the Ulster University. 
Before you decide whether or not to participate in the project, it is important 
that you understand what the research is for and what you will be asked to 
do. Please read the enclosed Participant Information Sheet and do not 
hesitate to ask any questions about anything that is unclear. Please make 
sure that you are happy before you decide what to do. Thank you for taking 
the time to consider this invitation.  
 
I would like to learn about your experience of Remote Telemonitoring Service 
so that I can understand what works for whom in what circumstances.  I am 
interested in your experiences, whether you are a current or past manager/ 
director related to Telemonitoring.  Your answers will be useful and will only 
be used for the purpose of this project. 
 
If you agree, I ask you to do two things: 
1. To spend some personal private reflective time, before we meet, 
considering your experiences as a practitioner of observing, directing or 
commissioning RTM. 
2. To participate in a one-to-one semi-structured interview with me. This is 
your time to share your reflections, feelings, experiences, attitudes and 
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thoughts about RTM. The one-to-one interview can be conducted at a 
venue and time of your choice and is expected to last about an-hour. It 
will be your opportunity to share your experience and knowledge.  
 
The record of your interview will be kept confidential and securely. Your 
comments will not be attributable, but your views will help create 
recommendations to shape the future development of the RTM service.   
 




Julie-Ann Augusto (formerly Walkden)  
PhD Research Student 
 
 
10.26 m ox Semi-Structured Interviews - Practitioner 
 
INTERVIEW GUIDE  
Optimisation of Vital Sign Remote Telemonitoring (RTM) - PhD 
Programme 
(RTM Senior Healthcare Professionals Semi-Structured Interviews) 
 
Participant Name:          ______________________________ 
Designation:           ______________________________ 
Year of Graduation:          ______________________________ 
Primary Qualification:       ______________________________ 
Contact Phone Number:   ______________________________ 
Contact e-mail address:   ______________________________ 
 
Experience of RTM Patient/ Disease Group: 
_____________________________________________________________
______ 
Date and time Interview conducted by Julie-Ann Augusto, researcher and 
Small Business Research Initiative Executive in Business Services 
Organisation: _______________________ 
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SEMI-STRUCTURED QUESTIONS:- 
 
1. Describe your experience with RTM and feel free to illustrate your 
experiences with reference to anonymous case studies – please 
remember not to disclose patient or carer details… 
 
2. Have you received training in RTM?  
a. If so please could you describe it and your views relating to RTM 
training… 
3.  Please tell me about how you use RTM. 
a. Do you tend to use track and trend or triage?  
b. Why do you make this choice? 
4. Which peripheral devices do you tend to choose and why? 
5. Please tell me what you have found works best for your patients and in 
what circumstances 
6. Are your thoughts and feelings generally positive, neutral or negative 
about RTM?...  
7. Do you choose to use RTM or are you given a quota by management to 
use the service? 
8. Do you think RTM is value for money?...  
9. If we now think just about the HPSS commissioned end-to-end service 
provided by the supplying consortium TF3 or U-TELL (Depends on 
practitioner’s experience – will be one or the other)  
a. What are your thoughts on this service? 
b. If you think the service could have been delivered more effectively 
please describe this? 
c. What do you believe are or would be the key factors to make 
deployment of this type of service most effective? 
d. What are our lessons learned from your perspective? 
10. What are the barriers to RTM from your perspective?... 
11. What is the future for RTM from your perspective?... 
12. Is there anything else you would like to tell me about RTM or technology 
in healthcare in general?.... 
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10.27 l ox Semi-Structured Interviews - Manager 
INTERVIEW GUIDE  
Optimisation of Vital Sign Remote Telemonitoring (RTM) - PhD 
Programme 
(RTM Senior Healthcare Officer Semi-Structured Interviews) 
 
Participant Name:          ______________________________ 
Designation:           ______________________________ 
Year of Graduation:          ______________________________ 
Primary Qualification:       ______________________________ 
Contact Phone Number:   ______________________________ 
Contact e-mail address:   ______________________________ 
 
Experience of RTM Patient/ Disease Group: 
_____________________________________________________________
______ 
Date & time Interview conducted by Julie-Ann Augusto, researcher and Small 





1. Describe your experience with RTM and feel free to illustrate your 
experiences with reference to anonymous case studies – please 
remember not to disclose patient or carer details… 
 
2. Have you received training in RTM?  
a. If so please could you describe it and your views relating to RTM 
training… 
3.  Please tell me about how you think we could use RTM. 
a. Describe use of track and trend or triage?  
b. Why would you make this choice? 
4. Which peripheral devices do you are or would be useful and why? 
5. Please tell me what you think works best for which patients and in what 
circumstances 
6. Are your thoughts and feelings generally positive, neutral or negative 
about RTM?...  
7. Do you think practitioners should have the choice to use RTM or should 
they be given a quota by management to use the service? 
8. Do you think RTM is value for money?...  
9. If we now think just about the HPSS commissioned end-to-end service 
provided by the supplying consortium TF3 or U-TELL  
a. What are your thoughts on this service? 
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b. If you think the service could have been delivered more effectively 
please describe this? 
c. What do you believe are or would be the key factors to make 
deployment of this type of service most effective? 
d. What are our lessons learned from your perspective? 
10. What are the barriers to RTM from your perspective?... 
11. What is the future for RTM from your perspective?... 
12. Is there anything else you would like to tell me about RTM or technology 
in healthcare in general?.... 
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APPENDIX 5 ACTION RESEARCH EXPANDED 
EXPLANATION 
10.28 Option 4 – Action Research: a fuller explanation of the 
methodology as the initial design was to utilise this approach. 
It was proposed that Action Research would be utilised given that the thoughts, 
feelings and behaviours of research participants was of interest within a context 
of patient centred care. Action Research, and most particularly Transformational 
Action Research, was initially selected as the Methodology to be applied and has 
been defined as follows... 
“Transformational action research promotes transformation as both end and 
means of research. In addition to knowledge creation, there is a concern with 
transformation of self and, if they so wish, with facilitated transformation of co-
researchers, participants and other stakeholders …. It can lead to human 
flourishing, in creative, spiritual and ethical senses, of both recipients of the 
research and those undertaking it (adapted from Titchen and Armstrong. 
2007)” (Titchen, McCormack and Manley, 2013).  
 
It was proposed that through the Methodology of Action Research, 
complemented and informed by the structured methods of data collection, the 
specific framework for success in RVT deployment would be synthesised to 
demonstrate alternative value and the expressed opinions of research 
participants. Early indications suggested a degree of correlation between a model 
for optimisation of RVT with the Alberta Context Tool but recognising the need to 
extend beyond to encompass purposeful application, multi-professional learning, 
support with specific training, enabling environment and supportive leadership.  
Furthermore, the MRC Framework (Craig et al. 2008) recognised that the 
complex interventions may demonstrate success if designed within a local 
context. However, any potential framework of critical success factors or added 
value created within the context of the South Eastern Trust’s RVT could be 
designed and suggested with transferability as an outcome or suggested utility 
but would be dependent upon data analysis. Transformational Action Research 
recognised the softer more creative metrics and allowed the clinical practitioners 
to analyse, interpret and personally develop themselves. 
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The utilisation of existing data was proposed as a method of enquiry to inform 
the workshops. It was proposed that the Transformational Action Research 
would add creative ecological and spiritual dimension to practice 
development, essentially permitting practitioners to develop their service and 
modality of care.  As a methodology it is useful in the context of RVT as there 
are many variables, fluidity within a developing arena and the need for on-
going iterative improvement and experimentation. It was believed that for this 
to happen the current context must be evaluated to inform programme 
development. Essentially when transformation action research commences 
practitioners would be proactively encouraged and enabled to make iterative 
improvements, but the context should be known to promote innovation and 
freedom to practice. A significant feature of the research is the development 
of practitioners, within the context of adoption of technology, and the 
improvement of patient care. In order to reduce the risk of bias or influence by 
the researcher within the iterative development expected in Transformational 
Action Research, the enquiry may be generated by those involved in the 
service rather than channelled by the researcher. It was recognised that it may 
not be possible, or even necessary to eliminate all researcher-bias. By 
involving service users and carers, through the application of a questionnaire 
it was deemed likely to maintain the patient centric focus; service user 
perception utilised to encourage and harness practitioners to change practice 
thus permitting patients to contribute to the shape of care to come. 
 
The possible modes of enquiry could have included the utilisation of a 
questionnaire and direct engagement of practitioners within workshops/ 
cycles of intervention. Practitioners, regardless of discipline or disease area, 
would be enabled to participate in a safe environment, where they could be 
given the opportunity to expressively share, learn, flourish and create. 
Transformational Action Research could be applied purposefully, and it is 
anticipated that it will enable practitioners to innovate, change, reform, 
develop and enable time for reflective practice (Titchen, McCormack and 
Manley. 2013). The practitioner group sessions, whilst permitting time for 
reflective activity, could be augmented by the application of Bryson’s 
Cognitive Mapping (Bryson. 1995) to elicit answers to intrinsic conundrums 
that exist revolving around the notion of Enabling Environments 
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(Hackman.2002). As a starting point, researcher intended to challenge 
practitioners with the question, ‘what do we/ I need to do to utilise RVT 
effectively within our/ my area of service delivery?’ In addition, the findings of 
the questionnaires from across the participant groups would provide 
quantitative data to demonstrate if the service had improved and qualitative 
narrative to describe the change and benefit. Three Transformational Action 
Research cycles were proposed as illustrated in the Figure 10.2. 
 
 
Figure 10.2: To illustrate the transformation action research cycle 
 
In planning the Transformational Action Research and determination of the 
critical success factors, it was planned that practitioners would be engaged in up 
to three cycles of group work following the principles of Action Research. The 
nature of the second and third cycles could have varied dependent upon the 
outcome of the first cycle or intervention. In each cycle the expectation is that the 
practitioners are expected to learn and adapt the mode of deployment to test if 
improvement has been made. This process acknowledged that only once the 
practitioners can articulate their outcomes and experiences, can a determination 
be made about the nature of the second intervention. Ergo, there would be a need 
to allow the second and third cycles, in the iterative process of Transformational 
Action Research, to vary and set their own improvement agenda. This approach 
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was seriously considered because it permitted freedom of expression for 
practitioners and for the researcher to enable through allowing the practitioner to 
control the direction of service development and outcome of research. Prior to 
the group sessions practitioners were to be encouraged to be reflexive and to 
complete a short on-line questionnaire. It was intended that the findings from the 
questionnaires would influence the design of the discussion to elicit from the 
practitioners the environmental factors to optimise RVT application and 
practitioner development. Whilst Hermeneutic Analysis was suggested to be 
applied to the findings of the initial part of the Transformational Action Research 
session the group of practitioners were to be encouraged to participate in 
Bryson’s technique for Cognitive Mapping, an example of a potential map is 
illustrated in Figure 10.3 
 
Figure 10.3: An illustration of an example cognitive map 
It was proposed that Bryson’s Technique for Cognitive Mapping Software would 
be applied to show power relationships and order of magnitude of emerging 
factors, benefits, issues and topics for consideration. The Bryson Technique 
permits the voices of all practitioners to be heard. As a process of engagement 
and eliciting ideas ergo data acquisition it facilitates anonymity, if the contributor 
prefers, during the group sessions and equally permits open discussion and 
disclosure (Bryson et al. 1995). The participants themselves make sense of the 
information presented which further enhances ownership. Within the context of 
Transformational Action Research, a key objective is that practitioners 
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themselves benefit and flourish through the process of participation. Indeed, it 
was expected to take practitioners from the present, to the future of technology 
appropriately embedded into practice to improve therapeutic benefit and patient 
outcomes. The output of the Action Session will be three-fold, through the 
utilisation of photographs the practitioners will be able express how they feel 
about connected health and that can be tracked over time, an affinity diagram/ 
cognitive map and an individually tailored action plan for each participant. The 
third output being the change to be evaluated; understanding of the outcome 
benefits. 
 
Moreover, to augment this method, Hermeneutic Phenomenological research 
method was proposed to be utilised to capture the essence of how practitioner’s 
lived experience shapes the development of practice within RVT (Karle. 2011). 
This was only to be undertaken during the opening session to enable free 
expression to be evaluated. It was intended that the practitioners would benefit 
from a safe environment to constructively express their issues and concerns and 
to enable iterative learning across clinical specialisms and professions. Learning, 
growth, practice and service development will be enabled. Concomitantly, 
practitioner debate and sharing of opinions were to be observed, challenged, 
documented and ideas deployed. There were to be three cycles of practitioner 
development at 6-monthly intervals involving representative RVT practitioners 
from across the disease groups and geography of SET. It was considered that if 
after two cycles, it was determined that options were exhausted or responses 
from participants saturated the third and final cycle may encompass a wider group 
of participants from across the region to test acceptability of beneficial factors. 
This approach was designed to enable the scope to be controlled whilst 
permitting a holistic and in-depth review of optimisation of RVT, identification of 
service user perceived benefits and/ or harm and enabling new knowledge to be 
created. 
 
However, whilst the methodology of Transformational Action Research was 
initially favoured to determine the answer to the overarching research question, 
a decision was taken to terminate the plan and change methodology. There were 
two key drivers, the first was that the methodology was far too complex and 
although compelling was not well proven. The second driver for change of 
Critical Appraisal of Remote Vital-Sign Telemonitoring 
396  Julie-Ann Walkden - July 2020 
research methodology was a serious lack of willingness to participate if Action 
Research was utilised, this was derived from a group meeting with SET RVT 
practitioners. Given that Action Research as a methodology is structured to 
embolden the practitioner to direct the research the methodology and data 
collection tools, methods and activities were shared with potential research 
participants. The response was such that researcher decided that pursuing the 
approach would be unproductive; 80% of the practitioners confirming that they 
would feel uncomfortable, were sceptical, decided it was too demanding of their 
time and resources and so could not consider consenting to participate. 
Therefore, whilst the researcher believed there were significant merits to the 
methodology the research design process would have to be reconsidered as 
without willing voluntary participation the outcome of research would be weak and 
findings inconclusive.  Despite the methodology being planned to an advanced 
stage there were too many barriers to proceed.  
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APPENDIX 6 RESEARCH ETHICS AND GOVERNANCE 
APPROVALS 
10.29 Health Research Authority Approval 
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Health Research Authority’s reproduced text:- 
20 July 2015  
  
Professor George Kernohan Institute of Nursing and Health Research Ulster 
University Shore Road, Newtownabbey. BT37 0QB  
  
Dear Professor Kernohan  
  
Study title: Exploring the conditions for optimisation of vital sign remote 
telemonitoring in the care of people with long term conditions REC reference: 
15/SC/0424 Protocol number: None IRAS project ID: 155990  
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Thank you for your letter of 17th of July, responding to the Proportionate 
Review Sub-Committee’s request for changes to the documentation for the 
above study.  
  
The revised documentation has been reviewed and approved by the sub-
committee.  
  
We plan to publish your research summary wording for the above study on 
the HRA website, together with your contact details. Publication will be no 
earlier than three months from the date of this favourable opinion letter.  The 
expectation is that this information will be published for all studies that receive 
an ethical opinion but should you wish to provide a substitute contact point, 
wish to make a request to defer, or require further information, please contact 
the REC Manager Mr Mark Dawson, nrescommittee.southcentral-
oxfordc@nhs.net. Under very limited circumstances (e.g. for student research 
which has received an unfavourable opinion), it may be possible to grant an 
exemption to the publication of the study.  
  
Confirmation of ethical opinion  
  
On behalf of the Committee, I am pleased to confirm a favourable ethical 
opinion for the above research on the basis described in the application form, 




Conditions of the favourable opinion  
  
The favourable opinion is subject to the following conditions being met prior 
to the start of the study.  
  
Management permission or approval must be obtained from each host 
organisation prior to the start of the study at the site concerned.  
  
Management permission (“R&D approval”) should be sought from all NHS 
organisations involved in the study in accordance with NHS research 
governance arrangements.  
  
Guidance on applying for NHS permission for research is available in the 
Integrated Research Application System or at http://www.rdforum.nhs.uk.   
  
Where a NHS organisation’s role in the study is limited to identifying and 
referring potential participants to research sites (“participant identification 
centre”), guidance should be sought from the R&D office on the information it 
requires to give permission for this activity.  
  
For non-NHS sites, site management permission should be obtained in 
accordance with the procedures of the relevant host organisation.  
  
Sponsors are not required to notify the Committee of approvals from host 
organisations.   
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Registration of Clinical Trials  
  
All clinical trials (defined as the first four categories on the IRAS filter page) 
must be registered on a publicly accessible database. This should be before 
the first participant is recruited but no later than 6 weeks after recruitment of 
the first participant.  
There is no requirement to separately notify the REC but you should do so at 
the earliest opportunity e.g. when submitting an amendment.  We will audit 
the registration details as part of the annual progress reporting process.   To 
ensure transparency in research, we strongly recommend that all research is 
registered but for non-clinical trials this is not currently mandatory.   If a 
sponsor wishes to request a deferral for study registration within the required 
timeframe, they should contact hra.studyregistration@nhs.net. The 
expectation is that all clinical trials will be registered, however, in exceptional 
circumstances non registration may be permissible with prior agreement from 
NRES. Guidance on where to register is provided on the HRA website.  
  
It is the responsibility of the sponsor to ensure that all the conditions are 
complied with before the start of the study or its initiation at a particular site 
(as applicable).  
  
Ethical review of research sites  
  
The favourable opinion applies to all NHS sites taking part in the study, subject 
to management permission being obtained from the NHS/HSC R&D office 





Approved documents  
  
The documents reviewed and approved by the Committee are:  
  
Document   Version   Date   Evidence of Sponsor insurance or indemnity (non 
NHS Sponsors only) [Ulster University Indemnity]  1  17 June 2015  Interview 
schedules or topic guides for participants [semi structured interviews - staff 
practitioner  ]  v2  14 July 2015  Interview schedules or topic guides for 
participants [semi structured interviews - staff manager]  v2  14 July 2015  
IRAS Checklist XML [Checklist_17072015]    17 July 2015  Letter from 
sponsor [Ulster University sponsor letter]  1  17 June 2015  Letter from 
statistician [Comments from Paul Slater Sample Size and Statistical Plan]  v1  
29 April 2015  Letters of invitation to participant [Letters of invitation to 
participant]  v7  14 July 2015  Letters of invitation to participant [Letters of 
invitation to participant]  v6  14 July 2015  Letters of invitation to participant 
[Letters of invitation to participant]  v2  14 July 2015  Letters of invitation to 
participant [Letters of invitation to participant]  v2  14 July 2015  Non-validated 
questionnaire [Patient questionnaire TF3]  v4  14 July 2015  Non-validated 
questionnaire [patient questionnaire UTELL  ]  v3  14 July 2015  Non-validated 
questionnaire [carer questionnaire TF3     ]  v4  14 July 2015  Non-validated 
questionnaire [carer questionnaire - UTELL  ]  v3  14 July 2015  Other [protocol 
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for dealing with issues  ]  v1  29 April 2015  Other [South Eastern Trust HR 
Policy  ]  v1  29 April 2015  Other [South Eastern Trust Complaints Policy  ]  
v1  29 April 2015  Other [CV for Trust PI Sarah Browne]  1  29 June 2015  
Other [Response to Oxford REC PRS Opinion]  v1  15 July 2015  Participant 
consent form [Participant Consent Form - Staff Member  ]  v4  14 July 2015  
Participant information sheet (PIS) [Participant Information Sheet - Patient/ 
Carer  ]  5  14 July 2015  Participant information sheet (PIS) [Participant 
Information Sheet - staff member  ]  v4  14 July 2015  REC Application Form 
[REC_Form_29062015]    29 June 2015  Referee's report or other scientific 
critique report [Ulster University Filter Committee approval]  v1  12 June 2015  
Referee's report or other scientific critique report [Peer review 1 - RG2 
Sinclair]  v1  29 April 2015  Referee's report or other scientific critique report 
[Action following Peer review 1 Sinclair]  v1  29 April 2015  Referee's report 
or other scientific critique report [Peer review 2 Stinson RG2]  v1  29 April 
2015  Referee's report or other scientific critique report [Action Following RG2 
peer review Stinson]  v1  29 April 2015  Referee's report or other scientific 
critique report [Ulster Uni Filter committee initial feedback]  v1  08 May 2015   
 
  
Referee's report or other scientific critique report [Action following Ulster Uni 
Filter committee initial feedback]   
v3  28 May 2015   
Research protocol or project proposal [  Exploring the conditions for 
optimisation of vital sign remote telemonitoring in the care of people with long 
term conditions   ]   
5  14 July 2015   
Summary CV for Chief Investigator (CI) [curriculum vitae Prof Kernohan (CI)]   
v1  29 May 2015   
Summary CV for student [CV Julie-Ann Augusto (student)]  v1  29 April 2015  
Summary CV for supervisor (student research) [CV Prof Kernohan 
(supervisor)]  v1  29 May 2015   
  
Statement of compliance  
  
The Committee is constituted in accordance with the Governance 
Arrangements for Research Ethics Committees and complies fully with the 
Standard Operating Procedures for Research Ethics Committees in the UK.  
  
After ethical review  
  
Reporting requirements  
  
The attached document “After ethical review – guidance for researchers” 
gives detailed guidance on reporting requirements for studies with a 
favourable opinion, including:  
  
 Notifying substantial amendments  Adding new sites and investigators 
 Notification of serious breaches of the protocol  Progress and safety 
reports  Notifying the end of the study  
  
The HRA website also provides guidance on these topics, which is updated 
in the light of changes in reporting requirements or procedures.  
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You are invited to give your view of the service that you have received from 
the National Research Ethics Service and the application procedure.  If you 
wish to make your views known please use the feedback form available on 
the HRA website: http://www.hra.nhs.uk/about-the-hra/governance/quality-
assurance   
  
We are pleased to welcome researchers and R & D staff at our NRES 
committee members’ training days – see details at http://www.hra.nhs.uk/hra-
training/   
  
15/SC/0424   Please quote this number on all correspondence  
  
  
With the Committee’s best wishes for the success of this project.  
  




PP Professor David Scott Vice-Chair  
  
Email: nrescommittee.southcentral-oxfordc@nhs.net  
  
Enclosures:    “After ethical review – guidance for researchers” [SL-AR2]  
  
Copy to: Mr Nick  Curry  
  
Mr Paul Carlin, South Eastern Health and Social Care Trust  
 
07 January 2017  
  
Professor George Kernohan Institute of Nursing and Health Research Ulster 
University Shore Road, Newtownabbey. BT37 0QB  
  
  
Dear Professor Kernohan   
  
Study Title: Exploring the conditions for optimisation of vital sign remote 
telemonitoringin the care of people with long term conditions REC reference: 
15/SC/0424 Protocol number: None IRAS project ID: 155990  
  
Thank you for sending the progress report for the above study dated 17 
August 2016. The report will be reviewed by the Chair of the Research Ethics 
Committee, and I will let you know if any further information is requested.  
  
The favourable ethical opinion for the study continues to apply for the duration 
of the research as agreed by the REC.   
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15/SC/0424:     Please quote this number on all correspondence  
  
Yours sincerely  
  
Amy Peters REC Assistant  
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10.30 South Eastern Trust Research Governance and Ethics 
Approval Letter 
 
Professor George Kernohan 
Institute of Nursing and Health Research 
Ulster University 










Dear Professor Kernohan 
 
 
Study Title: Exploring the conditions for optimisation of vital sign 
remote telemonitoring in the care of people with long term 
conditions 
 
HSC Trust Ref:  SET/15/17(Please quote this number in all future 
correspondence) 
IRAS Ref:        155990 
 
I am pleased to advise that the South Eastern H&SC Trust has given 
Research Governance Permission for the above project to commence.  
Permission is granted for the duration of the project to 31/08/2016 
 
The following documents have been approved for use in the project: 
 
Document Version Date 
Protocol 5 14/07/15 
Interview schedules or topic guides for 
participants (Semi structured interviews – 
staff practitioner) 
2 14/07/15 
Interview schedules or topic guides for 
participants (Semi structured interviews – 
staff manager) 
2 14/07/15 
Letters of Invitation to participant 7 14/07/15 
Letters of Invitation to participant 6 14/07/15 
Letters of Invitation to participant 2 14/07/15 
Letters of Invitation to participant 2 14/07/15 
Non –validated questionnaire (Patient 
Questionnaire TF3)  
4 14/07/15 
Non-Validated Questionnaire (Patient 
Questionnaire UTELL) 
3 14/07/15 
Non-Validated Questionnaire (Carer 
questionnaire TF3) 
4 14/07/15 
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Non-Validated Questionnaire (Carer 
questionnaire UTELL) 
3 14/07/15 
Other Protocol for dealing with issues 1 29/04/15 
Other SEHSCT HR Policy 1 29/04/15 
Other SEHSCT Complaints Policy 1 29/04/15 
Participant Consent Form – Staff 
Member) 
4 14/07/15 
Participant Information Sheet (PIS) – 
Patient/Carer 
5 14/07/15 




The following personnel have been approved to work on the study at this 
Trust: 
 
Name Indemnity Provided by 
Julie-Ann Augusto HSCNI 
Sarah Browne SET 
 
Permission is granted subject to the attached conditions which I would ask 
you to please ensure that all members of the research team make themselves 
familiar.  Failure to abide by these conditions will invalidate permission and 
may result in the cessation of the research. 
 
I wish you every success with your project. 
Yours sincerely, 
 
                             _     _ 
Mr Paul Carlin 
Research Manager 
Copy to: Julie-Ann Augusto 
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Conditions of Permission 
 
Research Governance permission is issued provided the researcher(s) 
involved adhere to and abide by the conditions below. 
 
• The researcher(s) must adhere strictly to the research protocol. 
 
• There must be no changes to the research protocol or approved study 
documentation without the prior consent of the Trust, the Research Ethics 
Committee and, where applicable, the MHRA. 
 
 
• There must be no changes in research staff without prior consent of the 
Trust. 
 
• The Research Office should be informed if the Chief Investigator or Principal 
Investigator(CI/PI) is unable to continue to fulfil his/her duties as CI/PI for 
any reason such as long term absence, change in employment etc. 
 
 
• There must be no increase in the resources required without prior consent of 
the Trust. 
 
• Researcher(s) must report all untoward incidents and serious adverse 
events to the Trust.   
 
 
• Any concerns in relation to the research protocol must be reported to the 
Trust. 
 
• Researcher(s) must adhere to good research practice principles in line with 
the ICH Good Clinical Practice (GCP) guidelines. 
• Researcher(s) must adhere to the Trust’s Research & Development  
Standard Operating Procedures (available from the Research Office on 
request) 
 
• On request, researcher(s) must make their research project available to 
Trust appointed monitors. 
 
 
• The lead researcher must make an annual report to the Research Office for 
the duration of the project. 
 
• The lead researcher should inform the Research Office on completion or 
termination of the project.   Completion reports must be sent to the Research 
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10.31 Ulster University Filter Committee Approval 
UNIVERSITY OF ULSTER     RESEARCH GOVERNANCE 
RG3 Filter Committee Report Form  
 
 









Filter Committee  
 
This form should be completed by Filter Committees for all research project 
applications in categories A to D (*for categories A, B, and D the University’s 
own application form – RG1a and RG1b – will have been submitted; for category 
C, the national, or ORECNI, application form will have been submitted). 
 
Where substantial changes are required the Filter Committee should return an 
application to the Chief Investigator for clarification/amendment; the Filter Committee 
can reject an application if it is thought to be unethical, inappropriate, incomplete or 
not valid/viable.   
 
Only when satisfied that its requirements have been met in full and any 
amendments are complete, the Filter Committee should make one of the 
following recommendations: 
 
The research proposal is complete, of an appropriate standard and is in   
 
• category A and the study may proceed*  
 
• category B and the study must be submitted to the University’s Research Ethics  




• category C and the study must be submitted for approval along with the necessary 
supporting materials from the Research Governance Section*** 
 







*The application form and this assessment should now be returned to the Chief Investigator.  
The Filter Committee should retain a copy of the complete set of forms. 
Signed:    
        Date: 10 June 2015 
 Nursing and Health Research Filter Committee  
 
Exploring the conditions for optimisation of 
vital sign remote telemonitoring in the care of 
people with long term conditions.  
Professor George Kernohan  
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** The application form and this assessment should now be returned to the Chief Investigator 
so that he/she can submit the application to the UUREC via the Research Governance section.  
The Filter Committee should retain a copy of the complete set of forms for their own records. 
 
*** The application form and this assessment should now be returned to the Chief Investigator 
so that he/she can prepare for application to an appropriate committee.  The Filter Committee 
should retain a copy of the complete set of forms for their own records. 
 
For all categories, details of the application and review outcome should be minuted using the 





Please complete the following 
       
The application should be accompanied by an appropriate and favourable Peer 
Review Report Form (if not, the Filter Committee should be prepared to address this 
as part of its review).  Please comment on the peer review (include whether or not 
there is evidence that the comments of the peer reviewers have been addressed). 
 
Peer review is complete and issues arising in ethical review have been addressed.  
 
 
Please provide an assessment of all component parts of the application, including 
questionnaires, interview schedules or outline areas for group 
discussion/unstructured interviews. 
 
This is a service-user questionnaire survey; one-to-one interviews with relevant staff,  
followed by a staff workshop to further verify findings. 
 
 
Please comment on the consent form and information sheet, in particular the level of 
language and accessibility. 
 
 
Completion of the survey may be taken to imply consent for the data to be used for research 
purpose and this will be explained. This project will not include data of a personal nature  
Committee noted that service use data is accessible as per Trust approval. 
 
 
Please comment on the qualifications of the Chief and other Investigators.  
 
Acceptable qualifications of the investigators for the proposed work. The researcher has a 
permanent and substantive contract of employment with SET and so is governed by 
governance relating to patient confidentiality.  
 
 
Please comment on the risks present in conducting the study and whether or not they 
have been addressed.  
 
 
No serious risk of harm has been identified. 
 
 
Please indicate whether or not the ethical issues have been identified and addressed.
    
 
The benefit in new knowledge gained will outweigh any risk of harm or inconvenience. In 
order to address any specific disclosure of poor practice in remote monitors, data will be 
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pseudo-anonymous (coded). The code will only be used in this event, so participant 
withdrawal will not affect data analysis. 
 
 
Please comment on whether or not the subjects are appropriate to the study and the 
inclusion/exclusion criteria have been identified and listed 
 
Appropriate subjects have been identified for study based upon their involvement as a user 
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APPENDIX 7 RESEARCH GOVERNANCE  AUDIT REPORT 
10.32 Undertaken Ulster University Jordanstown 16th 
October 2017 
RESEARCH GOVERNANCE AUDIT REPORT (Responses on page 2) 
Date: 16/10/17    Location:  Jordanstown 
 
Title: Exploring the conditions for optimisation of vital sign remote telemonitoring 
in the care of people with long term conditions 
 
Number:      15/0065     
 
Investigators interviewed:  CI:  Prof G Kernohan; Dr P McCullagh 
  
 
Proposed start date:   01/09/15    
    
Proposed end date:   30/11/17    
 
Date of approval by ORECNI: 20/07/15  
 
Original protocol being followed: Yes, data collection completed   
 
Number of participants approved: 280 service users – questionnaire 
 estimated 90 carers – questionnaire 
 20 staff – semi-structured interviews 
 12 Trust practitioners (validation workshop)  
 
Number recruited to date: 168 service users and carers  
16 staff  
 
Tissue or blood samples: N/A  
 
Transfer of samples: N/A  
 
Data anonymised: Yes  
 
Data storage/retention: Hard copies presented for this review but are 
normally kept on Trust premises. Will be 
transferred to CI after study completion. 
Electronic date will be transferred to CI after 
study completion. The office in the Trust is 
locked. No patient identifiers. Separate hard 
copy control list 
 
Retention of correspondence: UU approval letter - No   
     Indemnity statement - Yes  
       Copy of CI undertaking - No  
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Consent forms: Counted and checked, no issues.   
 
Information sheet: The patient/carer info sheet had a version 
number discrepancy. CI to check 
 
Data Protection, IP, Publication: Aware.  
 





1. Research Governance to provide a copy of University approval letter and 
indemnity statement 
Done. Received with thanks, 17/11/17 
 
2. CI to check and confirm that the approved version of the patient/carer information 
sheet was used 
 
Checked at PhD supervision 22/11/17. Investigators are satisfied that the 
correct version of information sheets were used. In detail: 
The versions of participant information sheets and all 4 questionnaires issued 
were correct and as per the version numbering on IRAS. Some documents 
were V3 (U-Tell) and others V4 (TF3 & general info sheet) but the critical date 




3. PhD student to discuss the back-up of electronic data with the CI, to prevent data 
loss   
Checked at supervision 22/11/17. All material is backed up:- on laptop, on 
HSC Server and on 2 encrypted pen drives. 
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APPENDIX 8 INITIAL FINDINGS OF QUANTITATIVE DATA 
REPORTED TO PARTICIPANTS VIA TRUST WEBSITE 
10.33 Patient and Carer Questionnaire Basic Findings 
Report 
 
SOUTH EASTERN TRUST & ULSTER UNIVERSITY 
 










Report compiled by: 
Julie-Ann Walkden 
PhD Student 
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Introduction 
 
A survey was carried out as part of a research data collection phase for a 
PhD research project. All South Eastern Trust patients in receipt of a 
Remote Telemonitoring Service in August 2015 were invited to participate in 
the research. On the 1st September, the PhD student sent to all eligible 
patients a pack containing: 
• A cover letter inviting participation in research 
• A participant information sheet to explain the research 
• A patient questionnaire 
• A questionnaire to be given to carers as appropriate 
• Stamped addressed return envelopes 
 
For those wanting to participate they returned their completed 
questionnaires to the Safe and Effective Care Department, South Eastern 
Trust by 18th September.  
 
In July, 2015, the researchers gave an undertaking to the Committee which 
reviewed the ethical considerations of the research project (the Proportionate 
Review Sub-Committee of the Health Research Authority, NRES Committee 
South Central – Oxford C), to share basic feedback with participants by 
publishing a short report on the Trust’s Website, www.setrust.hscni.net from 
31st March 2016. 
 






The researcher wanted to learn about the experience of patients who used 
either the u-Tell or TF3 Remote Telemonitoring Service so that care could be 
improved in the future.  The research was interested in patient and user 
experiences, whether a current user or user in the recent past or are a carer 
of someone who had used the system. All answers were of interest and will 
only be used for the purpose of this project. 
The questionnaires were colour coded: 
• u-Tell patient questionnaire was printed on blue paper 
• u-Tell carer questionnaire was printed on pink paper 
• TF3 patient questionnaire was printed on white paper 
• TF3 carer questionnaire was printed on yellow paper 
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Sample Population 
 
The research identified patients who were eligible to become participants 
and would be asked to complete the questionnaires. 
• There were 32 patients who used the u-Tell Remote Telemonitoring 
Service 
• There were 242 patients who used the TF3 Remote Telemonitoring 
Service 
o Of note, the researcher could not determine how many carers may 
be likely to respond as records were not available to assess this. 
 
Response rate 
   
• Of the 32 u-Tell questionnaires issued, 17 were returned, thereby 
yielding a response rate of 53% (blue questionnaires) 
o There was 1 Carer questionnaire returned completed (pink 
questionnaires) 
• Of the 242 TF3 questionnaires issued, 74 were returned, thereby yielding 
a response rate of 30.5% (white questionnaires) 
o There were 59 Carer questionnaires returned completed (yellow 
questionnaires) 
 
Analysis of questionnaires 
 
Questionnaires were analysed using the analytical tool SPSS (Statistical 
Package for Social Services). All responses to, both ‘tick box’ questions and 
‘free text’ narrative descriptions of service and experience were transcribed 
and typed. These records will be analysed in detail as part of the PhD 
research and will be discussed within the final report. However, a general 
overview of opinion expressed by patients and carers is that they were 
generally happy with Remote Telemonitoring. Many patients believed they 
were better supported with some participants using u-Tell reporting that 
Remote Telemonitoring gave them freedom. Some participants made 
practical suggestions as to how the Remote Telemonitoring services should 
be improved.  
 
The researchers wish to thank all the patients and carers who participated 
and to Claire Robinson of the South Eastern Trust’s Safe and Effective Care 
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APPENDIX 9 QUALITATIVE DATA SUMMARY TABLES 
10.34 Practitioner NVivo Data 
 
Table 10.6 To demonstrate the distribution of opinions and perspectives 














            
a 
Experience as a 
manager 
commissioner or 
Practitioner     3 6 
a   
Long term 
service   3 6 
b 
Feelings towards 
RVT     16 49 
b   Feel negative   5 13 
b     obtrusive 2 3 
b     
System can't 
be installed 3 3 
b   Feel neutral   4 5 
b   Feel Positive   15 31 
c 
Opinion 
expressed RTNI     16 144 
c   
Administrative 
support   1 1 
c   
Blood 
Pressure Cuff   2 2 






technology   10 14 
c   
Contact by 
email   2 3 
c   
Diabetes 
equipment   3 9 
c   Discharge   2 2 
c   INR   2 2 
c   
Monitoring 
some   2 2 
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unnecessary 
VS 
c   
Referral 
Process   7 22 
c   
Respiratory 
Equipment   5 11 
c   
Rural 
remoteness 
connectivity   3 7 
c   
Service 
creating work   10 17 
c   
What didn't 
work   11 34 
c   
What worked 
well   11 18 
d 
Opinion of models 
of RVT     14 38 
d   Track & trend   9 16 
d   Triage   9 18 
d   
Triage & track 
& trend   4 4 
e Training     16 32 
e   
More People 
Trained   5 5 
e   
RVT Training 
at time of 
service 
initiation   14 22 
e   
Train at 
University as 
Student   2 2 
e   
Training in 
RVT not on Uni 
curriculum   2 3 
f 
Staff Engagement 
Target     16 26 
f   
Chose to use 
RVT   9 10 
f   
Encouraged to 
use RVT   8 8 
f   
Management 
target   6 8 
g Value for money     16 25 
g   
Don’t know if 
Value for 
Money   11 13 
g   
No not Value 
for Money   5 9 
g   
Yes Value for 
Money   3 3 
h 
Outcome and 
Benefit     15 89 
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h   
Help people 
keep track 
Empower   12 58 
h   
Hospital 
attendances   7 16 
h   
Patient 
outcome 
negative   2 3 
h   
Patient 
outcome 
neutral   2 2 
h   
Patient 
outcome 
positive   8 10 
i Clinical Issues     16 174 
i   Anxiety   6 16 
i     
Increase 
Anxiety 4 7 
i     
Decrease 
Anxiety 3 5 
i   
Clinicians are 
Reluctant   5 6 
i   
Contact by 
Phone   8 13 
i   Duration   5 6 
i   
Extended 
Range of 
Conditions   2 3 
i   
Monitoring to 
adjust 
treatment   5 10 
i   
Need for better 
research   4 6 




technology   7 12 
i   
Patient 
Honesty   4 5 
i   
Patient 
identification 
process   13 58 
i   
Patient fear of 
technology   9 11 
i   
Patients own 
equipment   1 2 
i   Portal   3 5 
i   
Reading 
upload 
Frequency   5 6 
i     
Ad hoc 
submission 0 0 
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i     Frequent 1 1 
i     
Less than 3x 
per week 0 0 
i     Once a week 2 2 
i     
Very 
Frequent 0 0 
i     
Weekday 
submission 1 1 
i   Time   5 11 
i   
Work in a new 
way   2 4 
j 
Future of RVT the 
next generation     14 63 
j   
Electronic 
record   2 2 
j   
Need more 
Innovative 
Technology   12 61 
      
. 
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10.35 Manager NVivo Data 
Table 10.7 To demonstrate the distribution of opinions and perspectives 

















or Practitioner     8 21 
a   
Experience only 
as a manager or 
commissioner   8 21 
b 
Feelings 
towards RVT     8 11 
b   Feel negative   1 1 
b   Feel neutral   2 2 




RTNI     8 84 




kit   4 5 




kit   6 7 
c   
RVT TF3 service 
poor   3 6 
c   
Managers view 
of Referral Form   2 2 
c   RVT TF3 better   3 4 
c   
What the 
commissioners 
get wrong   7 27 
c   
Clinicians 
involved in 
service design   3 5 
c   
Contract 
Development 
Issues   2 3 




was required   5 12 
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design of service   1 3 
c   RVT purpose   1 4 
c   
Tech 
specification for 
contract   2 6 
d 
Opinion of 
models of RVT     7 20 
d   
Manager 
thoughts of track 
& trend   4 5 
d   
Managers 
thoughts triage   6 15 
e Training     8 16 
e   
No management 
training   7 11 




training   3 4 
e   
Managers view 
is that more 
training is or was 




Target     7 14 
f   
Set performance 
targets   6 9 
f   
Encourage 
engagement   4 5 
g 
Value for 
money     8 15 
g   
Don’t know if 
Value for Money   5 7 
g   
Not value for 
money   3 3 
g   
Yes value for 
money   4 5 
h 
Outcome and 
Benefit     8 36 
h   
Managers view 
of Patient and 
service user 
empowerment   6 17 




system   7 16 
h   
Utilisation 
Hospital 
Services   1 3 
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h     
RVT 
appropriate 
effect 0 0 
h     
RVT no 
effect 0 0 
h     
RVT 
reduced 
effect 0 0 
i Clinical Issues     8 110 
i   
Change or 
changed Clinical 
Practice    8 34 
i   
Clinical 
feedback   7 28 
i     
Clinical staff 
resistant to 
RVT 5 16 
i   
Managers view 
of Patient 
Identification   2 5 
i   Primary Care   2 6 
i   Research   7 26 
i   
Service user 
feedback   6 11 
j 
Future of RVT 
the next 
generation     8 74 
j   
Future service 
user 
engagement   5 18 
j   
Information is 
required for 
decision making   5 13 





technology   8 41 
j   NIECR   2 2 
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APPENDIX 10 DETAILED TRIANGULATION OF DATA  
10.36 Detailed Comparison of Data Streams 
10.36.1 ‘a’, Experience of RVT 
 
The overarching topic area of experience as a manager or commissioner or 
practitioner participant was split with noteworthy difference between the 
groups. The practitioner participants received formal training by the suppliers 
of technology, some had experience of early trials and all had developed their 
own personal knowledge through extended clinical practice. At least 50% had 
gained expert knowledge through being involved with research based clinical 
trials of the technology. The manager participant group had no direct 
experience with none having received formal training. Three of the managers 
had a clinical background and whilst holding strategic positions had close 
working with their specialist clinicians utilising the technology. One manager 
had an IT qualification so at least had a scientific understanding of possible 
case use and patient benefit but 50% only had observational and second-
hand information. Therefore, whilst the experience, skills and knowledge of 
senior executives within the Health and Social Care system was respected, 
greater weight and value was placed upon the opinions of practitioner 
participants. Moreover, as the nodal data was explored across the full range 
of topic areas the richness, apparent validity and the authority behind the 
narrative of the practitioner participants was recognised. Whereas, patient 
and carer participants received one-to-one training on a case by case basis 
and so were knowledgeable in the use of the equipment relevant for their own 
healthcare needs. The training received by patients at the time of installation 
helped to reduce anxiety associated with anticipation of being given new 
technology. Most (90) patients stated that the equipment was easy to use with 
64% strongly agreed with the statement that the equipment was easy to use. 
However, from a patient and carer perspective, whilst the technology was 
easy to use, there were two comments to suggest the reliability of the TF3 
home hub was questionable with ‘failure to upload' being cited as a reason for 
the triage nurses from the service contacting patients to repeat tests. In 
summary, overall training and experience of equipment was limited for 
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managers and was sufficient to enable use by practitioners, patients and 
carers.  
10.36.2 ‘b’, Summary overarching feelings towards RVT  
 
The two groups of staff participants had positive feelings towards RVT albeit 
the richness of data articulated by the practitioners gave a far fuller 
understanding of the rationale behind their feelings and their continued 
involvement in the service at the time of interview. On the other hand, the 
manager participants were positive but not to any meaningfully objective level 
with the positive affirmation relating to the opportunity to learn and to utilise 
information for decision making. Moreover, the strength of message from the 
Senior Civil Servant about failure to genuinely deliver the expected outcomes 
and therefore feelings were concomitantly negative. Five practitioner 
participants who expressed less than positive feelings did so framed within a 
potential risk of RVT becoming intrusive within a patient’s home, the very poor 
and laborious referral system associated with the TF3 service and limitation 
of the TF3 technology particularly connectivity where a mobile telephone 
network reception was limited or compromised. Such issues with the TF3 
system drove negativity for practitioners and failure to deliver expected 
outcomes for managers with positivity only reflected by better patient centred 
care for practitioners and the opportunity to exploit data for managers. Positive 
feelings towards RVT were generally expressed by patients and carers with a 
sense that care was patient centred due to an increased awareness of 
condition, peace of mind and feelings associated with empowerment. 
10.36.3 ‘c’, Wide-ranging opinions of RVT  
 
To compare and contrast this qualitative analysis section from the two data 
sources, the practitioner participants and the manager participants was 
interesting. These reflect the stance adopted by the manager participants who 
really were the commissioners of RVT for the region but for all intent and 
purposes were ‘onlookers’ who observed the outworking of a contract they 
had contrived and orchestrated. Whereas, the ‘lived experience’, expressed 
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by the practitioner participants, sharing RVT knowledge from personal clinical 
activity. Moreover, not only were the stances different but the manager 
participants only reflected upon their experience of the TF3 RVT whereas at 
least one quarter of practitioner participants also brought their experience of 
the U-Tell RVT into the discussion. The range of topics within this section 
varied where the manager participants demonstrated superficiality, if not 
frustration. From a strategic implementation perspective, the practitioner 
participants reflected a sense of ownership, personal contribution and effort 
with an improvement agenda being articulated. There were minor sub-node 
topics that could be compared; there were two significant contrasting sets of 
opinions expressed. The first is the referral form and the recognition of 
difference is clear. Two of the managers expressed a concern that the 
electronic referral form was a problem whereas most of practitioner 
participants (75% of those who primarily utilised the TF3 service) articulated 
a serious practical service issue with only the clinicians explaining the extent 
the barrier acted as a deterrent to referral and general use of the TF3 RVT 
service.  
The second area considered for comparison of the points of view is the idea 
of stakeholder engagement and the involvement of clinicians and or service 
users in service design. Both groups believe that co-creation, stakeholder 
engagement and meaningful clinical participation in the design phase were 
essential. The manager participants stated that clinical engagement did 
happen but that it could have had a broader base of engagement and been 
improved. The practitioner participants reported that they were involved and 
wanted to be involved but that the final decision making was made by the 
management. Therefore, real and meaningful engagement in future 
technology developments should be embedded and give authority for choice 
to the practitioners. The patients and carers did not express their opinions of 
RVT at the system or strategic perspectives rather from their own personal 
experience. Opinions were generally positive and supportive, articulated 
through agreement with statements to affirm utility and benefit with very few 
patients having a poor experience or less than encouraging opinion. Most 
patients (62) believed that they were more interested in using technology in 
general as a result of their experience with RVT. 
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10.36.4 ‘d’, Opinions of the models of RVT delivered 
 
Both participant groups shared their opinions of the different types of RVT 
albeit only four were able to reflect upon U-Tell RVT and the managers could 
only reflect upon the TF3 service. Overall, 21 participants contributed to the 
nodal topic. This topic really demonstrated the depth of understanding and 
meaning in relation to case use of triage versus track and trend. The 
managers all reiterated the contract narrative whereas the practitioner 
participants articulated their journey of learning and clinical application. No 
doubt clinical practitioners had given thought to the type of data collection and 
RVT that was appropriate for a group of patients but where parameters had 
to be set the task was undertaken on a personalised basis. One manager, 
with a non-clinical background, referred to a fault of clinical practice and a 
failure of clinicians to review cases as a reason for high alert rates i.e. 
suggesting the practitioners set parameters too low; whereas, the narrative of 
the practitioner respondents described a different scenario. Practitioners 
described exploratory activity when first utilising triage and how to effectively 
set patient vital sign parameters. Instead of ignoring alerts and resetting 
parameters, so as alerts would not occur, respiratory practitioners undertook 
an audit of clinical practice and alert data. The practitioners demonstrated 
meaning and effective utilisation of a well understood service for patients who 
were inherently unwell with chronic ill-health, seriously ill patients with non-
communicable diseases, particularly COPD, where there was not going to be 
a radicle improvement of health but the patient’s quality of life and well-being 
could undoubtedly be assisted through the appropriate and targeted 
intervention of a triage nurse and RVT. Patients and carers were not asked 
direct questions relating to models of care but as appropriate were asked 
about particular elements. The TF3 patients who required a triage service 
were asked about helpfulness; 93% of 68 TF3 patients agreed or strongly 
agreed that the actions of the triage nurses were generally helpful. Analysis 
from the two data paradigms would suggest general convergence in favour of 
the triage model for certain conditions. 
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10.36.5 ‘e’, The participants’ experience or opinion of RVT training 
and education 
 
The managers reported not having received any formal training beyond 
awareness sessions or three site visits; whereas the practitioner respondents 
did receive training in RVT. The staff and patients who used U-Tell received 
one-to-one tuition on three occasions prior to commencement whereas the 
staff who used TF3 reported group computer training on a dummy system and 
single demonstration at point of installation for patients. The U-Tell training 
was reported as superior to that provided to the practitioners who accessed 
TF3 as their mode of RVT. Five participants, one of whom was a manager, 
expressed concern by the absence of RVT awareness training in the 
undergraduate curriculum. 
As already discussed in 7.2.1, the patient’s and carer respondents recorded 
narrative in free text spaces of the questionnaires offering qualitative data as 
a contribution to the discussion in this topic area. Half of the participant service 
users expressed apprehension at the time of the RVT prescription but most 
(90) reflected the adequacy of one-to-one training at time of installation and 
that the systems were easy to use (Table 4.4).  
10.36.6 ‘f’, The encouragement of practitioners to engage, in 
particular the use of performance targets by managers 
 
This was an interesting topic to observe from the staff recipient’s experience 
and the perspective of the manager, as essentially it considers the 
management techniques to encourage or coerce practitioners to participate in 
RVT. In summary, the practitioner recognised that the managers had targets 
to achieve driven by simple contract performance metrics of patients utilising 
the system but took an approach not to be concerned by them. There certainly 
was not a naivety with the practitioners with regard to the need for resources 
to be put to good use as in general they reported that they utilised RVT as 
they wanted to, and observed, the wider clinical benefit of quality of life for 
their patients; empowering patients and improving quality of life was a 
motivator not management’s target setting. On the other hand, the managers 
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acknowledged that they did have targets and a performance management 
system with some contradictions, for example person-to-person engagement 
rather than the setting of targets versus performance target setting as a 
justified management tool. The one manager participant who lamented the 
notion of outcome-based metrics, which did not come to fruition, was in fact 
closer to the subjective measures clinician’s set themselves; using soft 
measures of personal experience on patient well-being as a driver to prescribe 
RVT. The patient and carer participants were not asked about system 
deployment or performance management nor did any participant express this 
topic area in free text opportunities. 
10.36.7 ‘g’, Perceived value for money of RVT 
 
The practitioner participants were removed from the practicalities of agreeing 
service levels, contract terms and conditions and payment of invoices and 
were only ever privy to the public announcements made by Permanent 
Secretaries at the Department of Health or Health Ministers. The majority, 
69% admitted not having the information to judge whether or not it was value 
for money. There were thoughts by some that it was poor value but countered 
by others who experienced U-Tell as being perceived as good value. 
However, one practitioner participant who had previously undertaken a 
research study within their own sector believed that the real value could not 
be articulated from a financial perspective but rather from the stance of direct 
benefit to the patient with an improved quality of life. The practitioners were 
aware of RVT being a service that was expected to drive down acute hospital 
utilisation and the associated costs, but none believed that was realistic or 
had been achieved.  
Six of the managers expressed views regarding perceived value for money 
with some contradictions. Even those with most authority in the 
commissioning of RVT did not definitively know the if the regional version of 
RVT, represented value for money or not and they did identify a need for a 
meaningful review and evaluation of the TF3 service.  
Whilst the managers recognised that RVT was a complex intervention, they 
needed a mechanism to distribute funding and monitor performance: they 
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used Monitored Patient Days (MPDs). This metric only indicated cost of a day 
of monitoring and indicated short-term activity rather than value or worth. This 
apparent mismatch in expectations was a potential barrier to RVT 
implementation and systemic change and may have impeded the benefit 
realisation or genuine consideration of value for money. Therefore, whilst 
there was no value for money demonstrated by the formal commissioned 
evaluation, there were mixed perceptions across the range of participants. 
There was a suggestion that the real value lies with patient benefit albeit the 
benefits associated with increased quality of life were not considered in the 
commissioned evaluation of the RTNI/ TF3 contract. One participant 
explained that RVT allowed the practitioners to focus their time on those 
patients who required direct clinical intervention whilst monitoring the 
progress of others. This is interpreted as efficient deployment of staff time if 
not seen as value for money. Service users did not contribute to this data 
beyond free text expressing the value. 
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APPENDIX 11 RECORD OF ADDITIONAL SUPPORTIVE 
STUDY / PHD TRAINING 
10.37 Record of Training 
JULIE-ANN WALKDEN B00549428 Part-Time PhD  
Record of Additional Research Studies   








European Innovation Partnership on 
Active & Healthcare Ageing (EIPAHA) 
- What's in it for Northern Ireland 4 
21.02.13 UUJ 
Online Course & test completed - 




NI Connected Health Ecosystem - 
Riddell Hall, Queens 6 
12.04.13 UUJ/ Unison 
Prof Sheila Peace - Gerontology 






Introduction to Good Clinical Practice 
(CGP) e-learning - Ethics 4 
01.05.13 UUJ 
Community of Practice - Research 
Day - Action Research 8 
18.06.13 UUJ 
Action Research Course - Institute of 
Nursing & Health Research 24 
18.09.13 
ECH 
Alliance Northern Ireland Ecosystem Meeting 8 
20.09.14 UUJ Research Ethics Committee 2 
24.09.13 UUJ 
Dr Mike Davidson - Writing to learn, 
Improve Your Writing Skills 3 
24.09.13 UUJ 
Dr Mike Davidson - Academic 
Integrity: Avoiding Plagiarism 1.5 
26.09.13 UUJ 
Paul Toombs & Dr Dave Filipovic-
Carter, Effective Progress in Your 2nd 
Year 6 
03.10.13 UUJ 
Prof Davina Poroch - Buffalo 
University.  One to one discussion 
about research question and 
methodology 2 
09.10.13 NIPEC 
Innovation & Commitment 
Transformation 6.5 
16.10.13 UUJ Research Ethics Committee 3 
17.10.13 UUJ 
Doctoral Innovation Programme (DIB) 
Session 1 Project Initiation - Est. The 
Scope of Project - Dr Martina Murphy 6 
21.10.13 UUJ 
Prof Bev Temple, University of 
Manitoba - Translating Research in 
the Field of Intellectual Disabilities & 
Setting the Stage 2 
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05.11.13 UUJ 
Research Ethics (IRAS) & Research 
Governance - Dr L Hanna-Trainor 2 
21.11.13 UUJ 
DIP Session 2 - Project Planning 
Implementation & Control - Dr Martina 
Murphy 2 
29.11.13 UUJ 
Essentials of Qualitative Analysis - 
Prof Brian Taylor 3 
06.12.13 
ECH 




Developing Understanding Research 
Ethics Through Being Student Rep on 




Developing Understanding Research 
Ethics Through Being Student Rep on 
UUJ Ethics Committee 3 




Developing Understanding Research 
Ethics Through Being Student Rep on 




ITTS Inverness Conference Lesson 
Learned Northern Peripheries 
Counties Remote Monitoring 9 
25.03.14 UUJ 
Connected Health Conference for 
Obesity & Diabetes Prevention - Dr 
Bond & Prof Black 4 
26.03.14 UUJ 








Dr Hilary Pinnock + Prof Brian 
McKinstry, COPD Telehealth Seminar 
1.5 




Utilizing Telehealth to Reduce 





Eindhoven Action Research Course 25.5 
12:06:14 SET 
Presentation to the Minister Poots on 
Optimisation of RTM 1.5 
20:06:14 
ECH 




Research Integrity and Ethics Score 
260/280 Weighted Total 92.9% 2.5 
13:07:14 
UUJ On-line 










Getting Published in the Arts (scored 
8/10) 3 
Chapter 10: Appendices 




Research Methods Literature Review 




Research Methods Social Sciences 




Research Methods in the Sciences 




Project Management (scored 10/11) 
3 
    TOTAL: 184 
04:09:14 UUJ 





Ecosystem Participatory Debate 
hosted by UUJ examining the topic of 
creating evidence for connected 
health technologies 3 
10:09:14 UUJ Ethics Committee   
11:09:14 CCH Clinical Workshop - Telemonitoring 3 
23:09:14 UUJ 
Writing in the 3rd Year of Your PhD 
(for 3rd year PhD Researchers): 
Planning 6 
24:09:14 UUJ Preparing for your Viva 6 
25:09:14 C-TRIC 
 6th Annual Translational Medicine 
(TMED6) Conference - 'Personalising 
Health and Care' - Presentation of a 
Paper on an INR/ U-Tell Research 
Project along with what is needed for 
the future is a formula for successful 
implementation of RTM & Conference 
Attendance 5 
29:09:14 UUJ Ethics Committee Training 6 
2:10:14 
ECH 
Alliance Connected Health Ecosystem 8 
08:10:14 NICON 
Northern Ireland Confederation for 
Health & Social Care (NICON) 
Celebrating Success - Planning for the 
Future eHealth 13 
09:10:14 NICON 
Northern Ireland Confederation for 
Health & Social Care (NICON) 
Celebrating Success - Planning for the 




Authority Ethics 4 
    Further Subtotal 251.5 
30:10:14 UUJ 
Managing Chronic Illness Group - 
getting started in research 4 
01:12:14 
ECH 
Alliance Ecosystem  4 
09:12:14 UU 





GASEL Workshop Sendai - skype 
connection 3 
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10:04:15 PHA 
PPI Standards and Neurological 
Conditions 4 
22 & 23 
:04:15 NICON 
A call to action - People, Place & 
Partnership - HPSS Conference 12 
03:04:15 UU Ethics Committee 2.5 




Advances in telecare: new solutions 
for carers and older people 3 
15:06:15 UU 
Qualitative study 1:1 interview (with 




Ecosystem Also gave a 5-minute 
presentation on innovation in health 
and social care using technology 
commissioned through pre-
commercial procurement - to develop 







Gave a 30-minute presentation on 
innovation in health and social care 
using technology commissioned 
through pre-commercial procurement 
- to develop new technologies to solve 
service problems 1 
22:06:15 
Queens 
University NICRN Primary Care CMG Meeting 1.5 
03:04:15 UU Ethics Committee 2.5 
10:08:15 UU Ethics Committee 2.5 
    Further Subtotal 304.5 
7&8:10:15 ABPI 2015 Clinical Innovation Conference 9 
10:11:15 UU 
Cochrane Literature Review Prof 
Martin 3 
25:11:15 InnovateUK Dallas Programme Report Workshop 3 




Ecosystem Also gave a 20-minute 
presentation on innovation in 
technology commissioned through 
pre-commercial procurement - MAGIC 
Project 6 
19, 20 & 
21:02:16 UU Thesis Bootcamp Dr Peta Freestone 24 
22 & 
23:08:16 UU Statistics Summer School (SPSS) 12 




Forum Policy Forum for Ireland (Dublin) 4.5 
10:11:16 NICRN 
Working with Industry - Partnership 
Clinical Research (Allan McGaw MD, 
PhD & Karen McIntyre) 3 
As at 
16:11:16   Further Subtotal 377 
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Presentation at inaugural North/ South 
Ecosystem: 7.35minuets presentation 
to international audience: Optimisation 
of Care: Providers, Patients and 
Enablement using Technology. 
(Published online post event) 5 
16:12:16 UU NVivo (introductory) 6 
10:01:17 UU NVivo (advanced) 6 
    Further Subtotal up to Seminar 2 394 




Participated in the Northern Ireland 
Primary Care Ethics Committee 2 
18 & 
19:05:17 NICON 
2-day conference - main topic 
transformation, e-health technology 
and digital future 16 
22:05:17 UU 









Personalised Medicine and 
Healthcare for an immediate future 24 
01:12:17 BSO & INI 
Chaired and delivered a conference 
on remote technologies for stroke 
rehabilitation. 7 
16:02:18 UU 
Hugh Kearness Successful Research 
- The Seven Secrets 2.5 
04:02:18 UU Thesis Producer 5.5 
17:04:18 NICON 
NHS confederation conference on 
transforming and delivering care with 
much focus upon eHealth 10 
18:04:18 NICON Day 2 NHS confederation 6 
19:04:18 UU SPSS Training Paul Slater 3 
20:04:18 NICRN 
Northern Ireland Clinical Research 
Network -research governance & 
ethics training day 6 
23:11:18 EU  
Presentation on Technology in 
Healthcare Vienne Austria & 
conference attendance   
    
RESEARCH STUDY FORMS NO 
LONGER USED BY UU DOCTORAL 
COLLEGE   
22:03:19 EU 
Presentation on Technology in 
Healthcare Cluj Napoka Romania & 
conference attendance 8 
23:05:19 UU 
Cancer Care Research Group - 
Person-based Approach 5 






Presentation on Technology in 
Healthcare Kuopio Finland & (3-day) 
conference attendance 8 
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21:08:19 UU Thesis Editing 3 
11 & 
12:09:19 C-TRIC 
10th Annual Translational Medicine 
(TMED10) Conference - Disruptive 
Innovation in Healthcare 
'Personalising Health and Care' - 
Poster Presentation - Acceptance of 
telemonitoring for people with long 
term conditions (unable to attend and 
so Dr PJ McCullagh represented)   
23:09:19 AAL 
Presentation on Technology in 
Healthcare Arhus Denmark & AAL 
conference (3day) attendance 8 
01:10:19 UU 
First Steps in Teaching and Learning 
in Higher Education Award 5 
12 & 
13:10:19 UU 
First Steps in Teaching and Learning 




Transcription: More than just words 
Webinar 1 
        
    TOTAL hours as at 19:11:19 536 
    
    
  full working days (8hrs/ day) 67.0 
  working weeks (5 days/ week) 13.4 
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APPENDIX 12 RECORD OF STUDY OUTPUTS 
10.38 10th Annual Translational (TMED10) Conference – 
Disruptive Innovation in Healthcare ‘Personalising Health 
and Care’ – Poster Presentation – Acceptance of 
telemonitoring for people with long term conditions 
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10.39 Publication - British Medical Journal Health & Care 
Informatic: Patient and carer survey of remote vital sign 





Volume 26, Issue 1, 18th December 2019 
Walkden J, McCullagh PJ, Kernohan WG 
Patient and carer survey of remote vital sign telemonitoring for self-
management of long-term conditions 
BMJ Health & Care Informatics 2019;26:e100079. doi: 10.1136/bmjhci-2019-
100079  
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10.40 Enterprise Ireland Horizon 2020 Science/ Industry/ 
Society Champions of EU Research awarded by John 
Halligan TD, Minister of State for Training, Skills, Innovation, 
Research and Development 
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10.41 Four International Presentations made by J-A Walkden 
which included the concepts of co-creation with clinicians, 
collaboration with patients and technology empowering 
patients  
 
Denmark September 2019, Finland June 2019, Romania March 2019 & 
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APPENDIX 13 NON-PEER REVIEWED  
10.42 None Peer-Reviewed Reports from Literature Review 
 
In 2016 the BBC reported upon the comments of England’s Chief Nurse, 
raising public alternatives to acute care. Whilst the linkages between expert 
opinion and advice were tenuous, they were plausible and the scope for 
comment could be extended to Remote Vital Sign Telemonitoring. The report 
was relevant as it encouraged care at home and by inference that should 
enable care to be delivered at home as an alternative  
“… means changing outdated models of care so that patients don't fall 
into cracks between different parts of the system and ensuring that we 
provide care based around their needs, and not those of NHS 
organisations,"  
a sentiment that is not only echoed in local Northern Ireland strategic policy, 
Bengoa (2016), but will be evident in the narrative of the SET practitioners 
opinions. 
The science reporter for the BBC, Gallagher (2017) reported how the 
smartphone ‘orders’ diabetes treatment. The report highlighted the findings of 
a trial whereby mice received implantable technology utilising optogenetic 
cells designed to respond to red LED light, controlled by a smartphone to 
generate drugs e.g. insulin. There is little scope beyond extending the 
boundaries of RVT and the results indicate the possibilities of monitoring to 
truly explore and afford liberation to patients in the future through personalised 
RVT and smartphones. 
 
